Rank,Title,Interventions,URL
1,Dexamethasone for COVID-19,Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04707534
2,Duvelisib to Combat COVID-19,Drug: Duvelisib|Procedure: Peripheral blood draw|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04372602
3,Immune Modulators for Treating COVID-19,Drug: Infliximab|Drug: Abatacept|Drug: Remdesivir|Drug: cenicriviroc,https://ClinicalTrials.gov/show/NCT04593940
4,Ivermectin Nasal Spray for COVID19 Patients,Drug: Ivermectin nasal|Drug: Ivermectin oral|Other: standard care,https://ClinicalTrials.gov/show/NCT04510233
5,Observational Cohort of COVID-19 Patients at Raymond-Poincare,,https://ClinicalTrials.gov/show/NCT04364698
6,Relationship Between CT- Value With Prognosis in COVID-19 Patients,Diagnostic Test: Cycle threshold,https://ClinicalTrials.gov/show/NCT04902157
7,COVID 19 Serology in Pulmonologists,,https://ClinicalTrials.gov/show/NCT04422574
8,Fugal Infection in COVID-19 Patients,Other: no intervention,https://ClinicalTrials.gov/show/NCT04914013
9,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,Drug: Decitabine|Other: Placebo Saline,https://ClinicalTrials.gov/show/NCT04482621
10,"Pilot Trial of XFBD, a TCM, in Persons With COVID-19",Drug: Xuanfei Baidu Granules|Other: Placebo,https://ClinicalTrials.gov/show/NCT04810689
11,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,Biological: COVI-MSC|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04903327
12,COVID-19 Surveillance Based on Smart Wearable Device,,https://ClinicalTrials.gov/show/NCT04459637
13,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Drug: Infliximab,https://ClinicalTrials.gov/show/NCT04425538
14,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,Biological: COVI-MSC|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04905836
15,Effect of COVID-19 Pandemic on Pediatric Cancer Care,,https://ClinicalTrials.gov/show/NCT04374838
16,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,Device: Seraph 100,https://ClinicalTrials.gov/show/NCT04547257
17,Forecast Number of Covid-19 Cases Worldwide,Other: Model Building|Other: Model validation,https://ClinicalTrials.gov/show/NCT04460274
18,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Device: Hyperbaric Oxygen Therapy,https://ClinicalTrials.gov/show/NCT04343183
19,Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19,Biological: COVI-AMG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04738175
20,Community Pharmacists Behaviour During Covid-19,,https://ClinicalTrials.gov/show/NCT04374513
21,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19,Biological: COVI-AMG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04771351
22,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,Drug: Tramadol|Other: Standard care delivered in the isolation hospitals.,https://ClinicalTrials.gov/show/NCT04454307
23,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US),Biological: COVI-DROPS|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04906694
24,Safety and Efficacy of C21 in Subjects With COVID-19,Drug: C21|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04452435
25,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms,Biological: COVI-AMG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04734860
26,Application of Desferal to Treat COVID-19,Drug: Deferoxamine,https://ClinicalTrials.gov/show/NCT04333550
27,Covid-19: Possible Role of Neutrophil Extracellular Traps,Diagnostic Test: NETosis markers,https://ClinicalTrials.gov/show/NCT04412382
28,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK),Biological: COVI-DROPS|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04900428
29,Dornase Alpha for the Treatment of COVID-19,Drug: Pulmozyme,https://ClinicalTrials.gov/show/NCT04432987
30,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,Drug: STI-5656|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04528667
31,Cognitive and Psychological Disorders After Severe COVID-19 Infection,Diagnostic Test: Cognitive assessment|Diagnostic Test: Imaging|Diagnostic Test: Routine care|Other: Psychiatric evaluation,https://ClinicalTrials.gov/show/NCT04937582
32,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,,https://ClinicalTrials.gov/show/NCT04483622
33,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Drug: Nafamostat Mesilate,https://ClinicalTrials.gov/show/NCT04628143
34,"Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients",Drug: NTR-441|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04941183
35,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug: Favipiravir|Other: Placebo,https://ClinicalTrials.gov/show/NCT04336904
36,Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients,Drug: 3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1),https://ClinicalTrials.gov/show/NCT04768179
37,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,"Drug: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies",https://ClinicalTrials.gov/show/NCT04427254
38,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug: Emtricitabine/tenofovir|Drug: Colchicine Pill|Drug: Rosuvastatin|Other: Standard treatment,https://ClinicalTrials.gov/show/NCT04359095
39,Oestrogen Treatment for COVID-19 Symptoms,Drug: Transdermal estradiol gel,https://ClinicalTrials.gov/show/NCT04853069
40,A Simple Approach to Treat COVID-19 Patients at Home.,Drug: Recommended treatment schedule|Drug: Control treatment schedule,https://ClinicalTrials.gov/show/NCT04794998
41,Study of AZD1222 for the Prevention of COVID-19 in Japan,Drug: AZD1222|Drug: 0.9% (w/v) saline,https://ClinicalTrials.gov/show/NCT04568031
42,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04445272
43,COVID-19. CT-Scan Modeling in COVID19 Sequelae,,https://ClinicalTrials.gov/show/NCT04747769
44,COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics),Diagnostic Test: ELISA|Diagnostic Test: RT-PCR,https://ClinicalTrials.gov/show/NCT04466644
45,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,Biological: anti-SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04354831
46,"A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients",Drug: GT0918 tablets or placebo,https://ClinicalTrials.gov/show/NCT04869228
47,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,Drug: Ivermectin and Doxycycline|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04523831
48,Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients,Drug: GIGA-2050,https://ClinicalTrials.gov/show/NCT04883138
49,PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US,Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04582266
50,Genotype and Susceptibility to COVID-19,"Other: Questionnaire administration,blood sampling and genetic analyses.",https://ClinicalTrials.gov/show/NCT04799834
51,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase)|Drug: 0.9%sodium chloride,https://ClinicalTrials.gov/show/NCT04445285
52,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Diagnostic Test: Lung ultrasound,https://ClinicalTrials.gov/show/NCT04351802
53,Fatigue and Sleep in Patients With COVID-19,Other: survey,https://ClinicalTrials.gov/show/NCT04657419
54,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug: Tocilizumab|Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04345445
55,Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,https://ClinicalTrials.gov/show/NCT04845048
56,Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults,Drug: AZD7442|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04723394
57,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",Drug: Silmitasertib|Drug: SOC,https://ClinicalTrials.gov/show/NCT04663737
58,Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19,Drug: Emricasan|Other: Placebo,https://ClinicalTrials.gov/show/NCT04803227
59,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,,https://ClinicalTrials.gov/show/NCT04401241
60,Convalescent Plasma Treatment in COVID-19,Biological: Convalescent Plasma (CP)|Other: Drugs and supportive care,https://ClinicalTrials.gov/show/NCT04476888
61,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug: CHLORPROMAZINE (CPZ)|Combination Product: Standard of Care (SOC),https://ClinicalTrials.gov/show/NCT04366739
62,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04366960
63,Balance in COVID-19,Other: Balance assessments,https://ClinicalTrials.gov/show/NCT04914364
64,Long-term Outcomes in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04508712
65,Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients,Drug: Placebo|Drug: Fluvoxamine,https://ClinicalTrials.gov/show/NCT04718480
66,Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma,Other: Convalescent Plasma with antibody against SARS-CoV-2.|Other: Standard treatment for COVID-19,https://ClinicalTrials.gov/show/NCT04803370
67,The IRCM POST-COVID-19 (IPCO) Clinic,Other: Medical follow-up,https://ClinicalTrials.gov/show/NCT04736732
68,Isotretinoin in Treatment of COVID-19,Drug: Isotretinoin Only Product in Oral Dose Form,https://ClinicalTrials.gov/show/NCT04361422
69,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic,Drug: Convalescent Plasma Transfusion|Drug: Hydroxychloroquine|Drug: DAS181|Drug: Ivermectin|Drug: Interferon Beta-1A,https://ClinicalTrials.gov/show/NCT04460547
70,Colchicine in Moderate Symptomatic COVID-19 Patients,Drug: Colchicine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04527562
71,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Other: Exposure,https://ClinicalTrials.gov/show/NCT04355741
72,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 500Mg Oral Tablet|Dietary Supplement: Glucose tablets,https://ClinicalTrials.gov/show/NCT04328272
73,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Drug: Nitric Oxide,https://ClinicalTrials.gov/show/NCT04388683
74,Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients,Drug: Virgin Coconut Oil,https://ClinicalTrials.gov/show/NCT04849637
75,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",Drug: AZD7442|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04625972
76,Screening for COVID-19,Diagnostic Test: suspected of COVID-19 infection,https://ClinicalTrials.gov/show/NCT04615208
77,Ivermectin Treatment Efficacy in Covid-19 High Risk Patients,Drug: Ivermectin 0.4mg/kg/day for 5 days,https://ClinicalTrials.gov/show/NCT04920942
78,Efficacy and Safety of Sirolimus in COVID-19 Infection,Drug: Sirolimus,https://ClinicalTrials.gov/show/NCT04461340
79,Developement and Evaluation of Serological Assays for COVID-19,,https://ClinicalTrials.gov/show/NCT04377763
80,Anti COVID-19 Convalescent Plasma Therapy,Biological: anti-SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04345679
81,Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals,Dietary Supplement: Anatolian Propolis,https://ClinicalTrials.gov/show/NCT04680819
82,Serological Surveillance for COVID-19 in Central North Carolina,,https://ClinicalTrials.gov/show/NCT04490174
83,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,Drug: Standard COVID-19 care|Dietary Supplement: Quercetin Phytosome,https://ClinicalTrials.gov/show/NCT04578158
84,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),Other: No intervention - quality of life measure,https://ClinicalTrials.gov/show/NCT04586413
85,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,Drug: Lactoferrin,https://ClinicalTrials.gov/show/NCT04421534
86,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,Diagnostic Test: Lung ultrasound use in patients hospitalized with COVID,https://ClinicalTrials.gov/show/NCT04542421
87,COVID-19: Salvage TOcilizumab as a Rescue Measure,Drug: iv Tocillizumab (TCZ),https://ClinicalTrials.gov/show/NCT04577534
88,SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes,Diagnostic Test: Anti-SARS-CoV2 Serology,https://ClinicalTrials.gov/show/NCT04816084
89,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,,https://ClinicalTrials.gov/show/NCT04610554
90,A Trial of NT-I7 in COVID-19 (SPESELPIS),Drug: Double-Blind NT-I7|Drug: Double-Blind Placebo,https://ClinicalTrials.gov/show/NCT04501796
91,Impact of Adipose Tissue in COVID-19,Other: Adipose tissue,https://ClinicalTrials.gov/show/NCT04639440
92,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,Biological: autologous adipose-derived stem cells,https://ClinicalTrials.gov/show/NCT04428801
93,DISulfiram for COvid-19 (DISCO) Trial,Drug: Disulfiram|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04485130
94,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",Other: Rehabilitation-focused program,https://ClinicalTrials.gov/show/NCT04628039
95,Hyperimmune Plasma for Critical Patients With COVID-19,Other: hyperimmune plasma,https://ClinicalTrials.gov/show/NCT04321421
96,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,"Drug: MCN (Methylene blue, vitamin C, N-acetyl cysteine)",https://ClinicalTrials.gov/show/NCT04370288
97,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug: Clevudine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04347915
98,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,Device: olfactory device,https://ClinicalTrials.gov/show/NCT04431908
99,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,Genetic: 1. Characterize the immune response after infection with SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04537338
100,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,Radiation: Low dose Radiotherapy,https://ClinicalTrials.gov/show/NCT04572412
101,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug: Aspirin 75mg|Drug: Clopidogrel 75mg|Drug: Rivaroxaban 2.5 MG|Drug: Atorvastatin 40mg|Drug: Omeprazole 20mg,https://ClinicalTrials.gov/show/NCT04333407
102,Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients,Drug: GSE and Xylitol,https://ClinicalTrials.gov/show/NCT04854486
103,MP1032 Treatment in Patients With Moderate to Severe COVID-19,Drug: MP1032|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04932941
104,To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants,Drug: Black Seed Oil Cap/Tab,https://ClinicalTrials.gov/show/NCT04914377
105,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",Drug: AZD7442|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04625725
106,Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Drug: Hydroxychloroquine (HCQ)|Other: Standard care|Other: Placebo,https://ClinicalTrials.gov/show/NCT04858633
107,Prediction of Clinical Course in COVID19 Patients,Other: CT-Scan,https://ClinicalTrials.gov/show/NCT04377685
108,Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),Drug: Aprepitant injectable emulsion|Drug: Saline Placebo,https://ClinicalTrials.gov/show/NCT04470622
109,KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,Biological: Low Dose of KBP-COVID-19|Biological: High Dose of KBP-COVID-19|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04473690
110,Catalysing the Containment of COVID-19,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04523090
111,An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,https://ClinicalTrials.gov/show/NCT04747821
112,COVID-19 Symptom Tracker,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04331509
113,COVID-19 Convalescent Plasma (CCP) Transfusion,Biological: COVID Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04412486
114,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,Drug: VentaProst (inhaled epoprostenol delivered via a dedicated delivery system),https://ClinicalTrials.gov/show/NCT04452669
115,Wearable Diagnostic for Detection of COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04742569
116,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Drug: Enoxaparin sodium|Drug: Unfractionated heparin|Drug: Fondapariniux|Drug: Argatroban,https://ClinicalTrials.gov/show/NCT04406389
117,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,Drug: 20 Mg Prednisone for 14 days|Drug: control,https://ClinicalTrials.gov/show/NCT04551781
118,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Drug: Huaier Granule,https://ClinicalTrials.gov/show/NCT04291053
119,COVID-19 Endoscopy Survey,Other: Practice details,https://ClinicalTrials.gov/show/NCT04342637
120,VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,,https://ClinicalTrials.gov/show/NCT04587323
121,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,Drug: Anti-SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04567173
122,Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients,"Drug: Methylprednisolone, Placebo",https://ClinicalTrials.gov/show/NCT04673162
123,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04365725
124,Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,Dietary Supplement: Rhea Health Tone®,https://ClinicalTrials.gov/show/NCT04627519
125,Telerehabilitation in Covid-19 After Hospital Discharge,Other: Standard Physiotherapy program|Other: Telerehabilitation,https://ClinicalTrials.gov/show/NCT04742946
126,Estrogen Therapy in Non-severe COVID-19 Patients,Drug: Estrogen Therapy,https://ClinicalTrials.gov/show/NCT04539626
127,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,Biological: covid-19 vaccine,https://ClinicalTrials.gov/show/NCT04706390
128,Oxygen Requirements and Use in Patients With COVID-19 in LMICs,,https://ClinicalTrials.gov/show/NCT04918875
129,Study of COVID-19 DNA Vaccine (AG0302-COVID19),Biological: AG0302-COVID19,https://ClinicalTrials.gov/show/NCT04527081
130,Clinical Study in the Treatment of Patients With Moderate Course of COVID-19,Drug: COVID-globulin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04842435
131,Study of COVID-19 DNA Vaccine (AG0301-COVID19),Biological: AG0301-COVID19,https://ClinicalTrials.gov/show/NCT04463472
132,SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,Diagnostic Test: Breath sample,https://ClinicalTrials.gov/show/NCT04497610
133,Thymic Function in Patients With COVID-19,Genetic: Single-Nucleotide Polymorphisms (SNP) within the TCRA/D region|Biological: Blood sample|Diagnostic Test: CT Scan|Biological: Bronchial fibroscopy,https://ClinicalTrials.gov/show/NCT04716907
134,"A Prospective ""Universal"" Observational Database for COVID-19",,https://ClinicalTrials.gov/show/NCT04347993
135,Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.,"Drug: LTX-109 gel, 3%|Drug: Placebo gel",https://ClinicalTrials.gov/show/NCT04854928
136,Clinical Study in the Treatment of Patients With COVID-19,Drug: Molixan|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04780672
137,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04513158
138,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",Drug: Transfusion of COVID-19 convalescent plasma,https://ClinicalTrials.gov/show/NCT04345991
139,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,Drug: Lambda 180 mcg S.C,https://ClinicalTrials.gov/show/NCT04534673
140,Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals,Other: Online survey questionnaire,https://ClinicalTrials.gov/show/NCT04753242
141,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,,https://ClinicalTrials.gov/show/NCT04355871
142,The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients,Drug: Co-trimoxazole|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04884490
143,Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population,,https://ClinicalTrials.gov/show/NCT04653857
144,"CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19",Device: CRP-apheresis,https://ClinicalTrials.gov/show/NCT04898062
145,COVID-19 Among Pregnant Women in Assiut,,https://ClinicalTrials.gov/show/NCT04822402
146,Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,Drug: Standard of care|Drug: Apremilast|Drug: Apremilast placebo|Drug: Lanadelumab|Drug: Lanadelumab placebo|Drug: Zilucoplan|Drug: Zilucoplan placebo,https://ClinicalTrials.gov/show/NCT04590586
147,The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection,Drug: FB2001|Drug: FB2001 Placebo,https://ClinicalTrials.gov/show/NCT04766931
148,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Device: oxyhydrogen|Device: Oxygen,https://ClinicalTrials.gov/show/NCT04336462
149,Rehabilitation for Patients With Persistent Symptoms Post COVID-19,Other: Concentrated rehabilitation for patients with persistent symptoms post COVID-19,https://ClinicalTrials.gov/show/NCT04836351
150,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,Drug: Melatonin|Other: Placebo (Methylcellulose) capsule,https://ClinicalTrials.gov/show/NCT04474483
151,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,Biological: Ad5-nCoV,https://ClinicalTrials.gov/show/NCT04552366
152,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),,https://ClinicalTrials.gov/show/NCT04389658
153,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug: Favipiravir|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04434248
154,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04730323
155,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",Biological: COVI-MSC,https://ClinicalTrials.gov/show/NCT04909892
156,Assessment of Vitamin D Level in COVID-19,Diagnostic Test: Vitamin D,https://ClinicalTrials.gov/show/NCT04949412
157,Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19,Drug: XAV-19|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04928430
158,Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct Assay,Diagnostic Test: ID Now™ COVID-19 Screening Test,https://ClinicalTrials.gov/show/NCT04785898
159,Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study,,https://ClinicalTrials.gov/show/NCT04932954
160,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),Biological: Group A (AG0302-COVID19)|Biological: Group A (Placebo)|Biological: Group B (AG0302-COVID19)|Biological: Group B (Placebo),https://ClinicalTrials.gov/show/NCT04655625
161,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,Biological: SARS-CoV-2 convalescent plasma|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04649879
162,Neuroradiolological Analysis of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04368390
163,Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects,Biological: DS-5670a|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04821674
164,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,Drug: FSD201|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04619706
165,COVID-19 Antithrombotic Rivaroxaban Evaluation,Drug: Rivaroxaban 10 mg,https://ClinicalTrials.gov/show/NCT04757857
166,Hyperimmune Plasma for Patients With COVID-19,Other: treated with hyperimmune plasma,https://ClinicalTrials.gov/show/NCT04614012
167,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug: FT516,https://ClinicalTrials.gov/show/NCT04363346
168,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,https://ClinicalTrials.gov/show/NCT04372979
169,Setting up a COVID-19 Care Facility at a Prison in Pakistan,Other: COVID-19 FACILITY,https://ClinicalTrials.gov/show/NCT04404179
170,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,Biological: Convalescent Plasma|Other: Best Supportive Care,https://ClinicalTrials.gov/show/NCT04456413
171,Antioxidant Therapy for COVID-19 Study,Dietary Supplement: Antioxidation Therapy|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04466657
172,"UPMC OPTIMISE-C19 Trial, a COVID-19 Study",Biological: Lilly Bamlanivimab|Biological: Regeneron Casirivimab + Imdevimab|Biological: Lilly Bamlanivimab + Etesevimab,https://ClinicalTrials.gov/show/NCT04790786
173,Rehabilitation Needs After COVID-19 Hospital Treatment,"Other: none, this study is observational",https://ClinicalTrials.gov/show/NCT04438239
174,Geriatric Care for Older People Hospitalised for COVID-19,,https://ClinicalTrials.gov/show/NCT04947943
175,Clinical Characteristics of Deceased With COVID-19,,https://ClinicalTrials.gov/show/NCT04874792
176,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,Drug: Placebo|Drug: Anti-SARS-CoV-2 equine immunoglobulin fragments (INOSARS),https://ClinicalTrials.gov/show/NCT04514302
177,Hematology and Clinical Picture in Pediatric COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04487119
178,Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic,,https://ClinicalTrials.gov/show/NCT04703777
179,The Effect of Vitamin D Supplementation on COVID-19 Recovery,Drug: Vit-D 0.2 MG/ML Oral Solution [Calcidol]|Drug: Physiological Irrigating Solution,https://ClinicalTrials.gov/show/NCT04883203
180,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,Drug: Tocilizumab|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04479358
181,SuPAR in Adult Patients With Covid-19,Diagnostic Test: Soluble Urokinase Plasminogen Activator Receptor,https://ClinicalTrials.gov/show/NCT04590794
182,The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial),Drug: Ivermectin 0.6mg/kg/day|Drug: Ivermectin 1.0mg/kg/day|Drug: Placebo|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04712279
183,The Role of Resistant Starch in COVID-19 Infection,Drug: Dietary Supplement containing resistant starch|Dietary Supplement: Placebo Starch,https://ClinicalTrials.gov/show/NCT04342689
184,Convalescent Plasma in the Treatment of Covid-19,Biological: Convalescent plasma from COVID-19 donors|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04730401
185,Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19,"Biological: Selenium, Zinc and Copper, Vitamin A, D, E plasma concentrations during patient hospitalization",https://ClinicalTrials.gov/show/NCT04877509
186,Tobacco Use and the Risk of COVID-19,Behavioral: Tobacco use,https://ClinicalTrials.gov/show/NCT04896918
187,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04343755
188,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,Drug: Zanubrutinib|Drug: Supportive Care|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04382586
189,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,Drug: Retrospective case-control analysis,https://ClinicalTrials.gov/show/NCT04382794
190,APT™ T3X on the COVID-19 Contamination Rate,Drug: Tetracycline hydrochloride 3%|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04716426
191,Non-contact ECG Sensor System for COVID19,Device: Non-contact ECG,https://ClinicalTrials.gov/show/NCT04341506
192,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Other: this study is non- interventional,https://ClinicalTrials.gov/show/NCT04341168
193,Efficacy of Psidii Guava's Extract For COVID-19,Drug: Extract Psidii guava|Combination Product: Standard therapy for Covid-19 patient,https://ClinicalTrials.gov/show/NCT04810728
194,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,Biological: BCG vaccine,https://ClinicalTrials.gov/show/NCT04659941
195,A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19,Biological: low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)|Biological: high-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)|Biological: placebo,https://ClinicalTrials.gov/show/NCT04869592
196,C5a Receptor Expression - COVID-19 (C5-COV),Other: draw blood,https://ClinicalTrials.gov/show/NCT04369820
197,Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection,Other: Sampling by venipuncture (and eventually by nasopharyngeal swab),https://ClinicalTrials.gov/show/NCT04750720
198,Study of Codivir in Patients With COVID-19,Drug: Covidir injections|Diagnostic Test: One Step Test|Diagnostic Test: IgM and IgG dosage|Diagnostic Test: RT-PCR SARS-CoV-2|Diagnostic Test: Screening blood test|Diagnostic Test: ECG|Diagnostic Test: Medical evaluation|Diagnostic Test: NEWS-2 score|Diagnostic Test: WHO score,https://ClinicalTrials.gov/show/NCT04930861
199,Clinical Study of Pregnant Women With COVID-19,,https://ClinicalTrials.gov/show/NCT04701944
200,TXA127 for the Treatment of Severe COVID-19,Drug: TXA127|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04401423
201,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,Drug: CPI-006|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04464395
202,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,Drug: bamlanivimab,https://ClinicalTrials.gov/show/NCT04656691
203,DAS181 for Severe COVID-19: Compassionate Use,Drug: DAS181,https://ClinicalTrials.gov/show/NCT04324489
204,Diagnosis of Endocrine Dysfunctions in Covid-19,,https://ClinicalTrials.gov/show/NCT04587375
205,Relation Between Lab Finding and COVID-19 Severity,"Diagnostic Test: D-dimer,CBC.ESR,CRP,|Diagnostic Test: Liver function tests ,serum ferritin and PCR for COVID-19 .",https://ClinicalTrials.gov/show/NCT04470557
206,Changes in Viral Load in COVID-19 After Probiotics,Dietary Supplement: Dietary supplementation in patients with covid disease admitted to hospital,https://ClinicalTrials.gov/show/NCT04666116
207,Covid-19 Rapid Diagnostic Tests on Blood Drop,,https://ClinicalTrials.gov/show/NCT04467008
208,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",Dietary Supplement: Investigational Product - ViraCide|Other: Placebo - Starch Powder Soft gels,https://ClinicalTrials.gov/show/NCT04596085
209,Role of Famotidine in the Clinical Improvement of COVID-19 Patients.,Drug: Famotidine 20 MG,https://ClinicalTrials.gov/show/NCT04504240
210,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,Drug: GC4419|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04555096
211,Povidone-Iodine Rinses in the Management of COVID-19,Drug: Povidone-iodine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04449965
212,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,Drug: Standard Treatment|Drug: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions,https://ClinicalTrials.gov/show/NCT04392141
213,Genosvid Diagnostic Test for Early Detection of COVID-19,Other: exhaled breath sampling,https://ClinicalTrials.gov/show/NCT04558372
214,Intravenous Infusion of CAP-1002 in Patients With COVID-19,Biological: CAP-1002|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04623671
215,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,Other: survey,https://ClinicalTrials.gov/show/NCT04418284
216,"Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults",Biological: AZD1222|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04516746
217,Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic,Drug: Ivermectin|Drug: Hydroxychloroquine|Behavioral: personal protective Measures,https://ClinicalTrials.gov/show/NCT04668469
218,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,Biological: intravenous immunoglobulin therapy,https://ClinicalTrials.gov/show/NCT04548557
219,Vitamin D Supplementation in Patients With COVID-19,Dietary Supplement: Vitamin D|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04449718
220,Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19,Other: prone position,https://ClinicalTrials.gov/show/NCT04754113
221,Post-COVID 19 Patients Undergoing Surgery,Procedure: scheduled surgery,https://ClinicalTrials.gov/show/NCT04922931
222,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,Other: Interview,https://ClinicalTrials.gov/show/NCT04632355
223,Dendritic Cell Vaccine to Prevent COVID-19,Biological: AV-COVID-19,https://ClinicalTrials.gov/show/NCT04685603
224,COVID-19 Infection in Cancer Pantients,Other: No intervention on patients,https://ClinicalTrials.gov/show/NCT04569292
225,Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity,Diagnostic Test: not required,https://ClinicalTrials.gov/show/NCT04670328
226,Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19,Drug: Dalcetrapib|Other: Placebo,https://ClinicalTrials.gov/show/NCT04676867
227,Risks of COVID19 in the Pregnant Population,Other: Biospecimen collection,https://ClinicalTrials.gov/show/NCT04379284
228,Genetic Bases of COVID-19 Clinical Variability,Genetic: Massive parallel sequencing of host genome,https://ClinicalTrials.gov/show/NCT04549831
229,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Other: blood sample,https://ClinicalTrials.gov/show/NCT04347850
230,In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection,Drug: tPA,https://ClinicalTrials.gov/show/NCT04926428
231,Multi-site Adaptive Trials for COVID-19,Drug: SOC + Intravenous Famotidine|Drug: SOC + Placebo,https://ClinicalTrials.gov/show/NCT04370262
232,Predictive Factors COVID-19 Patients,Other: Predictive factors for clinical response in patients with COVID-19.,https://ClinicalTrials.gov/show/NCT04427345
233,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection,Drug: Tocilizumab|Drug: Heparin - Therapeutic dosage|Drug: Heparin - Prophylactic dosage,https://ClinicalTrials.gov/show/NCT04600141
234,Antibodies Response to mRNA Vaccine Against Covid-19,Biological: BNT162b2 mRNA Covid-19 Vaccine,https://ClinicalTrials.gov/show/NCT04733807
235,Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology,Other: COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology,https://ClinicalTrials.gov/show/NCT04756869
236,A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19,Drug: VB-201 + Standard of care|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04733833
237,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,Drug: Clarithromycin 500mg|Drug: Azithromycin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04622891
238,A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures,Behavioral: Nurse-Community-Family Partnership Intervention,https://ClinicalTrials.gov/show/NCT04832919
239,The Nitazoxanide Plus Atazanavir for COVID-19 Study,Drug: Nitazoxanide and atazanavir/ritonavir|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04459286
240,A Simple Approach to Prevent Hospitalization for COVID-19 Patients,Drug: Recommended treatment schedule|Drug: Control treatment schedule,https://ClinicalTrials.gov/show/NCT04854824
241,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04497324
242,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),,https://ClinicalTrials.gov/show/NCT04379297
243,Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19,Biological: Novaferon|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04669015
244,Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen,Device: CoV-SCAN rapid COVID-19 antigen test,https://ClinicalTrials.gov/show/NCT04805840
245,Post-COVID-Health Study: Multidimensional Health Status of COVID-19 Survivors One Year After a SARS-CoV-2 Infection,,https://ClinicalTrials.gov/show/NCT04794985
246,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04403581
247,COVID-19 Virtual Care at Home,Other: Virtual Care at Home,https://ClinicalTrials.gov/show/NCT04420182
248,Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,Drug: Cenicriviroc (CVC)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04500418
249,Using Text Messages to Improve COVID-19 Vaccination Uptake,Behavioral: Text message content,https://ClinicalTrials.gov/show/NCT04895683
250,Study of Open Label Losartan in COVID-19,Drug: Losartan,https://ClinicalTrials.gov/show/NCT04335123
251,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,Diagnostic Test: LYMPHOCYTE MONOCYTE RATIO,https://ClinicalTrials.gov/show/NCT04534712
252,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,Dietary Supplement: Probiotics (2 strains 10x10^9 UFC)|Dietary Supplement: Placebo (potato starch and magnesium stearate),https://ClinicalTrials.gov/show/NCT04621071
253,Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection,Drug: Niclosamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04858425
254,Determination of Serum Trace Element and Physical Activity Levels in COVID-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04694716
255,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Biological: Ozone auto-hemotherapy,https://ClinicalTrials.gov/show/NCT04370223
256,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug: Baricitinib (janus kinase inhibitor),https://ClinicalTrials.gov/show/NCT04321993
257,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,Other: Blood donation from convalescent donor,https://ClinicalTrials.gov/show/NCT04351659
258,suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19,Drug: Anakinra|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04680949
259,A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia,Drug: STC3141,https://ClinicalTrials.gov/show/NCT04880694
260,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,Other: survey,https://ClinicalTrials.gov/show/NCT04568135
261,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution","Procedure: Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection",https://ClinicalTrials.gov/show/NCT04664023
262,Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,Other: ivermectin impregnated mask,https://ClinicalTrials.gov/show/NCT04723459
263,tDCS for Post COVID-19 Fatigue,Device: Transcranial Direct Current Stimulation,https://ClinicalTrials.gov/show/NCT04876417
264,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Dietary Supplement: Oral supplement enriched in antioxidants|Dietary Supplement: cellulose-containing placebo capsules,https://ClinicalTrials.gov/show/NCT04323228
265,Physical Activity Post COVID-19,Behavioral: Physical activity,https://ClinicalTrials.gov/show/NCT04768257
266,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,,https://ClinicalTrials.gov/show/NCT04420468
267,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,Diagnostic Test: Diagnostic test for SARS-Cov2 for patients and health staff,https://ClinicalTrials.gov/show/NCT04421625
268,Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study,Other: Observational,https://ClinicalTrials.gov/show/NCT04606498
269,Monitoring the IgG/IgM Antibodies in COVID-19 Patients,Diagnostic Test: Serodiagnosis of IgG and IgM,https://ClinicalTrials.gov/show/NCT04810117
270,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic",Diagnostic Test: RT-PCR|Diagnostic Test: LAMP|Diagnostic Test: POOL RT-PCR|Diagnostic Test: POOL LAMP,https://ClinicalTrials.gov/show/NCT04581083
271,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,Biological: exchange blood transfusion from normal donor|Biological: plasma from convalescent patients with COVID-19|Drug: Methylene Blue 5 MG/ML,https://ClinicalTrials.gov/show/NCT04376788
272,Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19,Other: No intervention (Retrospective Cohort Observational),https://ClinicalTrials.gov/show/NCT04834752
273,COVID-19 Infection in Healthcare Workers,Other: Cohort,https://ClinicalTrials.gov/show/NCT04386759
274,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Procedure: CT-scan with minimal invasive autopsy,https://ClinicalTrials.gov/show/NCT04366882
275,Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.,Biological: MAD0004J08|Other: Placebo,https://ClinicalTrials.gov/show/NCT04932850
276,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",Device: Invasive mechanical ventilation using the Unisabana-Herons Ventilator during 24 hours,https://ClinicalTrials.gov/show/NCT04497623
277,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),Biological: CoronaVac|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04582344
278,COvid-19 REgistry on THROMBOSIS Complications,,https://ClinicalTrials.gov/show/NCT04780295
279,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Combination Product: Ivermectin plus Nitazoxanide|Other: Standard Care,https://ClinicalTrials.gov/show/NCT04360356
280,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),"Drug: Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste, fumigation/inhalation of vitamin C|Drug: Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and 5% glucose|Drug: Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and high-dose vitamin C treatment",https://ClinicalTrials.gov/show/NCT04664010
281,"A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated","Biological: 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated|Biological: 3-doses schedule 2 of COVID-19 Vaccine (Vero Cell), Inactivated|Biological: 3-doses schedule 3 of COVID-19 Vaccine (Vero Cell), Inactivated|Biological: 2 doses of vaccine",https://ClinicalTrials.gov/show/NCT04863638
282,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Dietary Supplement: Probiotic|Dietary Supplement: Control,https://ClinicalTrials.gov/show/NCT04366180
283,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals,,https://ClinicalTrials.gov/show/NCT04706260
284,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,Drug: CNM-ZnAg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04610138
285,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,Combination Product: Iota carrageenan nasal spray and Ivermectin oral drops (used as buccal drops),https://ClinicalTrials.gov/show/NCT04425850
286,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04528368
287,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug: Dapagliflozin 10 MG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04350593
288,Impact of COVID-19 on Marshallese Communities in the U.S.,Other: Assessing the impact of COVID-19,https://ClinicalTrials.gov/show/NCT04474496
289,Ivermectin for Severe COVID-19 Management,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04646109
290,Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19,Biological: VIR-7831,https://ClinicalTrials.gov/show/NCT04913675
291,VIR-7831 for the Early Treatment of COVID-19 in Outpatients,Biological: VIR-7831|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04545060
292,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug: Lopinavir/ritonavir,https://ClinicalTrials.gov/show/NCT04364022
293,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Combination Product: Hydroxychloroquine plus Nitazoxanide|Other: Standard care,https://ClinicalTrials.gov/show/NCT04361318
294,CovidDB: The Covid-19 Inpatient Database,,https://ClinicalTrials.gov/show/NCT04344171
295,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Drug: Bemiparin,https://ClinicalTrials.gov/show/NCT04420299
296,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,Other: Individualized-Chinese herbal medicine,https://ClinicalTrials.gov/show/NCT04544605
297,ANTIcoagulation in Severe COVID-19 Patients,"Drug: Tinzaparin, Low dose prophylactic anticoagulation|Drug: Tinzaparin, High dose prophylactic anticoagulation|Drug: Tinzaparin,Therapeutic anticoagulation",https://ClinicalTrials.gov/show/NCT04808882
298,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19",Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04425629
299,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,Diagnostic Test: Performance evaluation (sensitivity and specificity) for COVID-19 diagnosis of the Vocus PTR-TOF process,https://ClinicalTrials.gov/show/NCT04706039
300,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2,Drug: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2),https://ClinicalTrials.gov/show/NCT04375046
301,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Other: olfactory and gustatory tests,https://ClinicalTrials.gov/show/NCT04354857
302,The VOICE-COVID-19,Device: Alexa Amazon,https://ClinicalTrials.gov/show/NCT04508972
303,Acceptance of Telemedicine During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04400448
304,An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization,Drug: Ivermectin Tablets|Drug: Doxycycline Tablets|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04729140
305,A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19,Drug: Brilacidin|Drug: Placebo|Drug: Standard of Care (SoC),https://ClinicalTrials.gov/show/NCT04784897
306,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug: Hydroxychloroquine - Daily dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Matched Placebo Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04352933
307,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,Drug: Sofosbuvir plus Ledipasvir,https://ClinicalTrials.gov/show/NCT04530422
308,Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,Drug: Melatonin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04784754
309,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,Other: Survey,https://ClinicalTrials.gov/show/NCT04403828
310,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,Drug: Brazilian Green Propolis Extract (EPP-AF)|Other: Standard care,https://ClinicalTrials.gov/show/NCT04480593
311,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,Biological: multipeptide cocktail,https://ClinicalTrials.gov/show/NCT04546841
312,Rehabilitation After Covid19-Clinical Results and Predictive Factors,Other: Rehabilitation,https://ClinicalTrials.gov/show/NCT04896905
313,A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.,Drug: APX-115|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04880109
314,Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,Drug: Antroquinonol|Other: Placebo,https://ClinicalTrials.gov/show/NCT04523181
315,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,Drug: Aprotinin,https://ClinicalTrials.gov/show/NCT04527133
316,Fase I Clinical Trial on NK Cells for COVID-19,Biological: Natural Killer Cells infusion,https://ClinicalTrials.gov/show/NCT04634370
317,CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany,,https://ClinicalTrials.gov/show/NCT04659187
318,Immunological Characteristics of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04679428
319,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Drug: ACE Inhibitors and Calcium Channel Blockers,https://ClinicalTrials.gov/show/NCT04379310
320,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,Biological: Prolastin|Drug: Standard Medical Treatment,https://ClinicalTrials.gov/show/NCT04495101
321,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,"Diagnostic Test: Serelogy testing, RT PCR",https://ClinicalTrials.gov/show/NCT04548908
322,"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug: SOC + IFX-1|Drug: SOC + Placebo,https://ClinicalTrials.gov/show/NCT04333420
323,Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04368884
324,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19,,https://ClinicalTrials.gov/show/NCT04701905
325,COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients,Biological: Serological COVID-19 vaccine immunogenicity,https://ClinicalTrials.gov/show/NCT04728828
326,Blood Types in Children With COVID-19,,https://ClinicalTrials.gov/show/NCT04682912
327,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug: Clazakizumab|Other: Placebo,https://ClinicalTrials.gov/show/NCT04381052
328,Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected),Drug: AZVUDINE|Drug: AZVUDINE placebo,https://ClinicalTrials.gov/show/NCT04668235
329,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,Diagnostic Test: Nasal Swab|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Throat swab|Diagnostic Test: Fingerstick|Diagnostic Test: Saliva specimen,https://ClinicalTrials.gov/show/NCT04557046
330,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),Diagnostic Test: ELISA and Rapid test to detect antibodies against COVID-19,https://ClinicalTrials.gov/show/NCT04490837
331,IFN-beta 1b and Remdesivir for COVID19,Drug: Interferon beta-1b|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04647695
332,Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey,Other: NOT APPLICABLE (NA),https://ClinicalTrials.gov/show/NCT04746443
333,"Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19",Biological: Sotrovimab (Gen1)|Biological: Sotrovimab (Gen2),https://ClinicalTrials.gov/show/NCT04779879
334,COVID-19 Immunologic Antiviral Therapy With Omalizumab,Biological: Omalizumab|Other: Placebo,https://ClinicalTrials.gov/show/NCT04720612
335,Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC),Drug: Ivermectin|Other: Placebo,https://ClinicalTrials.gov/show/NCT04894721
336,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,Biological: Administration of Equine immunoglobulin anti SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04610502
337,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,Biological: PSC-04,https://ClinicalTrials.gov/show/NCT04486001
338,Smell and Taste Disorders in COVID-19 Patients,Other: Investigation of smell and taste disorders,https://ClinicalTrials.gov/show/NCT04427332
339,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,Drug: Povidone-Iodine 0.4% NI|Drug: Povidone-Iodine 0.5% NI|Drug: Povidone-Iodine 0.6% NI|Drug: Povidone-Iodine 0.5% NS|Drug: Povidone-Iodine 0.6% NS|Other: Placebo comparator: DW-NI|Other: Placebo comparator: DW-NS,https://ClinicalTrials.gov/show/NCT04549376
340,Prognostic Prediction of COVID-19 Clinical Course Through the Development of Machine Learning Based Algorithms,,https://ClinicalTrials.gov/show/NCT04825301
341,Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,,https://ClinicalTrials.gov/show/NCT04546191
342,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),Device: Wearable Medical Device (Empatica E4)|Diagnostic Test: COVID-19 PCR Swab|Diagnostic Test: Pulse Oximeter,https://ClinicalTrials.gov/show/NCT04363489
343,Favipiravir Therapy in Adults With Mild COVID-19,Drug: Favipiravir|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04464408
344,COVID-19 Ozanimod Intervention Study,Drug: Ozanimod|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04405102
345,Effect of Prone Positioning in Patients With COVID-19,Other: Prone Lying Position|Other: alternate nostril breathing,https://ClinicalTrials.gov/show/NCT04710771
346,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,Biological: MSC|Drug: Control,https://ClinicalTrials.gov/show/NCT04611256
347,Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt,,https://ClinicalTrials.gov/show/NCT04694651
348,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19","Biological: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|Other: Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)",https://ClinicalTrials.gov/show/NCT04527575
349,Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients,Biological: Anti SARS-CoV-2 equine hyperimmune serum|Biological: placebo,https://ClinicalTrials.gov/show/NCT04838821
350,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",Biological: COVI-VAC|Other: Placebo,https://ClinicalTrials.gov/show/NCT04619628
351,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Drug: Plitidepsin 1.5 mg/day|Drug: Plitidepsin 2.0 mg/day|Drug: Plitidepsin 2.5 mg/day,https://ClinicalTrials.gov/show/NCT04382066
352,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,Other: Home-use Test and Follow-up Questionnaire,https://ClinicalTrials.gov/show/NCT04492904
353,Covid-19 Fear and Compliance With Protective Measures of Students,,https://ClinicalTrials.gov/show/NCT04849611
354,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04471051
355,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Drug: HCQ|Other: Standard therapy,https://ClinicalTrials.gov/show/NCT04408456
356,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),Biological: Intravenous Immune Globulin|Drug: Standard Medical Treatment,https://ClinicalTrials.gov/show/NCT04432324
357,Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support,Behavioral: Prone position,https://ClinicalTrials.gov/show/NCT04649658
358,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,Drug: Remdesivir|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04678739
359,Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19,Drug: Vitamin C|Drug: N-acetylcysteine (NAC)|Drug: NAC + Bromhexine (BMX),https://ClinicalTrials.gov/show/NCT04928495
360,COVID-19 Household Transmission Study,,https://ClinicalTrials.gov/show/NCT04445233
361,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),Biological: SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04390178
362,MultiOrgan Inflammatory Syndromes COVID-19 Related Study,Other: multisystem inflammatory syndrome in children (MIS-C),https://ClinicalTrials.gov/show/NCT04811456
363,"Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19",Drug: LNP-nCOV saRNA-02 Vaccine,https://ClinicalTrials.gov/show/NCT04934111
364,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,Diagnostic Test: Detection of anti-COVID-19 antibody level,https://ClinicalTrials.gov/show/NCT04387929
365,IMUNOR® Preparation in the Prevention of COVID-19,Drug: IMUNOR,https://ClinicalTrials.gov/show/NCT04710381
366,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,https://ClinicalTrials.gov/show/NCT04432103
367,CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,Drug: MR or M-M-R II ® vaccine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04333732
368,Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),Biological: Liquid Alpha1-Proteinase Inhibitor (Human)|Drug: Placebo|Drug: Standard Medical Treatment,https://ClinicalTrials.gov/show/NCT04547140
369,COVID-19 And Geko Evaluation: The CAGE Study,Device: geko T3,https://ClinicalTrials.gov/show/NCT04651374
370,Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps,Other: Osteopathic Manipulative Treatment (OMT),https://ClinicalTrials.gov/show/NCT04928456
371,Tableted COVID-19 Therapeutic Vaccine,Biological: V-SARS,https://ClinicalTrials.gov/show/NCT04380532
372,COVID-19 Detection Tests in Different Body Fluids,,https://ClinicalTrials.gov/show/NCT04473352
373,TCM Differentiation and Treatment Protocol of COVID-19,Drug: TCM prescriptions,https://ClinicalTrials.gov/show/NCT04306497
374,COVID-19 Convalescent Plasma Therapy,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04747158
375,Neuromodulation in COVID-19 Patients,Device: Transcranial direct-current stimulation|Device: Sham Transcranial direct-current stimulation,https://ClinicalTrials.gov/show/NCT04808284
376,Treatment of Patients With COVID-19 With Convalescent Plasma,Biological: convalescent plasma,https://ClinicalTrials.gov/show/NCT04415086
377,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)",,https://ClinicalTrials.gov/show/NCT04538586
378,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,Dietary Supplement: NRICM101,https://ClinicalTrials.gov/show/NCT04664049
379,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Device: MLS Laser|Other: Regular Inpatient Medical Care,https://ClinicalTrials.gov/show/NCT04391712
380,Cri Analog PG1 Effectiveness and Safety in Covid-19,"Drug: Analogs, Prostaglandin E1|Drug: Standard therapeutic protocol",https://ClinicalTrials.gov/show/NCT04536363
381,Covid-19 Pediatric Observatory,Other: hospitalized children with Covid19,https://ClinicalTrials.gov/show/NCT04336956
382,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",Other: Questionaire,https://ClinicalTrials.gov/show/NCT04537117
383,Evaluating the Impact of EnteraGam In People With COVID-19,Dietary Supplement: Bovine Plasma-Derived Immunoglobulin Concentrate|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04682041
384,Nervous System Symptoms Associated With COVID 19,Other: NEURO +|Other: NEURO -,https://ClinicalTrials.gov/show/NCT04922905
385,Traditional Chinese Medicine for Severe COVID-19,Drug: Traditional Chinese Medicine Prescription,https://ClinicalTrials.gov/show/NCT04323332
386,"Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients",Drug: ensovibep,https://ClinicalTrials.gov/show/NCT04834856
387,Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04750330
388,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),Biological: Convalescent anti-SARS-CoV-2 MBT Plasma|Drug: Standard Medical Treatment,https://ClinicalTrials.gov/show/NCT04547127
389,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,Procedure: Awake prone positioning|Procedure: Standard oxygen therapy,https://ClinicalTrials.gov/show/NCT04477655
390,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult,Biological: MVC-COV1901(S protein with adjuvant)|Biological: MVC-COV1901(Saline),https://ClinicalTrials.gov/show/NCT04695652
391,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,Biological: Mesenchymal Stromal Cells infusion,https://ClinicalTrials.gov/show/NCT04467047
392,Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection,Diagnostic Test: Hyperpolarized Xenon-129 MRI of the lungs|Diagnostic Test: Computed Tomography (CT)|Diagnostic Test: Pulmonary Function Tests (PFT)|Diagnostic Test: Six Minute Walk Test (6MWT)|Diagnostic Test: Sputum analysis|Diagnostic Test: Blood analysis|Other: Questionnaires,https://ClinicalTrials.gov/show/NCT04584671
393,Sildenafil in COVID-19,Drug: Sildenafil|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04489446
394,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Other: blood samples|Other: feces samples (COVI-BIOME ancillary study)|Other: sweat samples (COVIDOG ancillary study)|Other: saliva samples|Other: 6 minutes walk test|Other: Phone call|Other: Urine samples,https://ClinicalTrials.gov/show/NCT04352348
395,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,Other: plasma hyperimmune|Drug: standard therapy,https://ClinicalTrials.gov/show/NCT04385043
396,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,Diagnostic Test: Capillary Collection & Testing|Diagnostic Test: Venous Draw & Testing,https://ClinicalTrials.gov/show/NCT04597047
397,A Clinical Study Evaluating Inhaled Aviptadil on COVID-19,Drug: Inhaled Aviptadil|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04844580
398,Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19,Drug: Doxycycline Tablets|Drug: Rivaroxaban 15Mg Tab|Combination Product: Hydroxychloroquine and Azithromycin,https://ClinicalTrials.gov/show/NCT04715295
399,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults,Biological: MVC-COV1901 (High-Dose)|Biological: MVC-COV1901(Mid-Dose),https://ClinicalTrials.gov/show/NCT04822025
400,Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19,Drug: Vitamin C 500 MG Oral Tablet|Drug: Tenofovir disoproxyl fumarate 300 MG Oral Tablet|Drug: Tenofovir disoproxyl fumarate 300 MG plus emtricitabine 200 MG Oral Tablet,https://ClinicalTrials.gov/show/NCT04712357
401,The Salivary Raman COVID-19 Fingerprint,"Other: Raman analysis of saliva, characterization of the Raman database and building of the classification model",https://ClinicalTrials.gov/show/NCT04583306
402,Antibody Responses in Contacts of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04444310
403,Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO,Behavioral: Onsite Point-of-care,https://ClinicalTrials.gov/show/NCT04878328
404,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,Biological: UC-MSCs|Other: Placebo,https://ClinicalTrials.gov/show/NCT04339660
405,Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19,Other: Physical Activity Level|Other: Anxiety and Depression Assessment|Diagnostic Test: Exercise Capacity|Diagnostic Test: Pulmonary Function Test|Diagnostic Test: Cardiopulmonary Fitness Level,https://ClinicalTrials.gov/show/NCT04753346
406,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,Drug: Interferon beta-1b|Drug: Clofazimine,https://ClinicalTrials.gov/show/NCT04465695
407,Colchicine in COVID-19: a Pilot Study,Drug: Colchicine 1 MG Oral Tablet,https://ClinicalTrials.gov/show/NCT04375202
408,Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease,,https://ClinicalTrials.gov/show/NCT04871867
409,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19),Other: demographic and clinical data obtained from hospital's electronic medical record.,https://ClinicalTrials.gov/show/NCT04454372
410,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,"Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (hospitalized Patients )|Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (cured Patients)",https://ClinicalTrials.gov/show/NCT04402892
411,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,https://ClinicalTrials.gov/show/NCT04343768
412,Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19,Other: Hospitalization,https://ClinicalTrials.gov/show/NCT04724395
413,Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19,Drug: inhaled beclametasone|Drug: Inahaled beclomethasone / formoterol / glycopyrronium,https://ClinicalTrials.gov/show/NCT04937543
414,Mix and Match of the Second COVID-19 Vaccine Dose for Safety and Immunogenicity,"Biological: mRNA-1273 SARS-CoV-2 vaccine|Biological: BNT162b2|Biological: ChAdOx1-S [recombinant]|Other: 0, 28 day schedule|Other: 0, 112 day schedule",https://ClinicalTrials.gov/show/NCT04894435
415,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,Drug: Metformin|Drug: Naltrexone,https://ClinicalTrials.gov/show/NCT04604678
416,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04444115
417,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection),Genetic: GENETIC,https://ClinicalTrials.gov/show/NCT04644146
418,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,Other: observational,https://ClinicalTrials.gov/show/NCT04363099
419,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,https://ClinicalTrials.gov/show/NCT04385108
420,Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application,Device: Web-application,https://ClinicalTrials.gov/show/NCT04806880
421,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug: 1: ILT101|Drug: 2: Placebo Comparator,https://ClinicalTrials.gov/show/NCT04357444
422,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,Drug: Ivermectin and Doxycyline|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04591600
423,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),,https://ClinicalTrials.gov/show/NCT04355338
424,Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells),"Biological: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|Biological: a high-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|Biological: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|Biological: a high-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|Biological: a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56|Biological: a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56|Biological: a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56|Biological: a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",https://ClinicalTrials.gov/show/NCT04813562
425,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,Biological: COVID-19 Convalescent Plasma (CCP)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04421404
426,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Other: Exposure,https://ClinicalTrials.gov/show/NCT04370808
427,Inhaled Ivermectin and COVID-19,Drug: Ivermectin Powder,https://ClinicalTrials.gov/show/NCT04681053
428,Testing the Accuracy of a Digital Test to Diagnose Covid-19,Diagnostic Test: Covid-19 swab PCR test,https://ClinicalTrials.gov/show/NCT04407585
429,Co-infection Management in COVID-19 Critically Ill,Diagnostic Test: FilmArray Pneumonia,https://ClinicalTrials.gov/show/NCT04382092
430,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,Biological: AT-100,https://ClinicalTrials.gov/show/NCT04659122
431,Non-invasive Ventilatory Support of Patients Affected by COVID-19,Device: Non-invasive ventilatory support,https://ClinicalTrials.gov/show/NCT04382235
432,Predictors of Disease Severity in COVID-19 Patients,Other: Standard of health care,https://ClinicalTrials.gov/show/NCT04887142
433,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",Dietary Supplement: 5-ALA-Phosphate + SFC (5-ALA + SFC),https://ClinicalTrials.gov/show/NCT04542850
434,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04329832
435,Immunosupressive Treatment in COVID-19 Patients,Drug: NO-Immunosuppressive|Drug: Immunosuppressive|Drug: Immunoglubulins,https://ClinicalTrials.gov/show/NCT04382781
436,"Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19",Biological: ERUCOV-VAC 3 µg/0.5 ml Vaccine|Biological: ERUCOV-VAC 6 µg/0.5 ml Vaccine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04824391
437,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,Biological: convalescent plasma,https://ClinicalTrials.gov/show/NCT04388410
438,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,,https://ClinicalTrials.gov/show/NCT04344145
439,Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers,"Biological: SARS-CoV-2 Vaccine(Vero Cell), Inactivated",https://ClinicalTrials.gov/show/NCT04795414
440,CISCO-21 Prevent and Treat Long COVID-19.,Other: Resistance Exercise,https://ClinicalTrials.gov/show/NCT04900961
441,ImmuneSense™ COVID-19 Study,Other: T-Detect™ SARS-CoV-2 Assay,https://ClinicalTrials.gov/show/NCT04583982
442,Protecting Native Families From COVID-19,Behavioral: Motivational Interviewing|Behavioral: COVID-19 Symptom Monitoring System|Behavioral: Motivational Interviewing and COVID-19 Symptom Monitoring System|Other: Supportive Services,https://ClinicalTrials.gov/show/NCT04765475
443,"Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus",Device: Esophageal catheter,https://ClinicalTrials.gov/show/NCT04885517
444,Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home,Drug: tenofovir disoproxil and emtricitabine,https://ClinicalTrials.gov/show/NCT04685512
445,Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias,Other: questionnaire,https://ClinicalTrials.gov/show/NCT04649320
446,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,Diagnostic Test: RT-qPCR test|Diagnostic Test: COVID-VIRO® test,https://ClinicalTrials.gov/show/NCT04609969
447,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,Drug: IV Dexamethasone|Drug: Nasal Dexamethasone,https://ClinicalTrials.gov/show/NCT04513184
448,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,Drug: AVIGAN|Drug: Placebo Comparator,https://ClinicalTrials.gov/show/NCT04529499
449,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",Other: Aerobic Exercise Training|Other: Education,https://ClinicalTrials.gov/show/NCT04595773
450,"Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines",Biological: CoronoVac Vaccine,https://ClinicalTrials.gov/show/NCT04751721
451,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04426695
452,Spanish Survey on Third Wave of COVID-19,Other: Online survey,https://ClinicalTrials.gov/show/NCT04659473
453,Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients,Diagnostic Test: Electronic stethoscope,https://ClinicalTrials.gov/show/NCT04910191
454,Tele-assessment in Individuals With COVID-19,,https://ClinicalTrials.gov/show/NCT04900441
455,Leronlimab in Moderatelly Ill Patients With COVID-19 Pneumonia,Drug: Leronlimab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04901676
456,Honey and Nigella Sativa in COVID-19 Prophylaxis,Drug: Honey|Drug: Nigella sativa seed|Other: Placebo,https://ClinicalTrials.gov/show/NCT04767087
457,Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study,Diagnostic Test: Soton hyperinflammation score|Diagnostic Test: HScore,https://ClinicalTrials.gov/show/NCT04903834
458,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04362865
459,Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - Low dose|Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - High dose|Biological: One COVID-19 vaccine candidate (TMV-083) administration - High dose|Other: Placebo,https://ClinicalTrials.gov/show/NCT04497298
460,Frailty in Elderly Patients With COVID-19,Other: Relation between frailty and clinical outcomes in elderly patients with COVID-19.,https://ClinicalTrials.gov/show/NCT04412265
461,"Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey",Other: Cross sectional e-Survey on surgeons exposed to any educational intervention,https://ClinicalTrials.gov/show/NCT04732858
462,CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients,Drug: CPI-006 2 mg/kg + SOC|Drug: CPI-006 1 mg/kg + SOC|Drug: Placebo + SOC,https://ClinicalTrials.gov/show/NCT04734873
463,Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,Drug: Trimodulin|Other: Placebo (human albumin 1%),https://ClinicalTrials.gov/show/NCT04576728
464,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04480632
465,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04434157
466,DCI COVID-19 Surveillance Project,Diagnostic Test: SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection,https://ClinicalTrials.gov/show/NCT04780698
467,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug: Favipiravir|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04542694
468,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Drug: Chloroquine phosphate,https://ClinicalTrials.gov/show/NCT04443270
469,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,"Biological: NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells",https://ClinicalTrials.gov/show/NCT04324996
470,Respiratory Supports and COVID-19 Mortality,Other: Respiratory supports,https://ClinicalTrials.gov/show/NCT04832061
471,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,Drug: Lianhua Qingwen|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04433013
472,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),,https://ClinicalTrials.gov/show/NCT04351646
473,AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,Drug: AZD1656|Other: Placebo,https://ClinicalTrials.gov/show/NCT04516759
474,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug: HCQ & AZ,https://ClinicalTrials.gov/show/NCT04354597
475,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,Biological: SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04384497
476,COVID-19 and Vaccination Attitudes,Other: Survey,https://ClinicalTrials.gov/show/NCT04352582
477,COVID 19 Biomarkers,Diagnostic Test: serum inflammatory biomarkers,https://ClinicalTrials.gov/show/NCT04363008
478,COVID-19 in Home Healthcare,,https://ClinicalTrials.gov/show/NCT04642196
479,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,,https://ClinicalTrials.gov/show/NCT04361786
480,Surgical Management During the Era of COVID-19,,https://ClinicalTrials.gov/show/NCT04911868
481,Favipiravir in Hospitalized COVID-19 Patients,Drug: Favipiravir|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04359615
482,A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Two dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Three dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Two dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Three dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Two dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Three dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Two dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Three dose regimen|Biological: Low-dose placebo (18-59 years) & Two dose regimen|Biological: Low-dose placebo (18-59 years) & Three dose regimen|Biological: High-dose placebo (18-59 years) & Two dose regimen|Biological: High-dose placebo (18-59 years) & Three dose regimen|Biological: Low-dose placebo (60-85 years) & Two dose regimen|Biological: Low-dose placebo (60-85 years) & Three dose regimen|Biological: High-dose placebo (60-85 years) & Two dose regimen|Biological: High-dose placebo (60-85 years) & Three dose regimen,https://ClinicalTrials.gov/show/NCT04640402
483,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,Drug: IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care.,https://ClinicalTrials.gov/show/NCT04381884
484,The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients,Drug: Artecom® (pyronaridine-artesunate)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04701606
485,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,Diagnostic Test: Butterfly,https://ClinicalTrials.gov/show/NCT04433000
486,Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,Drug: BDB-001 Injection|Other: Conventional treatment,https://ClinicalTrials.gov/show/NCT04449588
487,COVID19 Severity Prediction and Health Services Research Evaluation,Other: Predictors adverse evolution|Other: Predictors of health care provide,https://ClinicalTrials.gov/show/NCT04463706
488,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",,https://ClinicalTrials.gov/show/NCT04406038
489,Immune Profiling of COVID19-patients Admitted to ICU,Other: No intervention,https://ClinicalTrials.gov/show/NCT04473131
490,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),Drug: Duvelisib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04487886
491,COVID-19 Vaccine Response,,https://ClinicalTrials.gov/show/NCT04852835
492,Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients,Drug: Remdesivir|Drug: Baricitinib|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04693026
493,"Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Participants ≥ 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure",Drug: BGE-175|Other: Placebo,https://ClinicalTrials.gov/show/NCT04705597
494,Azithromycin in Hospitalized COVID-19 Patients,Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04359316
495,Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC,Biological: ERUCOV-VAC|Other: Placebo Vaccine,https://ClinicalTrials.gov/show/NCT04691947
496,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,Other: COVID-19,https://ClinicalTrials.gov/show/NCT04534595
497,Adaptive COVID-19 Treatment Trial 3 (ACTT-3),Drug: Interferon beta-1a|Other: Placebo|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04492475
498,Proctologic Practice and Covid-19,,https://ClinicalTrials.gov/show/NCT04392245
499,COVID-19 Plasma Collection,Other: Plasma Donation,https://ClinicalTrials.gov/show/NCT04344015
500,Adaptive COVID-19 Treatment Trial (ACTT),Other: Placebo|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04280705
501,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Biological: Mesenchymal Stromal Cells|Other: Placebo,https://ClinicalTrials.gov/show/NCT04361942
502,Adaptive COVID-19 Treatment Trial 2 (ACTT-2),Other: Placebo|Drug: Remdesivir|Drug: Baricitinib,https://ClinicalTrials.gov/show/NCT04401579
503,COVID-19 : Study of INFLAmmasome and PLAtelets Functions,Biological: Blood samples,https://ClinicalTrials.gov/show/NCT04397822
504,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions,Other: questionnaire,https://ClinicalTrials.gov/show/NCT04579289
505,IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,,https://ClinicalTrials.gov/show/NCT04462120
506,Convalescent Plasma as Adjunct Therapy for COVID-19,Biological: Convalescent plasma treatment,https://ClinicalTrials.gov/show/NCT04873414
507,COVID-19 Tests With Saliva Specimens,Other: Saliva collection,https://ClinicalTrials.gov/show/NCT04567953
508,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug: Acalabrutinib,https://ClinicalTrials.gov/show/NCT04380688
509,A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan,,https://ClinicalTrials.gov/show/NCT04828772
510,Telmisartan for Treatment of COVID-19 Patients,Drug: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.,https://ClinicalTrials.gov/show/NCT04355936
511,Relationship Between Potential Predictors and Mortality in COVID-19 Patients ın Turkey,,https://ClinicalTrials.gov/show/NCT04789460
512,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug: Acalabrutinib,https://ClinicalTrials.gov/show/NCT04346199
513,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,Diagnostic Test: ELISPOT|Diagnostic Test: QUANTIFERON,https://ClinicalTrials.gov/show/NCT04648709
514,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,Drug: Ciclesonide Metered Dose Inhaler [Alvesco],https://ClinicalTrials.gov/show/NCT04330586
515,Tafenoquine in Patients With Mild to Moderate COVID-19,Drug: Tafenoquine Oral Tablet|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04533347
516,LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults,,https://ClinicalTrials.gov/show/NCT04799444
517,Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients,Biological: Anti COVID 19 Intravenous Immunoglobulin (C-IVIG),https://ClinicalTrials.gov/show/NCT04891172
518,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,Biological: Lenzilumab|Other: Placebo|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04583969
519,COVID 19 Preventive Measures Among Mansoura Nursing Students,,https://ClinicalTrials.gov/show/NCT04473547
520,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19),,https://ClinicalTrials.gov/show/NCT04641988
521,Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients,Drug: Thymalfasin,https://ClinicalTrials.gov/show/NCT04428008
522,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,Biological: immune plasma,https://ClinicalTrials.gov/show/NCT04622826
523,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug: Nafamostat Mesilate|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04352400
524,Losmapimod Safety and Efficacy in COVID-19,Drug: Losmapimod oral tablet|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04511819
525,Seroprevalence of COVID-19,Diagnostic Test: laboratory test,https://ClinicalTrials.gov/show/NCT04941053
526,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Genetic: Whole Genome Analysis|Genetic: T-cell receptor (TCR) repertoire|Genetic: SARS-CoV-2 viral composition,https://ClinicalTrials.gov/show/NCT04364828
527,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Telmisartan,https://ClinicalTrials.gov/show/NCT04359953
528,Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,https://ClinicalTrials.gov/show/NCT04668170
529,Convalescent Plasma for COVID-19 Research Donor Study,,https://ClinicalTrials.gov/show/NCT04555109
530,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04739410
531,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,Other: Survey Group,https://ClinicalTrials.gov/show/NCT04367896
532,A Longitudinal Study of COVID-19 Sequelae and Immunity,,https://ClinicalTrials.gov/show/NCT04411147
533,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,Behavioral: Positive COVID Test Result - Hypothetical Scenario|Behavioral: Negative COVID Test Result - Hypothetical Scenario|Behavioral: Unavailable COVID Test Result - Hypothetical Scenario,https://ClinicalTrials.gov/show/NCT04459520
534,Case Fatalities in Hospitalised COVID-19 Patients in the UK,Other: Patient Characteristics|Other: COVID-19 treatments|Other: Differences in triage|Other: Surge capacity,https://ClinicalTrials.gov/show/NCT04527458
535,Vitamin D and COVID-19 Trial,Dietary Supplement: vitamin D|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04536298
536,Adaptive COVID-19 Treatment Trial 4 (ACTT-4),Drug: Baricitinib|Drug: Dexamethasone|Other: Placebo|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04640168
537,Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients,Device: Clinical decision support system based on non-invasive multimodal monitoring,https://ClinicalTrials.gov/show/NCT04802018
538,STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19,Drug: Brensocatib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04817332
539,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study),Other: Antithrombotic Therapy (anticoagulant and/or antiplatelet) before admission for Covid19,https://ClinicalTrials.gov/show/NCT04518735
540,Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19,Biological: KDS-1000|Other: Placebo,https://ClinicalTrials.gov/show/NCT04797975
541,"International COVID19 Clinical Evaluation Registry,",Combination Product: Observational (registry),https://ClinicalTrials.gov/show/NCT04334291
542,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,Drug: Favipiravir|Drug: Oseltamivir 75mg,https://ClinicalTrials.gov/show/NCT04558463
543,NO-mediated Vascular Function in Covid-19 Patient,Diagnostic Test: Single passive leg movement,https://ClinicalTrials.gov/show/NCT04625036
544,Glucocorticoids in COVID-19 (CORTIVID),Drug: Methylprednisolone|Other: Placebo,https://ClinicalTrials.gov/show/NCT04438980
545,Laparoscopy and COVID-19 Contamination,Other: Additional and minimal collection of products of the human body carried out during a sample for standard of care,https://ClinicalTrials.gov/show/NCT04608383
546,COVID-19 Treatment in South Africa,Other: Standard of care (Paracetamol)|Drug: Artesunate-amodiaquine|Drug: Pyronaridine-artesunate|Drug: Favipiravir plus Nitazoxanide|Drug: Sofosbuvir/daclatasvir,https://ClinicalTrials.gov/show/NCT04532931
547,Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic,Procedure: Endoscopic procedure,https://ClinicalTrials.gov/show/NCT04598256
548,The Impact of Vaccination on Severity of Illness in COVID-19,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04912700
549,Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19,Drug: Dapsone 85 mg PO BID|Drug: Placebo 85 mg PO BID,https://ClinicalTrials.gov/show/NCT04935476
550,Leronlimab in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation,Drug: Leronlimab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04901689
551,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,Biological: MSCs,https://ClinicalTrials.gov/show/NCT04252118
552,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,,https://ClinicalTrials.gov/show/NCT04348396
553,A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19,Biological: Bamlanivimab|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04796402
554,The Factors That Affect the Infection of COVID-19,,https://ClinicalTrials.gov/show/NCT04848610
555,"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.",Drug: Selenium (as Selenious Acid)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04869579
556,Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19),,https://ClinicalTrials.gov/show/NCT04452942
557,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,Biological: High-titer Convalescent COVID-19 Plasma (CCP1)|Biological: Standard-titer Convalescent COVID-19 plasma (CCP2),https://ClinicalTrials.gov/show/NCT04524507
558,LYT-100 in Post-acute COVID-19 Respiratory Disease,Drug: LYT-100|Other: Placebo,https://ClinicalTrials.gov/show/NCT04652518
559,Determinants of Obtaining Covid Vaccination Among Health Care Workers,Other: no intervention,https://ClinicalTrials.gov/show/NCT04924894
560,Hemostasis in COVID-19: an Adaptive Clinical Trial,Drug: acetylsalicylic acid|Drug: Unfractionated heparin nebulized,https://ClinicalTrials.gov/show/NCT04466670
561,Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,"Other: Nursing care to reduce anxiety, fear and loneliness",https://ClinicalTrials.gov/show/NCT04481477
562,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,Device: CovX,https://ClinicalTrials.gov/show/NCT04358536
563,Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19,Drug: Famotidine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04724720
564,Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19,Drug: SNG001|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04732949
565,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral,https://ClinicalTrials.gov/show/NCT04379479
566,Amantadine for COVID-19,Drug: Amantadine|Drug: Lactose monohydrate,https://ClinicalTrials.gov/show/NCT04894617
567,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,Drug: Omegaven®|Drug: Sodium chloride,https://ClinicalTrials.gov/show/NCT04647604
568,Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study,"Diagnostic Test: Serology testing, RT PCR",https://ClinicalTrials.gov/show/NCT04872699
569,AGILE (Early Phase Platform Trial for COVID-19),Drug: CST-2: EIDD-2801|Drug: CST-2: Placebo|Drug: Nitazoxanide|Drug: VIR-7832|Drug: VIR-7831|Drug: CST-5: Placebo,https://ClinicalTrials.gov/show/NCT04746183
570,The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome,Other: Exercise,https://ClinicalTrials.gov/show/NCT04841759
571,ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19,Biological: Remdesivir|Drug: Remdesivir Placebo|Biological: Aviptadil|Drug: Aviptadil Placebo|Drug: Corticosteroid,https://ClinicalTrials.gov/show/NCT04843761
572,Effects of Telerehabilitation After Discharge in COVID-19 Survivors,Other: Telerehabilitation,https://ClinicalTrials.gov/show/NCT04794374
573,Africa COVID-19 Vaccine Hesitancy,,https://ClinicalTrials.gov/show/NCT04912284
574,Hydrogen Therapy in Patients With Moderate Covid-19,"Drug: Mixture 3,6% H2 in N2 (96.4%)",https://ClinicalTrials.gov/show/NCT04633980
575,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug: Tocilizumab Injection,https://ClinicalTrials.gov/show/NCT04317092
576,Covid-19 Patients Management During Home Isolation,Procedure: Oxygen therapy and physical therapy|Device: Oxygen therapy,https://ClinicalTrials.gov/show/NCT04945564
577,COVID-19 With Convalescent Plasma,Biological: convalescent plasma,https://ClinicalTrials.gov/show/NCT04616976
578,A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study,Other: Clinical Observation,https://ClinicalTrials.gov/show/NCT04649827
579,Ivermectin Versus Standard Treatment in Mild COVID-19,Drug: Ivermectin Tablets,https://ClinicalTrials.gov/show/NCT04937569
580,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),Drug: Chloroquine,https://ClinicalTrials.gov/show/NCT04627467
581,Protecting Our Community: COVID-19 Testing,Diagnostic Test: Home-based SARS-CoV-2 test kit,https://ClinicalTrials.gov/show/NCT04866303
582,COVID-19 Vaccine Induced Immunity,Drug: covid19 vaccine,https://ClinicalTrials.gov/show/NCT04713163
583,Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19,Drug: RO7496998|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04889040
584,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,Other: Risk factors,https://ClinicalTrials.gov/show/NCT04380662
585,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,Drug: Pyronaridine-Artesunate|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04475107
586,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),,https://ClinicalTrials.gov/show/NCT04449731
587,Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units,,https://ClinicalTrials.gov/show/NCT04829552
588,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug: Sarilumab|Other: Standar of care,https://ClinicalTrials.gov/show/NCT04357808
589,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),Biological: Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04341389
590,COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04666441
591,COVID-19: Respiratory and Sleep Follow-up,Other: No intervention,https://ClinicalTrials.gov/show/NCT04406324
592,Cardiac Injury in COVID-19: a Pathology Study,,https://ClinicalTrials.gov/show/NCT04367792
593,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Device: Web application users,https://ClinicalTrials.gov/show/NCT04331171
594,"The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life",Other: intervention group,https://ClinicalTrials.gov/show/NCT04824469
595,Long Term Outcomes of Coronavirus Disease-19 (COVID-19),Diagnostic Test: Chest Computed Tomography|Diagnostic Test: Pulmonary Function Tests|Other: Six Minutes Walk Test|Other: Quality of Life,https://ClinicalTrials.gov/show/NCT04715919
596,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,,https://ClinicalTrials.gov/show/NCT04362345
597,Ruxolitinib in the Treatment of Covid-19,Drug: INC424 / Ruxolitinib,https://ClinicalTrials.gov/show/NCT04414098
598,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,Drug: Maraviroc 300 mg|Other: Standard care therapy,https://ClinicalTrials.gov/show/NCT04441385
599,Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination,Diagnostic Test: Blood- and saliva tests,https://ClinicalTrials.gov/show/NCT04842305
600,Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients,Drug: Betadine© bucal 100 mg/ml|Drug: Oximen® 3%|Drug: Clorhexidine Dental PHB©|Drug: Vitis Xtra Forte©|Drug: Distilled Water,https://ClinicalTrials.gov/show/NCT04707742
601,Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients,Drug: Niclosamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04603924
602,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug: Prazosin|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04365257
603,Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System,Diagnostic Test: AP-23,https://ClinicalTrials.gov/show/NCT04860895
604,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Drug: Nafamostat Mesilate,https://ClinicalTrials.gov/show/NCT04390594
605,Cardiovascular Manifestations of COVID-19,Other: Chart review,https://ClinicalTrials.gov/show/NCT04701515
606,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,Drug: Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04397328
607,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,,https://ClinicalTrials.gov/show/NCT04427358
608,"Tolerability,Safety of JS016 in SARS-CoV-2 (COVID-19)",Drug: Combination Product: JS016 (anti-SARS-CoV-2 monoclonal antibody),https://ClinicalTrials.gov/show/NCT04931238
609,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7","Combination Product: Tomeka®|Drug: ""Vernonia amygdalina""",https://ClinicalTrials.gov/show/NCT04537585
610,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings",,https://ClinicalTrials.gov/show/NCT04568499
611,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,Biological: Sample,https://ClinicalTrials.gov/show/NCT04584593
612,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19",Drug: Covid-19 group,https://ClinicalTrials.gov/show/NCT04694703
613,"The Effect of Deep Breathing Exercise on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19",Behavioral: Deep Breathing Exercise with Triflo,https://ClinicalTrials.gov/show/NCT04696562
614,Safety and Immunity of Covid-19 aAPC Vaccine,Biological: Pathogen-specific aAPC,https://ClinicalTrials.gov/show/NCT04299724
615,Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project,,https://ClinicalTrials.gov/show/NCT04907890
616,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients,Other: Blood and derivatives.|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04345523
617,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,Biological: SARS-CoV-2 antibody based IVIG therapy,https://ClinicalTrials.gov/show/NCT04521309
618,Post-COVID Neurologic Symptoms : a Somatic Spectrum Disorder ?,,https://ClinicalTrials.gov/show/NCT04889313
619,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,Other: Placebo|Drug: Remdesivir|Biological: Risankizumab,https://ClinicalTrials.gov/show/NCT04583956
620,"Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19",Other: Autopsy,https://ClinicalTrials.gov/show/NCT04772833
621,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,Drug: 0.5% Povidone Iodine|Drug: 0.12% Chlorhexidine Gluconate Mouth Rinse|Drug: 1% Hydrogen Peroxide|Drug: 0.9% Normal Saline,https://ClinicalTrials.gov/show/NCT04603794
622,Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras,Biological: Thymic peptides,https://ClinicalTrials.gov/show/NCT04771013
623,Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU,Other: File inquiry,https://ClinicalTrials.gov/show/NCT04757792
624,Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,Device: Vielight RX Plus,https://ClinicalTrials.gov/show/NCT04418505
625,Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19,,https://ClinicalTrials.gov/show/NCT04930757
626,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin|Other: Placebo Tablet|Other: Placebo capsules,https://ClinicalTrials.gov/show/NCT04349592
627,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,Drug: Brequinar|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04425252
628,Oral 25-hydroxyvitamin D3 and COVID-19,Drug: Oral 25-Hydroxyvitamin D3,https://ClinicalTrials.gov/show/NCT04386850
629,Corticosteroids in Severe COVID-19 (ASAP-ESICM Study),Other: questionnaire,https://ClinicalTrials.gov/show/NCT04866082
630,"Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",,https://ClinicalTrials.gov/show/NCT04481620
631,RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers,Biological: C144-LS and C-135-LS,https://ClinicalTrials.gov/show/NCT04700163
632,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,Diagnostic Test: Brainstem Responses Assessment Sedation Score (BRASS)|Diagnostic Test: Electroencephalogram with EKG lead,https://ClinicalTrials.gov/show/NCT04527198
633,Niclosamide for Mild to Moderate COVID-19,Drug: Niclosamide|Drug: Placebo|Other: Telehealth monitoring,https://ClinicalTrials.gov/show/NCT04399356
634,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,Drug: Dexamethasone 2 MG/ML|Drug: Methylprednisolone Injection,https://ClinicalTrials.gov/show/NCT04603729
635,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",,https://ClinicalTrials.gov/show/NCT04374695
636,Antiviral Agents Against COVID-19 Infection,Drug: Atazanavir|Drug: Daclatasvir 60 mg|Drug: Sofusbuvir + Daclastavir 60 mg|Drug: Placebo Atazanavir|Drug: Placebo Daclatasvir 60 mg|Drug: Placebo Sofusbuvir + Daclatasvir 60 mg,https://ClinicalTrials.gov/show/NCT04468087
637,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,Other: COVID-19,https://ClinicalTrials.gov/show/NCT04581135
638,"Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity",,https://ClinicalTrials.gov/show/NCT04747366
639,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),"Biological: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|Biological: Three doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|Biological: Two doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|Biological: Three doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|Biological: Two doses of placebo at the schedule of day 0, 14 #middle-dose group#|Biological: Three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#|Biological: Two doses of placebo at the schedule of day 0, 14 #High-dose group#|Biological: Three doses of placebo at the schedule of day 0, 14, 28 #High-dose group#",https://ClinicalTrials.gov/show/NCT04636333
640,COVID-19 and Pregnancy: Placental and Immunological Impacts,Other: Specimens specific for the study,https://ClinicalTrials.gov/show/NCT04726111
641,Estradiol and Progesterone in Hospitalized COVID-19 Patients,Other: Placebo injection and placebo pill|Drug: Estradiol Cypionate 5 MG/ML|Drug: Progesterone 200 MG Oral Capsule,https://ClinicalTrials.gov/show/NCT04865029
642,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),Drug: Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04466540
643,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine,Drug: Corticosteroid with or without colchicine,https://ClinicalTrials.gov/show/NCT04654416
644,COVID-19 Vaccines International Pregnancy Exposure Registry,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04705116
645,Control of COVID-19 Outbreaks in Long Term Care,Drug: Favipiravir|Drug: Favipiravir Placebo,https://ClinicalTrials.gov/show/NCT04448119
646,An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province,,https://ClinicalTrials.gov/show/NCT04915001
647,Corticosteroids for COVID-19,Drug: Prednisone|Device: Point of Care testing device for C-reactive protein,https://ClinicalTrials.gov/show/NCT04795583
648,"Evaluation of Muscle Strength, Functional Independence, Myalgia, Fatigue and Dyspnea in COVID-19 Infection",,https://ClinicalTrials.gov/show/NCT04784546
649,Post-Covid-19 Emotional Aspects of Hospital Staff,,https://ClinicalTrials.gov/show/NCT04794920
650,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,Biological: Mesenchymal Stem Cells Transplantation,https://ClinicalTrials.gov/show/NCT04898088
651,COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients,Other: COVID-19 vaccine hesitancy scale in rheumatic diseases|Other: COVID-19 vaccine hesitancy associated factors,https://ClinicalTrials.gov/show/NCT04775563
652,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Device: Q-NRG Metobolic Cart Device|Device: MuscleSound Ultrasound|Device: Multifrequency Bioimpedance Spectroscopy,https://ClinicalTrials.gov/show/NCT04350073
653,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,Diagnostic Test: COVID-19 test|Diagnostic Test: Blood sampling,https://ClinicalTrials.gov/show/NCT04632732
654,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test",Diagnostic Test: Biozek Covid-19 Antigen Rapid Test (Saliva),https://ClinicalTrials.gov/show/NCT04926779
655,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)","Drug: NT-I7|Drug: Placebo|Procedure: Blood for research purposes|Procedure: Blood for pharmacokinetic samples|Procedure: Nasopharyngeal, oropharyngeal, or saliva swab|Procedure: Blood for anti-drug antibody (ADA)",https://ClinicalTrials.gov/show/NCT04498325
656,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),"Biological: Reporting of anosmia, ageusia and other clinical symptoms",https://ClinicalTrials.gov/show/NCT04407494
657,COVID-19 Saliva Test Research Study,Diagnostic Test: Saliva and NPS test,https://ClinicalTrials.gov/show/NCT04531501
658,COVID-19 SAFE Enrollment,Behavioral: Opt-out Recruitment Email|Behavioral: Opt-in Recruitment Email,https://ClinicalTrials.gov/show/NCT04506268
659,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,Drug: Favipiravir|Drug: Standard of care (SOC)|Drug: standard concomitant therapy,https://ClinicalTrials.gov/show/NCT04501783
660,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug: Hydroxychloroquine Sulfate (HCQ),https://ClinicalTrials.gov/show/NCT04345653
661,COVID-19 and the Developement of Phobic Fears of Disease,Other: Questionnaires for specific phobia,https://ClinicalTrials.gov/show/NCT04359121
662,"Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)",Drug: Ensovibep|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04870164
663,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers,Behavioral: Text-Messaging (TM)|Behavioral: Patient Navigation (PN),https://ClinicalTrials.gov/show/NCT04939532
664,Niclosamide in COVID-19,Drug: Niclosamide Oral Tablet|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04542434
665,Post COVID-19 Syndrome and the Gut-lung Axis,Dietary Supplement: Omni-Biotic Pro Vi 5|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04813718
666,Max COVID19- Study,,https://ClinicalTrials.gov/show/NCT04339608
667,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04437693
668,Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia,Drug: Cefditoren pivoxil 400mg,https://ClinicalTrials.gov/show/NCT04709172
669,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug: Hydroxychloroquine|Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir|Drug: Placebo of LPV/r Tablets,https://ClinicalTrials.gov/show/NCT04328285
670,Covid-19 Vaccination in Adolescents,Biological: Tozinameran|Biological: Oxford-AstraZeneca COVID-19 vaccine|Biological: CoronaVac,https://ClinicalTrials.gov/show/NCT04800133
671,Emotional Support and Stress Management in Patients Diagnosed With COVID-19,"Behavioral: Training video on anxiety, fear and loneliness in the COVID-19 environment.",https://ClinicalTrials.gov/show/NCT04482023
672,Covid-19 Messaging to Underserved Communities - 2nd Experiment,Behavioral: Acknowledgement Racial Injustice AMA|Behavioral: African American Sender Acknowledgement|Behavioral: African American Sender in Informational Videos.|Behavioral: Racial Inequality Highlighted|Behavioral: AMA Acknowledgement Drug Pricing|Behavioral: White Sender in Acknowledgement|Behavioral: White Sender in Informational Videos|Behavioral: No Racial Inequality Highlighting|Behavioral: Placebo videos,https://ClinicalTrials.gov/show/NCT04502056
673,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug: HCQ|Drug: HCQ+AZT|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04358081
674,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug: Povidone-Iodine 2%|Drug: Povidone-Iodine 0.5%|Drug: Isotonic saline 0.9%,https://ClinicalTrials.gov/show/NCT04347954
675,Health After Covid-19 in Tyrol,Other: online survey,https://ClinicalTrials.gov/show/NCT04661462
676,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers,Behavioral: Text-Messaging (TM)|Behavioral: Patient Navigation (PN),https://ClinicalTrials.gov/show/NCT04939519
677,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04353206
678,Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19,Drug: albuterol sulfate (MDI)|Drug: albuterol sulfate (nebulizer),https://ClinicalTrials.gov/show/NCT04681079
679,"A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19",Drug: ensovibep|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04828161
680,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Drug: Baricitinib or Anakinra,https://ClinicalTrials.gov/show/NCT04362943
681,COVID-19 - Cytokine Storm,Other: No intervention,https://ClinicalTrials.gov/show/NCT04474067
682,COVID-19 Testing in Patients With Vascular Disorders,Diagnostic Test: PCR,https://ClinicalTrials.gov/show/NCT04838093
683,Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19),Biological: AZD1222|Biological: rAd26-S,https://ClinicalTrials.gov/show/NCT04760730
684,Efficacy of Adaptogens in Patients With Long COVID-19,Dietary Supplement: ADAPT-232 oral solution|Other: Placebo oral solution,https://ClinicalTrials.gov/show/NCT04795557
685,NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients,,https://ClinicalTrials.gov/show/NCT04578197
686,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,Device: Apple Watch Series 5,https://ClinicalTrials.gov/show/NCT04376853
687,The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters,"Drug: Human fecal microbiota, MBiotix HBI|Drug: Placebo|Drug: SOC",https://ClinicalTrials.gov/show/NCT04824222
688,Polk COVID-19 and Flu Response,"Diagnostic Test: COVID-19 antigen and antibody tests, and influenza rapid test",https://ClinicalTrials.gov/show/NCT04682132
689,"Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19","Dietary Supplement: Vitamin D|Dietary Supplement: Omega DHA / EPA|Dietary Supplement: Vitamin C, Vitamin B complex and Zinc Acetate",https://ClinicalTrials.gov/show/NCT04828538
690,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug: Sarilumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04315298
691,"Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidate (VBI-2902a)",Biological: VBI-2902a|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04773665
692,Cytokine Status of Covid-19 Patients,Diagnostic Test: Flow cytometric analysis,https://ClinicalTrials.gov/show/NCT04531345
693,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,Biological: SARS-CoV-2 convalescent plasma treatment|Other: Standard care,https://ClinicalTrials.gov/show/NCT04425837
694,A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19),Drug: Placebo|Drug: Prothione™ (6g),https://ClinicalTrials.gov/show/NCT04742725
695,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Drug: Rivaroxaban|Other: Standard Of Care (SOC),https://ClinicalTrials.gov/show/NCT04416048
696,Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity,Biological: Adsorbed SARS-CoV-2 (inactivated) vaccine,https://ClinicalTrials.gov/show/NCT04789356
697,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04377750
698,Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.,Diagnostic Test: SARS-CoV-2 antigen rapid test,https://ClinicalTrials.gov/show/NCT04898127
699,COVID-19 IgG Antibodies in the Serum of Recovered Patients,Diagnostic Test: IgG antibodies immunoassay,https://ClinicalTrials.gov/show/NCT04470414
700,ACTIV-3: Therapeutics for Inpatients With COVID-19,Biological: LY3819253|Drug: Placebo|Biological: Remdesivir|Biological: VIR-7831|Biological: BRII-196/BRII-198|Biological: AZD7442|Drug: MP0420,https://ClinicalTrials.gov/show/NCT04501978
701,Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients,,https://ClinicalTrials.gov/show/NCT04839107
702,COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy,Drug: Coromec Registry with ECL-19,https://ClinicalTrials.gov/show/NCT04678193
703,COVID-19 Project ECHO in Nursing Homes,Other: Project ECHO,https://ClinicalTrials.gov/show/NCT04499391
704,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04418518
705,Computed Tomography for COVID-19 Diagnosis,Diagnostic Test: Chest computed tomography (CT)|Diagnostic Test: Reverse-transcription polymerase chain reaction (RT-PCR),https://ClinicalTrials.gov/show/NCT04355507
706,Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo,Biological: Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine 4 µg/0.5 ml Vaccine|Biological: Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine 6 µg/0.5 ml Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04838080
707,Atovaquone for Treatment of COVID-19,Drug: Experimental Group|Drug: Placebo Group,https://ClinicalTrials.gov/show/NCT04456153
708,International COVID-19 Clinical Evaluation Registry -2 (HOPE-2),,https://ClinicalTrials.gov/show/NCT04778020
709,Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,,https://ClinicalTrials.gov/show/NCT04455347
710,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,Drug: Nasal Spray,https://ClinicalTrials.gov/show/NCT04610801
711,#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support,Behavioral: eHealth for Covid-19 prevention and support,https://ClinicalTrials.gov/show/NCT04870723
712,Sirtuin1 in COVID19 Patients,Other: SIRTUIN1,https://ClinicalTrials.gov/show/NCT04907916
713,COVID-19 Close Contact Self-Testing Study,Behavioral: COVID-19 self-test|Behavioral: COVID-19 test referral,https://ClinicalTrials.gov/show/NCT04847479
714,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Drug: Angiotensin Receptor Blockers|Other: Placebo,https://ClinicalTrials.gov/show/NCT04394117
715,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),Drug: Sofosbuvir 400 MG plus Daclatasvir 200mg,https://ClinicalTrials.gov/show/NCT04535869
716,COVID-19 and Acute Invasive Fungal Rhinosinusitis,Diagnostic Test: Fungal rhinosinusitis,https://ClinicalTrials.gov/show/NCT04809480
717,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,"Other: Pro BNP , Vitamin D",https://ClinicalTrials.gov/show/NCT04487951
718,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,,https://ClinicalTrials.gov/show/NCT04379466
719,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",Drug: Anakinra Prefilled Syringe|Drug: Tocilizumab Prefilled Syringe|Drug: Standard-of-care treatment,https://ClinicalTrials.gov/show/NCT04412291
720,"Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients",Other: Data collection and clinical testing of subjects,https://ClinicalTrials.gov/show/NCT04853940
721,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,Radiation: Low dose whole lung radiotherapy for older patients with COVID-19 pneumonitis,https://ClinicalTrials.gov/show/NCT04493294
722,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,Drug: Maraviroc + Currently used therapy|Procedure: Curently used therapy for COVID-19 non-critical patients|Drug: Favipiravir + Currently used therapy|Drug: Maraviroc+Favipiravir+CT,https://ClinicalTrials.gov/show/NCT04475991
723,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug: Povidone-Iodine,https://ClinicalTrials.gov/show/NCT04371965
724,Seroconversion in COVID-19 Recovered Population,Diagnostic Test: IgG SARS CoV2,https://ClinicalTrials.gov/show/NCT04558385
725,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,,https://ClinicalTrials.gov/show/NCT04446286
726,The Burden of COVID-19 Survivorship,Other: Exercise Training,https://ClinicalTrials.gov/show/NCT04913129
727,poSt Covid-19 Infection centraL sENsitisaTion,Other: Indicators of central sensitisation,https://ClinicalTrials.gov/show/NCT04703452
728,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,Device: Extracorporeal blood purification using the oXiris® (AN69ST) hemofilter,https://ClinicalTrials.gov/show/NCT04478539
729,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Drug: Azithromycin Capsule,https://ClinicalTrials.gov/show/NCT04381962
730,CoVID-19 Plasma in Treatment of COVID-19 Patients,Biological: Convalescent COVID 19 Plasma,https://ClinicalTrials.gov/show/NCT04355897
731,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",Other: Data collection from lumbar puncture|Other: Data collection from blood draw|Other: CNS magnetic resonance imaging (MRI) imaging|Other: Microscopy of defined brain regions on autopsy specimens,https://ClinicalTrials.gov/show/NCT04472013
732,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19,Other: Discontinuation of ACEi/ARB|Other: Continuation of ACEi/ARB,https://ClinicalTrials.gov/show/NCT04351581
733,Crizanlizumab for Treating COVID-19 Vasculopathy,Drug: Crizanlizumab|Other: 0.9% saline,https://ClinicalTrials.gov/show/NCT04435184
734,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,Biological: WJ-MSCs,https://ClinicalTrials.gov/show/NCT04313322
735,Association of Comorbidities With COVID19,Diagnostic Test: realtime PCR,https://ClinicalTrials.gov/show/NCT04459390
736,Endothelial Function and COVID-19,,https://ClinicalTrials.gov/show/NCT04525443
737,Montelukast - a Treatment Choice for COVID-19,Drug: Montelukast|Drug: Hydroxychloroquine|Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04714515
738,Stopping ACE-inhibitors in COVID-19,"Drug: ACE inhibitor, angiotensin receptor blocker",https://ClinicalTrials.gov/show/NCT04353596
739,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,Dietary Supplement: Vitamin D3 (cholecalciferol)|Dietary Supplement: Zinc (zinc gluconate)|Dietary Supplement: Zinc (zinc gluconate) & Vitamin D (cholecalciferol)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04641195
740,ACTIV-6: COVID-19 Study of Repurposed Medications,Drug: Ivermectin Tablets,https://ClinicalTrials.gov/show/NCT04885530
741,Study on Sequential Immunization of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine,Biological: recombinant Ad5 vectored COVID-19 vaccine|Biological: RBD-based protein subunit vaccine (ZF2001) against COVID-19|Biological: trivalent split influenza vaccine,https://ClinicalTrials.gov/show/NCT04833101
742,Canadian COVID-19 Emergency Department Registry,,https://ClinicalTrials.gov/show/NCT04702945
743,COVID-19 Vaccination Take-Up,Behavioral: Financial incentives|Behavioral: Convenient scheduling link|Behavioral: Race concordant|Behavioral: Gender concordant,https://ClinicalTrials.gov/show/NCT04867174
744,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,Drug: Remdesivir|Drug: Pulmozyme|Drug: IC14|Drug: Celecoxib Famotidine|Drug: Narsoplimab|Drug: Aviptadil Acetate|Drug: Cyclosporine,https://ClinicalTrials.gov/show/NCT04488081
745,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,Dietary Supplement: Vitamin C|Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Zinc Citrate|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin B12,https://ClinicalTrials.gov/show/NCT04395768
746,COVID-19 Vaccine Effectiveness in Albanian Health Workers,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04811391
747,COVID-19 Watch + COVID-19 Pulse,Device: pulse oximeter|Other: COVID Watch,https://ClinicalTrials.gov/show/NCT04581863
748,The COVID-19 Mobile Health Study (CMHS),"Other: nCapp, a cell phone-based auto-diagnosis system",https://ClinicalTrials.gov/show/NCT04275947
749,Prophylaxis and Treatment of COVID-19,,https://ClinicalTrials.gov/show/NCT04844541
750,poSt Covid-19 Infection centraL Sensitisation 2,Other: Indicators of central sensitisation,https://ClinicalTrials.gov/show/NCT04701892
751,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Other: Usual Care|Drug: Anakinra|Drug: Siltuximab|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04330638
752,COVID-19 Vaccine Effectiveness Among Health Workers in Georgia,Biological: Covid-19 vaccines,https://ClinicalTrials.gov/show/NCT04868448
753,Extrapulmonary Presentations of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04896762
754,Dysautonomia in Patients Post COVID-19 Infection,Other: Dysautonomia,https://ClinicalTrials.gov/show/NCT04716465
755,COVID-19 Self-Testing Through Rapid Network Distribution,Behavioral: COVID-19 self-test|Behavioral: COVID-19 test referral,https://ClinicalTrials.gov/show/NCT04797858
756,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),Other: Respiratory rehabilitation program (RR).|Other: Respiratory tele-rehabilitation program (TRR).,https://ClinicalTrials.gov/show/NCT04634318
757,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,,https://ClinicalTrials.gov/show/NCT04649333
758,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",Other: COVID-19 exposure|Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04659759
759,"An Observational Clinical Study to Evaluate COVID-19 Symptoms in ""Long Hauler"" Patients Who Participated in K031-120 or K032-120",Other: KB109 + Self Supportive Care|Other: Self Supportive Care (SSC) Alone,https://ClinicalTrials.gov/show/NCT04814914
760,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,Drug: Methylprednisolone|Drug: Heparin,https://ClinicalTrials.gov/show/NCT04485429
761,Covid-19 Long-term Revalidation Follow-up,Diagnostic Test: 25 post ICU-patients|Other: 25 post non-ICU patients,https://ClinicalTrials.gov/show/NCT04685629
762,COVID-19 Pandemic and Worldwide Organ Procurement,,https://ClinicalTrials.gov/show/NCT04416256
763,Long-term Effects of COVID-19 in Adolescents,Other: No active intervention (observational only),https://ClinicalTrials.gov/show/NCT04686734
764,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Combination Product: Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),https://ClinicalTrials.gov/show/NCT04344431
765,Serological and PCR Testing for COVID-19,Diagnostic Test: Membrane-based immunoassay kit|Diagnostic Test: Quantitative antibody Tests|Diagnostic Test: PCR Test,https://ClinicalTrials.gov/show/NCT04404062
766,Vitamin D and COVID-19 Management,"Dietary Supplement: Ddrops® products, 50,000 IU, Oral|Dietary Supplement: Vitamin D3",https://ClinicalTrials.gov/show/NCT04385940
767,Pulmonary Rehabilitation in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04832867
768,Surgery in the Time of COVID-19 Pandemic,Other: Data extraction from medical files,https://ClinicalTrials.gov/show/NCT04684433
769,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized),Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|Drug: Isotretinoin (13 cis retinoic acid ) capsules|Drug: Aerosolized 13 cis retinoic acid|Drug: Standard treatment,https://ClinicalTrials.gov/show/NCT04353180
770,Hydroxychloroquine in COVID-19 Patients,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04394442
771,Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care,,https://ClinicalTrials.gov/show/NCT04456036
772,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",Drug: High dose Interferon-beta 1a|Drug: Lopinavir/Ritonavir|Drug: Low dose Interferon-beta 1a,https://ClinicalTrials.gov/show/NCT04521400
773,Methodist Health System COVID-19 Patient Registry,Other: Treatment for COVID-19,https://ClinicalTrials.gov/show/NCT04477889
774,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug: Gargle/Mouthwash,https://ClinicalTrials.gov/show/NCT04341688
775,Effect of Covid-19 on Outcomes of Pregnancy,"Diagnostic Test: Covid-19 PCR , IGM",https://ClinicalTrials.gov/show/NCT04629001
776,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostic Test: COVID-19 diagnostic test,https://ClinicalTrials.gov/show/NCT04337996
777,COVID-19 Active Research Experience (CARE),,https://ClinicalTrials.gov/show/NCT04368065
778,Management of Covid-19 Patients During Home Isolation,Device: Oxygen Therapy|Procedure: Physical Therapy,https://ClinicalTrials.gov/show/NCT04368923
779,Chinese Herbal Formula for COVID-19,Drug: mQFPD|Drug: organic brown rice,https://ClinicalTrials.gov/show/NCT04939415
780,Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member,Diagnostic Test: Serological test and phone interview,https://ClinicalTrials.gov/show/NCT04649944
781,The Influence of Covid-19 on the Audio-vestibular System,Diagnostic Test: Audio-Vestibular evaluation,https://ClinicalTrials.gov/show/NCT04709146
782,Alpha-1-Antitrypsin-Deficiency in COVID-19,Drug: AAT( Alpha 1 Antitrypsin),https://ClinicalTrials.gov/show/NCT04799873
783,Predict Adverse Events by Covid-19 Nephritis,,https://ClinicalTrials.gov/show/NCT04347824
784,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,,https://ClinicalTrials.gov/show/NCT04355715
785,"Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19.",Biological: AZD1222|Biological: rAd26-S,https://ClinicalTrials.gov/show/NCT04686773
786,Breathing Exercise After COVID-19 Pneumonia,Other: Breathing exercise with the phone application|Other: Breathing exercise,https://ClinicalTrials.gov/show/NCT04771598
787,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,Drug: Olokizumab 64 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04452474
788,ACT-20 in Patients With Severe COVID-19 Pneumonia,Biological: ACT-20-MSC|Biological: ACT-20-CM|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04398303
789,COVID-19: A POC Test Under Research & Evaluation,Diagnostic Test: Sample Collection/Performance Evaluation (A)|Diagnostic Test: Sample Collection/Performance Evaluation (B),https://ClinicalTrials.gov/show/NCT04408066
790,Profiling of Post Covid-19 Infection Patients: an Online Survey,Other: Filling in an online survey,https://ClinicalTrials.gov/show/NCT04912778
791,COVID-19 STAndard of Care in Sub-Saharan Africa,,https://ClinicalTrials.gov/show/NCT04885543
792,Evaluation of Inflammatory Cytokines During COVID-19,Diagnostic Test: Blood sample,https://ClinicalTrials.gov/show/NCT04824495
793,Rapid Experimental Medicine for COVID-19,Drug: Nafamostat Mesilate|Drug: TD139|Other: Standard care,https://ClinicalTrials.gov/show/NCT04473053
794,COvid Pandemic Institutional maNaGement,Other: Qualitative analysis for professionals|Other: Quantitative analysis for Professionals|Other: Quantitative analysis for Patients|Other: Tools development,https://ClinicalTrials.gov/show/NCT04908007
795,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",Biological: Gam-COVID-Vac|Other: Placebo,https://ClinicalTrials.gov/show/NCT04564716
796,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Biological: RPH-104 80 mg|Drug: Olokizumab 64 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04380519
797,Total-Body Parametric 18F-FDG PET of COVID-19,Device: uEXPLORER/mCT,https://ClinicalTrials.gov/show/NCT04841707
798,COntinuous Signs Monitoring In Covid-19 Patients,Device: Continuous vital sign monitoring - Isansys Patient Status Engine|Other: Machine Learning/AI Algorithm,https://ClinicalTrials.gov/show/NCT04581031
799,Lanadelumab for Treatment of COVID-19 Disease,Biological: lanadelumab|Other: regular care,https://ClinicalTrials.gov/show/NCT04422509
800,Semen Analysis Changes in Covid-19 Positivepatients,Diagnostic Test: semen analysis,https://ClinicalTrials.gov/show/NCT04595240
801,AiM COVID for Covid 19 Tracking and Prediction,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04354753
802,Ivermectin Role in Covid-19 Clinical Trial,Drug: ivermectin|Drug: hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04746365
803,The Corona and COVID-19 Study in Telemark and Agder,,https://ClinicalTrials.gov/show/NCT04514003
804,"Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients",Dietary Supplement: MAF capsules 148 mg|Dietary Supplement: M capsules 148 mg|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04762628
805,COVID-19 Impact on the Lombardy Region's Emergency System,,https://ClinicalTrials.gov/show/NCT04669925
806,Impact of the COVID-19 Pandemic on Vaccination,Other: Vaccine coverage assessment,https://ClinicalTrials.gov/show/NCT04657263
807,COVID-19 Patient Positioning Pragmatic Trial,Other: Prone|Other: Usual Care,https://ClinicalTrials.gov/show/NCT04359797
808,Respiratory Tele Monitoring COVID 19 (TMR COVID-19),Device: Radius PPG Tetherless Pulse Oximetry (Masimo)|Device: usual monitoring,https://ClinicalTrials.gov/show/NCT04821973
809,Lactoferrin in Covid-19 Hospitalized Patients,Dietary Supplement: Bovine lactoferrin|Dietary Supplement: Placebo administration,https://ClinicalTrials.gov/show/NCT04847791
810,"Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia",Drug: S-1226,https://ClinicalTrials.gov/show/NCT04738136
811,Sex-Informed Data in the COVID-19 Pandemic.,,https://ClinicalTrials.gov/show/NCT04497402
812,Immune Cell Subgroups in Covid 19 Patients,Diagnostic Test: Flow cytometric analysis,https://ClinicalTrials.gov/show/NCT04531319
813,Are Surgeons Ready to Get the COVID-19 Vaccine?,Other: Survey,https://ClinicalTrials.gov/show/NCT04799652
814,The Nanowear Wearable Covid-19 Observational and Analysis Trend,Device: Observational Study - no intervention,https://ClinicalTrials.gov/show/NCT04717024
815,Famotidine Outpatient COVID-19 Treatment Study,Drug: Famotidine,https://ClinicalTrials.gov/show/NCT04389567
816,Allocetra-OTS in COVID-19,Biological: Allocetra-OTS,https://ClinicalTrials.gov/show/NCT04513470
817,Reduction of COVID 19 Transmission to Health Care Professionals,Diagnostic Test: Blood group determination|Diagnostic Test: Antibody titration|Dietary Supplement: Probiotic,https://ClinicalTrials.gov/show/NCT04462627
818,Leflunomide in Mild COVID-19 Patients,Drug: Leflunomide,https://ClinicalTrials.gov/show/NCT04361214
819,Implementation of Physiotherapy on COVID-19 Patients in ICU,Other: Phsyiotherapy,https://ClinicalTrials.gov/show/NCT04347070
820,"OD-doxy-PNV-COVID-19 Old Drug "" DOXY "" for Prevention of New Virus "" COVID-19 """,Drug: Doxycyclin,https://ClinicalTrials.gov/show/NCT04584567
821,The Lymphoma and Leukemia Society COVID-19 Registry,Biological: Observational study: This registry data will provide more specific information about how people with blood cancer respond to COVID-19 virus and/or a COVID-19 vaccination.,https://ClinicalTrials.gov/show/NCT04794387
822,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,Drug: Apixaban 2.5 MG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04650087
823,Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations,Other: Change in SARS-CoV-2 Antibody Levels,https://ClinicalTrials.gov/show/NCT04944095
824,Nebulized PL for Post-COVID-19 Syndrome,Biological: Nebulized Platelet Lysate|Other: Nebulized Sterile Saline,https://ClinicalTrials.gov/show/NCT04487691
825,Beat COVID-19 - Observational Trial,,https://ClinicalTrials.gov/show/NCT04337762
826,Cellular-Mediated Immunity in COVID-19,Diagnostic Test: Multitest 6 color TBNK and BD Lyotubes,https://ClinicalTrials.gov/show/NCT04746521
827,"Novel COVID-19, A National Analysis",Other: Prevalence of COVID-19,https://ClinicalTrials.gov/show/NCT04413045
828,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,Device: Spartan COVID-19 System,https://ClinicalTrials.gov/show/NCT04473248
829,ESICM UNITE COVID-19 Project (UNITE-COVID),,https://ClinicalTrials.gov/show/NCT04836065
830,Remdesivir Efficacy In Management Of COVID-19 Patients,Drug: Remdesivir|Drug: Standard of care_1|Drug: Standard of care_2,https://ClinicalTrials.gov/show/NCT04853901
831,The COvid-19 Symptom MOntelukast Trial,Drug: Montelukast 10mg,https://ClinicalTrials.gov/show/NCT04389411
832,Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members,Diagnostic Test: Serology to determine SARS-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04813497
833,Duke COVID-19 Shared Data and Specimen Repository,,https://ClinicalTrials.gov/show/NCT04368234
834,WhatsApp in India During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04918849
835,Audio Vestibular Functions in COVID 19 Patients in Sohag Governate,,https://ClinicalTrials.gov/show/NCT04860193
836,TREM-1 Pathway Activation in COVID-19,Other: blood sampling,https://ClinicalTrials.gov/show/NCT04544891
837,Convalescent Plasma for Early Treatment of COVID-19,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Control (albumin 5%),https://ClinicalTrials.gov/show/NCT04390503
838,"A COVID-19 Symptom, Exposure and Immune Response Registry",,https://ClinicalTrials.gov/show/NCT04348942
839,Inhaled Ciclesonide for Outpatients With COVID19,Drug: Normal Saline intranasal and placebo inhaler|Drug: Ciclesonide|Drug: Ciclesonide nasal,https://ClinicalTrials.gov/show/NCT04435795
840,Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,Biological: Abatacept|Other: Placebo,https://ClinicalTrials.gov/show/NCT04472494
841,Convalescent Plasma in Outpatients With COVID-19,Biological: Convalescent Plasma|Biological: Saline,https://ClinicalTrials.gov/show/NCT04355767
842,Ivermectin In Treatment of COVID 19 Patients,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04425707
843,"Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali",Diagnostic Test: SARS-CoV-2 screening by molecular biology|Diagnostic Test: Serological screening,https://ClinicalTrials.gov/show/NCT04710316
844,Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug: Sargramostim|Other: Control,https://ClinicalTrials.gov/show/NCT04326920
845,A Study of LAM-002A for the Prevention of Progression of COVID-19,Drug: Apilimod Dimesylate Capsule|Other: Placebo,https://ClinicalTrials.gov/show/NCT04446377
846,Early Use of Hyperimmune Plasma in COVID-19,Other: hyperimmune plasma,https://ClinicalTrials.gov/show/NCT04721236
847,Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore,Drug: Remdesivir|Drug: Conventional,https://ClinicalTrials.gov/show/NCT04871633
848,Healthy Volunteer COVID-19 Antibody Testing Study,Diagnostic Test: COVID-19 antibody point of care test kit,https://ClinicalTrials.gov/show/NCT04529460
849,UNITE Study (UCSD-SW) for COVID-19,Device: Splenic Ultrasound,https://ClinicalTrials.gov/show/NCT04803409
850,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V,Drug: Niclosamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04870333
851,COVID-19 Pandemic and Academic Performance of Veterinary Students,Other: survey,https://ClinicalTrials.gov/show/NCT04387214
852,Using Smart Watches to Detect and Monitor COVID-19,,https://ClinicalTrials.gov/show/NCT04623047
853,Role of Microparticles in Covid-19 Infection,Other: Blood sample,https://ClinicalTrials.gov/show/NCT04448743
854,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Drug: Anakinra 149 MG/ML Prefilled Syringe [Kineret],https://ClinicalTrials.gov/show/NCT04443881
855,Complementary Intervention for COVID-19,Dietary Supplement: Licorice extract,https://ClinicalTrials.gov/show/NCT04487964
856,Predictors of COVID-19 Infection and Disease Progression,Diagnostic Test: Rt PCR,https://ClinicalTrials.gov/show/NCT04484597
857,The Prevent Severe COVID-19 (PRESECO) Study,Drug: Favipiravir|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04600895
858,Mushroom-based Product for COVID-19,Drug: FoTv,https://ClinicalTrials.gov/show/NCT04667247
859,Hypertonic Saline for COVID-19 Symptoms,Other: Wearing surgical face mask sprayed with hypertonic saline,https://ClinicalTrials.gov/show/NCT04465604
860,Covid-19 Risk Factors and Pattern Between Healthcare Workers,,https://ClinicalTrials.gov/show/NCT04646551
861,Awake Prone Position in Patients With COVID-19,Procedure: Awake prone position,https://ClinicalTrials.gov/show/NCT04924816
862,Favipiravir in High-risk COVID-19 Patients,Drug: Favipiravir,https://ClinicalTrials.gov/show/NCT04818320
863,Antibiotic Misuse During COVID-19 Pandemic,Other: online questionnaires,https://ClinicalTrials.gov/show/NCT04553055
864,Health Professional Exposure Assessment to Covid-19,Diagnostic Test: Diagnostic test Covid-19,https://ClinicalTrials.gov/show/NCT04429724
865,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,Drug: Anticoagulation Agents (Edoxaban and/or high dose LMWH)|Drug: Low dose Low molecular weight heparin or Placebo,https://ClinicalTrials.gov/show/NCT04542408
866,Urine Alkalinisation to Prevent AKI in COVID-19,Drug: Sodium Bicarbonate 150Meq/L/D5W Inj,https://ClinicalTrials.gov/show/NCT04655716
867,Convalescent Plasma for Severe COVID-19 Patients,Biological: Convalescent Plasma|Other: Best Supportive Care,https://ClinicalTrials.gov/show/NCT04547660
868,Implications of Covid-19 on the Lifestyle Changes,,https://ClinicalTrials.gov/show/NCT04423978
869,Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes,Other: survey|Other: Interview,https://ClinicalTrials.gov/show/NCT04716972
870,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,Drug: Acebilustat|Drug: Camostat,https://ClinicalTrials.gov/show/NCT04662086
871,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,Other: Smartphone-based voice and self-reported symptom collection,https://ClinicalTrials.gov/show/NCT04582331
872,COVID-19 Patients Admitted to the ICU,"Other: no intervention will be administered, this is a retrospective observational study.",https://ClinicalTrials.gov/show/NCT04816786
873,PEP Flute-selfcare in COVID-19,Device: PEP flute,https://ClinicalTrials.gov/show/NCT04530435
874,COVID-19 SARS-CoV-2 Screening Protocol,,https://ClinicalTrials.gov/show/NCT04740320
875,Low Dose Radiotherapy for COVID-19 Pneumonitis,Radiation: Radiotherapy,https://ClinicalTrials.gov/show/NCT04420390
876,Covid-19 Breath Test,Diagnostic Test: Breath Test & Cheek Swab,https://ClinicalTrials.gov/show/NCT04459962
877,Omega-3 Oil Use in COVID-19 Patients in Qatar,Drug: Omega 3 fatty acid,https://ClinicalTrials.gov/show/NCT04836052
878,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,Drug: Apixaban 2.5 MG|Drug: Apixaban 5MG|Drug: Aspirin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04498273
879,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,https://ClinicalTrials.gov/show/NCT03305341
880,SLV213 Treatment in COVID-19 Patients,Drug: SLV213|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04843787
881,Characteristics of Critically Ill COVID 19 Patients,Other: COVID19,https://ClinicalTrials.gov/show/NCT04465058
882,Chest Radiography in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04485338
883,Anxiety And Depression During COVID-19 IN INDIA,Behavioral: Registery Data Collection,https://ClinicalTrials.gov/show/NCT04369300
884,Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,Drug: Zilucoplan®|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04382755
885,Cetirizine and Famotidine for COVID-19,Drug: Cetirizine and Famotidine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04836806
886,Remote Monitoring of COVID-19 Positive Outpatients,Other: Remote Monitoring of COVID-19,https://ClinicalTrials.gov/show/NCT04853108
887,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,Drug: Camostat|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04662073
888,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",Device: Saliva test kit,https://ClinicalTrials.gov/show/NCT04568122
889,Covid-19 Infection and New Onset Type 1 Diabetes,,https://ClinicalTrials.gov/show/NCT04623697
890,ImmuneRACE - Immune Response Action to COVID-19 Events,,https://ClinicalTrials.gov/show/NCT04494893
891,Bacterial Surinfections in COVID-19 ICU Patients,,https://ClinicalTrials.gov/show/NCT04877808
892,3R Rehabilitation Management of COVID-19 Survivors,Other: Cardiopulmonary exercise (centre-based)|Other: Cardiopulmonary exercise (online-based),https://ClinicalTrials.gov/show/NCT04892979
893,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,Drug: Acebilustat|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04662060
894,A Simplified Test to Assess Flavor in COVID-19 Patients,Diagnostic Test: Flavor test|Other: Self-assesment questionnaire,https://ClinicalTrials.gov/show/NCT04840966
895,COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests,,https://ClinicalTrials.gov/show/NCT04790994
896,Suloexide in the Treatment of Early Stages of COVID-19,Drug: Sulodexide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04483830
897,Studying Students at Risk for COVID-19,"Other: Wearable devices, saliva samples, survey measures",https://ClinicalTrials.gov/show/NCT04766788
898,COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS,"Other: no intervention, observation only",https://ClinicalTrials.gov/show/NCT04860908
899,Risk Factors and Prognoses in Patients Hospitalized for COVID-19,Other: Hospital treatment of COVID disease,https://ClinicalTrials.gov/show/NCT04824677
900,MSCT Chest in Suspected COVID-19 Patients,Device: MSCT,https://ClinicalTrials.gov/show/NCT04492865
901,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,Other: questionnaire,https://ClinicalTrials.gov/show/NCT04561154
902,Study in COvid-19 Patients With iveRmectin (CORVETTE-01),Drug: Ivermectin 3 MG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04703205
903,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,Other: integrated clinical evaluation,https://ClinicalTrials.gov/show/NCT04629183
904,Inhaled Heparin for Hospitalised COVID-19 Patients,Drug: Unfractionated heparin,https://ClinicalTrials.gov/show/NCT04635241
905,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Radiation: Single fraction whole lung radiotherapy,https://ClinicalTrials.gov/show/NCT04377477
906,A Pilot Study of Sildenafil in COVID-19,Drug: Sildenafil citrate tablets,https://ClinicalTrials.gov/show/NCT04304313
907,TCB008 in Patients With COVID-19,Drug: TCB008,https://ClinicalTrials.gov/show/NCT04834128
908,Western Kenya Integrated COVID-19 Response,"Other: Training of youth, community health assistants and community health workers.|Other: Training clinicians in basic critical care and the management of severe COVID-19 cases",https://ClinicalTrials.gov/show/NCT04501458
909,PCR Cycle Threshold Values and COVID-19 Outcomes,Diagnostic Test: PCR Value,https://ClinicalTrials.gov/show/NCT04651413
910,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),Drug: Gimsilumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04351243
911,Gastrointestinal Manifestations Among Patients With COVID19,,https://ClinicalTrials.gov/show/NCT04544150
912,"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",,https://ClinicalTrials.gov/show/NCT04558203
913,Dual MRI for Cardiopulmonary COVID-19 Long Haulers,Drug: Hyperpolarized 129Xenon gas,https://ClinicalTrials.gov/show/NCT04828135
914,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,Drug: OP-101|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04458298
915,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),Biological: GC5131|Other: Placebo,https://ClinicalTrials.gov/show/NCT04555148
916,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US,Other: Social Network Strategy + COVID-19 messaging,https://ClinicalTrials.gov/show/NCT04743908
917,Cardiovascular Effects of COVID-19,Drug: AT-001,https://ClinicalTrials.gov/show/NCT04365699
918,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,Other: COVID-19 PCR and serology testing,https://ClinicalTrials.gov/show/NCT04424004
919,Late Clinical Events Associated With COVID-19 Infection,Other: Questionnaire|Other: Biocollection|Other: Follow-up visit,https://ClinicalTrials.gov/show/NCT04591613
920,Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test,Device: Rapid antigen testing and offsite PCR testing|Device: Rapid antigen testing and onsite PCR testing,https://ClinicalTrials.gov/show/NCT04904510
921,LLLT Treatment of Lung Inflammation in COVID-19,Device: Non-invasive red LLLT treatment to chest of patient.|Device: Sham Device Treatment,https://ClinicalTrials.gov/show/NCT04524715
922,Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California,Biological: Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04848584
923,Macro-scale Estimators of Covid-19's Worldwide Cases and Deaths,Other: frequency,https://ClinicalTrials.gov/show/NCT04757870
924,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,Diagnostic Test: SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04395391
925,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak,,https://ClinicalTrials.gov/show/NCT04650035
926,Clinical Study Spartan COVID-19 V2 System,Diagnostic Test: Spartan COVID-19 Test,https://ClinicalTrials.gov/show/NCT04575168
927,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,Other: Probiorinse|Other: Saline solution,https://ClinicalTrials.gov/show/NCT04458519
928,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,,https://ClinicalTrials.gov/show/NCT04422379
929,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Drug: HCQ & AZ vs HCQ+SIR,https://ClinicalTrials.gov/show/NCT04374903
930,Surgical Face Mask Effects in Patients With COVID-19,Other: Sit-To-Stand test,https://ClinicalTrials.gov/show/NCT04689542
931,Yale COVID-19 Recovery Study,Other: No intervention,https://ClinicalTrials.gov/show/NCT04895189
932,Early Versus Delayed Intubation of Patients With COVID-19,Other: Endotracheal intubation,https://ClinicalTrials.gov/show/NCT04632043
933,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses,Diagnostic Test: blood draw|Diagnostic Test: fingertip tests for POC assays|Diagnostic Test: saliva collection|Diagnostic Test: collection of swabs,https://ClinicalTrials.gov/show/NCT04483908
934,PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis,,https://ClinicalTrials.gov/show/NCT04741178
935,Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospital.,,https://ClinicalTrials.gov/show/NCT04860232
936,Ivermectin to Prevent Hospitalizations in COVID-19,Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04529525
937,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR,Diagnostic Test: Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol,https://ClinicalTrials.gov/show/NCT04599959
938,Prediction of Thrombosis Using D-dimer Trends in COVID-19,,https://ClinicalTrials.gov/show/NCT04827160
939,Tele-rehabilitation Program After Hospitalization for COVID-19,Other: TR|Other: TSu,https://ClinicalTrials.gov/show/NCT04821934
940,Comorbidities And Complications Associated With Covid-19 Infection,Other: complication,https://ClinicalTrials.gov/show/NCT04563442
941,Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals.,,https://ClinicalTrials.gov/show/NCT04860245
942,Arrhythmias in Patients With COVID-19,Device: C3+ Holter Monitor,https://ClinicalTrials.gov/show/NCT04395664
943,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,Drug: Bivalirudin Injection|Drug: Standard treatment,https://ClinicalTrials.gov/show/NCT04445935
944,Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis,Diagnostic Test: vaccination against COVID19,https://ClinicalTrials.gov/show/NCT04842708
945,Enriched Heparin Anti COVID-19 Trial,Drug: Heparin sodium|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04743011
946,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo,Biological: serological surveillance,https://ClinicalTrials.gov/show/NCT04701996
947,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,Device: Core Warming|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04494867
948,Awake Prone Position for Early Hypoxemia in COVID-19,Other: Self-prone position recommendation|Other: Usual care,https://ClinicalTrials.gov/show/NCT04344587
949,The RAPID COVID-19 TRIAGE Algorithm,Diagnostic Test: Spartan Cube Point-of Care Covid-19 test,https://ClinicalTrials.gov/show/NCT04353154
950,Hyperpolarized 129Xe MRI of Survivors of COVID-19,Drug: Hyperpolarized Xe129,https://ClinicalTrials.gov/show/NCT04659707
951,Physical Activity and the Risk of COVID-19 Infection and Mortality,,https://ClinicalTrials.gov/show/NCT04631861
952,Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application,Other: users,https://ClinicalTrials.gov/show/NCT04670003
953,Tele-monitoring of COVID-19 Survivors for Long-Term Impacts,Combination Product: cardiovascular and respiratory systems monitoring,https://ClinicalTrials.gov/show/NCT04644341
954,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug: MethylPREDNISolone 80 Mg/mL Injectable Suspension,https://ClinicalTrials.gov/show/NCT04355247
955,Convalescent Plasma in COVID-19 Elderly Patients,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04569188
956,Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study,,https://ClinicalTrials.gov/show/NCT04487665
957,Remdesivir- Ivermectin Combination Therapy in Severe Covid-19,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04944082
958,Immune Biomarkers of Outcome From COVID-19,Diagnostic Test: Peripheral blood sampling,https://ClinicalTrials.gov/show/NCT04436484
959,Current Pharmacological Practices in Severe COVID-19,Behavioral: Current clinical practices of participating physicians,https://ClinicalTrials.gov/show/NCT04691921
960,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,Biological: Biological,https://ClinicalTrials.gov/show/NCT04542967
961,SCB-2019 as COVID-19 Vaccine,Biological: SCB-2019|Biological: SCB-2019 with AS03 adjuvant|Biological: SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant,https://ClinicalTrials.gov/show/NCT04405908
962,Flow Controlled Ventilation in ARDS Associated With COVID-19,Device: Flow controlled ventilation (Evone-ventilator),https://ClinicalTrials.gov/show/NCT04399317
963,COVID-19 Study of Safety and Tolerability of Alvelestat,Drug: Alvelestat|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04539795
964,A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04725097
965,Convalescent Plasma Trial in COVID -19 Patients,Other: plasma therapy using convalescent plasma with antibody against SARS-CoV-2|Other: Routine care for COVID-19 patients,https://ClinicalTrials.gov/show/NCT04356534
966,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other: Surgical facial mask,https://ClinicalTrials.gov/show/NCT04337541
967,To Observe Whether Isoflurane Can Treat COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04492943
968,Community-based Post-exposure Prophylaxis for COVID-19,Other: Guduchi Ghanvati|Other: Standard guidelines,https://ClinicalTrials.gov/show/NCT04920773
969,French Cohort of COVID-19 Patients With Post-intensive Care Syndrome,Behavioral: Post-intensive Care unit syndrome,https://ClinicalTrials.gov/show/NCT04590170
970,Camostat Mesylate in COVID-19 Outpatients,Drug: Camostat Mesilate|Other: Placebo,https://ClinicalTrials.gov/show/NCT04353284
971,Convalescent Plasma for the Treatment of COVID-19,Drug: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04389710
972,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,Biological: Therapeutic plasma exchange (TPE)|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04441996
973,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Procedure: Ophthalmologic exam,https://ClinicalTrials.gov/show/NCT04387292
974,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,Drug: Cholecalciferol|Other: Placebo,https://ClinicalTrials.gov/show/NCT04636086
975,Patients Reactions Towards Their Diagnosis as Having COVID-19,,https://ClinicalTrials.gov/show/NCT04581928
976,Nebulized Heparin for COVID19-associated Acute Respiratory Failure,Drug: Heparin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04842292
977,Vocal Feature Analysis Algorithm for COVID-19 Detection,Device: Device used to record voice for screening,https://ClinicalTrials.gov/show/NCT04418544
978,IFN Beta-1b and Ribavirin for Covid-19,Drug: Interferon beta-1b|Drug: Ribavirin,https://ClinicalTrials.gov/show/NCT04494399
979,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,Dietary Supplement: Ovotransferrin,https://ClinicalTrials.gov/show/NCT04643054
980,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,,https://ClinicalTrials.gov/show/NCT04527497
981,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization,Device: Current Health,https://ClinicalTrials.gov/show/NCT04709068
982,Cytokine Storm Among Bangladeshi Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04598334
983,Macrophage Activation Markers in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04766294
984,Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner,,https://ClinicalTrials.gov/show/NCT04794361
985,Changes in Cellular Immune Profile During COVID-19 Infection,Other: Leukapheresis,https://ClinicalTrials.gov/show/NCT04470999
986,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,Other: Data collection from medical files,https://ClinicalTrials.gov/show/NCT04499300
987,Symprove (Probiotic) as an add-on to COVID-19 Management,Other: Symprove (probiotic)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04877704
988,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),,https://ClinicalTrials.gov/show/NCT04379440
989,Atorvastatin as Adjunctive Therapy in COVID-19,Drug: Atorvastatin,https://ClinicalTrials.gov/show/NCT04380402
990,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,,https://ClinicalTrials.gov/show/NCT04373486
991,Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive,Diagnostic Test: Roth´s Test,https://ClinicalTrials.gov/show/NCT04832828
992,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,Drug: Triazavirin (Riamilovir)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04581915
993,"Weathering the Storm: Lung, Heart, and Brain Vascular Rehabilitation for COVID-19",Other: Supervised Exercise Training Protocol|Other: Inspiratory Muscle and Exercise Training,https://ClinicalTrials.gov/show/NCT04887272
994,GRAd-COV2 Vaccine Against COVID-19,Biological: GRAd-COV2,https://ClinicalTrials.gov/show/NCT04528641
995,Convalescent Plasma for COVID-19 Patients (CPCP),Biological: Convalescent Plasma as Therapy for Covid-19 patients,https://ClinicalTrials.gov/show/NCT04521036
996,Rehabilitation Program for the Sequelae of COVID 19 Infection,,https://ClinicalTrials.gov/show/NCT04852718
997,The Role of Ultrasound in COVID-19,,https://ClinicalTrials.gov/show/NCT04377035
998,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,Other: MR-Pro-ADM,https://ClinicalTrials.gov/show/NCT04522310
999,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19",Dietary Supplement: Glycine|Dietary Supplement: N-acetylcysteine|Dietary Supplement: Alanine,https://ClinicalTrials.gov/show/NCT04703036
1000,Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia,Drug: Tofacitinib,https://ClinicalTrials.gov/show/NCT04750317
1001,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,Diagnostic Test: serology,https://ClinicalTrials.gov/show/NCT04543006
1002,Mental Status and Quality of Life of Post-COVID-19 Patients,Diagnostic Test: Assessment of mental state and quality of life,https://ClinicalTrials.gov/show/NCT04949035
1003,Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico,Dietary Supplement: Vitamin D3,https://ClinicalTrials.gov/show/NCT04793243
1004,Assessment of Efficacy of KAN-JANG® in Mild COVID-19,Drug: Kan Jang capsules|Other: Placebo capsules,https://ClinicalTrials.gov/show/NCT04847518
1005,Evaluating the Immune Response for COVID-19,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: COVID-19 Serology|Other: Symptoms questionnare,https://ClinicalTrials.gov/show/NCT04348422
1006,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),Biological: GAMUNEX-C|Drug: Standard Medical Treatment,https://ClinicalTrials.gov/show/NCT04480424
1007,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,Diagnostic Test: SARS-CoV-2 antibody immunoassays,https://ClinicalTrials.gov/show/NCT04496141
1008,"Allocetra-OTS in COVID-19, Phase II",Biological: Allocetra-OTS,https://ClinicalTrials.gov/show/NCT04590053
1009,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",Drug: rNAPc2|Drug: Heparin,https://ClinicalTrials.gov/show/NCT04655586
1010,Dietary Intake and Eating Habits During the COVID-19 Pandemic,Other: Diet tracking and survey,https://ClinicalTrials.gov/show/NCT04407533
1011,Administration of Chlorpromazine as a Treatment for COVID-19,Drug: Chlorpromazine,https://ClinicalTrials.gov/show/NCT04354805
1012,Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians,Biological: COVID-19 Vaccines,https://ClinicalTrials.gov/show/NCT04706143
1013,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Drug: Sarilumab Prefilled Syringe,https://ClinicalTrials.gov/show/NCT04386239
1014,Natural History Study of COVID-19 Using Digital Wearables,,https://ClinicalTrials.gov/show/NCT04927442
1015,Impact of Steroids on Inflammatory Response in Covid-19,Drug: Dexamethasone|Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04909918
1016,Vitamin A Supplementation in Children With Moderate to Severe COVID-19,Dietary Supplement: Vitamin A supplement,https://ClinicalTrials.gov/show/NCT04920760
1017,Cerebral Autoregulation and COVID-19,Other: NIRS (Near-Infrared Spectroscopy),https://ClinicalTrials.gov/show/NCT04930874
1018,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,Dietary Supplement: Acetyl L-Carnitine,https://ClinicalTrials.gov/show/NCT04623619
1019,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug: Amiodarone|Drug: Verapamil,https://ClinicalTrials.gov/show/NCT04351763
1020,Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,Other: State-trait anxiety inventory scale|Other: Edinburgh Postnatal Depression Scale (EDPS),https://ClinicalTrials.gov/show/NCT04558749
1021,Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection,Other: semi-directed entretien,https://ClinicalTrials.gov/show/NCT04849585
1022,HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID),Drug: Apixaban|Drug: Atorvastatin,https://ClinicalTrials.gov/show/NCT04801940
1023,Neurological and Neuropsychological Sequelae of COVID-19 Infection,Diagnostic Test: MRI|Diagnostic Test: Neuropsychological assessment|Diagnostic Test: Questionnaires Patient|Diagnostic Test: Questionnaires Family,https://ClinicalTrials.gov/show/NCT04745611
1024,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,Biological: COVID-19 Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04388527
1025,Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19,Device: PneumoniaCheck,https://ClinicalTrials.gov/show/NCT04912895
1026,SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease,Other: Standard of Care|Biological: SARS-CoV2-CTLS,https://ClinicalTrials.gov/show/NCT04896606
1027,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19",Other: Questionnaires|Other: Phone interviews,https://ClinicalTrials.gov/show/NCT04607941
1028,Assesment of the Metabolomic Signature in COVID-19 Patients,Other: COVID-19 patients,https://ClinicalTrials.gov/show/NCT04497272
1029,Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19,Diagnostic Test: Laboratory and instrumental examination,https://ClinicalTrials.gov/show/NCT04871789
1030,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic,Drug: Vitamin D|Diagnostic Test: ELISA,https://ClinicalTrials.gov/show/NCT04709744
1031,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,Drug: Thymalfasin,https://ClinicalTrials.gov/show/NCT04487444
1032,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,Device: DiaNose,https://ClinicalTrials.gov/show/NCT04476927
1033,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug: Ruxolitinib,https://ClinicalTrials.gov/show/NCT04338958
1034,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug: Nitric Oxide Gas|Other: Inhaled Supplemental Oxygen,https://ClinicalTrials.gov/show/NCT04338828
1035,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,Biological: BNT162b3,https://ClinicalTrials.gov/show/NCT04537949
1036,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),Diagnostic Test: Spartan COVID-19 v2 System,https://ClinicalTrials.gov/show/NCT04628208
1037,Etoposide in Patients With COVID-19 Infection,Drug: Etoposide,https://ClinicalTrials.gov/show/NCT04356690
1038,Aggrenox To Treat Acute Covid-19,Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04410328
1039,Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department,,https://ClinicalTrials.gov/show/NCT04786249
1040,World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments,Drug: Remdesivir|Drug: Acalabrutinib|Drug: Interferon beta-1a|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04647669
1041,COVID-19 Among Healthcare Workers in Belgian Hospitals,,https://ClinicalTrials.gov/show/NCT04373889
1042,Risk Factors and Characteristics of COVID 19 Infection in Patients With Haematological Diseases,,https://ClinicalTrials.gov/show/NCT04930731
1043,Tofacitinib for Treatment of Moderate COVID-19,Drug: Tofacitinib 10 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04415151
1044,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Diagnostic Test: Outpatient MRI,https://ClinicalTrials.gov/show/NCT04369807
1045,Rehabilitation After Admission in Intensive Care Unit for COVID-19,,https://ClinicalTrials.gov/show/NCT04523051
1046,DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients,Other: No intervention,https://ClinicalTrials.gov/show/NCT04784468
1047,Treatment of Angiotensin Peptide (1-7) for COVID-19,Biological: Biological/Vaccine: Angiotensin peptide (1-7) derived plasma,https://ClinicalTrials.gov/show/NCT04375124
1048,Clazakizumab vs. Placebo - COVID-19 Infection,Drug: Clazakizumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04494724
1049,IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.,Drug: PF-06650833|Drug: Matching Placebo,https://ClinicalTrials.gov/show/NCT04933799
1050,Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm,Diagnostic Test: AI model,https://ClinicalTrials.gov/show/NCT04561024
1051,Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients,Device: Carragelose|Device: NaCl,https://ClinicalTrials.gov/show/NCT04793984
1052,Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19,Drug: GX-I7|Drug: GX-I7 vehicle,https://ClinicalTrials.gov/show/NCT04730427
1053,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,,https://ClinicalTrials.gov/show/NCT04381351
1054,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug: Doxycycline|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04371952
1055,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Dietary Supplement: Quercetin Prophylaxis|Dietary Supplement: Quercetin Treatment,https://ClinicalTrials.gov/show/NCT04377789
1056,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Drug: Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB),https://ClinicalTrials.gov/show/NCT04357535
1057,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,Other: Observation,https://ClinicalTrials.gov/show/NCT04576351
1058,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,Drug: TM5614|Other: Placebo,https://ClinicalTrials.gov/show/NCT04634799
1059,Hydroxychloroquine for Treatment of Non-Severe COVID-19,Drug: Hydroxychloroquine tablets,https://ClinicalTrials.gov/show/NCT04860284
1060,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Drug: SnPP Protoporphyrin plus Sunlight exposure|Drug: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.|Other: placebo,https://ClinicalTrials.gov/show/NCT04371822
1061,Cyclosporine in Patients With Moderate COVID-19,Drug: Cyclosporine,https://ClinicalTrials.gov/show/NCT04412785
1062,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,Drug: Sofosbuvir|Drug: Daclatasvir,https://ClinicalTrials.gov/show/NCT04497649
1063,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,Biological: Anti-SARS-CoV-2 immunoglobulin,https://ClinicalTrials.gov/show/NCT04573855
1064,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution|Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04427098
1065,Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19,Other: Respiratory functions,https://ClinicalTrials.gov/show/NCT04789512
1066,Response of Korean Medicine Hospital to COVID-19,Other: Survey,https://ClinicalTrials.gov/show/NCT04529447
1067,Using Travelan to Boost Immune Response in Vitro to COVID-19,Other: Travelan OTC,https://ClinicalTrials.gov/show/NCT04643561
1068,Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning,Other: Machine learning|Other: Machine based evaluation,https://ClinicalTrials.gov/show/NCT04828915
1069,Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19,,https://ClinicalTrials.gov/show/NCT04780555
1070,Respiratory Physiotherapy in Severe COVID-19 Patients,Other: Respiratory physiotherapy,https://ClinicalTrials.gov/show/NCT04459819
1071,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04584450
1072,Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19,Other: Data extraction from medical files,https://ClinicalTrials.gov/show/NCT04779749
1073,Evaluation of ADG20 for the Prevention of COVID-19,Drug: ADG20|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04859517
1074,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,"Drug: Hydroxychloroquine , Sofosbuvir, daclatasvir|Drug: Standard of care treatment",https://ClinicalTrials.gov/show/NCT04443725
1075,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),Drug: Nitric Oxide,https://ClinicalTrials.gov/show/NCT04383002
1076,"Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19","Diagnostic Test: Electrocardiography ,Tomographic imaging",https://ClinicalTrials.gov/show/NCT04698083
1077,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,,https://ClinicalTrials.gov/show/NCT04376398
1078,Optimising Resource Allocation Via Prediction of Outcomes for Covid-19,,https://ClinicalTrials.gov/show/NCT04473105
1079,A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection,Drug: Xlear Nasal Spray|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04858620
1080,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia,Device: Hyperbaric Oxygen Therapy (HBOT),https://ClinicalTrials.gov/show/NCT04619719
1081,COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life,Other: Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings,https://ClinicalTrials.gov/show/NCT04679584
1082,Glutamine Supplementation and Short-term Mortality in Covid-19,Dietary Supplement: Standard enteral nutrition|Combination Product: Glutamine,https://ClinicalTrials.gov/show/NCT04909905
1083,Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection,Drug: Cannabidiol,https://ClinicalTrials.gov/show/NCT04731116
1084,Hexoskin Feasibility Study With COVID-19 Patients,Device: Monitoring physiological data with the Hexoskin smart shirt,https://ClinicalTrials.gov/show/NCT04453891
1085,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,,https://ClinicalTrials.gov/show/NCT04327674
1086,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,Drug: ISIS 721744|Drug: Normal Saline,https://ClinicalTrials.gov/show/NCT04549922
1087,How Brazilian Chiropractors Are Facing the COVID-19 Pandemic,Other: Electronic survey,https://ClinicalTrials.gov/show/NCT04534621
1088,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),Drug: PF-06650833|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04575610
1089,The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04769245
1090,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,Biological: Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)|Drug: COVID-19 standard care,https://ClinicalTrials.gov/show/NCT04473170
1091,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,Drug: Oxygen,https://ClinicalTrials.gov/show/NCT04500626
1092,Respiratory Aerosols in Patients With COVID-19 and Healthy Controls,Diagnostic Test: Resp-Aer-Meter|Diagnostic Test: Spirometry|Diagnostic Test: Qualitative and quantitative virus PCR of respiratory secretions in patients with high aerosol concentrations,https://ClinicalTrials.gov/show/NCT04739020
1093,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,Drug: Colchicine|Drug: Standard COVID-19 care,https://ClinicalTrials.gov/show/NCT04667780
1094,Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients,Other: Covid-19+ observational,https://ClinicalTrials.gov/show/NCT04892797
1095,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Other: Deep Venous Disease Diagnostic,https://ClinicalTrials.gov/show/NCT04361981
1096,"Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease",Drug: Part A: Upamostat 200 mg|Drug: Part A: Upamostat 400 mg|Drug: Part A and B: Placebo|Drug: Part B: Upamostat 200 or 400 mg,https://ClinicalTrials.gov/show/NCT04723537
1097,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic,Diagnostic Test: COVID-19 diagnostic PCR,https://ClinicalTrials.gov/show/NCT04480060
1098,COVID-19 Vaccination of Immunodeficient Persons (COVAXID),"Biological: Comirnaty (COVID-19, mRNA vaccine)",https://ClinicalTrials.gov/show/NCT04780659
1099,Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19,Drug: Favipiravir|Drug: Nitazoxanide|Other: Nitazoxanide Placebo,https://ClinicalTrials.gov/show/NCT04918927
1100,Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.,Drug: Remdesivir|Drug: Hydroxychloroquine|Drug: Tocilizumab|Drug: Lopinavir/ Ritonavir|Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04779047
1101,Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,,https://ClinicalTrials.gov/show/NCT04521088
1102,Virological and Immunological Monitoring in Patients (Suspected of/Confirmed With) COVID-19,Procedure: Blood draw|Procedure: Bronchoalveolar lavage|Procedure: SARS CoV-2 swabs,https://ClinicalTrials.gov/show/NCT04904692
1103,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults,Biological: hAd5-S-Fusion+N-ETSD vaccine,https://ClinicalTrials.gov/show/NCT04710303
1104,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,Diagnostic Test: Passive Microwave Radiometry,https://ClinicalTrials.gov/show/NCT04568525
1105,Epidemiological Multicohort Study of Latent COVID-19 Infections,Diagnostic Test: COVID-19 nasal/pharyngeal swab,https://ClinicalTrials.gov/show/NCT04695678
1106,Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?,"Device: IB10 sphingotest® bio-ADM® apparatus (Sphingotec GmbH, Hennigsdorf, Germany)",https://ClinicalTrials.gov/show/NCT04813939
1107,Decision Support System Algorithm for COVID-19 Diagnosis,Diagnostic Test: Thorax CT,https://ClinicalTrials.gov/show/NCT04479319
1108,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,Diagnostic Test: COVID-19 antibodies testing,https://ClinicalTrials.gov/show/NCT04445415
1109,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,Diagnostic Test: IgG SARS CoV 2 antibodies,https://ClinicalTrials.gov/show/NCT04563247
1110,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,"Dietary Supplement: D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester|Dietary Supplement: Placebo",https://ClinicalTrials.gov/show/NCT04573764
1111,Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing,Other: Epi-Net Intervention,https://ClinicalTrials.gov/show/NCT04910542
1112,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Other: Prone Positioning|Other: Supine Positioning,https://ClinicalTrials.gov/show/NCT04424797
1113,Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.,Diagnostic Test: Virological and serological tests,https://ClinicalTrials.gov/show/NCT04858581
1114,Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.,Drug: Hypertonic Saturated Saline Mouth Rinse Active Arm|Other: Placebo Plain Water Mouth Rinse Arm,https://ClinicalTrials.gov/show/NCT04842721
1115,Long COVID Kids DK - Investigating Long-term Covid-19,Other: LongCOVIDkidsDK,https://ClinicalTrials.gov/show/NCT04786353
1116,Randomised Study of Plasma Exchange in Severe COVID-19,Drug: OCTAPLAS,https://ClinicalTrials.gov/show/NCT04623255
1117,"Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial",Drug: Mefloquine as a prophylaxis against SARS-Cov-2 infection in household contacts of COVID 19 confirmed cases,https://ClinicalTrials.gov/show/NCT04847661
1118,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19),Diagnostic Test: Cardiac MRI|Diagnostic Test: Cardiac CT|Diagnostic Test: Electrocardiogram (ECG)|Diagnostic Test: Blood samples,https://ClinicalTrials.gov/show/NCT04625075
1119,Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection,Drug: Cytotoxic T Lymphocytes,https://ClinicalTrials.gov/show/NCT04765449
1120,The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients,"Drug: Chlorhexidine digluconate, povidone iodine",https://ClinicalTrials.gov/show/NCT04941131
1121,Protecting Health Care Workers During the COVID-19 Outbreak,Dietary Supplement: Ayurvedic Kadha,https://ClinicalTrials.gov/show/NCT04387643
1122,Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment,Drug: Azithromycin / Ivermectin / Ribaroxaban / Paracetamol|Drug: Azithromycin / Ribaroxaban / Paracetamol,https://ClinicalTrials.gov/show/NCT04673214
1123,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen,Diagnostic Test: KnowNow SARS-CoV-2 Rapid Antigen Test,https://ClinicalTrials.gov/show/NCT04733170
1124,Ramipril for the Treatment of COVID-19,Drug: Ramipril 2.5 MG Oral Capsule|Drug: Placebo oral capsule,https://ClinicalTrials.gov/show/NCT04366050
1125,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,Drug: Defibrotide,https://ClinicalTrials.gov/show/NCT04652115
1126,Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04764747
1127,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity,Drug: DAAD Compound,https://ClinicalTrials.gov/show/NCT04729153
1128,A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,Drug: NOX66,https://ClinicalTrials.gov/show/NCT04555213
1129,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,Biological: recovered covid 19 patients plasma,https://ClinicalTrials.gov/show/NCT04530370
1130,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,Device: miniprobe Alveoflex,https://ClinicalTrials.gov/show/NCT04451889
1131,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",,https://ClinicalTrials.gov/show/NCT04594356
1132,Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients,,https://ClinicalTrials.gov/show/NCT04887623
1133,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Other: Saline Nasal Irrigation|Other: Saline with Baby Shampoo Nasal Irrigation,https://ClinicalTrials.gov/show/NCT04347538
1134,The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing,Diagnostic Test: Spartan COVID-19 Platform,https://ClinicalTrials.gov/show/NCT04767958
1135,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,Drug: Atorvastatin + L-arginine + Folic acid + Nicorandil + Nebivolol|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04631536
1136,Retrospective Study of ImmunoFormulation for COVID-19,Dietary Supplement: ImmunoFormulation,https://ClinicalTrials.gov/show/NCT04666753
1137,COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,Biological: hAd5-S-Fusion+N-ETSD vaccine,https://ClinicalTrials.gov/show/NCT04843722
1138,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),Other: Observational,https://ClinicalTrials.gov/show/NCT04561193
1139,Remote-by-Default Care in the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04435041
1140,Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients,Device: Vascular occlusion test,https://ClinicalTrials.gov/show/NCT04689477
1141,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug: Bromhexine Oral Tablet and/or hydroxychloroquine tablet,https://ClinicalTrials.gov/show/NCT04355026
1142,Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress,Other: Hyperbaric Oxygen Therapy,https://ClinicalTrials.gov/show/NCT04800120
1143,Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients,Biological: Dupilumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04920916
1144,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug: Sirolimus|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04341675
1145,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers,Biological: hAd5-S-Fusion+N-ETSD vaccine,https://ClinicalTrials.gov/show/NCT04591717
1146,Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.,Other: Moderate Exercise Training (Age Group 1; Young adult 17 -30 years)|Other: Moderate Exercise Training (Age Group 2; 31 to 45 years)|Other: Moderate Exercise Training (Age Group 3; Above 45 years),https://ClinicalTrials.gov/show/NCT04927182
1147,Mesenchymal Stem Cell Infusion for COVID-19 Infection,Drug: Mesenchymal stem cells|Other: Placebo,https://ClinicalTrials.gov/show/NCT04444271
1148,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,Biological: Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs,https://ClinicalTrials.gov/show/NCT04276896
1149,Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes,Drug: HMW-HA,https://ClinicalTrials.gov/show/NCT04830020
1150,The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.,Other: oxygen mask,https://ClinicalTrials.gov/show/NCT04794400
1151,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,Drug: Tofacitinib 10 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04469114
1152,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,Procedure: Therapeutic Plasma Exchange (TPE),https://ClinicalTrials.gov/show/NCT04457349
1153,Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,Biological: Octagam 10%|Other: Placebo,https://ClinicalTrials.gov/show/NCT04400058
1154,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,Drug: Hydroxychloroquine Sulfate Tablets|Drug: Ivermectin 3mg Tab|Drug: Zinc|Drug: Povidone-Iodine|Dietary Supplement: Vitamin C,https://ClinicalTrials.gov/show/NCT04446104
1155,Infliximab in the Treatment of Patients With Severe COVID-19 Disease,Drug: Infliximab|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04922827
1156,Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV),Diagnostic Test: Blood count|Diagnostic Test: Blood collection|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Saliva samples|Diagnostic Test: Faeces samples|Genetic: Genetic blood collection|Other: Data collection,https://ClinicalTrials.gov/show/NCT04703114
1157,Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home,Drug: standard of care for COVID-19 as per the hospital guidelines|Dietary Supplement: Quercetin Phytosome (QP),https://ClinicalTrials.gov/show/NCT04861298
1158,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,,https://ClinicalTrials.gov/show/NCT04401098
1159,COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA,Biological: hAd5-S-Fusion+N-ETSD (Suspension for injection)|Drug: hAd5-SFusion+ N-ETSD (Oral capsule),https://ClinicalTrials.gov/show/NCT04732468
1160,Comparison of Two Different Doses of Bemiparin in COVID-19,Drug: Bemiparin sodium,https://ClinicalTrials.gov/show/NCT04604327
1161,Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19),Other: Observation,https://ClinicalTrials.gov/show/NCT04708912
1162,Trial of Imatinib for Hospitalized Adults With COVID-19,Drug: Imatinib|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04394416
1163,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Drug: N-acetylcysteine|Other: Peripheral Blood,https://ClinicalTrials.gov/show/NCT04374461
1164,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Diagnostic Test: Breath test,https://ClinicalTrials.gov/show/NCT04329507
1165,Comparison of COVID-19 and H1N1 Influenza Pneumonia,Device: computed Tomography,https://ClinicalTrials.gov/show/NCT04933994
1166,Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool,Diagnostic Test: Face mask sampling,https://ClinicalTrials.gov/show/NCT04481646
1167,Jinhua Qinggan Granules in the Treatment of COVID-19,"Combination Product: Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine|Other: Placebo Comparator",https://ClinicalTrials.gov/show/NCT04723524
1168,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Diagnostic Test: molecular testing for virus RNA using RT-PCR,https://ClinicalTrials.gov/show/NCT04377802
1169,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,Biological: COVID-19 Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04397757
1170,Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19,Drug: Allocetra-OTS,https://ClinicalTrials.gov/show/NCT04659304
1171,"A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19",Diagnostic Test: Recordings of cough sounds from adults,https://ClinicalTrials.gov/show/NCT04864535
1172,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,"Drug: Lenalidomide as a 5 mg capsule PO daily, days 1, 3, and 5.|Drug: Placebo",https://ClinicalTrials.gov/show/NCT04361643
1173,Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors,,https://ClinicalTrials.gov/show/NCT04665752
1174,Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity,Diagnostic Test: Lung ultrasound,https://ClinicalTrials.gov/show/NCT04689672
1175,Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug: Surfactant,https://ClinicalTrials.gov/show/NCT04568018
1176,A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19,Biological: Ampion|Other: Placebo,https://ClinicalTrials.gov/show/NCT04868890
1177,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",,https://ClinicalTrials.gov/show/NCT04318418
1178,Retrospective Evaluation of Lung Pathology in Subjects With COVID-19,,https://ClinicalTrials.gov/show/NCT04878913
1179,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,,https://ClinicalTrials.gov/show/NCT04285801
1180,Dietary Supplements for COVID-19,"Drug: Vitamin D3 50,000 IU|Dietary Supplement: Vitamin C/Zinc|Dietary Supplement: Vitamin K2/D|Other: Microcrystalline Cellulose Capsule|Other: Medium Chain Triglyceride Oil",https://ClinicalTrials.gov/show/NCT04780061
1181,Neuropathology in Adults Intensive Care Unit Patients With COVID 19,Procedure: autopsy,https://ClinicalTrials.gov/show/NCT04453670
1182,Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),Drug: theraputic heparin|Drug: prophylactic heparin|Drug: P2Y12,https://ClinicalTrials.gov/show/NCT04505774
1183,A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,Drug: Bemcentinib|Other: SoC,https://ClinicalTrials.gov/show/NCT04890509
1184,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,Drug: N-Acetyl cysteine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04455243
1185,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,,https://ClinicalTrials.gov/show/NCT04330599
1186,Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2,Device: Theram COVID-19 Rapid Antigen Test,https://ClinicalTrials.gov/show/NCT04878068
1187,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,Drug: RTB101|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04584710
1188,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19",Dietary Supplement: 5-ALA-Phosphate + SFC (5-ALA+SFC),https://ClinicalTrials.gov/show/NCT04854876
1189,Microbial Infection and AMR in Hospitalized Patients With Covid 19,,https://ClinicalTrials.gov/show/NCT04479982
1190,IMU-838 and Oseltamivir in the Treatment of COVID-19,Drug: IMU-838|Drug: Oseltamivir,https://ClinicalTrials.gov/show/NCT04516915
1191,Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study,Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04669990
1192,The Effects of Physical Activity Counseling on Physical Activity and Quality of Life in Covid-19 Patients,Behavioral: Physical activity counseling,https://ClinicalTrials.gov/show/NCT04853966
1193,Desidustat in the Management of COVID-19 Patients,Drug: Desidustat|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04463602
1194,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other: Rehabilitation,https://ClinicalTrials.gov/show/NCT04365738
1195,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Drug: Lopinavir/Ritonavir 400 mg/100 mg|Other: Placebo,https://ClinicalTrials.gov/show/NCT04372628
1196,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,Genetic: Whole exome sequencing,https://ClinicalTrials.gov/show/NCT04506229
1197,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients,,https://ClinicalTrials.gov/show/NCT04713852
1198,Attitude of Egyptian Population Toward COVID 19 in Ramadan,,https://ClinicalTrials.gov/show/NCT04401072
1199,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,Drug: Tocilizumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04412772
1200,A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects,Drug: C21|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04880642
1201,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Procedure: Collection of Biological Samples|Procedure: Symptom and Exposure Surveys,https://ClinicalTrials.gov/show/NCT04375761
1202,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,Biological: Umbilical cord derived mesenchymal stem cells|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04429763
1203,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Other: patients COVID 19,https://ClinicalTrials.gov/show/NCT04418206
1204,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,Drug: Ivermectin (IVM),https://ClinicalTrials.gov/show/NCT04343092
1205,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,Drug: prophylactic lactoferrin daily,https://ClinicalTrials.gov/show/NCT04427865
1206,The Evaluation of Hemostasis in Hospitalized COVID-19 Patients,Diagnostic Test: Phlebotomy,https://ClinicalTrials.gov/show/NCT04493307
1207,A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans,,https://ClinicalTrials.gov/show/NCT04852289
1208,Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes,Other: CPC+ZN|Other: CPC|Other: Negative Control,https://ClinicalTrials.gov/show/NCT04902976
1209,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug: Treatment and prophylaxis|Other: Standard Public Health measures,https://ClinicalTrials.gov/show/NCT04304053
1210,Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19,Dietary Supplement: Vitamin K2 in the form of Menaquinone-7 (MK-7)|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04770740
1211,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,Diagnostic Test: Transpulmonary pressure measurements,https://ClinicalTrials.gov/show/NCT04519411
1212,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,Drug: Disulfiram|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04594343
1213,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,Drug: CD24Fc|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04317040
1214,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,,https://ClinicalTrials.gov/show/NCT04380792
1215,A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects,Drug: OT-101|Drug: Artemisinin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04801017
1216,A Study of Baricitinib (LY3009104) in Participants With COVID-19,Drug: Baricitinib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04421027
1217,Survival TRial Using CytoKines in COVID-19 (STRUCK Trial),Biological: Ixekizumab|Biological: Aldesleukin|Drug: Colchicine|Drug: Standard of care (SOC),https://ClinicalTrials.gov/show/NCT04724629
1218,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Other: Data monitoring for 48h within the first 24 hours of admission for COVID-19,https://ClinicalTrials.gov/show/NCT04376879
1219,Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal,Drug: Favipiravir|Drug: Placebo|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04694612
1220,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Device: Seraph 100,https://ClinicalTrials.gov/show/NCT04361500
1221,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Drug: Colchicine Tablets|Other: Current care per UCLA treating physicians,https://ClinicalTrials.gov/show/NCT04355143
1222,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,Combination Product: MW33 injection|Combination Product: MW33 injection placebo,https://ClinicalTrials.gov/show/NCT04627584
1223,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,Drug: aerosolized DNase|Drug: NaCl,https://ClinicalTrials.gov/show/NCT04541979
1224,Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19),Drug: Famotidine 20 milligram tablet,https://ClinicalTrials.gov/show/NCT04565392
1225,RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.,Other: Breathing exercise,https://ClinicalTrials.gov/show/NCT04703478
1226,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Biological: Biological test,https://ClinicalTrials.gov/show/NCT04363385
1227,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,Device: Auricular percutaneous neurostimulation,https://ClinicalTrials.gov/show/NCT04514627
1228,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),Diagnostic Test: Quidel Sofia SARS Antigen FIA,https://ClinicalTrials.gov/show/NCT04610489
1229,Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,Drug: Remdesivir|Drug: Lopinavir/ Ritonavir and Remdesivir combination,https://ClinicalTrials.gov/show/NCT04738045
1230,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug: Therapeutic Anticoagulation,https://ClinicalTrials.gov/show/NCT04362085
1231,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),Biological: ConvP|Biological: FFP,https://ClinicalTrials.gov/show/NCT04589949
1232,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,Diagnostic Test: Prognostic score,https://ClinicalTrials.gov/show/NCT04484545
1233,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04351620
1234,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Other: survey,https://ClinicalTrials.gov/show/NCT04319315
1235,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostic Test: diagnostic tests for COVID-19 infection,https://ClinicalTrials.gov/show/NCT04372004
1236,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Drug: chlorine dioxide 3000 ppm,https://ClinicalTrials.gov/show/NCT04343742
1237,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,Diagnostic Test: Repeat SARS-CoV-2 IgG antibodies at 45-65 days,https://ClinicalTrials.gov/show/NCT04605952
1238,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04334252
1239,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,Drug: Angiotensin-(1-7)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04570501
1240,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,,https://ClinicalTrials.gov/show/NCT04360278
1241,The Vietnam Chloroquine Treatment on COVID-19,Drug: Chloroquine phosphate,https://ClinicalTrials.gov/show/NCT04328493
1242,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,Other: Baseline and during hospitalization blood samples|Other: Baseline blood sample,https://ClinicalTrials.gov/show/NCT04613297
1243,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Drug: Ravulizumab|Drug: Baricitinib|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04390464
1244,The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients,,https://ClinicalTrials.gov/show/NCT04817397
1245,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,Drug: Guduchi Ghan Vati,https://ClinicalTrials.gov/show/NCT04542876
1246,Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19),Drug: Pegylated Interferon-α2b|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04480138
1247,Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting,Biological: BAMLANIVIMAB|Biological: CASIRIVIMAB|Biological: IMDEVIMAB,https://ClinicalTrials.gov/show/NCT04840459
1248,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug: Ascorbic Acid,https://ClinicalTrials.gov/show/NCT04363216
1249,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,Diagnostic Test: interleuken 6 level measurment|Diagnostic Test: Interleukin-6 Gene-174C detection,https://ClinicalTrials.gov/show/NCT04544033
1250,Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19,Drug: ADG20|Drug: Normal saline,https://ClinicalTrials.gov/show/NCT04805671
1251,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug: Atovaquone/Azithromycin,https://ClinicalTrials.gov/show/NCT04339426
1252,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19","Diagnostic Test: N terminal pro B type natriuretic peptide (NTproBNP), D-Dimer, and serum Tropinin - I",https://ClinicalTrials.gov/show/NCT04433026
1253,Study to Assess the Effect of Meplazumab on COVID-19,Drug: Meplazumab for Injection|Drug: Sterile normal saline (0.9%),https://ClinicalTrials.gov/show/NCT04586153
1254,Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19,Biological: MesenCure,https://ClinicalTrials.gov/show/NCT04716998
1255,Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.,Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04847622
1256,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Device: gammaCore® (Vagus nerve stimulation),https://ClinicalTrials.gov/show/NCT04368156
1257,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",,https://ClinicalTrials.gov/show/NCT04403386
1258,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04334382
1259,Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19,Dietary Supplement: Nicotinamide|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04751604
1260,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,Drug: Ivermectin and Doxycycline|Other: Placebo,https://ClinicalTrials.gov/show/NCT04551755
1261,Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04714138
1262,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,Diagnostic Test: CT-Scan,https://ClinicalTrials.gov/show/NCT04424849
1263,Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19,Drug: Hospital standard of care for COVID-19|Drug: Isoquercetin,https://ClinicalTrials.gov/show/NCT04733651
1264,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,,https://ClinicalTrials.gov/show/NCT04345536
1265,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,Biological: hMSC,https://ClinicalTrials.gov/show/NCT04780685
1266,A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19,Biological: DelNS1-nCoV-RBD LAIV|Biological: Matching placebo,https://ClinicalTrials.gov/show/NCT04809389
1267,Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,Other: Ayurveda,https://ClinicalTrials.gov/show/NCT04716647
1268,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),Drug: Camostat Mesilate|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04583592
1269,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04342182
1270,Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France,,https://ClinicalTrials.gov/show/NCT04656444
1271,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug: Colchicine Tablets|Drug: Standard therapy for COVID-19 according to the stablished hospital protocols.,https://ClinicalTrials.gov/show/NCT04350320
1272,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,Biological: CCP,https://ClinicalTrials.gov/show/NCT04438057
1273,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,Biological: Biological sampling,https://ClinicalTrials.gov/show/NCT04380987
1274,Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19,Drug: Naltrexone Hydrochloride,https://ClinicalTrials.gov/show/NCT04708327
1275,The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients,Drug: Resveratrol|Drug: Placebo capsules,https://ClinicalTrials.gov/show/NCT04799743
1276,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Procedure: blood sampling,https://ClinicalTrials.gov/show/NCT04367662
1277,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,Biological: Convalescent Plasma|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04438694
1278,Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia,Procedure: Invasive ventilation strategy|Procedure: Non-invasive ventilation strategies,https://ClinicalTrials.gov/show/NCT04799691
1279,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,Diagnostic Test: Diagnostic Test: serology test for COVID-19,https://ClinicalTrials.gov/show/NCT04525911
1280,Risk of Contamination by COVID-19 During Oral Care With Aerosolization,Procedure: Oral care with/without aerosolization,https://ClinicalTrials.gov/show/NCT04817319
1281,Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,Other: no intervention,https://ClinicalTrials.gov/show/NCT04519034
1282,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,Drug: Cholecalciferol,https://ClinicalTrials.gov/show/NCT04552951
1283,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Device: BIOVITALS,https://ClinicalTrials.gov/show/NCT04343794
1284,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,Diagnostic Test: Imaging by thoracic scanner,https://ClinicalTrials.gov/show/NCT04418245
1285,COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,Biological: hAd5-S-Fusion+N-ETSD vaccine,https://ClinicalTrials.gov/show/NCT04845191
1286,Study of Sargramostim in Patients With COVID-19,Drug: Sargramostim|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04411680
1287,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,Device: KELEA Excellerated Water|Device: Water Without an Elevated Level of KELEA,https://ClinicalTrials.gov/show/NCT04490824
1288,Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients,Other: Pulmonary telerehabilitation|Other: progressive muscle relaxation training,https://ClinicalTrials.gov/show/NCT04741282
1289,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04347174
1290,Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients,Other: Survey,https://ClinicalTrials.gov/show/NCT04473118
1291,"Rapid Screening Circuit of COVID 19 in Schools, Pilot Study",Other: Escola L'Horitzó|Other: Escola John Talabot,https://ClinicalTrials.gov/show/NCT04878809
1292,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,Device: Viruxal Oral and Nasal Spray|Other: Placebo,https://ClinicalTrials.gov/show/NCT04357990
1293,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Drug: Povidone-Iodine|Drug: Essential oils|Other: Tap water,https://ClinicalTrials.gov/show/NCT04410159
1294,Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen,Biological: Ampion|Other: Saline,https://ClinicalTrials.gov/show/NCT04839965
1295,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,Drug: PHR160 Spray|Drug: Placebo|Drug: Standard treatment,https://ClinicalTrials.gov/show/NCT04463420
1296,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,Drug: 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse,https://ClinicalTrials.gov/show/NCT04478019
1297,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Procedure: Extended sampling and procedures,https://ClinicalTrials.gov/show/NCT04368013
1298,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,,https://ClinicalTrials.gov/show/NCT04368221
1299,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,Drug: Camostat Mesilate|Drug: Placebo|Other: Standard of Care Treatment,https://ClinicalTrials.gov/show/NCT04524663
1300,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,Drug: Ulinastatin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04393311
1301,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,Other: Shanshamani Vati Plus,https://ClinicalTrials.gov/show/NCT04621903
1302,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,Biological: Ampion|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04606784
1303,Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial),Drug: Baricitinib Oral Tablet [Olumiant]|Drug: Remdesivir|Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04832880
1304,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,Biological: COVID-19 convalescent hyperimmune plasma|Biological: Non-convalescent fresh frozen plasma (Standard plasma),https://ClinicalTrials.gov/show/NCT04392414
1305,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,Drug: Camostat|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04625114
1306,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug: Clazakizumab,https://ClinicalTrials.gov/show/NCT04348500
1307,Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19),Behavioral: questionnaire,https://ClinicalTrials.gov/show/NCT04583761
1308,"""CHANGE COVID-19 Severity""",Drug: Magnesium Citrate plus probiotic,https://ClinicalTrials.gov/show/NCT04941703
1309,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Device: Control swab|Device: Prototype swab,https://ClinicalTrials.gov/show/NCT04368260
1310,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Other: Physical Exercises,https://ClinicalTrials.gov/show/NCT04445376
1311,Convalescent Plasma as a Possible Treatment for COVID-19,Biological: Convalescent plasma|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04442191
1312,"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",,https://ClinicalTrials.gov/show/NCT04560608
1313,A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19,Drug: Enisamium Iodide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04682873
1314,Endothelial Dysfunction in Covid-19,,https://ClinicalTrials.gov/show/NCT04830683
1315,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,Drug: HB-adMSC|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04362189
1316,A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID),Biological: Ampion|Other: Placebo,https://ClinicalTrials.gov/show/NCT04880161
1317,"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection",Biological: AV-COVID-19|Other: GM-CSF,https://ClinicalTrials.gov/show/NCT04690387
1318,COVID-19 and Hereditary Metabolic Diseases,,https://ClinicalTrials.gov/show/NCT04645498
1319,Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04818463
1320,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,Device: Connected devices measurements,https://ClinicalTrials.gov/show/NCT04560855
1321,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,Drug: EC-18|Drug: Placebo EC-18,https://ClinicalTrials.gov/show/NCT04500132
1322,Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID,Device: 18F-FDG PET-CT,https://ClinicalTrials.gov/show/NCT04764721
1323,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,"Other: chlorine dioxide|Dietary Supplement: zinc acetate|Drug: Famotidine|Other: placebo|Dietary Supplement: lactoferrin, green tea extract",https://ClinicalTrials.gov/show/NCT04621149
1324,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,Drug: Melatonin|Drug: The usual treatment,https://ClinicalTrials.gov/show/NCT04409522
1325,Study to Evaluate Tempol (MBM-02) to Help Prevent Hospitalizations in COVID-19 Patients.,Drug: Tempol|Other: Placebo,https://ClinicalTrials.gov/show/NCT04729595
1326,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Device: current IPAC-UHN PPE|Device: modified IPAC-UHN PPE,https://ClinicalTrials.gov/show/NCT04373096
1327,Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia,Dietary Supplement: Saisei Maf capsules,https://ClinicalTrials.gov/show/NCT04845971
1328,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug: Colchicine Tablets,https://ClinicalTrials.gov/show/NCT04360980
1329,Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),https://ClinicalTrials.gov/show/NCT04676971
1330,Effect of Obesity Among COVID-19 Patients in Critical Care Settings,,https://ClinicalTrials.gov/show/NCT04674553
1331,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug: RhACE2 APN01|Drug: Physiological saline solution,https://ClinicalTrials.gov/show/NCT04335136
1332,Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19,Drug: Niclosamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04932915
1333,INB03 for the Treatment of Pulmonary Complications From COVID-19,Drug: INB03|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04370236
1334,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Device: GO2 PEEP MOUTHPIECE,https://ClinicalTrials.gov/show/NCT04331366
1335,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",Biological: Inactivated SARS-CoV-2 vaccine (Vero cell)|Biological: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine,https://ClinicalTrials.gov/show/NCT04560881
1336,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,Drug: Hydroxychloroquine|Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04391127
1337,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Other: No interventions planned,https://ClinicalTrials.gov/show/NCT04371679
1338,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,Diagnostic Test: IP-10 in CDS protocol,https://ClinicalTrials.gov/show/NCT04389645
1339,The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,Drug: SCTA01|Other: Placebo,https://ClinicalTrials.gov/show/NCT04644185
1340,Nigella Sativa in COVID-19,Dietary Supplement: Nigella sativa oil,https://ClinicalTrials.gov/show/NCT04401202
1341,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug: Favipiravir + Standard of Care|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04358549
1342,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug: Hydroxychloroquine Sulfate 200 MG|Other: Placebo,https://ClinicalTrials.gov/show/NCT04359537
1343,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,"Diagnostic Test: Standard 12-lead ECG, NT-proBNP, echocardiography",https://ClinicalTrials.gov/show/NCT04355884
1344,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,Drug: Interferon beta-1a|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04330690
1345,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,Biological: SARS-CoV-2 Specific T Cells,https://ClinicalTrials.gov/show/NCT04457726
1346,Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents,Other: No intervention,https://ClinicalTrials.gov/show/NCT04740658
1347,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Other: No intervention,https://ClinicalTrials.gov/show/NCT04352491
1348,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,Drug: Sodium Bicarbonate,https://ClinicalTrials.gov/show/NCT04374591
1349,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04331795
1350,Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study,Diagnostic Test: Serologic immune response evaluation,https://ClinicalTrials.gov/show/NCT04888793
1351,Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD),Diagnostic Test: COVID-19 RT-PCR test|Other: COVID-19 Vaccine Education Campaign,https://ClinicalTrials.gov/show/NCT04887129
1352,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,Diagnostic Test: home spirometry,https://ClinicalTrials.gov/show/NCT04438863
1353,Effect of COVID-19 on Platelet Aggregation,Other: venipuncture in peripheral vein,https://ClinicalTrials.gov/show/NCT04447131
1354,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1|Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1 (2 doses),https://ClinicalTrials.gov/show/NCT04435717
1355,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04333225
1356,Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),Drug: AT-527|Other: Placebo,https://ClinicalTrials.gov/show/NCT04396106
1357,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Device: Biosensors,https://ClinicalTrials.gov/show/NCT04335097
1358,Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.,Biological: SCB-2019,https://ClinicalTrials.gov/show/NCT04932824
1359,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,Biological: Ampion|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04456452
1360,Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care,,https://ClinicalTrials.gov/show/NCT04704388
1361,"Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine",Biological: TURCOVAC|Biological: CoronaVac,https://ClinicalTrials.gov/show/NCT04942405
1362,Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19),Drug: Tocilizumab|Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04332094
1363,COVID-19: The Effectiveness of Free Face Mask Distribution,Behavioral: Distribution of free face masks,https://ClinicalTrials.gov/show/NCT04866589
1364,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,Biological: Allogeneic Wharton's jelly-MSCs (WJ-MSC)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04869397
1365,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug: Chloroquine or Hydroxychloroquine|Drug: Lopinavir/Ritonavir|Other: Best standard of care|Drug: Rivaroxaban|Drug: Thromboprophylaxis|Drug: Candesartan|Drug: non-RAS blocking antihypertensives|Drug: Remdesivir|Drug: Asunercept 400mg|Drug: Asunercept 100mg|Drug: Asunercept 25mg|Drug: Pentaglobin,https://ClinicalTrials.gov/show/NCT04351724
1366,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,,https://ClinicalTrials.gov/show/NCT04476602
1367,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,Behavioral: Exercise training,https://ClinicalTrials.gov/show/NCT04549337
1368,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Drug: EDP1815|Drug: Dapagliflozin|Drug: Ambrisentan|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04393246
1369,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04344444
1370,Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04492254
1371,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),Drug: Remdesivir|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04596839
1372,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone|Drug: The standard therapy,https://ClinicalTrials.gov/show/NCT04623385
1373,Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),https://ClinicalTrials.gov/show/NCT04679350
1374,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other: Cash transfer,https://ClinicalTrials.gov/show/NCT04359264
1375,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Device: CytoSorb-Therapy,https://ClinicalTrials.gov/show/NCT04344080
1376,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,,https://ClinicalTrials.gov/show/NCT04452617
1377,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,Drug: Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04429867
1378,A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19,Biological: Adsorbed COVID-19 (inactivated) Vaccine,https://ClinicalTrials.gov/show/NCT04756830
1379,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04377659
1380,"Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults",Biological: EuCorVac-19|Other: Normal Saline,https://ClinicalTrials.gov/show/NCT04783311
1381,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,Diagnostic Test: Performance of the test antigenic and test RT-PCR,https://ClinicalTrials.gov/show/NCT04583189
1382,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）,Drug: FNC+Standard of Care|Drug: FNC dummy tablet+Standard of Care,https://ClinicalTrials.gov/show/NCT04425772
1383,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug: Methotrexate,https://ClinicalTrials.gov/show/NCT04352465
1384,Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,Biological: RUTI® vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04903184
1385,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,Biological: F-652|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04498377
1386,Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients,Other: COVID-19 antibody test,https://ClinicalTrials.gov/show/NCT04771559
1387,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,,https://ClinicalTrials.gov/show/NCT04380779
1388,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug: Clazakizumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04363502
1389,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin,https://ClinicalTrials.gov/show/NCT04381871
1390,A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19,Drug: BI 767551 intravenous|Drug: BI 767551 inhaled|Drug: Placebo intravenous|Drug: Placebo inhaled,https://ClinicalTrials.gov/show/NCT04822701
1391,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,Other: convalescent plasma,https://ClinicalTrials.gov/show/NCT04352751
1392,Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19,Drug: ATR-002|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04776044
1393,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Drug: Canakinumab 150 MG/ML [Ilaris],https://ClinicalTrials.gov/show/NCT04348448
1394,Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19,Drug: CovenD24,https://ClinicalTrials.gov/show/NCT04902183
1395,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Other: Interview,https://ClinicalTrials.gov/show/NCT04365816
1396,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04435314
1397,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,Drug: Desferal 500 MG Injection,https://ClinicalTrials.gov/show/NCT04389801
1398,COVID-19 Treatment Cascade Optimization Study,Behavioral: Navigation Services|Behavioral: Critical Dialogue|Behavioral: Brief Counseling|Behavioral: Referral and Digital Brochure,https://ClinicalTrials.gov/show/NCT04757298
1399,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,"Drug: Nitric Oxide lozenges, 30 mg|Drug: Placebo",https://ClinicalTrials.gov/show/NCT04601077
1400,Role of Co-trimoxazole in Severe COVID-19 Patients,Drug: oral co-trimoxazole,https://ClinicalTrials.gov/show/NCT04470531
1401,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),Drug: Enoxaparin|Drug: Rivaroxaban,https://ClinicalTrials.gov/show/NCT04640181
1402,Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age,Drug: Favipiravir,https://ClinicalTrials.gov/show/NCT04474457
1403,"A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers",Biological: UB-612|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04773067
1404,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,https://ClinicalTrials.gov/show/NCT04486313
1405,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,Diagnostic Test: Cardiac Magnetic resonance imaging,https://ClinicalTrials.gov/show/NCT04584411
1406,"Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.",,https://ClinicalTrials.gov/show/NCT04677283
1407,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults",Biological: BNT162b2,https://ClinicalTrials.gov/show/NCT04816669
1408,A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19,Drug: GX-I7,https://ClinicalTrials.gov/show/NCT04810637
1409,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,Other: CHX0.12+CPC0.05 oral rinse (PerioAidActive Control)|Other: placebo rinse,https://ClinicalTrials.gov/show/NCT04563689
1410,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,Drug: Convalescent Plasma|Other: Standard Care Therapy,https://ClinicalTrials.gov/show/NCT04374487
1411,Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic,Diagnostic Test: Nasopharyngeal swab for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04933981
1412,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,Drug: BCG Vaccine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04328441
1413,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04625738
1414,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),,https://ClinicalTrials.gov/show/NCT04432961
1415,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,Drug: GNS561,https://ClinicalTrials.gov/show/NCT04637828
1416,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,Biological: Convalescent plasma transfusion,https://ClinicalTrials.gov/show/NCT04502472
1417,RAPA-501-Allo Therapy of COVID-19-ARDS,Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19|Other: Placebo,https://ClinicalTrials.gov/show/NCT04482699
1418,The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care,Biological: SCTA01|Biological: SCTA01 Placebo,https://ClinicalTrials.gov/show/NCT04683328
1419,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,Device: Volatile Organic Compounds analysis|Other: Canine odor detection of Volatile Organic Compounds,https://ClinicalTrials.gov/show/NCT04614883
1420,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,Drug: Nuvastatic,https://ClinicalTrials.gov/show/NCT04542447
1421,A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,Drug: LY3819253|Drug: LY3832479|Drug: Placebo|Drug: VIR-7831|Drug: LY3853113,https://ClinicalTrials.gov/show/NCT04634409
1422,Registry of CytoSorb Therapy in COVID-19 ICU Patients,Device: CytoSorb 300 mL device,https://ClinicalTrials.gov/show/NCT04391920
1423,CICERO- A Care Home Study of COVID-19,Diagnostic Test: Q16 testing|Diagnostic Test: Nasopharyngeal swab and main laboratory,https://ClinicalTrials.gov/show/NCT04453553
1424,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Radiation: Radiation therapy,https://ClinicalTrials.gov/show/NCT04427566
1425,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,,https://ClinicalTrials.gov/show/NCT04365634
1426,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),Drug: Ivermectin Oral Product|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04405843
1427,Treatment for COVID-19 in High-Risk Adult Outpatients,Drug: Ascorbic Acid|Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Folic Acid|Drug: Lopinavir 200 MG / Ritonavir 50 MG [Kaletra],https://ClinicalTrials.gov/show/NCT04354428
1428,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Procedure: Biological samples specific to research|Procedure: Clinical examination|Procedure: Telephone follow-up,https://ClinicalTrials.gov/show/NCT04354610
1429,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,Drug: Hydroxychloroquine + Metabolic cofactor supplementation|Drug: Hydroxychloroquine + Sorbitol,https://ClinicalTrials.gov/show/NCT04573153
1430,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,Other: Moderate Intensity Aerobic Exercises,https://ClinicalTrials.gov/show/NCT04581291
1431,Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,Diagnostic Test: Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional),https://ClinicalTrials.gov/show/NCT04667442
1432,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,Biological: AdCLD-CoV19,https://ClinicalTrials.gov/show/NCT04666012
1433,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,Drug: BAT2020,https://ClinicalTrials.gov/show/NCT04432766
1434,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,Drug: Niclosamide suspension|Other: Placebo,https://ClinicalTrials.gov/show/NCT04558021
1435,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,Drug: Ivermectin Oral Product,https://ClinicalTrials.gov/show/NCT04429711
1436,CardioVascular Disease Progression and Prognosis in COVID-19,,https://ClinicalTrials.gov/show/NCT04606732
1437,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug: Siltuximab|Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04329650
1438,Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,,https://ClinicalTrials.gov/show/NCT04582903
1439,The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19,Drug: Clevudine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04891302
1440,A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19),Drug: Bamlanivimab,https://ClinicalTrials.gov/show/NCT04701658
1441,Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.,Dietary Supplement: Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C),https://ClinicalTrials.gov/show/NCT04828668
1442,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg|Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg|Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg|Other: Placebo,https://ClinicalTrials.gov/show/NCT04495933
1443,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",Drug: Quercetin|Dietary Supplement: bromelain|Drug: Zinc|Drug: Vitamin C,https://ClinicalTrials.gov/show/NCT04468139
1444,"PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64",Biological: PTX-COVID19-B|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04765436
1445,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,Device: Test Group: experimental - UVC Therapy applied,https://ClinicalTrials.gov/show/NCT04642326
1446,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,Biological: N-803|Other: Saline,https://ClinicalTrials.gov/show/NCT04385849
1447,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,,https://ClinicalTrials.gov/show/NCT04522076
1448,COVID-19 Seroprevalence Study in ITM Staff,,https://ClinicalTrials.gov/show/NCT04503447
1449,Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),https://ClinicalTrials.gov/show/NCT04679415
1450,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",Drug: Anakinra +/- Ruxolitinib (stages 2b/3)|Drug: Anakinra and Ruxolitinib (Advanced stage 3)|Drug: Tocilizumab +/- ruxolitinib (stages 2b/3)|Drug: Tocilizumab and Ruxolitinib (Advanced stage 3)|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04424056
1451,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Biological: Bactek-R,https://ClinicalTrials.gov/show/NCT04363814
1452,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Other: Neuromuscular Electrical Stimulation|Other: Physical Therapy Exercise,https://ClinicalTrials.gov/show/NCT04382729
1453,Covid-19 Pandemic Triage Score,Diagnostic Test: STC-19 score,https://ClinicalTrials.gov/show/NCT04371471
1454,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",Dietary Supplement: zinc gluconate and ascorbic acid,https://ClinicalTrials.gov/show/NCT04558424
1455,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),Drug: RBT-9 (90 mg)|Drug: 0.9% sodium chloride (normal saline),https://ClinicalTrials.gov/show/NCT04364763
1456,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,Drug: Isoquercetin (IQC-950AN),https://ClinicalTrials.gov/show/NCT04536090
1457,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,Drug: Levilimab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04397562
1458,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,Other: Data collection and clinical testing of subjects,https://ClinicalTrials.gov/show/NCT04400461
1459,Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination,Drug: MRNA-1273,https://ClinicalTrials.gov/show/NCT04930770
1460,Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19,Drug: AT-527|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04709835
1461,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole,https://ClinicalTrials.gov/show/NCT04551768
1462,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,Device: CytoSorb,https://ClinicalTrials.gov/show/NCT04518969
1463,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,Drug: Convalesscent Plasma,https://ClinicalTrials.gov/show/NCT04433910
1464,"A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.",Drug: ADX-629|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04847544
1465,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,Biological: BCG vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04417335
1466,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,Drug: Degarelix|Other: Saline,https://ClinicalTrials.gov/show/NCT04397718
1467,Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19,,https://ClinicalTrials.gov/show/NCT04681157
1468,"Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",Drug: Antithrombin III,https://ClinicalTrials.gov/show/NCT04651400
1469,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,Drug: LY3819253|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04411628
1470,"Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19",Drug: XVR011|Drug: Normal saline,https://ClinicalTrials.gov/show/NCT04884295
1471,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04497246
1472,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,Drug: liposomal lactoferrin|Drug: SOC therapy,https://ClinicalTrials.gov/show/NCT04475120
1473,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,Drug: Abivertinib|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04440007
1474,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug: Peginterferon Lambda-1a|Other: Placebo,https://ClinicalTrials.gov/show/NCT04331899
1475,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04441398
1476,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,Biological: AV-COVID-19,https://ClinicalTrials.gov/show/NCT04386252
1477,Effects of COVID 19 Vaccine on Egyptian Population,Biological: viral vector vaccine,https://ClinicalTrials.gov/show/NCT04809948
1478,"Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study","Combination Product: Menthol 0.02%, Methyl salicylate 0.05%, N- Acetyl cysteine 1.2 gm%, and Diclofenac sodium 1gm%",https://ClinicalTrials.gov/show/NCT04900129
1479,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,Drug: intermediate dose Enoxaparin/ unfractionated heparin|Drug: standard prophylactic dose Enoxaparin/ unfractionated heparin|Drug: Atorvastatin 20mg|Drug: Matched placebo,https://ClinicalTrials.gov/show/NCT04486508
1480,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,Drug: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04434131
1481,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug: Hydroxychloroquine|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04331834
1482,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug: Levamisole Pill + Budesonide+Formoterol inhaler|Drug: Lopinavir/Ritonavir + hydoxychloroquine,https://ClinicalTrials.gov/show/NCT04331470
1483,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,Drug: LY3819253|Drug: LY3832479|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04427501
1484,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",Device: RD-X19,https://ClinicalTrials.gov/show/NCT04662671
1485,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.",Diagnostic Test: BIOZEK COVID-19 Antigen Rapid Test,https://ClinicalTrials.gov/show/NCT04805892
1486,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,Drug: Heparin sodium|Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04530578
1487,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,,https://ClinicalTrials.gov/show/NCT04443803
1488,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug: PUL-042 Inhalation Solution|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04313023
1489,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Drug: Nafamostat Mesilate,https://ClinicalTrials.gov/show/NCT04623021
1490,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug: Defibrotide 25 mg/kg 24 hours continuous infusion for 15 days|Drug: Placebo 250 cc 24 hours continuous infusion for 15 days,https://ClinicalTrials.gov/show/NCT04348383
1491,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19),Drug: Remdesivir|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04292899
1492,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,Biological: allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Other: Intravenous saline injection (Placebo),https://ClinicalTrials.gov/show/NCT04336254
1493,"Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",Other: Non Intervention,https://ClinicalTrials.gov/show/NCT04465474
1494,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,Biological: Infusion IV of Mesenchymal Stem cells,https://ClinicalTrials.gov/show/NCT04416139
1495,Self- Versus Conventional-swabbing for COVID-19 Screening (COVISWAB),Other: nasopharyngeal swabbing procedure (self swabbing first)|Other: nasopharyngeal swabbing procedure (conventionnal swabbing first),https://ClinicalTrials.gov/show/NCT04831853
1496,Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection,Other: biological sample,https://ClinicalTrials.gov/show/NCT04624997
1497,Convalescent Plasma in the Treatment of Covid-19,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04600440
1498,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04423861
1499,"Safety, Tolerability and Efficacy of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation",Drug: nangibotide|Drug: placebo,https://ClinicalTrials.gov/show/NCT04429334
1500,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,Drug: Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole|Drug: Drug: Isotretinoin(Aerosolized 13 cis retinoic acid),https://ClinicalTrials.gov/show/NCT04577378
1501,"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",Biological: BNT162b1|Biological: BNT162b2|Other: Placebo|Biological: BNT162b2SA,https://ClinicalTrials.gov/show/NCT04368728
1502,Testing for COVID-19 Infection in Asymptomatic Persons,,https://ClinicalTrials.gov/show/NCT04345510
1503,JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects,Biological: Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04780321
1504,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug: PUL-042 Inhalation Solution|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04312997
1505,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,Biological: Adsorbed COVID-19 (inactivated) Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04456595
1506,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",Drug: Hydroxychloroquine|Drug: Mucodentol|Device: Personal protective equipment,https://ClinicalTrials.gov/show/NCT04466280
1507,COVID - AirPollution,,https://ClinicalTrials.gov/show/NCT04463862
1508,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),Drug: BGB-DXP593|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04551898
1509,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg|Drug: Drug: Standard treatment Standard treatment,https://ClinicalTrials.gov/show/NCT04578236
1510,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Drug: Doxycycline,https://ClinicalTrials.gov/show/NCT04370782
1511,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,Diagnostic Test: COVID 19 serology|Other: COVID 19 Self-Questionnaire,https://ClinicalTrials.gov/show/NCT04481633
1512,"A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",Drug: Favipiravir|Other: Placebo,https://ClinicalTrials.gov/show/NCT04425460
1513,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,"Dietary Supplement: Micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) oral suspension|Combination Product: Standard Therapy",https://ClinicalTrials.gov/show/NCT04568876
1514,Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology in Covid-19,Device: Senti V1.0 Device,https://ClinicalTrials.gov/show/NCT04695821
1515,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",Biological: bacTRL-Spike,https://ClinicalTrials.gov/show/NCT04334980
1516,Cognitive Training and Brain Stimulation in Patients With Post-COVID19 Cognitive Impairment,Device: Anodal tDCS|Device: Sham tDCS|Behavioral: Intensive cognitive training|Behavioral: Progressive muscle relaxation (PMR),https://ClinicalTrials.gov/show/NCT04944147
1517,Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units,Other: Inter ICU long distance patient transfer,https://ClinicalTrials.gov/show/NCT04930120
1518,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Diagnostic Test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test,https://ClinicalTrials.gov/show/NCT04352764
1519,Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention,Behavioral: Exercise|Behavioral: Controls,https://ClinicalTrials.gov/show/NCT04718506
1520,The COVID-19 Back-to-Normal Study,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04832932
1521,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug: Nitazoxanide Tablets|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04348409
1522,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",Drug: Remdesivir (RDV)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04539262
1523,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,Drug: Ciclesonide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04377711
1524,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,Drug: EDP1815|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04488575
1525,Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection,,https://ClinicalTrials.gov/show/NCT04681755
1526,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo,https://ClinicalTrials.gov/show/NCT04353518
1527,Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,Other: Cardiopulmonary resuscitation|Other: Modified Rankin score,https://ClinicalTrials.gov/show/NCT04373759
1528,Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19,Other: no intervention,https://ClinicalTrials.gov/show/NCT04349540
1529,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),,https://ClinicalTrials.gov/show/NCT04418375
1530,Dysphagia Management During COVID-19 Pandemic,Other: Survey,https://ClinicalTrials.gov/show/NCT04509752
1531,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,Drug: UNI911 INHALATION,https://ClinicalTrials.gov/show/NCT04576312
1532,COVID-19 Long-Haulers Study,Drug: Placebos|Drug: Leronlimab (700mg),https://ClinicalTrials.gov/show/NCT04678830
1533,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19),Diagnostic Test: Point-of-care rapid anti-SARS-CoV-2 antibody test (Orient Gene Biotech) and Dry Blood Spot collection (Euroimmun),https://ClinicalTrials.gov/show/NCT04738695
1534,Evaluation of the New Variant 501Y.V2 of COVID-19,,https://ClinicalTrials.gov/show/NCT04906850
1535,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,,https://ClinicalTrials.gov/show/NCT04371744
1536,A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19,Biological: CpG 1018/Alum-adjuvanted SCB-2019 vaccine|Biological: Placebo; 0.9% saline,https://ClinicalTrials.gov/show/NCT04672395
1537,Ketogenic Diet as Protective Factor During COVID-19,Dietary Supplement: Ketogenic diet with phytoextracts,https://ClinicalTrials.gov/show/NCT04615975
1538,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug: Telmisartan 40mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04360551
1539,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug: Clazakizumab 25 mg|Drug: Clazakizumab 12.5 mg|Other: Placebo,https://ClinicalTrials.gov/show/NCT04343989
1540,"A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)",Drug: ALLOCETRA-OTS|Other: Placebo,https://ClinicalTrials.gov/show/NCT04922957
1541,Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial,Dietary Supplement: Vitamin and trace elements|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04751669
1542,Artificial Intelligence - SARS-CoV-2 Risk Evaluation,,https://ClinicalTrials.gov/show/NCT04834934
1543,Slovenian National COVID-19 Prevalence Study,Diagnostic Test: NO intervention planned due to the observational study design - only a diagnostic testing,https://ClinicalTrials.gov/show/NCT04376996
1544,"A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)","Biological: SARS-CoV-2 Vaccine (Vero Cells), Inactivated|Biological: Placebo",https://ClinicalTrials.gov/show/NCT04852705
1545,"Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19","Biological: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|Other: Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",https://ClinicalTrials.gov/show/NCT04780035
1546,Risk Factors for Barotrauma in COVID-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04859881
1547,Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19),Drug: Remdesivir|Drug: RDV Placebo|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04745351
1548,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo,https://ClinicalTrials.gov/show/NCT04358809
1549,Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID),Dietary Supplement: Inflammation (I)|Dietary Supplement: Inflammation (II)|Dietary Supplement: Inflammation (III)|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04790240
1550,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",Drug: Colchicine|Drug: Prednisone tablet|Drug: standard of care,https://ClinicalTrials.gov/show/NCT04492358
1551,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,,https://ClinicalTrials.gov/show/NCT04422626
1552,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,"Drug: RESP301, a Nitric Oxide generating solution|Other: Standard of Care",https://ClinicalTrials.gov/show/NCT04460183
1553,Comparative Evaluation of Covid-19 Vaccines Response,"Biological: Covid-19 Inactive Vaccine, recombinant human adenovirus serotype number 26, mRNA VAccine",https://ClinicalTrials.gov/show/NCT04895007
1554,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",Drug: HB-adMSCs|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04348435
1555,"Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.",Drug: AMOR 18 Powder & Inhalation|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04900337
1556,The Noninvasive Ventilation to COVID-19 Patients,Device: noninvasive ventilation,https://ClinicalTrials.gov/show/NCT04568655
1557,Immunity After COVID-19 Vaccination,Other: Cellular and antibody response to spike antigens of SARS-CoV-2 in both groups in peripheral blood samples,https://ClinicalTrials.gov/show/NCT04883164
1558,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",Biological: Gam-COVID-Vac|Other: placebo,https://ClinicalTrials.gov/show/NCT04530396
1559,Nebulised Heparin in Patients With Severe COVID-19,Drug: Nebulised unfractionated heparin (UFH),https://ClinicalTrials.gov/show/NCT04545541
1560,Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic Diseases,Other: Cohort,https://ClinicalTrials.gov/show/NCT04907994
1561,A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml,https://ClinicalTrials.gov/show/NCT04916886
1562,RescuE pLAsma eXchange in Severe COVID-19,Other: Therapeutic plasma exchange,https://ClinicalTrials.gov/show/NCT04685655
1563,WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,,https://ClinicalTrials.gov/show/NCT04475471
1564,Asunercept in Patients With Severe COVID-19,Biological: Asunercept,https://ClinicalTrials.gov/show/NCT04535674
1565,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),,https://ClinicalTrials.gov/show/NCT04358029
1566,Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA,"Diagnostic Test: Test At Home's Proprietary ""Lollipop"" Buccal Cavity Swab",https://ClinicalTrials.gov/show/NCT04732637
1567,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug: Remdesivir|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04292730
1568,Awake Pronation for Covid-19 Treatment,Procedure: Prone Position (PP),https://ClinicalTrials.gov/show/NCT04667286
1569,Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection,Drug: Estetrol monohydrate 15 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04801836
1570,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Drug: Patients with the treatment agains COVID19,https://ClinicalTrials.gov/show/NCT04347278
1571,"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04431453
1572,COVID-19 and HIV Patients,Other: Seroprevalence of SARS-CoV-2 infection in patients with HIV infection,https://ClinicalTrials.gov/show/NCT04523012
1573,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug: Povidone-Iodine Nasal Spray and Gargle,https://ClinicalTrials.gov/show/NCT04364802
1574,Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),,https://ClinicalTrials.gov/show/NCT04528901
1575,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug: Zavegepant (BHV-3500)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04346615
1576,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",Other: BioMedomics COVID-19 IgM-IgG Rapid Test,https://ClinicalTrials.gov/show/NCT04367402
1577,Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen),Biological: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant|Biological: Saline placebo,https://ClinicalTrials.gov/show/NCT04944368
1578,Enhanced Triage for COVID-19,,https://ClinicalTrials.gov/show/NCT04750369
1579,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",Drug: ATI-450|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04481685
1580,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Behavioral: turkish physicians,https://ClinicalTrials.gov/show/NCT04327531
1581,COVID-19 Survivorship Registry,Other: Questionnaires,https://ClinicalTrials.gov/show/NCT04527315
1582,Covid-19 Associated Coagulopathy,Drug: Intermediate dose thromboprophylaxis|Drug: Standard of Care thromboprophylaxis,https://ClinicalTrials.gov/show/NCT04360824
1583,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,Drug: Bempegaldesleukin|Drug: Standard of Care|Other: Placebo,https://ClinicalTrials.gov/show/NCT04646044
1584,Study of Hemostasis in Case of Severe COVID-19,Other: Extra blood sample,https://ClinicalTrials.gov/show/NCT04359992
1585,Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP),Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,https://ClinicalTrials.gov/show/NCT03348670
1586,Can RIC Prevent Deterioration to Critical Care in Covid19,Procedure: Cuff application with inflation|Other: Sham inflation,https://ClinicalTrials.gov/show/NCT04699227
1587,Host Response Mediators in Coronavirus (COVID-19) Infection,Other: ARBs and/or ACE inhibitors|Other: Usual Care,https://ClinicalTrials.gov/show/NCT04510623
1588,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,Drug: Standard Therapy Protocol (STP)|Other: STP + Standard Plasma (SP)|Other: STP + COVID-19 Convalescent Plasma (CP),https://ClinicalTrials.gov/show/NCT04428021
1589,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,Other: Chest physiotherapy post-covid19,https://ClinicalTrials.gov/show/NCT04678700
1590,Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19,"Drug: IMP 1,000 plus SoC|Drug: IMP 5,000 plus SoC|Drug: IMP RP2D plus SoC|Drug: SoC",https://ClinicalTrials.gov/show/NCT04762186
1591,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04463264
1592,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,https://ClinicalTrials.gov/show/NCT04383548
1593,Favipiravir vs Hydroxychloroquine vs Control in COVID -19,Drug: Hydroxychloroquine|Drug: Favipiravir|Other: Routine care for COVID-19 patients,https://ClinicalTrials.gov/show/NCT04387760
1594,COVID-19 - Quality of Life After Infection,"Other: SF12, EQ-5D-5L and work status standardized quantitative assessments",https://ClinicalTrials.gov/show/NCT04377464
1595,COVID-19 Nasal Swab Trial,Device: CanSwab,https://ClinicalTrials.gov/show/NCT04649424
1596,The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU,Other: BRESCİA-COVİD Respiratory Severity Scale,https://ClinicalTrials.gov/show/NCT04799600
1597,The COVID-19 PUI Reality Check (CPRC) Study,Diagnostic Test: SARS-CoV-2 antibody testing,https://ClinicalTrials.gov/show/NCT04474288
1598,Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,Biological: Tigerase® and best available care|Other: Best available care,https://ClinicalTrials.gov/show/NCT04459325
1599,COVID-19 Antibodies Among Healthcare Workers,"Diagnostic Test: COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)",https://ClinicalTrials.gov/show/NCT04425889
1600,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,Other: Mesenchymal stem cells,https://ClinicalTrials.gov/show/NCT04713878
1601,Post Covid-19 Cardiopulmonary and Immunological Changes,,https://ClinicalTrials.gov/show/NCT04388436
1602,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,"Drug: Hydroxychloroquine, Azithromycin|Drug: Hydroxychloroquine, Doxycycline|Drug: Hydroxychloroquine, Clindamycin|Drug: Hydroxychloroquine, Clindamycin, Primaquine - low dose.|Drug: Hydroxychloroquine, Clindamycin, Primaquine - high dose.|Drug: Remdesivir|Drug: Tocilizumab|Drug: Methylprednisolone|Drug: Interferon-Alpha2B|Drug: Losartan|Drug: Convalescent Serum",https://ClinicalTrials.gov/show/NCT04349410
1603,Assessment of SARS-CoV-2 Seroprevalence in Detention,Biological: Blood draw,https://ClinicalTrials.gov/show/NCT04516512
1604,Capturing Infectious COVID-19 Asymptomatic Cases in Singapore,Diagnostic Test: BD Veritor Plus System for Rapid Detection of SARS CoV-2|Diagnostic Test: rt-PCR|Diagnostic Test: viral culture,https://ClinicalTrials.gov/show/NCT04812327
1605,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,Drug: Iota-Carrageenan,https://ClinicalTrials.gov/show/NCT04521322
1606,Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health,Other: maternal SARS-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04768244
1607,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,Other: Cardiorespiratory Exercise|Other: Modified Bai He Gu Jin Tang,https://ClinicalTrials.gov/show/NCT04572360
1608,Efficacy of Nicotine in Preventing COVID-19 Infection,Drug: Nicotine patch|Drug: Placebo patch,https://ClinicalTrials.gov/show/NCT04583410
1609,ENO Breathe vs Usual Care in COVID-19 Recovery,Other: ENO Breathe group,https://ClinicalTrials.gov/show/NCT04830033
1610,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug: Hydroxychloroquine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04315896
1611,Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm,Drug: Ruxolitinib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04362137
1612,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Biological: serology test|Biological: nasopharyngeal swab|Biological: rectal swab|Biological: saliva sample,https://ClinicalTrials.gov/show/NCT04355533
1613,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,Biological: COVID19 convalescent plasma infusion,https://ClinicalTrials.gov/show/NCT04535063
1614,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,,https://ClinicalTrials.gov/show/NCT04366206
1615,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,Drug: Camostat Mesylate|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04608266
1616,Myeloid Cells in Patients With Covid-19 Pneumonia,Other: Blood sampling|Other: Nasal Brushing,https://ClinicalTrials.gov/show/NCT04590261
1617,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),https://ClinicalTrials.gov/show/NCT04313127
1618,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,Drug: Pacritinib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04404361
1619,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,Other: Hypertension|Other: Diabetes type 2|Other: Obesity|Drug: Antihypertensive Agents|Drug: Statins (Cardiovascular Agents),https://ClinicalTrials.gov/show/NCT04426084
1620,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps,,https://ClinicalTrials.gov/show/NCT04695457
1621,Comorbidities and Risk Score in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04670094
1622,Corticosteroids in Severe COVID-19(ASAP-C Study),Other: questionnaire,https://ClinicalTrials.gov/show/NCT04648410
1623,Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease,,https://ClinicalTrials.gov/show/NCT04779359
1624,Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid,Diagnostic Test: Anti COVID19 IgG Antibodies,https://ClinicalTrials.gov/show/NCT04822012
1625,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",Biological: Gam-COVID-Vac|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04642339
1626,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,Drug: COVI-MSC|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04728698
1627,Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce,Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04491292
1628,A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19,Biological: CVnCoV|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04652102
1629,Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong,Biological: CoronaVac Vaccine|Biological: BNT162b2 Vaccine,https://ClinicalTrials.gov/show/NCT04898946
1630,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,Drug: EC-18|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04569227
1631,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",Drug: inhalable hydroxychloroquine (HCQ)|Drug: supportive and symptomatic treatment,https://ClinicalTrials.gov/show/NCT04477083
1632,Covid-19 Airway Management,,https://ClinicalTrials.gov/show/NCT04689724
1633,Cardiopulmonary Rehabilitation in COVID-19 Longhaulers,Other: Treadmill Exercise|Other: Concentrated Oxygen|Other: Concentrated Air,https://ClinicalTrials.gov/show/NCT04898205
1634,Use of Ascorbic Acid in Patients With COVID 19,Dietary Supplement: Vitamin C,https://ClinicalTrials.gov/show/NCT04323514
1635,Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19,Biological: DVX201,https://ClinicalTrials.gov/show/NCT04900454
1636,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",Biological: Gam-COVID-Vac,https://ClinicalTrials.gov/show/NCT04436471
1637,COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020,Diagnostic Test: Serological tests for SARS Cov-2,https://ClinicalTrials.gov/show/NCT04723290
1638,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,Other: Media Intervention|Procedure: Meditation Therapy|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Procedure: Yoga,https://ClinicalTrials.gov/show/NCT04482647
1639,Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above,"Biological: SARS-CoV-2 Vaccine (Vero Cell), Inactivated",https://ClinicalTrials.gov/show/NCT04917523
1640,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19","Diagnostic Test: Lung Function tests|Diagnostic Test: Exercise capacity|Diagnostic Test: Exercise physiology|Diagnostic Test: Health-related quality of life|Diagnostic Test: Respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening",https://ClinicalTrials.gov/show/NCT04410107
1641,Minnesota COVID-19 Testing Project,Behavioral: A $10 Survey Incentive|Behavioral: A $20 Survey Incentive|Behavioral: Emphasis of Government Involvement|Behavioral: Emphasis of Academic Researchers Involvement|Behavioral: Cost-Benefit Frame|Behavioral: Duty Frame|Behavioral: Racial/Ethnic Frame|Behavioral: No Messaging,https://ClinicalTrials.gov/show/NCT04568889
1642,Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry,Procedure: Prone Position,https://ClinicalTrials.gov/show/NCT04905875
1643,Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia,,https://ClinicalTrials.gov/show/NCT04444531
1644,PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial,Drug: Icosapent ethyl (IPE)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04460651
1645,Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines,Biological: mRNA-1273,https://ClinicalTrials.gov/show/NCT04889209
1646,Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19,Combination Product: NO Severe COVID-19,https://ClinicalTrials.gov/show/NCT04918901
1647,Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management,Drug: Niclosamide Oral Tablet,https://ClinicalTrials.gov/show/NCT04753619
1648,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,Biological: UC-MSCs|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04273646
1649,Saliva as Source of Detection for SARS-CoV-2,,https://ClinicalTrials.gov/show/NCT04424446
1650,COVID-19 Infection in Patients With Hepatocellular Carcinoma,Diagnostic Test: nasopharyngeal Covid 19 RT-PCR,https://ClinicalTrials.gov/show/NCT04367805
1651,Tele-Physiotherapy After COVID-19 Hospitalization,Other: Tele-physiotherapy group|Other: Control group,https://ClinicalTrials.gov/show/NCT04895371
1652,Prognostic Score in Covid-19,Other: data collection,https://ClinicalTrials.gov/show/NCT04780373
1653,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,Radiation: Low Dose Radiotherapy,https://ClinicalTrials.gov/show/NCT04534790
1654,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,,https://ClinicalTrials.gov/show/NCT04333862
1655,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Other: Physical exercise|Behavioral: Education sessions,https://ClinicalTrials.gov/show/NCT04375709
1656,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug: Fluvoxamine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04342663
1657,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,Drug: Losartan 50 mg and Spironolactone 25 mg pillules oral use,https://ClinicalTrials.gov/show/NCT04643691
1658,"Prospective COVID-19 Cohort Study, Dominican Republic",Other: Alcohol based hand sanitizer,https://ClinicalTrials.gov/show/NCT04898738
1659,Burden of COVID-19 Infection in Populations With High or Low Risk of Infection,,https://ClinicalTrials.gov/show/NCT04636203
1660,"Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines",Biological: CoronoVac Vaccine,https://ClinicalTrials.gov/show/NCT04751695
1661,Genetic Basis of COVID-19 Infection,Diagnostic Test: Whole Exome Sequencing,https://ClinicalTrials.gov/show/NCT04384250
1662,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug: Dexamethasone injection|Drug: placebo|Procedure: conventional oxygen|Procedure: CPAP|Procedure: HFNO|Procedure: mechanical ventilation,https://ClinicalTrials.gov/show/NCT04344730
1663,Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19,Other: ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE|Other: PLACEBO,https://ClinicalTrials.gov/show/NCT04820803
1664,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,Procedure: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04408209
1665,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Other: other,https://ClinicalTrials.gov/show/NCT04347369
1666,Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19,Other: Sarcopenia diagnosis,https://ClinicalTrials.gov/show/NCT04780126
1667,Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults,Biological: SARS-CoV-2 vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04866069
1668,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,Drug: Plasma from COVID-19 convalescent patient|Drug: Human immunoglobulin,https://ClinicalTrials.gov/show/NCT04381858
1669,Surveillance of Individuals Following SARS-CoV-2 Infection,,https://ClinicalTrials.gov/show/NCT04383444
1670,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.,,https://ClinicalTrials.gov/show/NCT04477213
1671,Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults,Other: physical activity program,https://ClinicalTrials.gov/show/NCT04647682
1672,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Drug: Antibiotics|Drug: Hormones|Drug: Anticoagulant Therapy|Device: Оxygen therapy,https://ClinicalTrials.gov/show/NCT04461925
1673,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic,Other: COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04521010
1674,The VIDA After COVID Study,Behavioral: Virtual Intervention Program,https://ClinicalTrials.gov/show/NCT04945590
1675,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine","Biological: IIBR-100, low dose (prime)|Biological: IIBR-100 medium dose (prime)|Biological: IIBR-100 high-dose (prime)|Biological: IIBR-100 low-dose (prime-boost)|Other: Saline Placebo (single)|Other: Saline Placebo (double)|Biological: IIBR-100 medium-dose (prime-boost)|Biological: IIBR-100 high-dose (prime-boost)|Biological: IIBR-100 top-dose (prime-boost)",https://ClinicalTrials.gov/show/NCT04608305
1676,Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma,Other: blood sample analyses,https://ClinicalTrials.gov/show/NCT04805203
1677,COVID 19-Caregivers IGg Seroconversion,Other: Blood sampling,https://ClinicalTrials.gov/show/NCT04353323
1678,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),Drug: Bardoxolone Methyl|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04494646
1679,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,"Drug: Yu-Ping-Feng formula|Drug: Xiang-Sha-Liu-Jun formula|Drug: Liu-Wei-Di-Huang formula|Drug: Placebo for ""Deficiency of Qi and Yang""|Drug: Placebo for ""Deficiency of Qi and Yin""",https://ClinicalTrials.gov/show/NCT04668222
1680,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug: Bevacizumab,https://ClinicalTrials.gov/show/NCT04305106
1681,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,Other: Respiratory Training|Other: Aerobic training,https://ClinicalTrials.gov/show/NCT04613050
1682,Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.,Drug: Oral 13 cis retinoic acid|Drug: Aerosolized 13 cis retinoic acid|Combination Product: 13 cis retinoic acid doses orally in combination with spike protein based vaccine|Combination Product: Aerosolized 13 cis retinoic acid in combination with spike protein based vaccine|Biological: Biological: spike protein based vaccine such as ChAdOx1 nCoV-19 vaccine,https://ClinicalTrials.gov/show/NCT04730895
1683,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,Drug: Cyclosporin A,https://ClinicalTrials.gov/show/NCT04540926
1684,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,Biological: NestaCell®|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04315987
1685,COVID Breath Test - Ancon,Diagnostic Test: Breath test,https://ClinicalTrials.gov/show/NCT04760639
1686,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,Drug: AstroStem-V,https://ClinicalTrials.gov/show/NCT04527224
1687,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,Behavioral: Hospital: DD-CA|Behavioral: Hospital: Usual Care (UC),https://ClinicalTrials.gov/show/NCT04591015
1688,Fight COVID-19 Trial,Drug: Oral,https://ClinicalTrials.gov/show/NCT04303299
1689,"COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older",Biological: SARS-CoV-2 mRNA Vaccine (CVnCoV)|Biological: Quadrivalent influenza vaccine (QIV)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04848467
1690,COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece,"Device: Mouthpiece B1(Mouthpiece MPC-ST GMDN:62534 Generic name: Endoscopic bite block, basic, reusable",https://ClinicalTrials.gov/show/NCT04864015
1691,Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients,Drug: DWJ1248 with Remdesivir|Drug: Placebo with Remdesivir,https://ClinicalTrials.gov/show/NCT04713176
1692,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug: Azithromycin|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04332107
1693,Over-the-counter Medications & COVID-19,,https://ClinicalTrials.gov/show/NCT04500639
1694,Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients,Drug: NuSepin® 0.1 mg|Drug: NuSepin® 0.2 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04565379
1695,The Prone Position in Covid-19 Affected Patients,Procedure: Prone position,https://ClinicalTrials.gov/show/NCT04365959
1696,Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults,Biological: SARS-CoV-2 VLP Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04818281
1697,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug: methylprednisolone therapy|Other: Standard care,https://ClinicalTrials.gov/show/NCT04244591
1698,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",Drug: DWRX2003|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04541485
1699,The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19),Drug: Leukotriene Receptor Antagonist|Other: Placebo,https://ClinicalTrials.gov/show/NCT04871828
1700,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,Procedure: airway management during sedation or general anesthesia,https://ClinicalTrials.gov/show/NCT04449042
1701,COVID-19 Recovered Volunteer Research Participant Pool Registry,,https://ClinicalTrials.gov/show/NCT04359602
1702,COVID-19 PrEP HCW HCQ Study,Drug: Hydroxychloroquine (HCQ),https://ClinicalTrials.gov/show/NCT04354870
1703,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,Device: Innova Lateral Flow Device,https://ClinicalTrials.gov/show/NCT04629157
1704,Carrageenan Nasal Spray for COVID-19 Prophylaxis,Device: Carrageenan nasal and throat spray|Device: Saline nasal and throat spray,https://ClinicalTrials.gov/show/NCT04590365
1705,S-Nitrosylation Therapy of COVID-19,Drug: SNO|Drug: Nitrogen gas,https://ClinicalTrials.gov/show/NCT04528771
1706,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",,https://ClinicalTrials.gov/show/NCT04370821
1707,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,,https://ClinicalTrials.gov/show/NCT04346056
1708,[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,Other: Water (E) Mouth rinse with the solution provided|Other: Chlorhexidine gluconate (A) Mouth rinse with the solution provided|Other: Hydrogen peroxide (B) Mouth rinse with the solution provided|Other: Betadine (C) Mouth rinse with the solution provided|Other: Alcohol mouthwash (Listerine) (D) Mouth rinse with the solution provided,https://ClinicalTrials.gov/show/NCT04719208
1709,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),Biological: mRNA-1273,https://ClinicalTrials.gov/show/NCT04283461
1710,Sustained Immunity to SARS-CoV-2,Diagnostic Test: Serologic immunoassays to SARS-CoV-2 antibodies,https://ClinicalTrials.gov/show/NCT04562285
1711,MAVIPAN: My Life and the COVID-19 Pandemic,"Other: No intervention, this is an observational study that uses validated questionnaires and qualitative interviews..",https://ClinicalTrials.gov/show/NCT04575571
1712,Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults,Biological: mRNA-1273|Biological: mRNA-1273.351,https://ClinicalTrials.gov/show/NCT04785144
1713,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,Diagnostic Test: Conjunctival swab and nasopharyngeal swab,https://ClinicalTrials.gov/show/NCT04444596
1714,Photodynamic Therapy for the Treatment of COVID-19,Procedure: photobiomodulation and photodynamic therapy,https://ClinicalTrials.gov/show/NCT04416113
1715,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04728919
1716,Direct and Indirect Impact of COVID-19 In Older Populations,,https://ClinicalTrials.gov/show/NCT04381312
1717,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug: Tinzaparin or unfractionated heparin,https://ClinicalTrials.gov/show/NCT04344756
1718,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug: Tocilizumab (TCZ)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04320615
1719,Bronchiactasis as Atypical Presentation in COVID-19,,https://ClinicalTrials.gov/show/NCT04910113
1720,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,Biological: Bacille Calmette-Guérin (BCG)|Other: Placebo Comparator,https://ClinicalTrials.gov/show/NCT04379336
1721,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive.,Drug: Camostat,https://ClinicalTrials.gov/show/NCT04455815
1722,"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants",Biological: BNT162b2|Biological: BNT162b2.B.1.351,https://ClinicalTrials.gov/show/NCT04713553
1723,Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection,Drug: Plitidepsin|Drug: Dexamethasone|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04784559
1724,AiM Covid Self Monitoring,Other: Other,https://ClinicalTrials.gov/show/NCT04425044
1725,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting,Diagnostic Test: Testing for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04519372
1726,A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug: Placebo|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04372186
1727,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,Drug: Cyclosporine|Drug: Standard treatment,https://ClinicalTrials.gov/show/NCT04392531
1728,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,Drug: Ivermectin + Doxycycline + Placebo|Drug: Ivermectin + Placebo|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04407130
1729,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug: Bevacizumab Injection,https://ClinicalTrials.gov/show/NCT04344782
1730,Risk of COVID-19 Infection After Vaccination,"Other: The COVID-19 vaccines BNT162b2, mRNA-1273 and ChAdOx1",https://ClinicalTrials.gov/show/NCT04848441
1731,Covid-19 Epidemic Lockdown Impact on Psychomotor Performance,,https://ClinicalTrials.gov/show/NCT04761718
1732,Tele-coaching in Patients With COVID-19,Other: Exercise,https://ClinicalTrials.gov/show/NCT04791072
1733,Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.,Drug: Canrenoate Potassium|Drug: Normal Saline,https://ClinicalTrials.gov/show/NCT04912011
1734,A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,Drug: MSTT1041A|Drug: MSTT1041A-matched Placebo|Drug: UTTR1147A|Drug: UTTR1147A-matched Placebo,https://ClinicalTrials.gov/show/NCT04386616
1735,the Impact of Covid-19 Pandemic Stress on Pregnancy Outcomes,Device: covid 19 on pregnancy outcomes,https://ClinicalTrials.gov/show/NCT04839068
1736,Defibrotide in COVID-19 Pneumonia,Drug: Defibrotide Injection,https://ClinicalTrials.gov/show/NCT04335201
1737,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Behavioral: Self-management booklet (SWitCh: Stay well during COVID-19),https://ClinicalTrials.gov/show/NCT04408157
1738,COVID-19 Risk From Attending Outpatient Radiology Appointments,Other: Observational,https://ClinicalTrials.gov/show/NCT04544176
1739,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug: Tociliuzumab,https://ClinicalTrials.gov/show/NCT04363736
1740,Professional's Health in Epidemiological Crisis Covid-19,"Other: Immune response monitoring , blood samples",https://ClinicalTrials.gov/show/NCT04885478
1741,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,Drug: Prednisone,https://ClinicalTrials.gov/show/NCT04534478
1742,Detection of COVID-19 Using Breath Analysis - Validation Study,Diagnostic Test: Breath Biopsy Analysis,https://ClinicalTrials.gov/show/NCT04602949
1743,Prognosis and Course of COVID-19 Infection in Hospitalised Patients,Diagnostic Test: Chitotriosidase activity,https://ClinicalTrials.gov/show/NCT04752085
1744,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,Behavioral: Cognitive and behavioral intervention.|Behavioral: Problem-solving and relationship improvement intervention.,https://ClinicalTrials.gov/show/NCT04463433
1745,Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence,,https://ClinicalTrials.gov/show/NCT04786197
1746,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04404244
1747,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug: Ruxolitinib Oral Tablet,https://ClinicalTrials.gov/show/NCT04334044
1748,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Combination Product: Azithromycin with amoxicillin/clavulanate|Drug: amoxicillin/clavulanate,https://ClinicalTrials.gov/show/NCT04363060
1749,Corticosteroid Nasal Spray in COVID-19 Anosmia,Drug: mometasone furoate nasal spray,https://ClinicalTrials.gov/show/NCT04484493
1750,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,https://ClinicalTrials.gov/show/NCT04343248
1751,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,Drug: Sarilumab,https://ClinicalTrials.gov/show/NCT04661527
1752,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva,Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Saliva sample|Diagnostic Test: axillary sweat sample|Other: Data collection,https://ClinicalTrials.gov/show/NCT04578509
1753,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug: Placebos|Drug: Leronlimab (700mg),https://ClinicalTrials.gov/show/NCT04343651
1754,Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO),Biological: COVID-19 convalescent plasma,https://ClinicalTrials.gov/show/NCT04712344
1755,COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray,Device: Hydrogen peroxide|Device: Placebo,https://ClinicalTrials.gov/show/NCT04878042
1756,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug: Progesterone 100 MG,https://ClinicalTrials.gov/show/NCT04365127
1757,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,Drug: Pirfenidone|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04653831
1758,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,Procedure: Ophthalmologic exam,https://ClinicalTrials.gov/show/NCT04385810
1759,Investigation the Effect of Montelukast in COVID-19,Drug: Montelukast Oral Tablet|Drug: Montelukast plus Favicovir (Favipiravir)|Drug: Favicovir (Standard Treatment),https://ClinicalTrials.gov/show/NCT04718285
1760,Covid-19 Pandemic: Patients' Experience in T1D,Other: Online survey,https://ClinicalTrials.gov/show/NCT04384471
1761,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,Drug: LAU-7b|Drug: Placebo oral capsule,https://ClinicalTrials.gov/show/NCT04417257
1762,The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms,Drug: Amantadine Hydrochloride|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04854759
1763,Efficacy and Safety of Corticosteroids in COVID-19,Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04273321
1764,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Other: Immunological profiling,https://ClinicalTrials.gov/show/NCT04351711
1765,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug: thalidomide|Drug: placebo,https://ClinicalTrials.gov/show/NCT04273529
1766,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug: placebo|Drug: Thalidomide,https://ClinicalTrials.gov/show/NCT04273581
1767,"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04510207
1768,Differential Leucocyte Count and Covid-19 Diagnosis,Diagnostic Test: Differential Leucocyte Count (CLDC) device and algorithm,https://ClinicalTrials.gov/show/NCT04643860
1769,Low Dose Radiation Therapy for Covid-19 Pneumonia,Radiation: Low dose radiation therapy,https://ClinicalTrials.gov/show/NCT04394793
1770,Assiut University Registry for ACS Patients During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04691609
1771,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,Device: ADAM Sensor,https://ClinicalTrials.gov/show/NCT04393558
1772,To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19,Drug: SCTA01|Other: Placebo,https://ClinicalTrials.gov/show/NCT04709328
1773,National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units,Other: observation,https://ClinicalTrials.gov/show/NCT04779541
1774,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,"Diagnostic Test: Evaluation of clinical, instrumental and laboratory diagnostics tests",https://ClinicalTrials.gov/show/NCT04501822
1775,Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy,,https://ClinicalTrials.gov/show/NCT04867213
1776,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,https://ClinicalTrials.gov/show/NCT04359680
1777,Expressive Writing for COVID-19 Resilience for Parents,Behavioral: Expressive writing,https://ClinicalTrials.gov/show/NCT04589117
1778,A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,Drug: Remdesivir|Drug: Tocilizumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04409262
1779,Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Drug: DFV890|Drug: Standard of Care (SoC),https://ClinicalTrials.gov/show/NCT04382053
1780,D-dimer Levels in Pregnant With COVID-19,Other: Blood D-dimer assay,https://ClinicalTrials.gov/show/NCT04389554
1781,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin D,https://ClinicalTrials.gov/show/NCT04372017
1782,Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA,Device: Seraph®-100 Microbind® Affinity Blood Filter,https://ClinicalTrials.gov/show/NCT04413955
1783,Support for COVID19 Patients at Home,Other: Telecare Group|Other: Control group,https://ClinicalTrials.gov/show/NCT04898179
1784,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,Diagnostic Test: Breath Biopsy,https://ClinicalTrials.gov/show/NCT04602871
1785,Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis,Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04854837
1786,"Endocrine, Metabolic and Microbiome Influence on the Post COVID-19 Syndrome",,https://ClinicalTrials.gov/show/NCT04860869
1787,Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample,Diagnostic Test: TestNPass,https://ClinicalTrials.gov/show/NCT04654442
1788,Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19),Diagnostic Test: Lung biopsy,https://ClinicalTrials.gov/show/NCT04775134
1789,"Oral Health, Microbial Burden and COVID-19",Other: Swab,https://ClinicalTrials.gov/show/NCT04668911
1790,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Other: observation,https://ClinicalTrials.gov/show/NCT04343781
1791,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Drug: metenkefalin + tridecactide|Drug: The standard of care,https://ClinicalTrials.gov/show/NCT04374032
1792,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,Behavioral: Brief informational infographic|Behavioral: Placebo control (non-behavioral infographic),https://ClinicalTrials.gov/show/NCT04557241
1793,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,Biological: Convalescent Plasma Infusion,https://ClinicalTrials.gov/show/NCT04644198
1794,Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes,Drug: Silymarin,https://ClinicalTrials.gov/show/NCT04816682
1795,A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,Drug: DWJ1248|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04721535
1796,Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients,Diagnostic Test: Cardiopulmonary exercise test,https://ClinicalTrials.gov/show/NCT04689490
1797,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",Biological: SAB-185|Other: Normal Saline,https://ClinicalTrials.gov/show/NCT04469179
1798,Coronavirus-19 (COVID-19) and Related Outcomes in School Aged Children (ABC Health Outcomes in Children),,https://ClinicalTrials.gov/show/NCT04757831
1799,Hemostatic Profile in Patients Affected by COVID-19,Other: Observational study,https://ClinicalTrials.gov/show/NCT04595110
1800,Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19,Radiation: 99mTc-pertechnetate|Radiation: 99mTc-pertechnetate aerosol|Drug: 99mTc-pertechnetate aerosol,https://ClinicalTrials.gov/show/NCT04724538
1801,Characterizing Long-term Cognitive and Emotional Impairment in Post-COVID-19 Sequelae,Diagnostic Test: questionnaires and neuropsychological assessment,https://ClinicalTrials.gov/show/NCT04881305
1802,Mind Body Intervention for COVID-19 Long Haul Syndrome,Behavioral: Mind Body Syndrome Therapy for Long Covid,https://ClinicalTrials.gov/show/NCT04854772
1803,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19","Device: Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.|Device: Capillary and salivary sampling",https://ClinicalTrials.gov/show/NCT04405492
1804,Evaluating Clinical Parameters of COVID-19 in Pregnancy,,https://ClinicalTrials.gov/show/NCT04470583
1805,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,Drug: Angiotensin 1-7,https://ClinicalTrials.gov/show/NCT04605887
1806,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),Biological: COVID 19 Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04554992
1807,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,,https://ClinicalTrials.gov/show/NCT04329559
1808,Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population,Diagnostic Test: Plasma IgG levels,https://ClinicalTrials.gov/show/NCT04568850
1809,Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19,Other: 6 minute walk test|Other: 1 minute Sit to Stand Test|Other: Fatigue Severity Scale|Other: Medical Research Council (MRC) dyspnea scale|Other: SF-12|Other: Beck Depression Inventory|Other: Beck Anxiety Inventory|Other: 5 times sit to stand test|Other: 6 point Likert Scale,https://ClinicalTrials.gov/show/NCT04834739
1810,Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.,Drug: sodium pyruvate nasal spray,https://ClinicalTrials.gov/show/NCT04871815
1811,the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis,Procedure: laparoscopic appendectomy,https://ClinicalTrials.gov/show/NCT04786041
1812,NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients,Drug: NBT-NM108|Other: Usual Care Only,https://ClinicalTrials.gov/show/NCT04540406
1813,"A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19, Infection",,https://ClinicalTrials.gov/show/NCT04807075
1814,Neonatal Complications of Coronavirus Disease (COVID-19),Other: No intervention - exposure is to COVID-19,https://ClinicalTrials.gov/show/NCT04386109
1815,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,Other: mHealth Assessments,https://ClinicalTrials.gov/show/NCT04397614
1816,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug: Placebos|Drug: Leronlimab (700mg),https://ClinicalTrials.gov/show/NCT04347239
1817,Timing of Corticosteroids in COVID-19,Drug: Early-Dexamethasone|Drug: Late-Dexamethasone,https://ClinicalTrials.gov/show/NCT04530409
1818,"Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave.",,https://ClinicalTrials.gov/show/NCT04592510
1819,COVID-19 Anosmia Study,Drug: Omega-3 Fatty Acid Supplement|Drug: Placebo/Control,https://ClinicalTrials.gov/show/NCT04495816
1820,Face Masks to Reduce COVID-19 in Bangladesh,Device: Face mask|Behavioral: Face mask awareness,https://ClinicalTrials.gov/show/NCT04630054
1821,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,Drug: Ethanol with Asprin,https://ClinicalTrials.gov/show/NCT04554433
1822,Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children,Other: no intervention. observational cohort study,https://ClinicalTrials.gov/show/NCT04490811
1823,Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19,Diagnostic Test: clinical features and laboratory values,https://ClinicalTrials.gov/show/NCT04659876
1824,Hypertension in Patients Hospitalized With COVID-19,,https://ClinicalTrials.gov/show/NCT04318301
1825,Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,Drug: Dexamethasone high dose|Drug: Dexamethasone low dose,https://ClinicalTrials.gov/show/NCT04726098
1826,Expressive Writing for COVID-19 Resilience,Behavioral: Expressive writing,https://ClinicalTrials.gov/show/NCT04589104
1827,Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection,Drug: Mouthwash Product|Other: Water rinse,https://ClinicalTrials.gov/show/NCT04931004
1828,The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations,Behavioral: COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04900259
1829,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,Biological: Mesenchymal Stromal Cells,https://ClinicalTrials.gov/show/NCT04400032
1830,Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19,Device: Observational measurement of biometric data. No change to health care provided.,https://ClinicalTrials.gov/show/NCT04548895
1831,Enzalutamide Treatment in COVID-19,Drug: Enzalutamide Pill,https://ClinicalTrials.gov/show/NCT04475601
1832,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",,https://ClinicalTrials.gov/show/NCT04426253
1833,Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients,Other: Dietary Supplement,https://ClinicalTrials.gov/show/NCT04907877
1834,Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study,Diagnostic Test: Rapid Antigen Test (PanBio Ag test),https://ClinicalTrials.gov/show/NCT04894760
1835,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Other: serological test|Other: Rapid molecular test|Genetic: Next generation Sequencing (NGS) analysis|Other: serum chemistry analysis,https://ClinicalTrials.gov/show/NCT04345315
1836,Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19,Drug: Ribavirin Capsules|Drug: Favipiravir,https://ClinicalTrials.gov/show/NCT04828564
1837,LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID),,https://ClinicalTrials.gov/show/NCT04344002
1838,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 250 MG,https://ClinicalTrials.gov/show/NCT04405921
1839,Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit,Other: No intervention (Retrospective Cohort Observational),https://ClinicalTrials.gov/show/NCT04805645
1840,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,Drug: Favipiravir|Drug: Placebo|Other: Standard of care treatment,https://ClinicalTrials.gov/show/NCT04346628
1841,The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19,Dietary Supplement: L. reuteri DSM 17938 + vitamin D|Dietary Supplement: Placebo + vitamin D,https://ClinicalTrials.gov/show/NCT04734886
1842,National Covid-19 Surveillance Physicians,Diagnostic Test: Antibody test (SARS-CoV2),https://ClinicalTrials.gov/show/NCT04459312
1843,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,Other: General Public cohort,https://ClinicalTrials.gov/show/NCT04377815
1844,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,Drug: NIVOLUMAB|Other: Routine standard of care,https://ClinicalTrials.gov/show/NCT04413838
1845,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04341207
1846,The Effect of Covid-19 Process,Behavioral: Time management & participation & the leisure time activity,https://ClinicalTrials.gov/show/NCT04872725
1847,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine (placebo)|Drug: Zinc|Drug: Zinc (Placebo),https://ClinicalTrials.gov/show/NCT04377646
1848,"Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients",Other: oropharyngeal and intestinal microbiota|Other: host genotype|Other: host immune factors|Other: viral sequence,https://ClinicalTrials.gov/show/NCT04669938
1849,Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE),Drug: M5049|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04448756
1850,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Other: Moxibustion plus Cupping,https://ClinicalTrials.gov/show/NCT04374084
1851,Oral Isotretinoin and Covid-19 Infection,,https://ClinicalTrials.gov/show/NCT04663906
1852,Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19,Drug: nicotinamide,https://ClinicalTrials.gov/show/NCT04910230
1853,Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults,Biological: Experimental Group,https://ClinicalTrials.gov/show/NCT04911790
1854,Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19),Other: POCT,https://ClinicalTrials.gov/show/NCT04779424
1855,Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold),Device: COVID-19 SARS-CoV IgG/IgM antibody rapid test,https://ClinicalTrials.gov/show/NCT04902911
1856,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector,Diagnostic Test: Serological testing,https://ClinicalTrials.gov/show/NCT04939402
1857,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,Drug: Renin-angiotensin system inhibitors,https://ClinicalTrials.gov/show/NCT04493359
1858,Cardiovascular Risk Stratification in Covid-19,,https://ClinicalTrials.gov/show/NCT04555187
1859,Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs,Behavioral: No video|Behavioral: Video Text,https://ClinicalTrials.gov/show/NCT04924803
1860,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,Other: Lung CT scan analysis in COVID-19 patients,https://ClinicalTrials.gov/show/NCT04395482
1861,"Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19",Diagnostic Test: PCR,https://ClinicalTrials.gov/show/NCT04666207
1862,Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,Drug: BIO101|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04472728
1863,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,,https://ClinicalTrials.gov/show/NCT04370275
1864,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,Drug: Ramelteon 8mg,https://ClinicalTrials.gov/show/NCT04470297
1865,Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta,Diagnostic Test: Interlukein 6 and procalcitonin serum levels,https://ClinicalTrials.gov/show/NCT04945811
1866,Tobacco Use and COVID-19 Incidence in the Finnish General Population,"Other: Not applicable, this is an observational study",https://ClinicalTrials.gov/show/NCT04915781
1867,Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers,Drug: Previfenon®|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04446065
1868,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,,https://ClinicalTrials.gov/show/NCT04359459
1869,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug: BLD-2660,https://ClinicalTrials.gov/show/NCT04334460
1870,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,Drug: Famotidine|Drug: N-Acetyl cysteine,https://ClinicalTrials.gov/show/NCT04545008
1871,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,Diagnostic Test: Data collection and rhinopharyngeal swab,https://ClinicalTrials.gov/show/NCT04318431
1872,Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease,Drug: Medium dose prednisolone|Drug: Low dose prednisolone,https://ClinicalTrials.gov/show/NCT04657484
1873,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,"Diagnostic Test: SARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)",https://ClinicalTrials.gov/show/NCT04604249
1874,COVID-19 Prophylaxis South Africa (COVER HCW),Drug: Nitazoxanide|Drug: Sofosbuvir/Daclatasvir,https://ClinicalTrials.gov/show/NCT04561063
1875,Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.,Device: Volatile Organic Compounds analysis (e-noses)|Other: Canine odor detection of Volatile Organic Compounds|Device: Volatile Organic Compounds analysis (mass spectrometry)|Device: Volatile Organic Compounds analysis in sweat (mass spectrometry),https://ClinicalTrials.gov/show/NCT04817371
1876,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,"Other: hypoxia : 14.3 and 12.7% FIO2, hypercapnia 7% CO2, inspiratory mechanical constraint",https://ClinicalTrials.gov/show/NCT04363749
1877,Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19.,Dietary Supplement: Probiotic: Lactobacillus salivarius PS7 + Vit D + Zinc|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04937556
1878,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,Drug: MAS825|Drug: Matching placebo,https://ClinicalTrials.gov/show/NCT04382651
1879,The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes,Other: No intervention,https://ClinicalTrials.gov/show/NCT04879251
1880,Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19,Diagnostic Test: SARS-CoV2 Autoantibody detection,https://ClinicalTrials.gov/show/NCT04542980
1881,Canine COVID-19 Detection Phase 2 and 3,Behavioral: Testing with medical detection dogs,https://ClinicalTrials.gov/show/NCT04948190
1882,Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older,Biological: SARS-CoV-2 mRNA vaccine formulation 1|Biological: SARS-CoV-2 mRNA vaccine formulation 2|Biological: SARS-CoV-2 mRNA vaccine formulation 3|Biological: Placebo (0.9% normal saline),https://ClinicalTrials.gov/show/NCT04798027
1883,Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children,,https://ClinicalTrials.gov/show/NCT04838834
1884,Genetics of COVID-19 Susceptibility and Manifestations,,https://ClinicalTrials.gov/show/NCT04371432
1885,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04663555
1886,"Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population",Other: Questionnaires COVID+|Other: Questionnaires COVID-,https://ClinicalTrials.gov/show/NCT04893070
1887,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,Drug: Peginterferon Lambda-1A|Other: placebo,https://ClinicalTrials.gov/show/NCT04354259
1888,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",Biological: Gam-COVID-Vac Lyo,https://ClinicalTrials.gov/show/NCT04437875
1889,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",Drug: Omega 3/Nigella Sativa Oil|Drug: Omega 3/Nigella Sativa Oil/Indian Costus|Drug: Omega 3/Nigella Sativa Oil/Quinine pills|Drug: Omega 3/Nigella Sativa Oil/Anise seed capsule|Drug: Omega 3/Nigella Sativa Oil/Deglycyrrhizinated Licorice|Drug: Active Comparator,https://ClinicalTrials.gov/show/NCT04553705
1890,Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia,Dietary Supplement: Taxifolin Aqua,https://ClinicalTrials.gov/show/NCT04871802
1891,Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts,Diagnostic Test: Serological test for the detection of IgG anti-SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04808986
1892,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic,Behavioral: Semi-directive interview|Behavioral: Questionnaire : Preparedness for Caregiving Scale,https://ClinicalTrials.gov/show/NCT04625296
1893,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,,https://ClinicalTrials.gov/show/NCT04391881
1894,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,Diagnostic Test: ID NOW vs. Accula,https://ClinicalTrials.gov/show/NCT04403035
1895,Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry,Diagnostic Test: Nasopharyngeal sampling|Diagnostic Test: Saliva sampling,https://ClinicalTrials.gov/show/NCT04712175
1896,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,Drug: Favipiravir (3200 mg + 1200 mg)|Drug: Favipiravir (3600 mg + 1600 mg)|Drug: Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine|Drug: Favipiravir (3200 mg + 1200 mg) combined with Azithromycin|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine combined with Azithromycin,https://ClinicalTrials.gov/show/NCT04411433
1897,Gastrointestinal Symptoms in COVID-19,Other: SARS-CoV2 infection,https://ClinicalTrials.gov/show/NCT04691895
1898,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,Biological: MVC-COV1901,https://ClinicalTrials.gov/show/NCT04487210
1899,The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms,,https://ClinicalTrials.gov/show/NCT04813328
1900,Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff,Biological: Monitoring of the immune response,https://ClinicalTrials.gov/show/NCT04896788
1901,Screening of Health-care Workers in an University Hospital for SARS-CoV-2,Other: Investigation of the prevalence of test positivity,https://ClinicalTrials.gov/show/NCT04567836
1902,Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19,Dietary Supplement: Best Standard of Care + CARDIO|Dietary Supplement: Best Standard of Care,https://ClinicalTrials.gov/show/NCT04465513
1903,Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19),Device: Ion Mobility Spectrometry (IMS),https://ClinicalTrials.gov/show/NCT04556318
1904,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",Drug: Placebo Administration|Biological: Vaccine Therapy,https://ClinicalTrials.gov/show/NCT04639466
1905,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,Device: Electric pad for human external pain therapy,https://ClinicalTrials.gov/show/NCT04363541
1906,"Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19",Biological: Nanocovax|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04922788
1907,Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults,Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell）,https://ClinicalTrials.gov/show/NCT04894227
1908,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,,https://ClinicalTrials.gov/show/NCT04348240
1909,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,Biological: AdimrSC-2f,https://ClinicalTrials.gov/show/NCT04522089
1910,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Combination Product: Hydroxychloroquine Sulfate + Azithromycin|Drug: Hydroxychloroquine Sulfate,https://ClinicalTrials.gov/show/NCT04336332
1911,"A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers",Biological: SC-Ad6-1,https://ClinicalTrials.gov/show/NCT04839042
1912,COVID-19 Breastfeeding Guideline for African-Americans,Behavioral: COVID-19 Breastfeeding Support,https://ClinicalTrials.gov/show/NCT04476940
1913,Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region,Other: Questionnaire|Other: medical consultation,https://ClinicalTrials.gov/show/NCT04817293
1914,Exploratory Study: COVID-19 and Pregnancy,Diagnostic Test: SARS-CoV-2 serology,https://ClinicalTrials.gov/show/NCT04647994
1915,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),Diagnostic Test: Rapid Diagnostic Test vs PCR,https://ClinicalTrials.gov/show/NCT04613310
1916,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,Biological: Mesenchymal cells|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04366271
1917,The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients,Radiation: Non-enhanced CT scan of the chest,https://ClinicalTrials.gov/show/NCT04560530
1918,"A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients",Drug: Telacebec|Drug: COVID-19 Standard of care,https://ClinicalTrials.gov/show/NCT04847583
1919,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04540419
1920,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,Drug: LY3819253|Drug: Placebo|Drug: LY3832479,https://ClinicalTrials.gov/show/NCT04497987
1921,International Registry of Healthcare Workers Exposed to COVID-19 Patients,Other: Comparative Observational Cohort Study,https://ClinicalTrials.gov/show/NCT04626076
1922,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Placebo on a 0- and 28-day schedule|Biological: Placebo on a 0- and 14-day schedule,https://ClinicalTrials.gov/show/NCT04412538
1923,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,Drug: Remdesivir-HU,https://ClinicalTrials.gov/show/NCT04610541
1924,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age",Biological: Biological/Vaccine: BNT162b2 10mcg|Biological: BNT162b2 20mcg|Biological: BNT162b2 30mcg,https://ClinicalTrials.gov/show/NCT04816643
1925,Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults,"Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 2, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Two Doses, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Spray",https://ClinicalTrials.gov/show/NCT04798001
1926,Impact of COVID-19 on Psoriasis Practice,,https://ClinicalTrials.gov/show/NCT04581044
1927,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug: Favipiravir Combined With Tocilizumab|Drug: Favipiravir|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04310228
1928,The ALIGHIERI Survey: an Italian Overview of Global Impact of tHe COVID-19 pandemIc on General surgERy practIce,Other: survey,https://ClinicalTrials.gov/show/NCT04824664
1929,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,Other: Prone position|Other: Supine position,https://ClinicalTrials.gov/show/NCT04543760
1930,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,Other: Systemic indirect endovenous ozone therapy,https://ClinicalTrials.gov/show/NCT04359303
1931,A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2,Drug: BI 767551 intravenous|Drug: BI 767551 inhalation|Drug: Placebo intravenous|Drug: Placebo inhalation,https://ClinicalTrials.gov/show/NCT04894474
1932,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",Drug: INM005|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04494984
1933,Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,Dietary Supplement: Manremyc|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04452773
1934,Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation,Behavioral: Early rehabilitation|Behavioral: Subacute rehabilitation|Behavioral: Mindfulness training|Behavioral: Personalized ambulatory training,https://ClinicalTrials.gov/show/NCT04615390
1935,Endovascular Thrombectomy in COVID-19 Infected Patients,Other: Mechanical Trombectomy,https://ClinicalTrials.gov/show/NCT04406090
1936,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,Drug: MRG-001|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04646603
1937,Role of Inflammasomes in COVID-19 Disease,Other: COVID-19 patients,https://ClinicalTrials.gov/show/NCT04385017
1938,Views on COVID-19 and Vaccination,Behavioral: Healthcare Providers' Communication about the COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04706403
1939,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Drug: Iloprost|Drug: Isotonic saline,https://ClinicalTrials.gov/show/NCT04420741
1940,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,Biological: VXA-CoV2-1,https://ClinicalTrials.gov/show/NCT04563702
1941,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,Diagnostic Test: PET-CT of 18F-FDG,https://ClinicalTrials.gov/show/NCT04512118
1942,The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study,Biological: SARS-CoV-2 vaccination,https://ClinicalTrials.gov/show/NCT04741386
1943,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",Other: Prone Positioning,https://ClinicalTrials.gov/show/NCT04517123
1944,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,,https://ClinicalTrials.gov/show/NCT04468035
1945,Large-scale COVID-19 Population Screening,,https://ClinicalTrials.gov/show/NCT04847804
1946,Covid-19 in Hematological Malignancies,,https://ClinicalTrials.gov/show/NCT04733729
1947,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of placebo at the emergency vaccination schedule|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of placebo at the routine vaccination schedule,https://ClinicalTrials.gov/show/NCT04352608
1948,Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,Biological: COVID-19 convalescent plasma,https://ClinicalTrials.gov/show/NCT04545047
1949,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28",https://ClinicalTrials.gov/show/NCT04383574
1950,A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),Biological: medium dosage inactivated SARS-CoV-2 vaccine|Biological: high dosage inactivated SARS-CoV-2 vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04758273
1951,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),Device: Volatile Organic Compounds analysis,https://ClinicalTrials.gov/show/NCT04379154
1952,The Heart Hive COVID-19 Study,Other: COVID-19 experience surveys,https://ClinicalTrials.gov/show/NCT04468256
1953,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",Biological: BNT162b2|Other: Placebo,https://ClinicalTrials.gov/show/NCT04588480
1954,The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study,Diagnostic Test: CT scan|Diagnostic Test: Pulmonary Function Test,https://ClinicalTrials.gov/show/NCT04868864
1955,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,https://ClinicalTrials.gov/show/NCT04486482
1956,A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),Biological: medium dosage inactivated SARS-CoV-2 vaccine|Biological: high dosage inactivated SARS-CoV-2 vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04756323
1957,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",Drug: anti-SARS-CoV-2 IgY|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04567810
1958,Pulmonary Inflammation in COVID-19 ARDS,Diagnostic Test: Bronchoalveolar lavage,https://ClinicalTrials.gov/show/NCT04935450
1959,COVID-19 Pandemic and Medical Students,Other: Naser Al-Husban,https://ClinicalTrials.gov/show/NCT04726865
1960,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,Behavioral: High intensity interval training|Behavioral: Standard care,https://ClinicalTrials.gov/show/NCT04647734
1961,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",Biological: TY027|Other: 0.9% saline,https://ClinicalTrials.gov/show/NCT04649515
1962,Inspiratory Effort in COVID-19,,https://ClinicalTrials.gov/show/NCT04666246
1963,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Diagnostic Test: Cytokines dosage|Diagnostic Test: Complement dosage,https://ClinicalTrials.gov/show/NCT04346017
1964,Piclidenoson for Treatment of COVID-19,Drug: Piclidenoson|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04333472
1965,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug: Hydroxychloroquine|Drug: Indomethacin|Drug: Zithromax Oral Product,https://ClinicalTrials.gov/show/NCT04344457
1966,A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above,Biological: SARS-CoV-2 mRNA Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04847102
1967,Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19),Other: Intestinal parasite,https://ClinicalTrials.gov/show/NCT04473365
1968,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,Biological: Human Amniotic Fluid,https://ClinicalTrials.gov/show/NCT04497389
1969,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt,,https://ClinicalTrials.gov/show/NCT04531111
1970,Impact of Covid-19 in Congenital Heart Disease,,https://ClinicalTrials.gov/show/NCT04336384
1971,FREEDOM COVID-19 Anticoagulation Strategy,Drug: Enoxaparin|Drug: Apixaban,https://ClinicalTrials.gov/show/NCT04512079
1972,SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study,Drug: Ivermectin 6 Mg Oral Tablet,https://ClinicalTrials.gov/show/NCT04832945
1973,COVID-19 Survival - The COVIVA Study,,https://ClinicalTrials.gov/show/NCT04366765
1974,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",Drug: BGB DXP593|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04532294
1975,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,,https://ClinicalTrials.gov/show/NCT04445610
1976,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),Dietary Supplement: Bioarginina®,https://ClinicalTrials.gov/show/NCT04637906
1977,Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study,Radiation: Low dose radiotherapy,https://ClinicalTrials.gov/show/NCT04904783
1978,Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event,Other: Concert|Diagnostic Test: Rapid nasopharyngeal antigen test for Sars-Cov-2|Diagnostic Test: Saliva Sample,https://ClinicalTrials.gov/show/NCT04872075
1979,COVID-19 Vaccines Safety Tracking (CoVaST),Biological: BNT162b2|Biological: mRNA-1273|Biological: AZD1222|Biological: CoronaVac|Biological: Sinopharm|Biological: Gam-COVID-Vac|Biological: JNJ-78436735|Biological: CVnCoV|Biological: NVX-CoV2373|Biological: BBV152,https://ClinicalTrials.gov/show/NCT04834869
1980,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Dietary Supplement: Natural Honey|Other: Standard Care,https://ClinicalTrials.gov/show/NCT04323345
1981,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru",Biological: Inactivated SARS CoV 2 vaccine (Vero cell) Wuhan/Beijing/Placebo,https://ClinicalTrials.gov/show/NCT04612972
1982,TD-0903 for ALI Associated With COVID-19,Drug: TD-0903|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04402866
1983,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia,,https://ClinicalTrials.gov/show/NCT04485364
1984,Colchicine and Post-COVID-19 Pulmonary Fibrosis,Drug: Colchicine 0.5 MG|Other: the standard protocol only,https://ClinicalTrials.gov/show/NCT04818489
1985,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,Other: convalescent plasma application to SARS-CoV-2 infected patients,https://ClinicalTrials.gov/show/NCT04389944
1986,A Study of Risk Factors for the COVID-19 Virus Infection,Other: Questionnaires,https://ClinicalTrials.gov/show/NCT04697927
1987,Improving Cognitive Health in COVID-19 Survivors,Device: AKL-T01,https://ClinicalTrials.gov/show/NCT04843930
1988,Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve Wellness,,https://ClinicalTrials.gov/show/NCT04910282
1989,Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial,Other: Fulfilling Questionaires,https://ClinicalTrials.gov/show/NCT04883190
1990,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Drug: Imatinib Mesylate|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04422678
1991,Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt,,https://ClinicalTrials.gov/show/NCT04536285
1992,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,https://ClinicalTrials.gov/show/NCT04414124
1993,Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19,Drug: Apixaban 2.5 MG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04746339
1994,Efficacy and Safety of COVID-19 Convalescent Plasma,Biological: anti-SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04397523
1995,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19",Biological: SOC plus 15mg/kg EB05 IV|Other: SOC plus Placebo IV,https://ClinicalTrials.gov/show/NCT04401475
1996,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans,,https://ClinicalTrials.gov/show/NCT04565067
1997,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",Drug: IMU-838|Other: Placebo,https://ClinicalTrials.gov/show/NCT04379271
1998,A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients,Biological: C19-IG 20%|Drug: 0.9% Sodium chloride,https://ClinicalTrials.gov/show/NCT04847141
1999,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,Combination Product: Immunofree tablets and Reginmune capsule,https://ClinicalTrials.gov/show/NCT04494204
2000,Survey of the Anxiety Associated With the COVID-19 Pandemic,Diagnostic Test: Online Questionnaire,https://ClinicalTrials.gov/show/NCT04331106
2001,Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert,,https://ClinicalTrials.gov/show/NCT04824625
2002,Exploring Brain Damages After COVID-19 Infection,Procedure: Auditory Evoked Potentials (AEP)|Procedure: Blink and Masseter Inhibitory Reflex,https://ClinicalTrials.gov/show/NCT04405986
2003,Obstetric Anesthesia Experiences in COVID-19 Positive Patients,Procedure: Anesthesia management,https://ClinicalTrials.gov/show/NCT04691934
2004,Psychological Impact of Covid-19 Assiut University Hospital Experience,,https://ClinicalTrials.gov/show/NCT04789226
2005,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,,https://ClinicalTrials.gov/show/NCT04639427
2006,Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19,Drug: intranasal ivermectin spray,https://ClinicalTrials.gov/show/NCT04716569
2007,Elmo Respiratory Support Project - COVID-19,Other: ELMO PROJECT AT COVID-19: STUDY IN HUMANS|Device: ELMO PROJECT AT COVID-19: PROOF OF CONCEPT AND USABILITY,https://ClinicalTrials.gov/show/NCT04470258
2008,Perceptions and Representations of Vaccination Against COVID-19,Behavioral: Interview,https://ClinicalTrials.gov/show/NCT04896957
2009,Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,Drug: semaglutide,https://ClinicalTrials.gov/show/NCT04615871
2010,Home Pulse Oximeter Use in Patients With COVID-19,Device: Home Pulse Oximetry Monitoring,https://ClinicalTrials.gov/show/NCT04373161
2011,Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19),Drug: ABBV-47D11|Drug: Placebo for ABBV-47D11|Drug: ABBV-2B04|Drug: Placebo for ABBV-2B04,https://ClinicalTrials.gov/show/NCT04644120
2012,Perceived Health After Hospitalization for COVID-19,Other: Questionnaires,https://ClinicalTrials.gov/show/NCT04912804
2013,"Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ",Other: No intervention. Method study. Psychometric testing,https://ClinicalTrials.gov/show/NCT04740372
2014,SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial,Combination Product: Shampoo and saline|Combination Product: Saline and Listerine|Combination Product: Shampoo and Listerine|Combination Product: Saline and Saline,https://ClinicalTrials.gov/show/NCT04802408
2015,Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia,Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04509973
2016,Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19,Diagnostic Test: Sonoclot,https://ClinicalTrials.gov/show/NCT04668404
2017,Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta,Behavioral: Video-based Psychotherapy,https://ClinicalTrials.gov/show/NCT04841681
2018,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,Diagnostic Test: Direct Antigen Tests for COVID-19,https://ClinicalTrials.gov/show/NCT04568356
2019,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,Drug: Low Molecular Weight Heparin,https://ClinicalTrials.gov/show/NCT04393805
2020,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04405271
2021,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Other: oxygen treatment,https://ClinicalTrials.gov/show/NCT04312100
2022,Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19,Procedure: prone position,https://ClinicalTrials.gov/show/NCT04834947
2023,COVID-19 Preventive Behavior in African Americans,Behavioral: Sm-EMA,https://ClinicalTrials.gov/show/NCT04700462
2024,Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients,,https://ClinicalTrials.gov/show/NCT04828460
2025,"Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures",Behavioral: Participate in a massive musical event,https://ClinicalTrials.gov/show/NCT04668625
2026,A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19,Drug: XC221|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04940182
2027,Covid-19 and ONline GAmbling,,https://ClinicalTrials.gov/show/NCT04714008
2028,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04386044
2029,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality,https://ClinicalTrials.gov/show/NCT04344938
2030,Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）,Other: Echocardiography,https://ClinicalTrials.gov/show/NCT04352842
2031,Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan,Drug: Ivermectin / Iota-Carrageenan,https://ClinicalTrials.gov/show/NCT04701710
2032,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,Drug: Convalescent Plasma Transfusion|Other: Supportive Care|Drug: Random Donor Plasma,https://ClinicalTrials.gov/show/NCT04346446
2033,COVID-19 Follow up Intensive Care Studies,,https://ClinicalTrials.gov/show/NCT04460170
2034,Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients,Diagnostic Test: Inflammatory markers sampling,https://ClinicalTrials.gov/show/NCT04867161
2035,Silymarin in COVID-19 Pneumonia,Drug: Silymarin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04394208
2036,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,Biological: Injection of Secretome-MSCs|Drug: Standard treatment of Covid-19,https://ClinicalTrials.gov/show/NCT04753476
2037,Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome,Drug: Hyperbaric oxygen|Procedure: Sham treatment,https://ClinicalTrials.gov/show/NCT04842448
2038,Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector),Biological: Recombinant SARS-CoV-2 Ad5 vectored vaccine|Biological: Inactive SARS-CoV-2 vaccine (Vero cell),https://ClinicalTrials.gov/show/NCT04892459
2039,Impact of the Coronavirus (COVID-19) on Patients With Cancer,,https://ClinicalTrials.gov/show/NCT04330521
2040,Hospital COVID-19 Surge and Associated Mortality Risk,Other: Surge Index,https://ClinicalTrials.gov/show/NCT04688372
2041,Almitrine and COVID-19 Related Hypoxemia,,https://ClinicalTrials.gov/show/NCT04380727
2042,Pulmonary Optical Coherence Tomography in COVID-19 Patients,Diagnostic Test: Optical Coherence Tomography (OCT),https://ClinicalTrials.gov/show/NCT04410549
2043,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,Procedure: biopsies of subcutaneous adipose tissue,https://ClinicalTrials.gov/show/NCT04427878
2044,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug: Almitrine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04357457
2045,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),Procedure: Biospecimen Collection|Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04513990
2046,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,Drug: Dexamethasone|Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04499313
2047,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,Drug: Molgramostim nebuliser solution|Other: Placebo nebuliser solution,https://ClinicalTrials.gov/show/NCT04569877
2048,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,Drug: XC221|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04487574
2049,High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients,Drug: Ascorbic acid,https://ClinicalTrials.gov/show/NCT04710329
2050,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,,https://ClinicalTrials.gov/show/NCT04550403
2051,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,Dietary Supplement: Zinc Picolinate|Dietary Supplement: Resveratrol|Dietary Supplement: Zinc Picolinate Placebo|Dietary Supplement: Resveratrol Placebo,https://ClinicalTrials.gov/show/NCT04542993
2052,Novel Experimental COVID-19 Therapies Affecting Host Response,Drug: TXA127|Drug: TRV027|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04924660
2053,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,https://ClinicalTrials.gov/show/NCT04344951
2054,Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,Drug: ATYR1923 1 mg/kg|Drug: ATYR1923 3 mg/kg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04412668
2055,COVID-19 Impact on Rheumatic Patients,Behavioral: self-administered structured questionnaire,https://ClinicalTrials.gov/show/NCT04407299
2056,Vitamin D on Prevention and Treatment of COVID-19,Dietary Supplement: Vitamin D,https://ClinicalTrials.gov/show/NCT04334005
2057,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug: TD-0903|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04350736
2058,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,Drug: Rivaroxaban 10 MG,https://ClinicalTrials.gov/show/NCT04662684
2059,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,Other: Certified cloth face mask plus preventive information|Behavioral: Preventive information,https://ClinicalTrials.gov/show/NCT04471766
2060,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,Biological: COVID-19 convalescent plasma treatment,https://ClinicalTrials.gov/show/NCT04642014
2061,Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT),Drug: Adalimumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04705844
2062,Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04692129
2063,Study on the Performance and Safety of Sentinox in COVID-19 Patients,Device: Sentinox--Group A|Device: Sentinox--Group B,https://ClinicalTrials.gov/show/NCT04909996
2064,GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19),Biological: GLS-5310|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04673149
2065,Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia,Drug: Tocilizumab 200 Mg/10 mL (20 Mg/mL) INTRAVEN VIAL (ML),https://ClinicalTrials.gov/show/NCT04873141
2066,The COVID-RASi Trial (COVID-19),Drug: Angiotensin converting enzyme inhibitor|Drug: Angiotensin II Receptor Blockers,https://ClinicalTrials.gov/show/NCT04591210
2067,Telemedicine in Outpatient Covid-19 Patients,Device: Withings ScanWatch,https://ClinicalTrials.gov/show/NCT04471636
2068,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,Procedure: Biospecimen Collection|Other: Diagnostic Laboratory Biomarker Analysis|Other: Electronic Health Record Review|Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04497779
2069,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04452812
2070,The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components,,https://ClinicalTrials.gov/show/NCT04836754
2071,Evaluation of Silver Nanoparticles for the Prevention of COVID-19,Device: Mouthwash and nose rinse with the AgNPs solution|Device: Mouthwashes and nose rinse in a conventional way,https://ClinicalTrials.gov/show/NCT04894409
2072,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",Other: Saliva based assay: crude RNA extraction|Other: Validation of the NGS method|Other: Validation of the LAMP assays|Other: Validation of the POCT Antigen and Antibody tests,https://ClinicalTrials.gov/show/NCT04625257
2073,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,Procedure: Prone positioning,https://ClinicalTrials.gov/show/NCT04589936
2074,Best Practices in Perinatal Mental Health During COVID-19,,https://ClinicalTrials.gov/show/NCT04779775
2075,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,Diagnostic Test: AAZ Covid-19 rapid test,https://ClinicalTrials.gov/show/NCT04525417
2076,Novaferon for COVID-19 Treatment Trial (NCTT-005),Biological: Novaferon|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04708158
2077,Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term,,https://ClinicalTrials.gov/show/NCT04836767
2078,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,"Device: Masimo, LidCO",https://ClinicalTrials.gov/show/NCT04392089
2079,COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience,Drug: Hydroxychloroquine Pill,https://ClinicalTrials.gov/show/NCT04554979
2080,Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04479150
2081,"Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals","Diagnostic Test: S-binding IgG, RBD-binding IgG and N-binding IgG immunoassays and SARS-CoV-2 serum neutralization assay, quantitative serum immunoglobulin tests|Diagnostic Test: Assessment of proinflammatory cytokine production and immunophenotypic analysis after stimulation with overlapping S-peptides in peripheral blood mononuclear cells (PBMC)",https://ClinicalTrials.gov/show/NCT04871165
2082,Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older,Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent)|Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine (bivalent)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04904549
2083,Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2),Drug: Standardized Brazilian Green Propolis Extract|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04800224
2084,Plasma Rich Antibodies From Recovered Patients From COVID19,Other: Antibody-Rich Plasma from COVID-19 recovered patients,https://ClinicalTrials.gov/show/NCT04348877
2085,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,Drug: SNG001|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04385095
2086,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,Drug: Enzalutamide,https://ClinicalTrials.gov/show/NCT04456049
2087,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug: favipiravir|Drug: Standard of care therapy,https://ClinicalTrials.gov/show/NCT04349241
2088,"COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery",,https://ClinicalTrials.gov/show/NCT04524520
2089,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Procedure: Stellate Ganglion Block,https://ClinicalTrials.gov/show/NCT04402840
2090,USZ BioResource COVID,Other: blood sampling for biobank,https://ClinicalTrials.gov/show/NCT04414657
2091,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug: Eculizumab,https://ClinicalTrials.gov/show/NCT04346797
2092,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),Diagnostic Test: Quantitative analysis of anti-SARS-CoV-2-antibodies|Diagnostic Test: SARS-CoV-2 diagnostic rapid test,https://ClinicalTrials.gov/show/NCT04453280
2093,"The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection",Diagnostic Test: Inflammatory Parameters|Other: 25 OH Vitamin D Level,https://ClinicalTrials.gov/show/NCT04945577
2094,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,,https://ClinicalTrials.gov/show/NCT04448145
2095,Endoscopic Interventions in Patients With COVID-19,Procedure: Endoscopic intervention,https://ClinicalTrials.gov/show/NCT04423003
2096,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,"Drug: Patch, Nicotine|Drug: Patch, Placebo",https://ClinicalTrials.gov/show/NCT04598594
2097,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,Drug: DWJ1248|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04521296
2098,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Other: blood sample,https://ClinicalTrials.gov/show/NCT04371510
2099,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans®,Biological: ProTrans®,https://ClinicalTrials.gov/show/NCT04896853
2100,CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge,Other: Chelsea Critical Care Physical Assessment Tool,https://ClinicalTrials.gov/show/NCT04762056
2101,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug: Meplazumab for Injection,https://ClinicalTrials.gov/show/NCT04275245
2102,Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04629222
2103,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA],https://ClinicalTrials.gov/show/NCT04359667
2104,Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.,,https://ClinicalTrials.gov/show/NCT04323878
2105,COVID-19 Antigen Rapid Test Kit,Diagnostic Test: SG Diagnostics COVID-19 Antigen Rapid Test Kit|Diagnostic Test: Polymerase chain reaction (PCR) test,https://ClinicalTrials.gov/show/NCT04889365
2106,Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection,Biological: Equine COVID-19 Antiserum|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04834908
2107,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,Drug: Chloroquine phosphate|Other: Telemedicine,https://ClinicalTrials.gov/show/NCT04331600
2108,PSYCHIATRIC Disorders and Covid-19,"Other: Brief Psychiatric Rating Scale|Other: Depression, Anxiety and Stress Scale|Other: Impact of Event Scale-Revised|Other: Connor-Davidson Resilience Scale 10 items (CD-RISC 10)",https://ClinicalTrials.gov/show/NCT04358042
2109,Preop COVID Testing Patterns,,https://ClinicalTrials.gov/show/NCT04838119
2110,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),"Biological: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|Biological: Two doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|Biological: Three doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 14, 28|Biological: Two doses of placebo at the schedule of day 0, 28（middle-dose group）|Biological: Two doses of placebo at the schedule of day 0, 28（high-dose group）|Biological: Three doses of placebo at the schedule of day 0, 14, 28（high-dose group）",https://ClinicalTrials.gov/show/NCT04530656
2111,Dasatinib for the Treatment of Moderate and Severe COVID-19,Drug: Dasatinib Anhydrous|Drug: Placebo Administration,https://ClinicalTrials.gov/show/NCT04830735
2112,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia,Other: Blood samples,https://ClinicalTrials.gov/show/NCT04505605
2113,Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study,"Other: Clinical, functional and radiological lung involvement evolution",https://ClinicalTrials.gov/show/NCT04605757
2114,Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,Drug: dapansutrile capsules|Drug: placebo capsules,https://ClinicalTrials.gov/show/NCT04540120
2115,A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine,Biological: Moderna COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04811664
2116,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database,,https://ClinicalTrials.gov/show/NCT04738331
2117,Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug: Canakinumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04362813
2118,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,Diagnostic Test: Antibody Test,https://ClinicalTrials.gov/show/NCT04446338
2119,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,Other: Personal protective equipment from biological hazard,https://ClinicalTrials.gov/show/NCT04427267
2120,Outcomes of Covid-19 Protective Measures in Endoscopy,,https://ClinicalTrials.gov/show/NCT04371354
2121,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,Biological: SARS-CoV-2 convalescent plasma|Biological: Plasma from a volunteer donor,https://ClinicalTrials.gov/show/NCT04373460
2122,The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19),,https://ClinicalTrials.gov/show/NCT04844515
2123,Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients,Diagnostic Test: PCR test,https://ClinicalTrials.gov/show/NCT04717011
2124,A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections,,https://ClinicalTrials.gov/show/NCT04623138
2125,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Drug: rhDNase I,https://ClinicalTrials.gov/show/NCT04409925
2126,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug: Imatinib tablets|Drug: Baricitinib Oral Tablet|Other: Supportive tratment,https://ClinicalTrials.gov/show/NCT04346147
2127,COVID-19 Child Health Investigation of Latent Disease in Hamburg,,https://ClinicalTrials.gov/show/NCT04534608
2128,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Diagnostic Test: Tuberculin test,https://ClinicalTrials.gov/show/NCT04347876
2129,An Open-Label Study of Apabetalone in Covid Infection,Drug: Apabetalone|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04894266
2130,COVID Screening Strategies in Homeless Shelters,Diagnostic Test: COVID-19 Swab,https://ClinicalTrials.gov/show/NCT04438070
2131,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Drug: Fluoxetine,https://ClinicalTrials.gov/show/NCT04377308
2132,Halodine Nasal Antiseptic in Patients With COVID-19,Drug: Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP,https://ClinicalTrials.gov/show/NCT04517188
2133,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,Other: care modalities|Other: Teleconsultation either by phone or by computer consultation,https://ClinicalTrials.gov/show/NCT04370171
2134,Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19,Drug: Evolocumab|Drug: Saline solution,https://ClinicalTrials.gov/show/NCT04941105
2135,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug: T3 solution for injection|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04348513
2136,COVID-19 Community Research Partnership,,https://ClinicalTrials.gov/show/NCT04342884
2137,Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04924829
2138,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,,https://ClinicalTrials.gov/show/NCT04527601
2139,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,Drug: Octagam,https://ClinicalTrials.gov/show/NCT04411667
2140,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04527211
2141,Immunity After COVID-19 Vaccination,Other: Blood sampling (4 per year),https://ClinicalTrials.gov/show/NCT04924855
2142,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,Drug: Naltrexone|Dietary Supplement: NAD+|Other: Placebo,https://ClinicalTrials.gov/show/NCT04604704
2143,P-Co-Li (Pulmonary Covid-19 Study),Other: Steroid Taper (Prednisone),https://ClinicalTrials.gov/show/NCT04782700
2144,HFNT vs. COT in COVID-19,Device: High Flow Nasal Therapy|Device: Conventional Oxygen Therapy,https://ClinicalTrials.gov/show/NCT04655638
2145,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,Biological: Lenzilumab|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04351152
2146,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,Diagnostic Test: ENT exam|Diagnostic Test: Olfactometry|Diagnostic Test: Brain MRI,https://ClinicalTrials.gov/show/NCT04526054
2147,Convalescent Plasma in Pediatric COVID-19,Biological: Convalescent Plasma (CP)|Drug: Standard COVID-19 therapies,https://ClinicalTrials.gov/show/NCT04458363
2148,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug: Levamisole|Drug: Isoprinosine|Drug: Levamisole and Isoprinosine,https://ClinicalTrials.gov/show/NCT04360122
2149,Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil),Other: Hospital admission|Other: Non-hospitalization procedures,https://ClinicalTrials.gov/show/NCT04479488
2150,Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan,Biological: Sputnik V,https://ClinicalTrials.gov/show/NCT04871841
2151,Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients,Diagnostic Test: Lab workup (on admission and regularly during follow up).,https://ClinicalTrials.gov/show/NCT04584606
2152,The Effect of Inspiratory Muscle Training in Post COVID-19 Patients,Other: Inspiratory Muscle Training,https://ClinicalTrials.gov/show/NCT04811859
2153,Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,Drug: mavrilimumab|Other: Placebo,https://ClinicalTrials.gov/show/NCT04447469
2154,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19,Drug: Losartan|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04328012
2155,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,Other: convalescent plasma from recovered COVID 19 donor,https://ClinicalTrials.gov/show/NCT04347681
2156,Fear Among Dentists During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04383626
2157,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug: TJ003234|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04341116
2158,Description of the Population With Genitourinary Tumors and COVID-19,,https://ClinicalTrials.gov/show/NCT04578132
2159,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,Device: therapeutic plasmaexchnage,https://ClinicalTrials.gov/show/NCT04613986
2160,Effects of Early Use of Nitazoxanide in Patients With COVID-19,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04552483
2161,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Other: - Synthetic anti-malarial drugs,https://ClinicalTrials.gov/show/NCT04356417
2162,Tele-rehabilitation Versus Home Exercise Program in COVID-19,Other: Remote controlled exercise|Other: Home exercise,https://ClinicalTrials.gov/show/NCT04482634
2163,"To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults",Biological: CoVepiT (OSE13E),https://ClinicalTrials.gov/show/NCT04885361
2164,Sargramostim Use in COVID-19 to Recover Patient Health,Drug: Sargramostim|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04707664
2165,European Pathology Laboratories and COVID-19,Other: Activity,https://ClinicalTrials.gov/show/NCT04476823
2166,Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,Other: Sample collection,https://ClinicalTrials.gov/show/NCT04403880
2167,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,Biological: intradermal injection of BCG Vaccine|Other: placebo,https://ClinicalTrials.gov/show/NCT04350931
2168,"Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers",Biological: COVID-eVax|Device: Cliniporator® and EPSGun,https://ClinicalTrials.gov/show/NCT04788459
2169,The Açaí Berry COVID-19 Anti-Inflammation Trial,Dietary Supplement: Açaí palm berry extract - natural product|Other: Placebo,https://ClinicalTrials.gov/show/NCT04404218
2170,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Other: Prone decubitus,https://ClinicalTrials.gov/show/NCT04358939
2171,Asymptomatic SARS-CoV-2 Detection in Children,,https://ClinicalTrials.gov/show/NCT04853316
2172,Study to Evaluate the Safety and Effectiveness of an Immunobiological Drug (Anti SARS-CoV-2) in the Treatment of CoViD-19,Drug: Anti-SARS-CoV-2|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04913779
2173,SARS-CoV-2 IgG and IgM Serologic Assays,Diagnostic Test: Serologic assays for antibodies to SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04562246
2174,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,,https://ClinicalTrials.gov/show/NCT04346043
2175,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,Drug: Tenofovir/ Emtricitabine ( 300 mg / 200 mg daily during 60 days) + Personal Protective Equipment (PPE)|Other: Placebo (1 tablet daily during 60 days) + Personal Protective Equipment (PPE),https://ClinicalTrials.gov/show/NCT04519125
2176,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,,https://ClinicalTrials.gov/show/NCT04332913
2177,The McGill RAAS-COVID-19 Trial,Other: Temporarily holding the RAAS inhibitor [intervention]|Other: RAAS inhibitor [continued standard of care],https://ClinicalTrials.gov/show/NCT04508985
2178,Neurologic Manifestations of COVID-19,,https://ClinicalTrials.gov/show/NCT04386083
2179,Post Covid Syndrome: Clinical Pattern and Functional Assessment,,https://ClinicalTrials.gov/show/NCT04561141
2180,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug: Nivolumab Injection,https://ClinicalTrials.gov/show/NCT04343144
2181,Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013),Drug: Molnupiravir|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04939428
2182,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,Drug: Drug COVID19-0001-USR|Drug: normal saline,https://ClinicalTrials.gov/show/NCT04595136
2183,Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults,"Biological: ChAdV68-S|Biological: ChAdV68-S-TCE|Biological: SAM-LNP-S|Biological: SAM-LNP-S-TCE|Other: Sodium Chloride, 0.9%",https://ClinicalTrials.gov/show/NCT04776317
2184,Cardiovascular Consequences After COVID-19,Other: Infectious Disease and Cardiology Clinical Consultations,https://ClinicalTrials.gov/show/NCT04452630
2185,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,Diagnostic Test: conjunctival swab,https://ClinicalTrials.gov/show/NCT04654325
2186,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,Drug: Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour|Drug: Placebo of NICOTINE Transdermal patch,https://ClinicalTrials.gov/show/NCT04608201
2187,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,Biological: COVID-19 convalescent plasma,https://ClinicalTrials.gov/show/NCT04375098
2188,Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001),Drug: Molnupiravir|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04575584
2189,"Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)",Device: POC CoviDx™ Rapid Antigen Test,https://ClinicalTrials.gov/show/NCT04750629
2190,Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial,Drug: Nafamostat Mesilate|Biological: Convalescent plasma|Drug: Enoxaparin|Drug: Dalteparin|Drug: Tinzaparin|Drug: Aspirin,https://ClinicalTrials.gov/show/NCT04483960
2191,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Other: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,https://ClinicalTrials.gov/show/NCT04413864
2192,Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),Drug: Molnupiravir|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04575597
2193,Nebulised Dornase Alfa for Treatment of COVID-19,Drug: Dornase Alfa Inhalation Solution [Pulmozyme],https://ClinicalTrials.gov/show/NCT04359654
2194,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,Other: Clinical assessment,https://ClinicalTrials.gov/show/NCT04515108
2195,COVID-19 and Chilblains,Diagnostic Test: Biological sample collection,https://ClinicalTrials.gov/show/NCT04455308
2196,Austrian COVID-19 Registry,,https://ClinicalTrials.gov/show/NCT04351529
2197,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Other: Monitoring for aggravation|Other: Evaluate HACOR score effectivity in this patients,https://ClinicalTrials.gov/show/NCT04342104
2198,FOLLOW-UP OF PATIENTS WITH COVID-19.,Other: Follow-up of patients with COVID-19,https://ClinicalTrials.gov/show/NCT04609839
2199,Ultrasound Grayscale Analysis in ARDS covid19,Device: Ultrasound,https://ClinicalTrials.gov/show/NCT04863534
2200,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,,https://ClinicalTrials.gov/show/NCT04347460
2201,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,Biological: CK0802|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04468971
2202,Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection,Other: Oxygen therapy,https://ClinicalTrials.gov/show/NCT04849598
2203,Clinical Features of Severe Patients With COVID-19,"Diagnostic Test: The demographic, clinical, laboratory, and instrumental data",https://ClinicalTrials.gov/show/NCT04450017
2204,Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.,Device: Device: Physiomer undiluted seawater nasal spray,https://ClinicalTrials.gov/show/NCT04916639
2205,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,Other: ECG-Holter,https://ClinicalTrials.gov/show/NCT04374045
2206,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,Behavioral: Maslach Burnout Inventory (MBI),https://ClinicalTrials.gov/show/NCT04424771
2207,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,Drug: Fuzheng Huayu Tablet|Drug: Vitamin C tablets|Other: Placebo|Other: respiratory function rehabilitation training,https://ClinicalTrials.gov/show/NCT04279197
2208,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,Device: aerosol box|Device: transparent sheet,https://ClinicalTrials.gov/show/NCT04412226
2209,Efficacy of Iodine Complex Against COVID-19 Patients,Drug: Iodine Complex|Drug: Placebo|Drug: Idoine Complex,https://ClinicalTrials.gov/show/NCT04473261
2210,COVID-19 Antibody Responses In Cystic Fibrosis,,https://ClinicalTrials.gov/show/NCT04863573
2211,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),,https://ClinicalTrials.gov/show/NCT04443712
2212,Ivermectin in Adults With Severe COVID-19.,Drug: Ivermectin|Other: Placebo,https://ClinicalTrials.gov/show/NCT04602507
2213,Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,Biological: RUTI® vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04453488
2214,The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents,Diagnostic Test: SARS-CoV-2 specific IgM and IgG detection|Diagnostic Test: ELISpot: detection of the T cells specific to different SARS-CoV-2 proteins|Diagnostic Test: Flow cytometry: detection of the SARS-CoV-2 specific T-helpers and cytotoxic T lymphocytes,https://ClinicalTrials.gov/show/NCT04898140
2215,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,,https://ClinicalTrials.gov/show/NCT04348214
2216,COVID-19 and Deep Venous Thrombosis,,https://ClinicalTrials.gov/show/NCT04338932
2217,COVID-19 - No Health Without Mental Health,Behavioral: Co-mestring (co-coping),https://ClinicalTrials.gov/show/NCT04421612
2218,Repurposed Approved Therapies for Outpatient Treatment of Patients With Early-Onset COVID-19 and Mild Symptoms,Drug: Fluvoxamine Maleate 100 MG [Luvox]|Drug: Metformin Extended Release Oral Tablet|Drug: Ivermectin oral tablets or sublingual waffles|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04727424
2219,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Device: Telerehabilitation,https://ClinicalTrials.gov/show/NCT04368845
2220,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,,https://ClinicalTrials.gov/show/NCT04420286
2221,Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum,Other: Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived from Bovine Colostrum,https://ClinicalTrials.gov/show/NCT04916574
2222,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,Biological: COVID-19 Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04374526
2223,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Other: Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors,https://ClinicalTrials.gov/show/NCT04364893
2224,RT-PCR Database Analysis for COVID-19 Infections and Re-infection,,https://ClinicalTrials.gov/show/NCT04653844
2225,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),Drug: FOY-305|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04657497
2226,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,Diagnostic Test: blood test for SARS-COV2 serology,https://ClinicalTrials.gov/show/NCT04470648
2227,Prevalence of Thrombosis in COVID-Patients,Diagnostic Test: duplex sonography,https://ClinicalTrials.gov/show/NCT04615026
2228,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),"Biological: Garadacimab, Factor XIIa Antagonist Monoclonal Antibody|Drug: Placebo",https://ClinicalTrials.gov/show/NCT04409509
2229,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,Combination Product: Aerosolized All-Trans Retinoic acid plus oral Tamoxifen|Other: Standard treatment,https://ClinicalTrials.gov/show/NCT04568096
2230,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,Drug: HCQ,https://ClinicalTrials.gov/show/NCT04491994
2231,COVID-19 and Cancer Consortium Registry,Other: Web-based REDCap survey,https://ClinicalTrials.gov/show/NCT04354701
2232,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,Procedure: AN69-Oxiris|Procedure: AN69-Standard,https://ClinicalTrials.gov/show/NCT04597034
2233,Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan,,https://ClinicalTrials.gov/show/NCT04697030
2234,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,Other: Standardized crisis management and coping protocol plan toward Coronavirus disease 2019 (COVID-19),https://ClinicalTrials.gov/show/NCT04389476
2235,Characterisation of the Immune Response to SARS-CoV-2,Other: blood test,https://ClinicalTrials.gov/show/NCT04729452
2236,COVID-19 And Lingering Symptoms In Primary Care Patients,,https://ClinicalTrials.gov/show/NCT04813731
2237,Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04840940
2238,Lactoferrin Use in (SARS-CoV-2) Management,Dietary Supplement: Lactoferrin,https://ClinicalTrials.gov/show/NCT04860219
2239,Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19,Dietary Supplement: Vitamin D supplementation in pregnant women,https://ClinicalTrials.gov/show/NCT04825093
2240,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,,https://ClinicalTrials.gov/show/NCT04420312
2241,Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04505631
2242,COVID-19 Infection and Epithelial Cell Markers,,https://ClinicalTrials.gov/show/NCT04787588
2243,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,Drug: Brequinar|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04575038
2244,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,Other: Sampling of tissue,https://ClinicalTrials.gov/show/NCT04445597
2245,COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,,https://ClinicalTrials.gov/show/NCT04559009
2246,COVID-19 and Mental Health,Other: Exposure to the SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04407195
2247,"Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19",Drug: Pentarlandir™ UPPTA|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04911777
2248,COVID-19 in Patients With Chronic Liver Diseases,Other: Prospective Chart Review,https://ClinicalTrials.gov/show/NCT04439084
2249,Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program,,https://ClinicalTrials.gov/show/NCT04681950
2250,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Device: Performing of lung ultrasound,https://ClinicalTrials.gov/show/NCT04432805
2251,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug: 2: Usual practice + SYMBICORT RAPIHALER|Other: 1: Usual practice,https://ClinicalTrials.gov/show/NCT04331054
2252,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,Drug: Aerosolized 13 cis retinoic acid|Drug: Aerosolized All trans retinoic acid|Other: Placebo,https://ClinicalTrials.gov/show/NCT04396067
2253,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,Drug: NK-1R antagonist,https://ClinicalTrials.gov/show/NCT04468646
2254,Immunophenotyping Assessment in a COVID-19 Cohort,Procedure: Biological sample collection|Procedure: Data Collection: Clinical Care Assessments,https://ClinicalTrials.gov/show/NCT04378777
2255,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,Biological: Decidual Stromal Cells (DSC),https://ClinicalTrials.gov/show/NCT04451291
2256,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Drug: thromboprophylaxis with low-molecular-weight heparin or fondaparinux,https://ClinicalTrials.gov/show/NCT04359212
2257,Rhu-pGSN for Severe Covid-19 Pneumonia,Drug: Recombinant human plasma gelsolin (Rhu-pGSN)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04358406
2258,Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study,Device: Breath Biopsy face masks with removable filters and fitted PVA strip|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: oropharyngeal swabs,https://ClinicalTrials.gov/show/NCT04508556
2259,Natural History of COVID-19-Related Atrial Fibrillation,"Device: ILR, PMK, ICD",https://ClinicalTrials.gov/show/NCT04830774
2260,Eye Detection to Identify Novel Coronavirus Infection,Diagnostic Test: Novel coronavirus infection,https://ClinicalTrials.gov/show/NCT04907981
2261,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Device: Transcutaneous Auricular Vagus Nerve Stimulation,https://ClinicalTrials.gov/show/NCT04379037
2262,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,Biological: Dental pulp mesenchymal stem cells,https://ClinicalTrials.gov/show/NCT04302519
2263,Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019,Drug: Sacubitril / Valsartan Oral Tablet [Entresto]|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04883528
2264,REsearching Covid-19 Outcomes in Diabetes (RECODE),,https://ClinicalTrials.gov/show/NCT04805970
2265,Use of PCR-Sars-CoV-2 in Children,,https://ClinicalTrials.gov/show/NCT04412317
2266,Imaging Immune Activation in COVID-19,Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine),https://ClinicalTrials.gov/show/NCT04815096
2267,Urine Alkalinisation in COVID-19,Drug: Sodium bicarbonate|Drug: standard care,https://ClinicalTrials.gov/show/NCT04806061
2268,COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19,Diagnostic Test: Rapid Diagnostic Test vs PCR,https://ClinicalTrials.gov/show/NCT04703140
2269,SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,Diagnostic Test: Presence of specific anti-SARS-CoV-2 antibodies,https://ClinicalTrials.gov/show/NCT04482361
2270,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood,,https://ClinicalTrials.gov/show/NCT04401436
2271,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,Drug: Pirfenidone|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04607928
2272,A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes,"Behavioral: Blended Gaming COVID-19 Training System (BGCTS)|Behavioral: Usual care, infection control briefing",https://ClinicalTrials.gov/show/NCT04783025
2273,COVID-19 and Anti-CD14 Treatment Trial,Biological: anti-CD14|Other: Placebo|Drug: remdesivir,https://ClinicalTrials.gov/show/NCT04391309
2274,Lung Irradiation for COVID-19 Pneumonia,Radiation: Phase 1|Radiation: Phase 2,https://ClinicalTrials.gov/show/NCT04393948
2275,COVID-19 and Lung Ultrasound Utility,Device: Butterfly iQ,https://ClinicalTrials.gov/show/NCT04591158
2276,Plasma Therapy of COVID-19 in Severely Ill Patients,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Non-convalescent Plasma (control plasma),https://ClinicalTrials.gov/show/NCT04359810
2277,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug: Dexamethasone and Hydroxychloroquine|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04347980
2278,ACTIV-2: A Study for Outpatients With COVID-19,"Biological: bamlanivimab|Drug: Placebo (IV)|Biological: BRII-196/BRII-198|Biological: AZD7442 (IV)|Biological: AZD7442 (IM)|Drug: SNG001|Drug: Camostat|Drug: Placebo (IM)|Drug: Placebo (Inhaled solution)|Drug: Placebo (oral tablet)|Biological: C135-LS + C144-LS|Drug: Placebo (SC injections)|Biological: SAB-185 (3,840 Units/kg)|Biological: SAB-185 (10,240 Units/kg)",https://ClinicalTrials.gov/show/NCT04518410
2279,Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial,"Dietary Supplement: OL-1, standard dose|Dietary Supplement: OL-1, high dose|Dietary Supplement: Placebo",https://ClinicalTrials.gov/show/NCT04847349
2280,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,Drug: EG-HPCP-03a|Drug: EG-HPCP-03a Placebo|Drug: Standard of Care|Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04561180
2281,Covid-19 in Lupus Patients,,https://ClinicalTrials.gov/show/NCT04355702
2282,Does COVID-19 Pandemic Reduce In-hospital Mortality?,Other: in-hospital mortality rate,https://ClinicalTrials.gov/show/NCT04480515
2283,OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection,Diagnostic Test: Optical coherence tomography angiography,https://ClinicalTrials.gov/show/NCT04601012
2284,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,Biological: Adenovirus Type-5 Vectored COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04568811
2285,Assessment of Executive Functions After Covid-19,,https://ClinicalTrials.gov/show/NCT04771624
2286,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,Drug: BTL-TML-COVID|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04522830
2287,Rapid Screening for Olfactory Disorders in Covid-19 Infection,Diagnostic Test: Olfactory test,https://ClinicalTrials.gov/show/NCT04696601
2288,COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA),,https://ClinicalTrials.gov/show/NCT04881253
2289,Borderline COVID-19 PCR Test Result,Diagnostic Test: SARS-CoV-2 PCR,https://ClinicalTrials.gov/show/NCT04636294
2290,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,Diagnostic Test: comparison of sample collection methods,https://ClinicalTrials.gov/show/NCT04537572
2291,Lactoferrin for Prevention of COVID-19 in Health Care Workers,Dietary Supplement: Bovine Lactoferrin|Dietary Supplement: Maltodextrin,https://ClinicalTrials.gov/show/NCT04526821
2292,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug: Favipiravir,https://ClinicalTrials.gov/show/NCT04333589
2293,Prayer in Commbate to Corona Virus - Covid -19,Other: PRAYER,https://ClinicalTrials.gov/show/NCT04631380
2294,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Diagnostic Test: Serologic SARS-CoV-2 screening,https://ClinicalTrials.gov/show/NCT04387890
2295,"Outpatient Treatment of SARS-CoV-2 With Ivermectin, Fluvoxamine, and Metformin (COVID-19)",Drug: Metformin|Drug: Placebo|Drug: Fluvoxamine|Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04510194
2296,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),Biological: BM-MSCs|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04346368
2297,Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall,Other: Concert,https://ClinicalTrials.gov/show/NCT04896970
2298,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,Other: nutritional intervention,https://ClinicalTrials.gov/show/NCT04451694
2299,"Social Activity, Loneliness and Stigma During COVID-19 Outbreak",Behavioral: Digital social activity video intervention|Behavioral: Informational sheet|Behavioral: Stigma awareness video intervention,https://ClinicalTrials.gov/show/NCT04734171
2300,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,,https://ClinicalTrials.gov/show/NCT04442165
2301,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,,https://ClinicalTrials.gov/show/NCT04412473
2302,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",Drug: IVIG,https://ClinicalTrials.gov/show/NCT04500067
2303,Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University,Biological: Astrazeneca/Oxford Vaccine|Biological: Sinopharm vaccine,https://ClinicalTrials.gov/show/NCT04885764
2304,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",Diagnostic Test: visual analogue scale,https://ClinicalTrials.gov/show/NCT04657445
2305,A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19,Drug: Ambrisentan|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04771000
2306,COVID-19 and Tissue Damage in Vital Organs,"Procedure: Liver, lung, heart and kidney biopsy",https://ClinicalTrials.gov/show/NCT04678687
2307,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,Other: Airway pressure release ventilation,https://ClinicalTrials.gov/show/NCT04386369
2308,COVID-19 Related Health and Infection Control Practices Among Dentists,Other: No intervention,https://ClinicalTrials.gov/show/NCT04423770
2309,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,Drug: Standard of Care (SOC) + ANG-3777|Drug: Standard Of Care (SOC) + Placebo,https://ClinicalTrials.gov/show/NCT04459676
2310,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,,https://ClinicalTrials.gov/show/NCT04438941
2311,"Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults",Biological: SARS-CoV-2 inactivated vaccine,https://ClinicalTrials.gov/show/NCT04651790
2312,FAvipiravir and HydroxyChloroquine Combination Therapy,Combination Product: Favipiravir and Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04392973
2313,Long-term Impact of Infection With Novel Coronavirus (COVID-19),,https://ClinicalTrials.gov/show/NCT04362150
2314,Pulmonary Embolism and COVID-19,Other: intensive care unit admission ratio,https://ClinicalTrials.gov/show/NCT04590378
2315,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,,https://ClinicalTrials.gov/show/NCT04343339
2316,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant|Other: Placebo,https://ClinicalTrials.gov/show/NCT04533399
2317,Vienna Versus SARS-CoV-2 Virus Study,Diagnostic Test: Laboratory Analyses,https://ClinicalTrials.gov/show/NCT04407429
2318,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,,https://ClinicalTrials.gov/show/NCT04403932
2319,COVID-19 PCR Test Results in Asymptomatic Pregnants,Diagnostic Test: Reverse transcription polymerase chain reaction,https://ClinicalTrials.gov/show/NCT04410939
2320,Outpatient Treatment With CoVid-19 With Prexablu,Drug: Sublingual Methylene blue|Other: Control patients,https://ClinicalTrials.gov/show/NCT04619290
2321,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,Other: Online Survey about Dietary and Lifestyle Habits,https://ClinicalTrials.gov/show/NCT04437121
2322,Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients,Other: retrospective metagenomics on clinical samples collected during hospitalization,https://ClinicalTrials.gov/show/NCT04516486
2323,COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04487873
2324,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,,https://ClinicalTrials.gov/show/NCT04414059
2325,"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom",Biological: SARS-CoV-2 rS/Matrix M1-Adjuvant|Other: Placebo|Biological: Licensed seasonal influenza vaccine,https://ClinicalTrials.gov/show/NCT04583995
2326,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Drug: Melphalan|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04380376
2327,Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents,Biological: SARS-CoV-2 Inactivated Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04884685
2328,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,Biological: COVID-19 convalescent plasma|Biological: Anti-COVID-19 human immunoglobulin|Drug: Standard (specific) therapy for COVID-19,https://ClinicalTrials.gov/show/NCT04395170
2329,Evaluation of Covid 19 Anxiety in Endometriosis Patients,,https://ClinicalTrials.gov/show/NCT04337346
2330,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,Dietary Supplement: Oxaloacetate Medical Food/Dietary Supplement,https://ClinicalTrials.gov/show/NCT04592354
2331,COVID19-FOIE National Observatory,,https://ClinicalTrials.gov/show/NCT04375670
2332,COVID-19 Associated Endothelial Dysfunction Study,Diagnostic Test: Procedure : Multimodal microvascular assessment at study inclusion,https://ClinicalTrials.gov/show/NCT04773899
2333,Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:,Drug: Montelukast|Other: placebo,https://ClinicalTrials.gov/show/NCT04695704
2334,Psychiatric Consultation for COVID-19 Patients,Behavioral: Psychiatric counseling,https://ClinicalTrials.gov/show/NCT04395872
2335,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,Biological: Mesenchymal stromal cells|Other: Placebo,https://ClinicalTrials.gov/show/NCT04615429
2336,HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,Genetic: Expression of receptors and activating proteases|Genetic: Polymorphism of the HSD3B1,https://ClinicalTrials.gov/show/NCT04516850
2337,"A Phase 2 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",Drug: BRII-196 and BRII-198|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04787211
2338,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug: Carrimycin|Drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate|Drug: basic treatment,https://ClinicalTrials.gov/show/NCT04286503
2339,Proxalutamide Treatment for COVID-19 Female Outpatients,Drug: Proxalutamide|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04853134
2340,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04542031
2341,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,Drug: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet|Drug: Telmisartan 40Mg Oral Tablet|Drug: Atorvastatin 20 Mg Oral Tablet,https://ClinicalTrials.gov/show/NCT04466241
2342,Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia,Drug: Ivermectin|Drug: ASP|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04703608
2343,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04646655
2344,Polyvalent Immunoglobulin in COVID-19 Related ARds,Drug: Human immunoglobulin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04350580
2345,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Diagnostic Test: COVID-19 PCR and Serology,https://ClinicalTrials.gov/show/NCT04392323
2346,Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19,Drug: COVID-19 group (Group I)|Drug: Type II Diabetes Mellitus and COVID-19 group (Group II),https://ClinicalTrials.gov/show/NCT04695158
2347,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,Behavioral: Kukaa Salama: mHealth intervention|Device: Face Mask + Soap,https://ClinicalTrials.gov/show/NCT04631367
2348,Treatment of Nosocomial COVID-19,Drug: Bamlanivimab,https://ClinicalTrials.gov/show/NCT04748588
2349,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.",Other: Patient with SAR-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04552340
2350,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,Device: Active PBMT/sMF|Device: Placebo PBMT/sMF,https://ClinicalTrials.gov/show/NCT04386694
2351,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Other: Discontinuation of ARB/ACEI|Other: Continuation of ARB/ACEI,https://ClinicalTrials.gov/show/NCT04338009
2352,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),Biological: UC-MSCs|Biological: Saline containing 1% Human serum albumin（solution without UC-MSCs）,https://ClinicalTrials.gov/show/NCT04288102
2353,Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19,Drug: Corticosteroids and Derivatives,https://ClinicalTrials.gov/show/NCT04586114
2354,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Procedure: Combined use of a respiratory broad panel multiplex PCR and procalcitonin|Other: Usual antibiotic treatment,https://ClinicalTrials.gov/show/NCT04334850
2355,Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY,,https://ClinicalTrials.gov/show/NCT04325412
2356,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,Biological: Covax-19™,https://ClinicalTrials.gov/show/NCT04428073
2357,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,Biological: Autologous Adipose MSC's,https://ClinicalTrials.gov/show/NCT04352803
2358,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,Drug: Losartan,https://ClinicalTrials.gov/show/NCT04606563
2359,Treat COVID-19 Patients With Regadenoson,Drug: Regadenoson|Other: Placebo Control,https://ClinicalTrials.gov/show/NCT04606069
2360,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug: Danoprevir+Ritonavir,https://ClinicalTrials.gov/show/NCT04345276
2361,Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug: Ganovo+ritonavir+/-Interferon nebulization,https://ClinicalTrials.gov/show/NCT04291729
2362,Distance Learning for Dental Student During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04401371
2363,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Drug: Ruxolitinib Oral Tablet,https://ClinicalTrials.gov/show/NCT04361903
2364,Generic Testing of Antigen Tests for COVID-19 in Denmark,Diagnostic Test: Comparison of antigen tests with RT-PCR as reference method,https://ClinicalTrials.gov/show/NCT04913116
2365,"COVID-19 Vaccine Messaging, Part 1",Other: Control message|Other: Baseline message|Other: Personal freedom message|Other: Economic freedom message|Other: Self-interest message|Other: Community interest message|Other: Economic benefit message|Other: Guilt message|Other: Embarrassment message|Other: Anger message|Other: Trust in science message|Other: Not bravery message,https://ClinicalTrials.gov/show/NCT04460703
2366,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),Other: Intervention group_rehabilitation program,https://ClinicalTrials.gov/show/NCT04466800
2367,COVID-19 Search in Conjunctival Cells,Diagnostic Test: conjunctival swab,https://ClinicalTrials.gov/show/NCT04364594
2368,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,Procedure: Blood sampling|Procedure: Throat swab,https://ClinicalTrials.gov/show/NCT04405466
2369,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,Drug: unfractionated Heparin,https://ClinicalTrials.gov/show/NCT04487990
2370,Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura,,https://ClinicalTrials.gov/show/NCT04724850
2371,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition,,https://ClinicalTrials.gov/show/NCT04573634
2372,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Drug: Anluohuaxian,https://ClinicalTrials.gov/show/NCT04334265
2373,Predictors of Severe COVID-19 Outcomes,,https://ClinicalTrials.gov/show/NCT04388813
2374,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.,Diagnostic Test: Clungene rapid test cassette,https://ClinicalTrials.gov/show/NCT04402814
2375,"Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics",Behavioral: Trial-Based Cognitive Therapy|Behavioral: Mindfulness-Based Health Promotion|Behavioral: Positive psychotherapy,https://ClinicalTrials.gov/show/NCT04852770
2376,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",Drug: Rivaroxaban|Other: Placebo|Other: Standard of Care (SOC),https://ClinicalTrials.gov/show/NCT04508023
2377,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",Device: High flow nasal cannula (HFNC)|Device: Helmet NIV|Device: Face-mask NIV,https://ClinicalTrials.gov/show/NCT04715243
2378,Proxalutamide Treatment for Hospitalized COVID-19 Patients,Drug: Proxalutamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04728802
2379,Anti-SARS Cov-2 T Cell Infusions for COVID 19,Biological: Dose Finding Phase (MTD)|Biological: Partially HLA-matched SARS-CoVSTs|Other: Routine care (no SARS-CoVSTs),https://ClinicalTrials.gov/show/NCT04401410
2380,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,Other: COVID-19 and Intensive Care,https://ClinicalTrials.gov/show/NCT04390074
2381,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,Behavioral: heat therapy|Behavioral: exercise training,https://ClinicalTrials.gov/show/NCT04673318
2382,VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans,Behavioral: Behavioral economics,https://ClinicalTrials.gov/show/NCT04805931
2383,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,https://ClinicalTrials.gov/show/NCT04383535
2384,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Diagnostic Test: EUROIMMUN assay,https://ClinicalTrials.gov/show/NCT04349202
2385,Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit,Drug: Proxalutamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04853927
2386,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Drug: Peginterferon lambda alfa-1a subcutaneous injection|Other: Saline,https://ClinicalTrials.gov/show/NCT04344600
2387,Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt,Other: Kaplan Meier analysis,https://ClinicalTrials.gov/show/NCT04488588
2388,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,"Biological: SARS-CoV-2 rS - Phase 1|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1|Other: Normal saline solution (NSS), Placebo - Phase 1|Other: Normal saline solution (NSS), Placebo - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1|Other: Normal saline solution (NSS), Placebo, Day 21 - Phase 1|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2|Other: Normal saline solution (NSS), Placebo, Day 189 - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2|Other: Normal saline solution (NSS), Placebo, Day 21 - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2",https://ClinicalTrials.gov/show/NCT04368988
2389,Neuroinflammation in COVID-19 and Depression,Other: [18F]FEPPA PET scan|Other: [11C]SL25.1188 PET scan,https://ClinicalTrials.gov/show/NCT04854785
2390,Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection,Diagnostic Test: serum NGAL and cystatin c,https://ClinicalTrials.gov/show/NCT04603664
2391,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults","Biological: Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|Biological: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|Biological: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 in elderly",https://ClinicalTrials.gov/show/NCT04617483
2392,Inspiratory Muscle Training in COVID-19 Patients,Device: inspiratory muscle traiing,https://ClinicalTrials.gov/show/NCT04595097
2393,"ARB, ACEi, DRi in COVID-19",Drug: Angiotensin converting enzyme inhibitor,https://ClinicalTrials.gov/show/NCT04364984
2394,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostic Test: rapid salivary test,https://ClinicalTrials.gov/show/NCT04357327
2395,COVID-19 in Pediatric Oncology and Hematology Centers in France,"Other: No intervention, observational",https://ClinicalTrials.gov/show/NCT04433871
2396,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,,https://ClinicalTrials.gov/show/NCT04513964
2397,Contrast Enhanced Ultrasound in COVID-19,Drug: Sulfur hexafluoride lipid-type A microspheres,https://ClinicalTrials.gov/show/NCT04640038
2398,SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults,"Biological: 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)|Drug: Sodium chloride, USP, for injection (0.9% NaCl)|Biological: 50 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)",https://ClinicalTrials.gov/show/NCT04784767
2399,The Effect of Melatonin and Vitamin C on COVID-19,Dietary Supplement: Vitamin C|Dietary Supplement: melatonin|Dietary Supplement: Placebo|Other: Symptom Survey,https://ClinicalTrials.gov/show/NCT04530539
2400,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients,,https://ClinicalTrials.gov/show/NCT04679272
2401,Prevalence of Perimyocarditis After Covid-19 Vaccine,Diagnostic Test: Laboratory Blood Tests|Diagnostic Test: ECG|Diagnostic Test: PCR|Diagnostic Test: Antibody test|Diagnostic Test: Echocardiography|Diagnostic Test: MRI,https://ClinicalTrials.gov/show/NCT04865900
2402,"Evaluation of COVID-19 Fear, Anxiety and Their Effects in Physiotherapy Technician Students",Other: Survey,https://ClinicalTrials.gov/show/NCT04802642
2403,Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia,Drug: Cerebrolysin,https://ClinicalTrials.gov/show/NCT04830943
2404,COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark,Procedure: blood sampling,https://ClinicalTrials.gov/show/NCT04775407
2405,COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach,,https://ClinicalTrials.gov/show/NCT04424940
2406,Ivermectin Reproposing for Mild Stage COVID-19 Outpatients,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04784481
2407,Modulation of Hyperinflammation in COVID-19,Device: Control group|Device: SLEDD with a L-MOD,https://ClinicalTrials.gov/show/NCT04353674
2408,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,Biological: UC-MSCs|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04865107
2409,"Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine",Biological: VLA2001|Biological: AZD1222,https://ClinicalTrials.gov/show/NCT04864561
2410,Kidney Injury Severity and COVID-19,Diagnostic Test: mRNA in urine test,https://ClinicalTrials.gov/show/NCT04386564
2411,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug: Hydrocortisone|Drug: Sodium Chloride 9mg/mL,https://ClinicalTrials.gov/show/NCT04348305
2412,Characteristics of Long COVID-19 Syndrome,Other: No intervention,https://ClinicalTrials.gov/show/NCT04793269
2413,Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis,,https://ClinicalTrials.gov/show/NCT04834401
2414,COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy,Drug: Methylene Blue and Photodynamic Therapy,https://ClinicalTrials.gov/show/NCT04933864
2415,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,Other: Tele-exergaming Tablet,https://ClinicalTrials.gov/show/NCT04743401
2416,Stellate Ganglion Blockade in COVID-19 Positive Patients,Procedure: Stellate Ganglion Block,https://ClinicalTrials.gov/show/NCT04445337
2417,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,Other: non applicable,https://ClinicalTrials.gov/show/NCT04412031
2418,The Critical Care Response to the COVID-19 Pandemic in Madrid,,https://ClinicalTrials.gov/show/NCT04393324
2419,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,Biological: IN01 vaccine,https://ClinicalTrials.gov/show/NCT04537130
2420,Spread and Course of COVID-19 Infections,,https://ClinicalTrials.gov/show/NCT04377724
2421,Back to School COVID-19 Simulation Study,Behavioral: Personal behaviours,https://ClinicalTrials.gov/show/NCT04531254
2422,Acute Kidney Injury in Patients With CoVID-19,"Other: duration of hospitalization, mortality rate",https://ClinicalTrials.gov/show/NCT04872764
2423,Study of Recombinant Protein Vaccine With Adjuvant Against COVID-19 in Adults 18 Years of Age and Older,Biological: SARS-CoV-2 recombinant protein vaccine Formulation 1|Biological: SARS-CoV-2 recombinant protein vaccine Formulation 2|Biological: SARS-CoV-2 recombinant protein vaccine Formulation 3,https://ClinicalTrials.gov/show/NCT04762680
2424,Musculoskeletal Symptoms in Post Acute Covid-19 Patients,Other: Survey|Other: Laboratory parameters|Other: chest computed tomography,https://ClinicalTrials.gov/show/NCT04932889
2425,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?,Diagnostic Test: Exposure: Positive COVID-19 infection|Diagnostic Test: Exposure: Negative COVID-19 infection,https://ClinicalTrials.gov/show/NCT04696913
2426,Helmet Non-Invasive Ventilation for COVID-19 Patients,Device: Helmet non-invasive ventilation,https://ClinicalTrials.gov/show/NCT04477668
2427,Prospective Two-arm Study of Fertility in Men With COVID-19,"Diagnostic Test: Sperm test|Diagnostic Test: hormone levels (testosterone, FSH, LH, prolactin)|Diagnostic Test: SARS-CoV-2 Ig G levels|Other: Testis pathology samples",https://ClinicalTrials.gov/show/NCT04716179
2428,Vitamin D Testing and Treatment for COVID 19,Dietary Supplement: Vitamin D3,https://ClinicalTrials.gov/show/NCT04407286
2429,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,Other: Serum protein level analysis,https://ClinicalTrials.gov/show/NCT04628637
2430,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,Drug: Interferon alfa|Drug: Selinexor|Drug: Lenzilumab,https://ClinicalTrials.gov/show/NCT04534725
2431,Fostamatinib for Hospitalized Adults With COVID-19,Drug: Placebo|Drug: fostamatinib,https://ClinicalTrials.gov/show/NCT04579393
2432,Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region,Other: No intervention,https://ClinicalTrials.gov/show/NCT04874740
2433,The Effect of COVID-19 on Diabetes Mellitus,,https://ClinicalTrials.gov/show/NCT04592055
2434,COVID19 Clinical Predictors and Outcome,Other: SARS-CoV2 Infection,https://ClinicalTrials.gov/show/NCT04416347
2435,Effects of COVID-19 Hospitalization on Physical Performance,Other: Therapeutic Exercise,https://ClinicalTrials.gov/show/NCT04751630
2436,Effects of COVID-19 in Chronic Pain,Other: Survey,https://ClinicalTrials.gov/show/NCT04878900
2437,Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage,Other: No intervention performed,https://ClinicalTrials.gov/show/NCT04928469
2438,Comparison of ME/CFS and Long COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04806620
2439,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,,https://ClinicalTrials.gov/show/NCT04433325
2440,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection,https://ClinicalTrials.gov/show/NCT04403672
2441,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Drug: Tocilizumab 180 MG/ML|Drug: Methylprednisolone Sodium Succinate,https://ClinicalTrials.gov/show/NCT04377503
2442,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),Diagnostic Test: Blood test for IgG antibodies against SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04581148
2443,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,,https://ClinicalTrials.gov/show/NCT04356586
2444,COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,Other: Decision tool for clinicians,https://ClinicalTrials.gov/show/NCT04743232
2445,Lung Recruitment Device for COVID-19,Procedure: Chest physiotherapy using a non-invasive oscillating device,https://ClinicalTrials.gov/show/NCT04361435
2446,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,Dietary Supplement: L-citrulline|Other: Placebo,https://ClinicalTrials.gov/show/NCT04404426
2447,Post Intensive Care Syndrome in COVID19 Patients,Diagnostic Test: Questionnaires,https://ClinicalTrials.gov/show/NCT04422444
2448,Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19),Biological: NBP2001 adjuvanted with alum (RBD 30μg/dose)|Biological: NBP2001 adjuvanted with alum (RBD 50μg/dose)|Other: Normal Saline,https://ClinicalTrials.gov/show/NCT04760743
2449,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),Diagnostic Test: Biological Sample Collection,https://ClinicalTrials.gov/show/NCT04387955
2450,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04732663
2451,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,Device: Hyperbaric oxygen|Device: Sham,https://ClinicalTrials.gov/show/NCT04647656
2452,Silent Hypoxia and Awake Proning in COVID-19 Patients,Other: Self measurement with pulse oximeter,https://ClinicalTrials.gov/show/NCT04647747
2453,A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),Drug: AMY-101|Other: WFI 5% glucose,https://ClinicalTrials.gov/show/NCT04395456
2454,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,Biological: SARS-CoV-2 vaccine formulation 1 with adjuvant 1|Biological: SARS-CoV-2 vaccine formulation 1 with adjuvant 2|Biological: SARS-CoV-2 vaccine formulation 2 with adjuvant 1|Biological: SARS-CoV-2 vaccine formulation 2 with adjuvant 2|Biological: SARS-CoV-2 vaccine formulation 2 without adjuvant|Biological: Placebo (0.9% normal saline),https://ClinicalTrials.gov/show/NCT04537208
2455,Maternal Morbidity and Mortality During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04519502
2456,Characteristics of COVID-19 Patients in Kazakhstan in Early 2020,,https://ClinicalTrials.gov/show/NCT04627194
2457,Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP,Diagnostic Test: Serology test for COVID-19,https://ClinicalTrials.gov/show/NCT04575545
2458,COVID-19 (VA CURES-1),Drug: Convalescent Plasma|Other: Masked Saline Placebo,https://ClinicalTrials.gov/show/NCT04539275
2459,Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2),Drug: Fluvoxamine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04668950
2460,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Device: Hyperbaric oxygen therapy,https://ClinicalTrials.gov/show/NCT04358926
2461,Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine,Other: Sperm collection,https://ClinicalTrials.gov/show/NCT04778033
2462,Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients,Drug: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04910295
2463,Closed Loop Ventilation in Patients With COVID-19,Device: Intellivent ASV,https://ClinicalTrials.gov/show/NCT04873336
2464,Efficacy of Ivermectin in Outpatients With Non-severe COVID-19,Drug: Ivermectin Tablets|Other: Placebo,https://ClinicalTrials.gov/show/NCT04834115
2465,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,,https://ClinicalTrials.gov/show/NCT04354519
2466,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,Other: blood sample,https://ClinicalTrials.gov/show/NCT04590222
2467,Effect of Pioglitazone on T2DM Patients With COVID-19,Drug: Pioglitazone 45 mg,https://ClinicalTrials.gov/show/NCT04604223
2468,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Drug: Vitamin D|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04411446
2469,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,,https://ClinicalTrials.gov/show/NCT04634214
2470,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,Drug: COVID-19 Convalscent Plasma,https://ClinicalTrials.gov/show/NCT04474340
2471,Checkpoint Blockade in COVID-19 Pandemic,Drug: Tocilizumab|Biological: Pembrolizumab (MK-3475),https://ClinicalTrials.gov/show/NCT04335305
2472,EAT-DUTA AndroCoV Trial,Drug: Dutasteride 0.5 mg|Drug: Azithromycin|Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04729491
2473,Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04745923
2474,Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,Drug: Artemether-lumefantrine (AL)|Drug: Pyronaridine-artesunate (PA),https://ClinicalTrials.gov/show/NCT04695197
2475,Predictive Factors for COVID-19 in Rheumatology,Drug: Disease-modifying antirheumatic drugs (DMARDs),https://ClinicalTrials.gov/show/NCT04567576
2476,Liver Transplantation and Coronavirus Disease 2019 (COVID-19),Other: COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04695756
2477,COVID-19 Vaccination in Oncologic Patients,,https://ClinicalTrials.gov/show/NCT04918888
2478,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19",Biological: MVA-SARS-2-ST|Biological: Licensed COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04895449
2479,EMPOWER - BAME vs COVID,,https://ClinicalTrials.gov/show/NCT04399733
2480,hCT-MSCs for COVID19 ARDS,Biological: human cord tissue mesenchymal stromal cells,https://ClinicalTrials.gov/show/NCT04399889
2481,Predictive Models for Intensive Care Admission and Death of COVID-19,"Other: predict admission of covid-19 patients to ICU and death with routine and quickly avalaible clinical, biological and radiological variables?",https://ClinicalTrials.gov/show/NCT04401228
2482,Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity,Diagnostic Test: Diagnostic tests,https://ClinicalTrials.gov/show/NCT04828629
2483,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),Other: Questionnaires on psychological quality of life,https://ClinicalTrials.gov/show/NCT04375644
2484,Serologic Response to the SARS-CoV-2 mRNA-1273 Vaccine in Select Subsets of Oncology Patients,Other: Blood Sample,https://ClinicalTrials.gov/show/NCT04854980
2485,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,Drug: Nebulized Furosemide|Drug: Nebulized Saline,https://ClinicalTrials.gov/show/NCT04588792
2486,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,Other: No interventions,https://ClinicalTrials.gov/show/NCT04535154
2487,Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19,Procedure: Emergency surgical procedures,https://ClinicalTrials.gov/show/NCT04758286
2488,Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19,Diagnostic Test: Resting electrocardiogram|Diagnostic Test: Stress test|Diagnostic Test: Cardiac echocardiography|Diagnostic Test: Cardiac rhythm monitoring|Other: Questionnaire|Device: Injected Cardiac MRI|Biological: Blood sampling for biobank,https://ClinicalTrials.gov/show/NCT04936503
2489,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,,https://ClinicalTrials.gov/show/NCT04355481
2490,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,Device: Contrast-enhanced CMR|Diagnostic Test: Exercise test ECG|Biological: Blood sample|Diagnostic Test: Resting 12 lead ECG|Diagnostic Test: 24 hour Holter ECG,https://ClinicalTrials.gov/show/NCT04636320
2491,The DAWN Camostat Trial for Ambulatory COVID-19 Patients,Drug: Camostat|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04730206
2492,Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection,Drug: EXO-CD24,https://ClinicalTrials.gov/show/NCT04747574
2493,Use of nMoABs for the Treatment of COVID-19 in Patients With HM.,,https://ClinicalTrials.gov/show/NCT04932967
2494,Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients,Device: High Flow Nasal Oxygen (HFNO) treatment|Device: Continuous Positive Airway Pressure (CPAP) therapy using OxyJet,https://ClinicalTrials.gov/show/NCT04681859
2495,Outcomes in Emergency Laparotomies During COVID-19 Pandemic,Procedure: Emergency Laparotomy,https://ClinicalTrials.gov/show/NCT04419571
2496,Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19,Behavioral: Messaging informed by construal level theory|Behavioral: Usual Care,https://ClinicalTrials.gov/show/NCT04871776
2497,The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change,,https://ClinicalTrials.gov/show/NCT04896060
2498,The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19,"Other: hospitalisation, necessity of ICU, mortality rate, lung involvement",https://ClinicalTrials.gov/show/NCT04591704
2499,COVID-SErology in Rheumatoid Arthritis (COVID-19),Other: Serological analyses to be lead on a pre-existing biobank,https://ClinicalTrials.gov/show/NCT04407559
2500,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,Drug: Placebo|Drug: DuACT,https://ClinicalTrials.gov/show/NCT04563208
2501,Study to Evaluate the Effect of a Probiotic in COVID-19,Dietary Supplement: Probiotic,https://ClinicalTrials.gov/show/NCT04390477
2502,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults,Biological: Ad26.COV2.S|Other: Placebo,https://ClinicalTrials.gov/show/NCT04614948
2503,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,Other: Usual Care|Other: APPS,https://ClinicalTrials.gov/show/NCT04547283
2504,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19),Biological: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 1|Biological: GBP510 (RBD 10μg/dose) - Stage 1|Other: Normal saline (0.9% sodium chloride solution) - Stage 1|Biological: GBP510 adjuvanted with AS03 (RBD 25μg/dose) - Stage 1|Biological: GBP510 (RBD 25μg/dose) - Stage 1|Biological: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 2|Biological: GBP510 adjuvanted with AS03 (RBD 25μg/dose)- Stage 2|Biological: GBP510 (RBD 25μg/dose)- Stage 2|Other: Normal saline (0.9% sodium chloride solution)- Stage 2,https://ClinicalTrials.gov/show/NCT04750343
2505,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,Biological: BM-Allo.MSC|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04397796
2506,Hydroxy Chloroquine and Covid in RA Patients,,https://ClinicalTrials.gov/show/NCT04471649
2507,LILLE COVID RESEARCH NETWORK (Covid-19),,https://ClinicalTrials.gov/show/NCT04475211
2508,Convalescent Plasma Therapy in Severe COVID-19 Infection,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04403477
2509,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,,https://ClinicalTrials.gov/show/NCT04598620
2510,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,Diagnostic Test: Non-invasive cardiac imaging,https://ClinicalTrials.gov/show/NCT04412369
2511,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",Biological: MVA-SARS-2-S vaccinations (days 0 & 28),https://ClinicalTrials.gov/show/NCT04569383
2512,Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment,Other: Survey,https://ClinicalTrials.gov/show/NCT04872738
2513,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19),Biological: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1|Other: Normal saline (0.9% sodium chloride solution) - Stage 1|Biological: GBP510 adjuvanted with Alum (RBD 25μg/dose) - Stage 1|Biological: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 2|Biological: GBP510 adjuvanted with Alum (RBD 25μg/dose)- Stage 2|Other: Normal saline (0.9% sodium chloride solution)- Stage 2,https://ClinicalTrials.gov/show/NCT04742738
2514,Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,,https://ClinicalTrials.gov/show/NCT04488562
2515,Early Treatment of Cytokine Storm Syndrome in Covid-19,Drug: Anakinra|Drug: Normal saline,https://ClinicalTrials.gov/show/NCT04362111
2516,CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)),Device: Continuous Glucose Monitor (CGM),https://ClinicalTrials.gov/show/NCT04756141
2517,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,Other: Health supplements,https://ClinicalTrials.gov/show/NCT04581018
2518,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,Diagnostic Test: Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR,https://ClinicalTrials.gov/show/NCT04510454
2519,Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate,Behavioral: Community health worker engagement,https://ClinicalTrials.gov/show/NCT04930965
2520,London's Exogenous Surfactant Study for COVID19,Drug: Bovine Lipid Extract Surfactant,https://ClinicalTrials.gov/show/NCT04375735
2521,The Effect of Covid-19 on Patient Outcomes Among Operated Patients,Other: COVID-19 infection status,https://ClinicalTrials.gov/show/NCT04525716
2522,Rational Use of Personal Protective Equipment During COVID-19 Pandemic,Other: New PPE|Other: Old PPE,https://ClinicalTrials.gov/show/NCT04712045
2523,Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,Drug: Guduchi Ghan Vati,https://ClinicalTrials.gov/show/NCT04480398
2524,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,https://ClinicalTrials.gov/show/NCT04780334
2525,Cod Liver Oil for Covid-19 Prevention Study,Dietary Supplement: Cod liver oil|Dietary Supplement: Corn oil (placebo),https://ClinicalTrials.gov/show/NCT04609423
2526,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,Other: Mesenchymal stromal cell-based therapy,https://ClinicalTrials.gov/show/NCT04525378
2527,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,Drug: Melatonin intravenous|Drug: Placebo intravenous,https://ClinicalTrials.gov/show/NCT04568863
2528,The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19,Other: no intervention,https://ClinicalTrials.gov/show/NCT04663659
2529,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,Other: stress and anxiety questionnaire,https://ClinicalTrials.gov/show/NCT04383886
2530,Virtual Reality Intervention to Alleviate Breathlessness (COVID-19),Device: COVVR,https://ClinicalTrials.gov/show/NCT04844567
2531,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,,https://ClinicalTrials.gov/show/NCT04525287
2532,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,,https://ClinicalTrials.gov/show/NCT04367714
2533,Comparison Between Positive and Negative COVID-19 Pneumonia,"Other: Clinical, laboratory and imaging characteristics of pneumonia",https://ClinicalTrials.gov/show/NCT04507893
2534,The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions,Behavioral: Theory-based messages|Behavioral: General messages,https://ClinicalTrials.gov/show/NCT04813770
2535,Respiratory Muscles After Hospitalisation for COVID-19,Diagnostic Test: Comprehensive assessment of respiratory muscle function.,https://ClinicalTrials.gov/show/NCT04854863
2536,Baseline Vitamin D Deficiency and COVID-19 Disease Severity,Other: Vitamin D,https://ClinicalTrials.gov/show/NCT04628000
2537,Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women,Diagnostic Test: Lung ultrasound,https://ClinicalTrials.gov/show/NCT04823234
2538,Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic,Procedure: Emergency surgery,https://ClinicalTrials.gov/show/NCT04450277
2539,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System,,https://ClinicalTrials.gov/show/NCT04616950
2540,Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients,Other: exposure to COVID19,https://ClinicalTrials.gov/show/NCT04817553
2541,"Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic",Other: Data collection (,https://ClinicalTrials.gov/show/NCT04834882
2542,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,Drug: Chloroquine or Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04353336
2543,"Immune Response to Vaccination Against Covid-19, a Follow up Study",Drug: Vaccination,https://ClinicalTrials.gov/show/NCT04920357
2544,"Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults",Biological: VLA2001,https://ClinicalTrials.gov/show/NCT04671017
2545,Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS,Other: HD-tDCS 4mA|Other: HD-tDCS 2mA,https://ClinicalTrials.gov/show/NCT04844554
2546,Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH,Drug: Endothelial Protocol,https://ClinicalTrials.gov/show/NCT04813471
2547,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,,https://ClinicalTrials.gov/show/NCT04394429
2548,SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,Diagnostic Test: SARS-CoV-2 serological assessment (IgG),https://ClinicalTrials.gov/show/NCT04615000
2549,Neurocognitive Functions of Recovered COVID-19 Patients,Behavioral: Trier Social Stress Test,https://ClinicalTrials.gov/show/NCT04622748
2550,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients,Drug: Dose of tinzaparin or dalteparin,https://ClinicalTrials.gov/show/NCT04593654
2551,COVID-19 Pandemic on Health Care and Rehabilitation Outcomes,,https://ClinicalTrials.gov/show/NCT04882670
2552,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,Diagnostic Test: indirect calorimetry,https://ClinicalTrials.gov/show/NCT04391686
2553,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,Biological: Gam-COVID-Vac|Other: placebo,https://ClinicalTrials.gov/show/NCT04656613
2554,Mesenchymal Stem Cells for the Treatment of COVID-19,Biological: PrimePro|Other: Placebo,https://ClinicalTrials.gov/show/NCT04573270
2555,Neuroimaging Findings in Patients With COVID-19,Diagnostic Test: Neuroimaging Findings in Patients With COVID-19,https://ClinicalTrials.gov/show/NCT04734223
2556,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),Drug: Dornase Alfa,https://ClinicalTrials.gov/show/NCT04387786
2557,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,Drug: IVIG,https://ClinicalTrials.gov/show/NCT04616001
2558,Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals,Diagnostic Test: Blood sample|Diagnostic Test: Saliva sample,https://ClinicalTrials.gov/show/NCT04858607
2559,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",Biological: Kamada Anti-SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04550325
2560,Prone Positioning for Patients on General Medical Wards With COVID19,Other: Prone positioning,https://ClinicalTrials.gov/show/NCT04383613
2561,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",Other: newborns from covid 19 positive mothers,https://ClinicalTrials.gov/show/NCT04337320
2562,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,Other: Ketogenic diet,https://ClinicalTrials.gov/show/NCT04492228
2563,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04514874
2564,Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period,,https://ClinicalTrials.gov/show/NCT04586140
2565,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,Diagnostic Test: chest x-ray,https://ClinicalTrials.gov/show/NCT04470739
2566,Tracheal Intubation in COVID-19 Patients,Procedure: Endotracheal intubation,https://ClinicalTrials.gov/show/NCT04909476
2567,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04438837
2568,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,Other: thromboprofylaxis protocol|Other: standard protocol,https://ClinicalTrials.gov/show/NCT04394000
2569,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,,https://ClinicalTrials.gov/show/NCT04341103
2570,Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome,Diagnostic Test: Assessment of lung mechanics and heart-lung interactions,https://ClinicalTrials.gov/show/NCT04597853
2571,Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19),,https://ClinicalTrials.gov/show/NCT04948242
2572,A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study,Procedure: Blood sample,https://ClinicalTrials.gov/show/NCT04800146
2573,Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections,Drug: Sodium Pyruvate|Other: Saline,https://ClinicalTrials.gov/show/NCT04824365
2574,Can the Electronic Nose Smell COVID-19?,Device: Aeonose,https://ClinicalTrials.gov/show/NCT04475562
2575,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,Diagnostic Test: SARS-CoV-2 S1/S2 IgG,https://ClinicalTrials.gov/show/NCT04526405
2576,Covid-19 Vaccine Response in Elderly Subjects,Biological: Specific antibody and cellular immune response after anti-SARS-CoV-2 vaccine administration,https://ClinicalTrials.gov/show/NCT04760704
2577,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04354584
2578,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,Drug: Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04410562
2579,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug: Clazakizumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04659772
2580,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia,Other: management strategy of outpatient with mild to moderate SARS-CoV-2 pneumonia,https://ClinicalTrials.gov/show/NCT04542044
2581,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood",Diagnostic Test: POC SARS-Cov-2 IgG Antibody test,https://ClinicalTrials.gov/show/NCT04699903
2582,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,Device: Threshold IMT device|Other: Conventional physical therapy,https://ClinicalTrials.gov/show/NCT04617119
2583,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,Other: Standard Oxygen Delivery System|Other: Double-Trunk Mask|Other: Surgical Mask,https://ClinicalTrials.gov/show/NCT04629989
2584,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug: Ruxolitinib,https://ClinicalTrials.gov/show/NCT04331665
2585,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),Dietary Supplement: N-acetyl glucosamine (NAG),https://ClinicalTrials.gov/show/NCT04706416
2586,Antithrombin III in Infectious Disease Caused by COVID-19,Drug: Antithrombin III,https://ClinicalTrials.gov/show/NCT04899232
2587,"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship",,https://ClinicalTrials.gov/show/NCT04609501
2588,Measuring Work-Related Stress in Primary Care in the Covid-19 Pandemic,Other: Health and Safety Executive's (HSE) Management Standards Indicator Tool (MSIT) to measure work-related stress,https://ClinicalTrials.gov/show/NCT04948255
2589,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,,https://ClinicalTrials.gov/show/NCT04503434
2590,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,Drug: Povidine iodine nasal swabs,https://ClinicalTrials.gov/show/NCT04510402
2591,"Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI",Other: Contrast-enhanced MRI|Other: Measurement of respiratory muscle force,https://ClinicalTrials.gov/show/NCT04735757
2592,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,Drug: Brexanolone|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04537806
2593,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,Behavioral: Doctorgram Patient Kit,https://ClinicalTrials.gov/show/NCT04480411
2594,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,Diagnostic Test: COVID-19 PCR,https://ClinicalTrials.gov/show/NCT04479124
2595,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort),Drug: Interleukin-7|Drug: PLACEBO,https://ClinicalTrials.gov/show/NCT04927169
2596,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome,Diagnostic Test: Respiratory monitoring|Diagnostic Test: Respiratory muscles ultrasound|Diagnostic Test: Electro impedance tomography|Diagnostic Test: Capnography|Diagnostic Test: Arterial blood gas|Diagnostic Test: Quasistatic pressure-volume curve,https://ClinicalTrials.gov/show/NCT04667923
2597,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,,https://ClinicalTrials.gov/show/NCT04567979
2598,Post-coronavirus Disease-2019 Fatigue,Diagnostic Test: Cardiopulmonary stress test (CPET),https://ClinicalTrials.gov/show/NCT04851561
2599,Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC),Drug: Heparin,https://ClinicalTrials.gov/show/NCT04372589
2600,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),Other: Cognitive Behavioural Group Therapy for Perinatal Anxiety,https://ClinicalTrials.gov/show/NCT04495803
2601,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug: Hydroxychloroquine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04318444
2602,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,,https://ClinicalTrials.gov/show/NCT04641806
2603,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,Dietary Supplement: Vitamin D,https://ClinicalTrials.gov/show/NCT04579640
2604,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,Device: Virtual reality therapy first|Device: Conventional therapy first,https://ClinicalTrials.gov/show/NCT04537858
2605,Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19,Dietary Supplement: palmitoylethanolamide|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04912921
2606,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,Drug: Favipiravir|Drug: Only Standard Treatment,https://ClinicalTrials.gov/show/NCT04402203
2607,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),Other: questionnaire,https://ClinicalTrials.gov/show/NCT04581746
2608,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19,Other: Admission to ICU for COVID-19,https://ClinicalTrials.gov/show/NCT04462393
2609,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,,https://ClinicalTrials.gov/show/NCT04441502
2610,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,Other: Observational study,https://ClinicalTrials.gov/show/NCT04382417
2611,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Other: questionnaire assesment,https://ClinicalTrials.gov/show/NCT04353011
2612,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Other: questionnaire assesment,https://ClinicalTrials.gov/show/NCT04351633
2613,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,Diagnostic Test: Throat swab sample for measuring current infection with SARS-CoV-2|Diagnostic Test: Blood sample for serology to measure past infection with SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04411576
2614,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",Drug: Opaganib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04467840
2615,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,Other: no intervention,https://ClinicalTrials.gov/show/NCT04432779
2616,Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients,,https://ClinicalTrials.gov/show/NCT04682548
2617,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,Biological: Ad26.COV2.S|Other: Placebo,https://ClinicalTrials.gov/show/NCT04505722
2618,The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic,Other: Questionnaire Survey,https://ClinicalTrials.gov/show/NCT04910243
2619,Pulmozyme to Improve COVID-19 ARDS Outcomes,Drug: Pulmozyme|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04402944
2620,Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR),Diagnostic Test: Cardiac Magnetic Resonance Imaging (CMR)|Diagnostic Test: Blood test|Diagnostic Test: 6-minute walk test,https://ClinicalTrials.gov/show/NCT04864899
2621,Can the Electronic Nose Smell COVID-19 Antibodies?,Device: Aeonose,https://ClinicalTrials.gov/show/NCT04475575
2622,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04388670
2623,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),Drug: Dornase Alfa Inhalation Solution [Pulmozyme]|Procedure: standard procedure,https://ClinicalTrials.gov/show/NCT04355364
2624,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,Diagnostic Test: PCR for COVID-19,https://ClinicalTrials.gov/show/NCT04479137
2625,Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,,https://ClinicalTrials.gov/show/NCT04633915
2626,Early CPAP in COVID-19 Confirmed or Suspected Patients,Device: Continuous Positive Airway Pressure,https://ClinicalTrials.gov/show/NCT04390191
2627,Efficacy and Safety of COVID-19 Vaccine in Cancer Patients,Procedure: Biospecimen Collection|Other: Electronic Health Record Review,https://ClinicalTrials.gov/show/NCT04865133
2628,Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug: poractant alfa,https://ClinicalTrials.gov/show/NCT04384731
2629,(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC,Dietary Supplement: CBDRA60 supplement|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04777981
2630,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,Behavioral: Mental imagery,https://ClinicalTrials.gov/show/NCT04583449
2631,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug: Hydroxychloroquine as post exposure prophylaxis|Other: Others(No intervention),https://ClinicalTrials.gov/show/NCT04330144
2632,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,Device: Digital oximeter monitoring,https://ClinicalTrials.gov/show/NCT04587921
2633,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,Device: Lucira COVID-19 All-In-One test kit,https://ClinicalTrials.gov/show/NCT04720235
2634,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Drug: Nafamostat Mesylate,https://ClinicalTrials.gov/show/NCT04418128
2635,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),Drug: Tinzaparin,https://ClinicalTrials.gov/show/NCT04730856
2636,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Radiation: Lung Low Dose Radiation,https://ClinicalTrials.gov/show/NCT04414293
2637,Baricitinib Therapy in COVID-19,Drug: Baricitinib 4 MG Oral Tablet,https://ClinicalTrials.gov/show/NCT04358614
2638,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,Dietary Supplement: Nicotinamide riboside|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04407390
2639,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,Diagnostic Test: Anti-SARS-CoV2 Serology|Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04516928
2640,COVID-19 Registry Rhineland-Palatinate (Germany),Other: Prospective oberservational registry,https://ClinicalTrials.gov/show/NCT04335188
2641,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),Diagnostic Test: Point-of-care test for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04408170
2642,A Novel Nomogram to Predict Severity of COVID-19,Other: other,https://ClinicalTrials.gov/show/NCT04366024
2643,Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol),Drug: open label BSS (pepto Bismol),https://ClinicalTrials.gov/show/NCT04811339
2644,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Drug: Icosapent ethyl,https://ClinicalTrials.gov/show/NCT04412018
2645,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04366154
2646,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",Biological: Non applicable,https://ClinicalTrials.gov/show/NCT04392388
2647,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug: Hydroxychloroquine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04318015
2648,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette,https://ClinicalTrials.gov/show/NCT04393961
2649,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,Drug: Broncho-Vaxom®,https://ClinicalTrials.gov/show/NCT04496245
2650,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug: Tacrolimus|Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04341038
2651,Registry on NEN Patients and COVID-19,,https://ClinicalTrials.gov/show/NCT04444401
2652,Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19,Other: Impact of respiratory isolation on quality of life,https://ClinicalTrials.gov/show/NCT04677478
2653,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other: PSG,https://ClinicalTrials.gov/show/NCT04371029
2654,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04345848
2655,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,"Diagnostic Test: Assessing antibody responses, neutralizing capacity and memory B-cell function",https://ClinicalTrials.gov/show/NCT04469634
2656,The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19),Drug: Lucinactant,https://ClinicalTrials.gov/show/NCT04389671
2657,Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease,Diagnostic Test: Serological Assay for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04818892
2658,Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults,Drug: Poly-ICLC (Hiltonol®) or Placebo,https://ClinicalTrials.gov/show/NCT04672291
2659,COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI),,https://ClinicalTrials.gov/show/NCT04756518
2660,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,Biological: Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords,https://ClinicalTrials.gov/show/NCT04456361
2661,Efficacy of Ivermectin in COVID-19,Drug: Ivermectin 6 MG Oral Tablet (2 tablets),https://ClinicalTrials.gov/show/NCT04392713
2662,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,Drug: Oseltamivir|Drug: hormones|Device: oxygen therapy|Procedure: mesenchymal stem cells,https://ClinicalTrials.gov/show/NCT04371601
2663,Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,,https://ClinicalTrials.gov/show/NCT04598347
2664,Immune Response of Haemodialysis Patients Post Covid-19 Vaccination,,https://ClinicalTrials.gov/show/NCT04872751
2665,Sofosbuvir in Treatment of COVID 19,Drug: sofosbuvir|Drug: Sofosbuvir ledipsavir|Drug: Daclatasvir,https://ClinicalTrials.gov/show/NCT04460443
2666,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,,https://ClinicalTrials.gov/show/NCT04433039
2667,SQuISH-COVID: A Pilot Study,,https://ClinicalTrials.gov/show/NCT04372472
2668,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,Diagnostic Test: Serological screening for IgG and IgM antibodies against COVID-19,https://ClinicalTrials.gov/show/NCT04374123
2669,Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic,Other: Online Survey,https://ClinicalTrials.gov/show/NCT04558645
2670,Russian Cardiovascular Registry of COVID-19,,https://ClinicalTrials.gov/show/NCT04724707
2671,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostic Test: Lung ultrasound,https://ClinicalTrials.gov/show/NCT04338568
2672,The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT),Device: Chatbot on COVID-19 vaccine hesitancy|Other: Control intervention,https://ClinicalTrials.gov/show/NCT04881227
2673,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,Drug: Berberine|Drug: Montmorrillonite,https://ClinicalTrials.gov/show/NCT04479202
2674,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,Other: Survey,https://ClinicalTrials.gov/show/NCT04376944
2675,The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms,Combination Product: acupuncture and standard care|Drug: standard care,https://ClinicalTrials.gov/show/NCT04844710
2676,Head and Neck cancERs International cOviD-19 collabOraTion,Other: non interventional study,https://ClinicalTrials.gov/show/NCT04632173
2677,Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction,Drug: Vitamin A|Device: Electronic portable aromatic rehabilitation (EPAR) diffuser,https://ClinicalTrials.gov/show/NCT04900415
2678,COVID-19 Among Egyptian Health Care Providers,Other: self-administered questionnaire,https://ClinicalTrials.gov/show/NCT04357431
2679,Detection of Covid-19 in Tissue Samples of Orthopedic Origin,Diagnostic Test: RT-PCR,https://ClinicalTrials.gov/show/NCT04916561
2680,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,Drug: Interleukin-7|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04407689
2681,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,Device: Life2000® Ventilator,https://ClinicalTrials.gov/show/NCT04581161
2682,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Drug: Interleukin-7|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04379076
2683,Ivermectin in Treatment of COVID-19,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04445311
2684,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),Biological: Longeveron Mesenchymal Stem Cells (LMSCs)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04629105
2685,SARS-CoV2 Seroprevalence in Pregnant Women and Blood Donors,,https://ClinicalTrials.gov/show/NCT04893057
2686,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04377997
2687,A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.,Other: data collection|Other: analysis of blood samples,https://ClinicalTrials.gov/show/NCT04760990
2688,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug: Pyridostigmine Bromide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04343963
2689,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,Drug: Enoxaparin|Drug: Prophylactic/Intermediate Dose Enoxaparin,https://ClinicalTrials.gov/show/NCT04401293
2690,Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients,Drug: Carrimycin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04672564
2691,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,Biological: SBI-101,https://ClinicalTrials.gov/show/NCT04445220
2692,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),Device: MindRhythm Harmony,https://ClinicalTrials.gov/show/NCT04445493
2693,Host Immune Response to Novel RNA COVID-19 Vaccination,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04784689
2694,Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization,Behavioral: Post-hospitalization nutritional monitoring,https://ClinicalTrials.gov/show/NCT04933929
2695,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,Drug: Bacille Calmette-Guérin (BCG)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04537663
2696,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04466371
2697,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Drug: Hydroxychloroquine|Dietary Supplement: Vitamins and Minerals|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04590274
2698,"""NORPLASMA"" Covid-19 Convalescent Plasma Treatment Monitoring Study",,https://ClinicalTrials.gov/show/NCT04463823
2699,"A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)",Drug: FP-025 100 mg|Drug: FP-025 300 mg|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04750278
2700,Niclosamide In Moderate COVID-19,Drug: Niclosamide Oral Tablet|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04436458
2701,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,Drug: Linagliptin tablet|Drug: Insulin,https://ClinicalTrials.gov/show/NCT04542213
2702,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,,https://ClinicalTrials.gov/show/NCT04380714
2703,"Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset",Other: ARDS and COVID19 treatments,https://ClinicalTrials.gov/show/NCT04729075
2704,"A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH",Drug: Placebo|Drug: PDNO,https://ClinicalTrials.gov/show/NCT04885491
2705,The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19,Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)|Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8)|Drug: MSC-exosomes delivered intravenously every other day (8:8:8),https://ClinicalTrials.gov/show/NCT04798716
2706,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,Other: Blood sampling,https://ClinicalTrials.gov/show/NCT04596098
2707,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,Drug: Trans Sodium Crocetinate|Drug: Normal saline,https://ClinicalTrials.gov/show/NCT04573322
2708,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,Procedure: Therapeutic Plasma Exchange|Drug: Ruxolitinib,https://ClinicalTrials.gov/show/NCT04374149
2709,RAS and Coagulopathy in COVID19,Biological: TRV027|Other: sodium chloride 0.9%,https://ClinicalTrials.gov/show/NCT04419610
2710,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,Diagnostic Test: Vaginal fluid Covid-19 PCR test,https://ClinicalTrials.gov/show/NCT04437940
2711,Collection of Anti-SARS-CoV-2 Immune Plasma,,https://ClinicalTrials.gov/show/NCT04344977
2712,Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients,"Other: Questionnaire, phone call",https://ClinicalTrials.gov/show/NCT04451317
2713,COVID-19: Herd Immunity Study in the Czech Republic,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,https://ClinicalTrials.gov/show/NCT04401085
2714,Prognostic Factors of COVID19,,https://ClinicalTrials.gov/show/NCT04405726
2715,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,Drug: Tofacitinib|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04390061
2716,"Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients",Device: Vçac,https://ClinicalTrials.gov/show/NCT04840953
2717,Estrogen Patch for COVID-19 Symptoms,Drug: Estradiol patch,https://ClinicalTrials.gov/show/NCT04359329
2718,Prophylactic Ivermectin in COVID-19 Contacts,Drug: Ivermectin Tablets,https://ClinicalTrials.gov/show/NCT04422561
2719,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,,https://ClinicalTrials.gov/show/NCT04430322
2720,Physiopathology and Sequelae of COVID-19 Infection,Biological: blood test,https://ClinicalTrials.gov/show/NCT04563676
2721,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,,https://ClinicalTrials.gov/show/NCT04416438
2722,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,Drug: Cholecalciferol,https://ClinicalTrials.gov/show/NCT04535791
2723,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,Diagnostic Test: SARS-CoV2 serum antibody testing,https://ClinicalTrials.gov/show/NCT04389294
2724,Ivermectin as a Novel Therapy in COVID-19 Treatment,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04403555
2725,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Survey Administration,https://ClinicalTrials.gov/show/NCT04447222
2726,Efficacy of Faviprevir in COVID-19 Treatment,Drug: Favipiravir|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04351295
2727,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection,Biological: Gam-COVID-Vac|Other: Placebo,https://ClinicalTrials.gov/show/NCT04640233
2728,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,Combination Product: AZD7442|Other: Placebo,https://ClinicalTrials.gov/show/NCT04507256
2729,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Other: Serologic testing,https://ClinicalTrials.gov/show/NCT04383587
2730,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Drug: Ciclesonide Inhalation Aerosol,https://ClinicalTrials.gov/show/NCT04381364
2731,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,Drug: Artemisinin / Artesunate|Other: placebo,https://ClinicalTrials.gov/show/NCT04387240
2732,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Other: Biological sample and clinical data collection,https://ClinicalTrials.gov/show/NCT04383652
2733,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,Diagnostic Test: Imaging of the lungs,https://ClinicalTrials.gov/show/NCT04401163
2734,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Other: pulmonary ultrasound,https://ClinicalTrials.gov/show/NCT04370249
2735,Use of Remote Monitoring for COVID-19 Patient,Device: LifeSignals Biosensor 1AX*|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04425720
2736,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Drug: Ivermectin|Drug: Camostat Mesilate|Dietary Supplement: Artemesia annua|Drug: Artesunate,https://ClinicalTrials.gov/show/NCT04374019
2737,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),,https://ClinicalTrials.gov/show/NCT04363671
2738,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,Other: Closed face shield with Surgical face mask use|Other: Surgical face mask use only,https://ClinicalTrials.gov/show/NCT04647305
2739,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),"Biological: Biological collection with nasopharyngeal samples, saliva, blood, stool and urine",https://ClinicalTrials.gov/show/NCT04597736
2740,"Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.",Drug: S-1226 (8%)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04949386
2741,COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients,,https://ClinicalTrials.gov/show/NCT04689464
2742,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,Other: Survey Administration,https://ClinicalTrials.gov/show/NCT04630015
2743,Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic,Other: Survey Administration,https://ClinicalTrials.gov/show/NCT04474301
2744,A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),Biological: Mesenchymal stem cell|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04888949
2745,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),Drug: CYT107|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04426201
2746,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),Drug: CYT107|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04442178
2747,Emergence of the COVID 19 Epidemic in the City of Nice,,https://ClinicalTrials.gov/show/NCT04449094
2748,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,Biological: Cell therapy protocol 1|Biological: Cell therapy protocol 2,https://ClinicalTrials.gov/show/NCT04366063
2749,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug: ACEIs|Drug: Conventional treatment,https://ClinicalTrials.gov/show/NCT04345406
2750,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,,https://ClinicalTrials.gov/show/NCT04322188
2751,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,Drug: Isoflurane Inhalant Product|Drug: Sevoflurane inhalant product,https://ClinicalTrials.gov/show/NCT04415060
2752,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,Dietary Supplement: 300 mg of omega3-FA,https://ClinicalTrials.gov/show/NCT04658433
2753,Lung Ultrasound to Diagnose COVID-19,Diagnostic Test: COVID-19 RT-PCR|Procedure: lung ultrasound,https://ClinicalTrials.gov/show/NCT04368338
2754,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,,https://ClinicalTrials.gov/show/NCT04385069
2755,Oral Side Effects of COVID-19 Vaccine,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04706156
2756,Clinical and Haematological Phenotypes in Long COVID,Diagnostic Test: Blood sampling (venesection),https://ClinicalTrials.gov/show/NCT04659889
2757,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,,https://ClinicalTrials.gov/show/NCT04456075
2758,Proactive Care of Ambulatory COVID19 Patients,Other: consultation|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04371107
2759,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,Drug: Pentoxifylline|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04433988
2760,Cardiac Imaging in SARS-CoV-2 (COVID-19),,https://ClinicalTrials.gov/show/NCT04403607
2761,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,Other: Serology test follow-up,https://ClinicalTrials.gov/show/NCT04488484
2762,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),Procedure: lung ultrasound (LUS),https://ClinicalTrials.gov/show/NCT04393402
2763,The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU,Diagnostic Test: 4C mortality score,https://ClinicalTrials.gov/show/NCT04800770
2764,What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India,Behavioral: Information|Behavioral: Buddy|Behavioral: Gossip intervention|Behavioral: Information assigned in community|Behavioral: Buddy assigned in community,https://ClinicalTrials.gov/show/NCT04870593
2765,Mouth Rinses for Inactivation of COVID-19,Drug: 1.5% w/v Hydrogen Peroxide|Drug: 0.12% Chlorhexidine Gluconate|Drug: 27% Ethanol plus essential oils|Drug: 0.5% w/v Povidone-iodide|Drug: 0.075% Cetylpyridinium Chloride|Other: Saline,https://ClinicalTrials.gov/show/NCT04584684
2766,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Other: Pulmonary ultrasound,https://ClinicalTrials.gov/show/NCT04335019
2767,Special Investigation of COMIRNATY in the Population With Underlying Diseases,Biological: BNT162b2,https://ClinicalTrials.gov/show/NCT04880447
2768,Tocilizumab Treatment in Patients With COVID-19,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04363853
2769,An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY,Other: Standard of Care (SoC)|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04575064
2770,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,Drug: inhaled type I interferon|Drug: WFI water nebulization,https://ClinicalTrials.gov/show/NCT04469491
2771,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Drug: Dipyridamole,https://ClinicalTrials.gov/show/NCT04424901
2772,Human Ab Response & immunoMONItoring of COVID-19 Patients,Biological: Blood samples collection|Other: Saliva collection,https://ClinicalTrials.gov/show/NCT04373200
2773,Thrombosis and Covid-19,Diagnostic Test: TEM-tPA,https://ClinicalTrials.gov/show/NCT04366778
2774,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Other: Blood test|Other: Standardised questionnaires,https://ClinicalTrials.gov/show/NCT04380896
2775,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug: Tocilizumab Injection|Drug: Deferoxamine,https://ClinicalTrials.gov/show/NCT04361032
2776,The Natural History of Hospitalized COVID-19 Patients,Other: Observational cohort study on the natural history of hospitalized SARS-COV-2 patients.,https://ClinicalTrials.gov/show/NCT04424992
2777,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,Procedure: Conventional oxygen therapy|Procedure: High flow nasal cannula,https://ClinicalTrials.gov/show/NCT04609462
2778,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Other: Equipment with smartwatch throughout hospital stay on the general ward,https://ClinicalTrials.gov/show/NCT04357834
2779,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,https://ClinicalTrials.gov/show/NCT04367142
2780,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,Device: EarSats Pulse Oximeter Probe,https://ClinicalTrials.gov/show/NCT04529408
2781,Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly,Dietary Supplement: Placebo|Dietary Supplement: Lactobacillus,https://ClinicalTrials.gov/show/NCT04756466
2782,Use of Convalescent Plasma for COVID-19,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04408040
2783,Sarilumab for Patients With Moderate COVID-19 Disease,Biological: SARILUMAB,https://ClinicalTrials.gov/show/NCT04359901
2784,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Other: blood sample,https://ClinicalTrials.gov/show/NCT04304690
2785,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,Drug: Favipiravir,https://ClinicalTrials.gov/show/NCT04445467
2786,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Behavioral: COVID-surgRES questionaire,https://ClinicalTrials.gov/show/NCT04338945
2787,"Short Term, High Dose Vitamin D Supplementation for COVID-19",Drug: Vit D,https://ClinicalTrials.gov/show/NCT04459247
2788,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Drug: Baricitinib Oral Tablet,https://ClinicalTrials.gov/show/NCT04393051
2789,Canine COVID-19 Detection,Behavioral: Collection of odour samples,https://ClinicalTrials.gov/show/NCT04509713
2790,The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04351347
2791,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,Biological: Convalescent Plasma|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04425915
2792,Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04526990
2793,Low Dose Radiotherapy in COVID-19 Pneumonia,Radiation: Low Dose Radiotherapy,https://ClinicalTrials.gov/show/NCT04390412
2794,Diabetes Outcomes in COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04573335
2795,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Other: blood sampling|Other: additional blood tubes,https://ClinicalTrials.gov/show/NCT04355351
2796,Pediatric SARS-CoV-2 and MIS-C Long-term Follow-up,,https://ClinicalTrials.gov/show/NCT04830852
2797,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,Diagnostic Test: SARS-CoV-2 Ab,https://ClinicalTrials.gov/show/NCT04480580
2798,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,Biological: BBV152A - Phase I|Biological: BBV152B - Phase I|Biological: BBV152C - Phase I|Biological: Placebo - Phase I|Biological: BBV152A - Phase II|Biological: BBV152B - Phase II,https://ClinicalTrials.gov/show/NCT04471519
2799,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,Diagnostic Test: COVID-19 Antibody testing,https://ClinicalTrials.gov/show/NCT04448717
2800,Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo for Inhalation|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04840992
2801,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,Biological: Saliva collection|Other: Clinical assessment,https://ClinicalTrials.gov/show/NCT04460638
2802,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo,https://ClinicalTrials.gov/show/NCT04566770
2803,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,Drug: Chloroquine|Drug: zinc,https://ClinicalTrials.gov/show/NCT04447534
2804,Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation'). A Prospectvie Cohort.,Other: biobank,https://ClinicalTrials.gov/show/NCT04885452
2805,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),Drug: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04391101
2806,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,Other: severity of lung involvement with COVID-19.,https://ClinicalTrials.gov/show/NCT04577235
2807,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,Drug: Ivermectin|Drug: Azithromycin|Drug: Cholecalciferol,https://ClinicalTrials.gov/show/NCT04399746
2808,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",Diagnostic Test: Blood sample for serological test,https://ClinicalTrials.gov/show/NCT04441684
2809,About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.,Other: Fecal and oral samples,https://ClinicalTrials.gov/show/NCT04913142
2810,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Device: mouthrinse with bêta-cyclodextrin and citrox|Device: mouthrinse without bêta-cyclodextrin and citrox,https://ClinicalTrials.gov/show/NCT04352959
2811,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,Diagnostic Test: COVID 19 Diagnostic Test,https://ClinicalTrials.gov/show/NCT04416061
2812,AstraZeneca Vax - Sputnik V Combination Study,Biological: AZD1222|Biological: rAd26-S,https://ClinicalTrials.gov/show/NCT04684446
2813,First-in-Human Study of Orally Administered GS-441524 for COVID-19,Drug: GS-441524,https://ClinicalTrials.gov/show/NCT04859244
2814,Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland,Diagnostic Test: Cardiovascular Magnetic Resonance Imaging,https://ClinicalTrials.gov/show/NCT04823182
2815,Primary Prevention of Infection by COVID-19 in Health Providers,Dietary Supplement: Group A: oropharygeal spray and immunostimulant|Dietary Supplement: Group B: Placebo oropharyngeal spray + Active principle immunostimulant|Dietary Supplement: Group C:Active principle oropharyngeal spray + Placebo taken PO|Dietary Supplement: Group D:Placebo oropharyngeal spray + Placebo taken PO,https://ClinicalTrials.gov/show/NCT04420260
2816,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,Drug: Sofosbuvir and Ledipasvir|Drug: Nitazoxanide,https://ClinicalTrials.gov/show/NCT04498936
2817,Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19,Dietary Supplement: β-hydroxy β-methyl butyrate (HMB) enriched amino acid|Dietary Supplement: Balanced amino acid,https://ClinicalTrials.gov/show/NCT04858412
2818,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Other: Obvio-19 app,https://ClinicalTrials.gov/show/NCT04437719
2819,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion,Biological: DZIF-10c|Other: Placebo,https://ClinicalTrials.gov/show/NCT04631666
2820,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Procedure: Surgery,https://ClinicalTrials.gov/show/NCT04323644
2821,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",,https://ClinicalTrials.gov/show/NCT04362969
2822,Ivermectina Colombia (IVERCOL),Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04886362
2823,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation,Biological: DZIF-10c|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04631705
2824,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Other: Study A|Other: Study B|Other: Study C|Other: Study D,https://ClinicalTrials.gov/show/NCT04351503
2825,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,Other: no intervention,https://ClinicalTrials.gov/show/NCT04407169
2826,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,Dietary Supplement: Omnibiotic AAD|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04420676
2827,Recovery of Patients From COVID-19 After Critical Illness,,https://ClinicalTrials.gov/show/NCT04401254
2828,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",Drug: INO-4800|Device: CELLECTRA® 2000|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04642638
2829,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,Biological: Convalescent Plasma|Other: Placebo,https://ClinicalTrials.gov/show/NCT04479163
2830,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19,Drug: Enoxaparin|Drug: Rivaroxaban|Drug: Apixaban,https://ClinicalTrials.gov/show/NCT04736901
2831,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,Biological: biological assays in particular on the lipid metabolism,https://ClinicalTrials.gov/show/NCT04435223
2832,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,Drug: Standard of Care (SOC) and Colchicine+Rosuvastatin,https://ClinicalTrials.gov/show/NCT04472611
2833,Thromboembolic Risk Screening in Patients With Cancer and COVID-19,Diagnostic Test: Peripheral venous ultrasound,https://ClinicalTrials.gov/show/NCT04616846
2834,Investigation of the Characteristics of Chronic Pain Developing After COVID-19,,https://ClinicalTrials.gov/show/NCT04883216
2835,New Antiviral Drugs for Treatment of COVID-19,"Drug: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :",https://ClinicalTrials.gov/show/NCT04392427
2836,Efficacy of Tocilizumab on Patients With COVID-19,Drug: Tocilizumab|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04356937
2837,Post COVID-19 Functional Status in Egypt,Other: Post COVID-19 Functional Satus Scale,https://ClinicalTrials.gov/show/NCT04479293
2838,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,,https://ClinicalTrials.gov/show/NCT04368871
2839,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,,https://ClinicalTrials.gov/show/NCT04556565
2840,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,Biological: BCG vaccine (Freeze-dried),https://ClinicalTrials.gov/show/NCT04475302
2841,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Biological: avdoralimab|Other: Placebo,https://ClinicalTrials.gov/show/NCT04371367
2842,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,Drug: Sevoflurane|Drug: Propofol,https://ClinicalTrials.gov/show/NCT04359862
2843,Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland,Other: Survey,https://ClinicalTrials.gov/show/NCT04753463
2844,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,Biological: COVID-19 convalescent plasma (CCP) plus standard of care (SOC)|Biological: Standard of care (SOC) plus placebo,https://ClinicalTrials.gov/show/NCT04516811
2845,Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19,Drug: Acetylsalicylic acid|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04808895
2846,Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.,Other: Questionnaire|Other: Interview,https://ClinicalTrials.gov/show/NCT04910607
2847,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Other: Questionnaire|Diagnostic Test: IgG,https://ClinicalTrials.gov/show/NCT04336657
2848,Efficacy of FES Cycling After a Severe Form of COVID-19,Behavioral: Physical therapy that include a standardized cycling training with functional electrical stimulation|Behavioral: Physical therapy that include a standardized cycling training with no additional functional electrical stimulation,https://ClinicalTrials.gov/show/NCT04841746
2849,Complicated Grief in ICU in the Aftermath of COVID-19,Other: questionnaire,https://ClinicalTrials.gov/show/NCT04554264
2850,COVID-19 Infection in Patients Receiving Anti-CD20 Therapy,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04884477
2851,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,Diagnostic Test: Anti-SARS-CoV2 Serology|Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04387838
2852,Phase 2 Study of RSLV-132 in Subjects With Long COVID,Drug: RSLV-132|Drug: Sodium Chloride 0.9%,https://ClinicalTrials.gov/show/NCT04944121
2853,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,Drug: Masitinib|Drug: Isoquercetin|Drug: Best Supportive Care,https://ClinicalTrials.gov/show/NCT04622865
2854,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,Drug: GLS-1200|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04408183
2855,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Biological: IMM-101|Other: Observation,https://ClinicalTrials.gov/show/NCT04442048
2856,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,Other: Clinical interview|Biological: Blood collection|Biological: Saliva collection,https://ClinicalTrials.gov/show/NCT04408001
2857,Implementation of Rehabilitation Program for Post COVID-19,Behavioral: Rehabilitation,https://ClinicalTrials.gov/show/NCT04694768
2858,COVID-19 Vaccine Induced Adaptive Immune Responses,,https://ClinicalTrials.gov/show/NCT04729374
2859,COVID-19 Progression in End-Stage Kidney Disease,,https://ClinicalTrials.gov/show/NCT04495907
2860,Femoral frACturEs and COVID-19.,Other: COVID-19,https://ClinicalTrials.gov/show/NCT04657510
2861,Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals,Diagnostic Test: ILI and COVID-19 detection,https://ClinicalTrials.gov/show/NCT04716543
2862,"Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19",Other: A survey of 60 questions was created through the internet-based 'Google Forms surveys' site.,https://ClinicalTrials.gov/show/NCT04806815
2863,Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04753762
2864,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection",Other: No intervention,https://ClinicalTrials.gov/show/NCT04451577
2865,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection,,https://ClinicalTrials.gov/show/NCT04739345
2866,Postpartum Sexual Function in Pregnant Women With COVID-19,,https://ClinicalTrials.gov/show/NCT04389489
2867,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,Diagnostic Test: echocardiogram 2D,https://ClinicalTrials.gov/show/NCT04498299
2868,Communication in ICU During COVID-19,Behavioral: Communication,https://ClinicalTrials.gov/show/NCT04602351
2869,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,,https://ClinicalTrials.gov/show/NCT04495764
2870,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),Diagnostic Test: Anti-SARS-CoV2 Serology|Behavioral: Questionnaire|Diagnostic Test: Anti-SARS-CoV2 serological controls and serum neutralization,https://ClinicalTrials.gov/show/NCT04404270
2871,COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI),Other: Observation to monitor patients for these infections,https://ClinicalTrials.gov/show/NCT04818853
2872,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,Behavioral: The psychosocial effects of COVID-19 pandemic on dental professionals,https://ClinicalTrials.gov/show/NCT04674644
2873,Convalescent Plasma in the Treatment of COVID 19,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04343261
2874,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,Drug: Daily Vitamin D3|Drug: Daily placebo|Drug: Bolus vitamin D3|Drug: Bolus placebo,https://ClinicalTrials.gov/show/NCT04482673
2875,Predicting Death and ICU Admission in COVID-19 Patients in ED,,https://ClinicalTrials.gov/show/NCT04371562
2876,Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19,Drug: Antithrombin + best available treatment|Drug: Best available treatment,https://ClinicalTrials.gov/show/NCT04745442
2877,NOWDx Test for the Detection of Antibodies to COVID-19,Device: NOWDx COVID-19 Test,https://ClinicalTrials.gov/show/NCT04690413
2878,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),,https://ClinicalTrials.gov/show/NCT04367064
2879,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations,Diagnostic Test: SARS-CoV2 antibody measurement,https://ClinicalTrials.gov/show/NCT04853004
2880,Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,Drug: NP-120 (Ifenprodil),https://ClinicalTrials.gov/show/NCT04382924
2881,HYPONATREMIA IN COVID-19 PATIENTS,,https://ClinicalTrials.gov/show/NCT04493268
2882,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic,Behavioral: Telemedicine visit|Behavioral: In-person postoperative visit,https://ClinicalTrials.gov/show/NCT04652674
2883,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,Drug: allogeneic mesenchymal stem cell|Other: Placebo,https://ClinicalTrials.gov/show/NCT04535856
2884,Neurologic Manifestations of COVID 19 in Children,Other: Observational study only,https://ClinicalTrials.gov/show/NCT04379089
2885,Registry of COVID-19 Patients at AOUI Verona,Other: not applicable (observational study),https://ClinicalTrials.gov/show/NCT04497194
2886,"Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals",Drug: GX-19N,https://ClinicalTrials.gov/show/NCT04915989
2887,Cellular Senescence and COVID-19 Long-Hauler Syndrome,,https://ClinicalTrials.gov/show/NCT04903132
2888,Prasugrel in Severe COVID-19 Pneumonia,Drug: Prasugrel Hydrochloride 10 MG Oral Tablet|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04445623
2889,Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19,Biological: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04910269
2890,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),Device: TCC-COVID mHealth solution,https://ClinicalTrials.gov/show/NCT04399109
2891,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,Drug: EXO 1 inhalation|Drug: EXO 2 inhalation|Drug: Placebo inhalation,https://ClinicalTrials.gov/show/NCT04491240
2892,Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients,Procedure: Expanded Hemodialysis for Covid19 maintenance hemodialysis patients|Procedure: Hemodialysis by protein-leaking dialyzer for Covid19 maintenance hemodialysis patients,https://ClinicalTrials.gov/show/NCT04685447
2893,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Device: Hydrogen Oxygen Generator with Nebulizer|Other: Standard-of-care,https://ClinicalTrials.gov/show/NCT04378712
2894,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",Drug: Metformin Glycinate|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04625985
2895,Senior-COVID-Rea Multicentric Survey,Other: Group1,https://ClinicalTrials.gov/show/NCT04422340
2896,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04468009
2897,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04406233
2898,Mechanisms for Covid-19 Disease Complications,,https://ClinicalTrials.gov/show/NCT04314232
2899,Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.,Biological: serology testing profiles description|Biological: immune response characterization|Other: in vivo brain PET-TSPO acquisitions|Other: brain MRI assessment|Behavioral: neurocognitive assessment,https://ClinicalTrials.gov/show/NCT04785157
2900,Evaluation of Antibody Tests for COVID-19,Diagnostic Test: Diagnostic test,https://ClinicalTrials.gov/show/NCT04360954
2901,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04261517
2902,QuadraMune(TM) for Prevention of COVID-19,Dietary Supplement: QuadraMune(TM),https://ClinicalTrials.gov/show/NCT04421391
2903,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,,https://ClinicalTrials.gov/show/NCT04365530
2904,African Covid-19 Critical Care Outcomes Study,,https://ClinicalTrials.gov/show/NCT04367207
2905,Surgical Telemedicine in the COVID-19 Pandemic Era,Other: Completion of pre-pandemic survey|Other: Completion of survey after peak of pandemic|Other: Completion of post telemedicine encounter survey,https://ClinicalTrials.gov/show/NCT04376710
2906,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,Other: Questionnaire and interview,https://ClinicalTrials.gov/show/NCT04466839
2907,Nigella 5 in the Treatment of SARS COV2 (COVID-19),Drug: Nigella|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04914767
2908,NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons,Device: NOWDx COVID-19 Test,https://ClinicalTrials.gov/show/NCT04799392
2909,"Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults",Drug: GX-19N,https://ClinicalTrials.gov/show/NCT04715997
2910,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),"Device: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03|Device: OLO-1 Medical Molecular Sieve Oxygen Generator",https://ClinicalTrials.gov/show/NCT04594460
2911,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,Diagnostic Test: Serological testing,https://ClinicalTrials.gov/show/NCT04426292
2912,Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva,Drug: Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate|Drug: Colgate Peroxyl® -1.5% Hydrogen peroxide|Other: Oral-B® Gum & Enamel Care -Cetylpyridinium chloride|Other: No rinsing,https://ClinicalTrials.gov/show/NCT04723446
2913,Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus,Other: Follow-up phone call,https://ClinicalTrials.gov/show/NCT04615676
2914,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",Drug: IgIV,https://ClinicalTrials.gov/show/NCT04403269
2915,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,Other: Active COVID-19 disease,https://ClinicalTrials.gov/show/NCT04423640
2916,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,Diagnostic Test: Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection,https://ClinicalTrials.gov/show/NCT04463849
2917,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,Other: No intervention / Evaluation of the ferritin and glycosylated ferritin by standard approved serological tests,https://ClinicalTrials.gov/show/NCT04469153
2918,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,Other: No intervention,https://ClinicalTrials.gov/show/NCT04381273
2919,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug: L-ascorbic acid,https://ClinicalTrials.gov/show/NCT04357782
2920,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",Drug: GX-19|Drug: Saline,https://ClinicalTrials.gov/show/NCT04445389
2921,Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department,Other: Hospitalisation for SARS-COV2 infection,https://ClinicalTrials.gov/show/NCT04779021
2922,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications,Combination Product: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid,https://ClinicalTrials.gov/show/NCT04382950
2923,COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility,Other: Observation group 1,https://ClinicalTrials.gov/show/NCT04913701
2924,Study of a Live rNDV Based Vaccine Against COVID-19,Biological: Recombinant NDV Vectored Vaccine for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04871737
2925,Sero-prevalence COVID-19 Among Belgian Children,,https://ClinicalTrials.gov/show/NCT04613817
2926,A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults,Biological: COVID-HIGIV|Other: Placebo (saline),https://ClinicalTrials.gov/show/NCT04661839
2927,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug: Enoxaparin Prophylactic Dose|Drug: Heparin Infusion|Drug: Heparin SC|Drug: Enoxaparin/Lovenox Intermediate Dose,https://ClinicalTrials.gov/show/NCT04367831
2928,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,,https://ClinicalTrials.gov/show/NCT04405362
2929,Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19,Dietary Supplement: Vitamin D3,https://ClinicalTrials.gov/show/NCT04868903
2930,"NCI COVID-19 in Cancer Patients, NCCAPS Study",Procedure: Biospecimen Collection|Other: Data Collection|Other: Quality-of-Life Assessment|Other: Questionnaire Administration,
2931,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",Other: Data collection,https://ClinicalTrials.gov/show/NCT04395742
2932,Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19,Other: observation no intervention,https://ClinicalTrials.gov/show/NCT04800731
2933,"Anakinra, COVID-19, Cytokine Storm",Drug: Anakinra|Drug: 0.9% Saline,https://ClinicalTrials.gov/show/NCT04603742
2934,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",,https://ClinicalTrials.gov/show/NCT04389515
2935,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,,https://ClinicalTrials.gov/show/NCT04466462
2936,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04390022
2937,Virtual Assistant for COVID-19 PPE,"Other: Virtual Assistant first, then Human Coach|Other: Human Coach first, then Virtual Assistant",https://ClinicalTrials.gov/show/NCT04435275
2938,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),,https://ClinicalTrials.gov/show/NCT04565080
2939,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",Biological: Intramuscular Vaccine,https://ClinicalTrials.gov/show/NCT04450004
2940,Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04512300
2941,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Drug: Clarithromycin,https://ClinicalTrials.gov/show/NCT04398004
2942,Blood Volume Assessment in COVID-19 ICU Patients - BVAC19,Device: BVA-100,https://ClinicalTrials.gov/show/NCT04517695
2943,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",Drug: EIDD-2801|Drug: Placebo (PBO),https://ClinicalTrials.gov/show/NCT04405570
2944,Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).,Diagnostic Test: Immune response study,https://ClinicalTrials.gov/show/NCT04526977
2945,Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 Pandemic,Other: Education,https://ClinicalTrials.gov/show/NCT04801134
2946,Improving COVID-19 Vaccine Uptake in Nursing Homes,Behavioral: High touch multi-pronged behavioral intervention,https://ClinicalTrials.gov/show/NCT04732819
2947,Tenecteplase in Patients With COVID-19,Drug: Tenecteplase|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04505592
2948,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Device: COVID-19 barrier box,https://ClinicalTrials.gov/show/NCT04366141
2949,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,Biological: Hyperimmune plasma|Drug: Standard of care for SARS-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04366245
2950,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),Biological: Convalescent Plasma from COVID-19 donors,https://ClinicalTrials.gov/show/NCT04384588
2951,Convalescent Plasma for Patients With COVID-19,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04385199
2952,Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters,Diagnostic Test: Sperm analysis,https://ClinicalTrials.gov/show/NCT04937608
2953,COVID-19 in Patients With HIV,Other: No intervention,https://ClinicalTrials.gov/show/NCT04333953
2954,Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV),"Diagnostic Test: Serum collection, adverse events collection",https://ClinicalTrials.gov/show/NCT04878796
2955,Different PEEP Settings of COVID-19 Induced ARDS,Other: Gas exchanges at different PEEP|Other: lung mechanics at different PEEP|Other: Hemodynamics changes at different PEEP,https://ClinicalTrials.gov/show/NCT04359251
2956,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04373824
2957,COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection,Drug: low molecular weight Heparin as standard of care treatment,https://ClinicalTrials.gov/show/NCT04787510
2958,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),Biological: Anti-SARS-CoV-2 Human Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04377672
2959,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug: Bromhexine Hydrochloride Tablets|Drug: Arbidol Hydrochloride Granules|Drug: Recombinant Human Interferon α2b Spray,https://ClinicalTrials.gov/show/NCT04273763
2960,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug: Azithromycin 500 milligram (mg) oral Tablet|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04369365
2961,COVID-19 Biorepository,,https://ClinicalTrials.gov/show/NCT04568148
2962,NOSOcomial COVID-19 in ICU (NOSOCOVID),Other: Patients admitted in Intensive Care Units,https://ClinicalTrials.gov/show/NCT04659356
2963,Extracellular Vesicle Infusion Therapy for Severe COVID-19,Biological: DB-001,https://ClinicalTrials.gov/show/NCT04493242
2964,RGD PET/CT Imaging in COVID-19 Patients,Diagnostic Test: [68Ga]Ga-DOTA-(RGD)2 PET/CT,https://ClinicalTrials.gov/show/NCT04596943
2965,A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants,Biological: mRNA-1273.211,https://ClinicalTrials.gov/show/NCT04927065
2966,Right Ventricular Dysfunction in Ventilated Patients With COVID-19,Diagnostic Test: Echocardiography,https://ClinicalTrials.gov/show/NCT04764032
2967,Effects of Fuzheng Huayu Tablets on COVID-19,Drug: Fuzheng Huayu tablet,https://ClinicalTrials.gov/show/NCT04645407
2968,Transpulmonary Driving Pressure in ARDS COVID19 Patients,,https://ClinicalTrials.gov/show/NCT04381286
2969,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,,https://ClinicalTrials.gov/show/NCT04347928
2970,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,Diagnostic Test: Test for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04444687
2971,Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19,Drug: Emtricitabine/Tenofovir Disoproxil Fumarate 200 MG-245 MG Oral Tablet [TRUVADA]|Drug: Baricitinib + dexamethasone|Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04890626
2972,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,Biological: Human Amniotic Fluid,https://ClinicalTrials.gov/show/NCT04319731
2973,Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients,Behavioral: Questionnaire|Biological: blood sample and salivary sample,https://ClinicalTrials.gov/show/NCT04798053
2974,A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,Biological: Recombinant new coronavirus vaccine (CHO cell) group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,https://ClinicalTrials.gov/show/NCT04646590
2975,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",Diagnostic Test: nasal pharyngeal (NP) swab samples|Diagnostic Test: peripheral blood draw,https://ClinicalTrials.gov/show/NCT04391400
2976,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,Drug: ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,https://ClinicalTrials.gov/show/NCT04366323
2977,Synthetic CBD as a Therapy for COVID-19,Drug: CBD|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04686539
2978,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,Drug: Favipiravir,https://ClinicalTrials.gov/show/NCT04600999
2979,Understanding COVID-19,Other: NA (no intervention),https://ClinicalTrials.gov/show/NCT04329546
2980,COVID-19 IgG Formation in Physicians at ALGH and Their Household Members,,https://ClinicalTrials.gov/show/NCT04540484
2981,Eosinophil and Anticoagulation in COVID-19 Patients,Drug: LMWH,https://ClinicalTrials.gov/show/NCT04507282
2982,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,Other: Blood sample,https://ClinicalTrials.gov/show/NCT04354766
2983,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,,https://ClinicalTrials.gov/show/NCT04618861
2984,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),Drug: Alisporivir|Other: Standard of care (SOC),https://ClinicalTrials.gov/show/NCT04608214
2985,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug: Melatonin 2mg|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04353128
2986,Study of GRAd-COV2 for the Prevention of COVID-19 in Adults,Biological: GRAd-COV2|Other: Placebo,https://ClinicalTrials.gov/show/NCT04791423
2987,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,Drug: Mavrilimumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04492514
2988,Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04714125
2989,Monocytes and NK Cells Activity in Covid-19 Patients,Diagnostic Test: Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04375176
2990,Stress and Recovery in Frontline COVID-19 Workers,Behavioral: Lifestyle (Meditation)|Behavioral: Lifestyle (Exercise),https://ClinicalTrials.gov/show/NCT04713111
2991,Correlation Fear of COVID-19 & Dental Treatment Anxiety,Other: Cross Sectional study using scientifically validated psychometric Scales,https://ClinicalTrials.gov/show/NCT04497818
2992,Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19),Dietary Supplement: propolis,https://ClinicalTrials.gov/show/NCT04916821
2993,Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients,Drug: Voclosporin|Drug: Tacrolimus,https://ClinicalTrials.gov/show/NCT04701528
2994,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,Drug: Oseltamivir|Drug: Azithromycin|Biological: Umbilical Cord Mesenchymal Stem Cells,https://ClinicalTrials.gov/show/NCT04457609
2995,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,"Diagnostic Test: PCR, lung ultrasound",https://ClinicalTrials.gov/show/NCT04443140
2996,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug: Mavrilimumab|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04463004
2997,Myocardial Injury and Quality of Life After COVID-19,,https://ClinicalTrials.gov/show/NCT04794062
2998,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug: Mavrilimumab|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04399980
2999,Maternal-foetal Transmission of SARS-Cov-2,"Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta",https://ClinicalTrials.gov/show/NCT04395924
3000,Depression and Anxiety in Long Term Coronavirus Disease COVID-19,Other: Depression|Other: Anxiety,https://ClinicalTrials.gov/show/NCT04893668
3001,Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina,Diagnostic Test: serology,https://ClinicalTrials.gov/show/NCT04673279
3002,'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission,"Behavioral: Coaching, Cleaning, Communication, Collaboration",https://ClinicalTrials.gov/show/NCT04739449
3003,Incidence of VAP in Patients With Severe COVID-19,Diagnostic Test: bronchoalveolar lavage,https://ClinicalTrials.gov/show/NCT04766983
3004,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,Drug: Treamid|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04527354
3005,Semen Parameters and COVID-19 in Infertile Men,Other: Clinical assessment,https://ClinicalTrials.gov/show/NCT04643522
3006,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,Drug: Ibrutinib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04375397
3007,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,Behavioral: Biobehavioral Tele-rehabilitation Sessions,https://ClinicalTrials.gov/show/NCT04663945
3008,Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.,Diagnostic Test: Diagnostic Test:Blood test,https://ClinicalTrials.gov/show/NCT04904523
3009,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04397939
3010,Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.,Diagnostic Test: rapid antigen testing versus RT-PCR,https://ClinicalTrials.gov/show/NCT04839094
3011,A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants,Biological: mRNA-1273,https://ClinicalTrials.gov/show/NCT04860297
3012,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,Drug: Intramuscular injection|Biological: Intramuscular vaccine,https://ClinicalTrials.gov/show/NCT04636697
3013,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),Drug: Methylprednisolone|Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04636671
3014,Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients,Procedure: nasopharyngeal and throat swab|Procedure: collection of mucosal lining fluid|Procedure: blood collection via fingerprick,https://ClinicalTrials.gov/show/NCT04590352
3015,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,Diagnostic Test: Covid19 RT-PCR|Other: lung ultrasound,https://ClinicalTrials.gov/show/NCT04666064
3016,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),Diagnostic Test: Pulmonary function tests|Diagnostic Test: Imaging|Biological: Blood sampling,https://ClinicalTrials.gov/show/NCT04416100
3017,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,Biological: VPM1002|Other: Placebo,https://ClinicalTrials.gov/show/NCT04439045
3018,Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04895462
3019,Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study),Behavioral: Telephonic medical visit|Procedure: Gastrointestinal endoscopy|Procedure: Abdominal ultrasound,https://ClinicalTrials.gov/show/NCT04401033
3020,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,Drug: Human Ezrin Peptide 1 (HEP1)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04627233
3021,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04632706
3022,Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis,Drug: Sirolimus,https://ClinicalTrials.gov/show/NCT04948203
3023,Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients,Drug: exogenous surfactant,https://ClinicalTrials.gov/show/NCT04847375
3024,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,Drug: Edoxaban Tablets|Drug: Colchicine Tablets,https://ClinicalTrials.gov/show/NCT04516941
3025,Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit,Diagnostic Test: Liver function tests,https://ClinicalTrials.gov/show/NCT04669509
3026,Characterizing the Immune Response and Neuronal Damage in COVID-19,"Other: Analysis of cytokine response, innate and adaptive immune response, complement activation, and serum neurofilaments as a marker of neurological damage.",https://ClinicalTrials.gov/show/NCT04510012
3027,Camostat With Bicalutamide for COVID-19,Drug: Camostat Mesilate|Drug: Bicalutamide 150 mg,https://ClinicalTrials.gov/show/NCT04652765
3028,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,Other: Prolectin-M; a (1-6)-alpha-D-Mannopyranose class|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04512027
3029,Emotional Burden of Healthcare Professionals and Covid Infection 19,Other: quetionnary,https://ClinicalTrials.gov/show/NCT04350099
3030,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,Other: venous ultrasound|Biological: blood sample,https://ClinicalTrials.gov/show/NCT04377490
3031,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,Other: PHQ-9 Depression Scale|Other: GAD-7 General anxiety disorder scale|Other: 38-questions questionnaire,https://ClinicalTrials.gov/show/NCT04432948
3032,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Other: Tested for SARS-CoV-2 (regardless of the result)|Other: Clinical diagnosis of COVID-19 by a health care professional,https://ClinicalTrials.gov/show/NCT04366986
3033,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",Biological: mRNA-1273|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04649151
3034,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",Biological: mRNA-1273|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04470427
3035,Impact of Covid-19 Pandemic on Management of Head and Neck Cancers,,https://ClinicalTrials.gov/show/NCT04704466
3036,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,,https://ClinicalTrials.gov/show/NCT04441372
3037,A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,Biological: Covigenix VAX-001 placebo|Biological: Covigenix VAX-001,https://ClinicalTrials.gov/show/NCT04591184
3038,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Other: Cardiac surgery,https://ClinicalTrials.gov/show/NCT04366167
3039,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,Drug: Ensifentrine Dose 1|Drug: Placebo pMDI,https://ClinicalTrials.gov/show/NCT04527471
3040,"A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19",Biological: mRNA-1283|Biological: mRNA-1273|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04813796
3041,Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19,Drug: COR-101|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04674566
3042,Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome,Other: Use of High Flow Nasal Cannula alone|Other: Use of Non-invasive Ventilation|Other: Use of Continuous Positive Airway Pressure,https://ClinicalTrials.gov/show/NCT04725084
3043,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),Other: [TIMP-2]*[IGFBP-7],https://ClinicalTrials.gov/show/NCT04393428
3044,COVID-19 in Patients With Anosmia in Egypt,,https://ClinicalTrials.gov/show/NCT04473157
3045,Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19,Diagnostic Test: Arterial blood gas (ABG)|Other: Recording of hemodynamic monitoring|Other: Recording of respiratory monitoring,https://ClinicalTrials.gov/show/NCT04894214
3046,COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana,Behavioral: COVID-19 Vaccine Education at the Point of COVID-19 Testing,https://ClinicalTrials.gov/show/NCT04939506
3047,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04414241
3048,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",Biological: UB-612,https://ClinicalTrials.gov/show/NCT04545749
3049,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",Biological: Biological: mRNA-1273|Biological: Placebo|Biological: mRNA-1273.351,https://ClinicalTrials.gov/show/NCT04405076
3050,A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age,Biological: mRNA-1273|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04796896
3051,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,Biological: BBV152|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04641481
3052,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome,Drug: Tocilizumab|Drug: Infliximab,https://ClinicalTrials.gov/show/NCT04734678
3053,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",Other: Hospitalized Patients for COVID-19 Infection,https://ClinicalTrials.gov/show/NCT04432922
3054,COVID-19 Mortality Prediction Model,Device: COViage,https://ClinicalTrials.gov/show/NCT04358510
3055,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,Drug: XCEL-UMC-BETA|Other: Placebo,https://ClinicalTrials.gov/show/NCT04390139
3056,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,Biological: Convalescent Plasma|Other: Saline solution,https://ClinicalTrials.gov/show/NCT04364737
3057,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),,https://ClinicalTrials.gov/show/NCT04386512
3058,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),Biological: Mesenchymal Stromal Cells|Other: Supportive Care,https://ClinicalTrials.gov/show/NCT04345601
3059,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug: Hydroxychloroquine|Drug: Oseltamivir|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04338698
3060,The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients,Drug: HCQ01|Drug: standard of care (SOC) for COVID-19,https://ClinicalTrials.gov/show/NCT04731051
3061,"Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19",Behavioral: Edinburgh Postnatal Depression Scale|Behavioral: Breast Feeding Adherence|Behavioral: Fear of Covid-19 Scale,https://ClinicalTrials.gov/show/NCT04769700
3062,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Other: Human Biological samples,https://ClinicalTrials.gov/show/NCT04325646
3063,"To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.",Drug: DWRX2003,https://ClinicalTrials.gov/show/NCT04749173
3064,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Procedure: Follow-up at 14 days,https://ClinicalTrials.gov/show/NCT04338100
3065,"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]",Other: Human biological samples,https://ClinicalTrials.gov/show/NCT04644159
3066,Defiances to Face COVID-19 Pandemic in Mexico,Behavioral: Fear of Covid-19 Scale,https://ClinicalTrials.gov/show/NCT04771117
3067,Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins,Diagnostic Test: Sampling,https://ClinicalTrials.gov/show/NCT04465981
3068,COVID-19 Induced Telogen Effluvium,Diagnostic Test: Blood Tests,https://ClinicalTrials.gov/show/NCT04834102
3069,COVID-19 and Obstetric Transmission,Diagnostic Test: RT-PCR and antibody testing,https://ClinicalTrials.gov/show/NCT04418557
3070,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,Other: An auto-questionnaire comprising three psychometric scales,https://ClinicalTrials.gov/show/NCT04463758
3071,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",Drug: LEAF-4L6715,https://ClinicalTrials.gov/show/NCT04378920
3072,Rehabilitation Status of Children With Cerebral Palsy and Anxiety of Their Caregivers During the Covid19 Pandemic,,https://ClinicalTrials.gov/show/NCT04916873
3073,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,Drug: Senicapoc,https://ClinicalTrials.gov/show/NCT04594668
3074,"Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome",,https://ClinicalTrials.gov/show/NCT04447144
3075,Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,Other: mortality,https://ClinicalTrials.gov/show/NCT04457570
3076,"Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients",,https://ClinicalTrials.gov/show/NCT04456101
3077,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,Other: Online Survey,https://ClinicalTrials.gov/show/NCT04412278
3078,Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV),,https://ClinicalTrials.gov/show/NCT04812496
3079,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Behavioral: Tele-delivered psychological intervention,https://ClinicalTrials.gov/show/NCT04409821
3080,The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions,Behavioral: COVID-19 Pandemic,https://ClinicalTrials.gov/show/NCT04924790
3081,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,Combination Product: autologous activated platelet-rich plasma|Drug: Avigan,https://ClinicalTrials.gov/show/NCT04715360
3082,Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19,Diagnostic Test: ECG data analysis|Drug: Treatment data collect|Biological: Biological check-up data collect|Other: Collection of clinical events of interest,https://ClinicalTrials.gov/show/NCT04937621
3083,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,Drug: HB-adMSCs,https://ClinicalTrials.gov/show/NCT04349631
3084,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),Biological: MSC,https://ClinicalTrials.gov/show/NCT04377334
3085,Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease),Device: Ion Mobility Spectrometry (IMS),https://ClinicalTrials.gov/show/NCT04649931
3086,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04441710
3087,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",Biological: BNT162b2|Other: Placebo,https://ClinicalTrials.gov/show/NCT04754594
3088,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",Drug: HLX71|Other: Placebo,https://ClinicalTrials.gov/show/NCT04583228
3089,Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care,Dietary Supplement: MOLECULAR HYDROGEN|Dietary Supplement: PLACEBO MAGNESIUM,https://ClinicalTrials.gov/show/NCT04716985
3090,The Impact of COVID-19 Pandemic on Hip and Knee Replacement,Other: Pandemic period,https://ClinicalTrials.gov/show/NCT04883788
3091,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),Other: quality of live assessment,https://ClinicalTrials.gov/show/NCT04491214
3092,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),Biological: COVID-19 convalescent plasma,https://ClinicalTrials.gov/show/NCT04432272
3093,Evaluation of Humoral Immunity Following COVID-19 in Pregnancy,Procedure: Blood sample,https://ClinicalTrials.gov/show/NCT04568044
3094,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),Drug: Hydroxychloroquine Sulfate|Drug: Ascorbic Acid,https://ClinicalTrials.gov/show/NCT04328961
3095,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,,https://ClinicalTrials.gov/show/NCT04347694
3096,Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.,Drug: History of exposure to anti-CD20 treatment since 01/01/2010|Biological: Completion of COVID19 vaccine at least 4 weeks ago,https://ClinicalTrials.gov/show/NCT04877496
3097,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Other: No special intervention,https://ClinicalTrials.gov/show/NCT04341766
3098,Sleep Quality in Healthcare Personnel During COVID-19,Other: Web Based Survey,https://ClinicalTrials.gov/show/NCT04395300
3099,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,,https://ClinicalTrials.gov/show/NCT04341792
3100,Frequency of Perforated Appendicitis in Times of COVID-19,Other: appendectomy,https://ClinicalTrials.gov/show/NCT04472052
3101,COVID19 Neurological Manifestation,,https://ClinicalTrials.gov/show/NCT04496128
3102,Anti Infective Agents Impact in COVID-19 Pneumonia,Drug: favorable outcome,https://ClinicalTrials.gov/show/NCT04453501
3103,Inflammatory Signal Inhibitors for COVID-19 (MATIS),Drug: Ruxolitinib|Drug: Fostamatinib|Other: Standard of care,https://ClinicalTrials.gov/show/NCT04581954
3104,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),"Other: Questionnaires, spirometry",https://ClinicalTrials.gov/show/NCT04365595
3105,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,,https://ClinicalTrials.gov/show/NCT04270383
3106,Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home,Biological: Ligilactobacillus salivarius MP101,https://ClinicalTrials.gov/show/NCT04922918
3107,Vascular Abnormalities Detected With Chest CT in COVID-19,Diagnostic Test: Chest CT|Diagnostic Test: Chest CTA,https://ClinicalTrials.gov/show/NCT04824313
3108,Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY),Drug: Methylprednisolone sodium succinate|Biological: Human normal immunoglobulin (IVIg),https://ClinicalTrials.gov/show/NCT04826588
3109,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,Drug: BCG-10 vaccine|Drug: 0.9% saline,https://ClinicalTrials.gov/show/NCT04648800
3110,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,Procedure: Therapeutic Plasma Exchange,https://ClinicalTrials.gov/show/NCT04485169
3111,Corona And Manual Professions,,https://ClinicalTrials.gov/show/NCT04834583
3112,Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients,"Dietary Supplement: Nusapure standardized olive leaves capsule, 750 mg (50% oleuropein)",https://ClinicalTrials.gov/show/NCT04873349
3113,DIgital Online SuPport for COVID-19 StrEss,Behavioral: Guided online support program|Behavioral: WHO recommendations (waiting condition),https://ClinicalTrials.gov/show/NCT04324190
3114,Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT,,https://ClinicalTrials.gov/show/NCT04789395
3115,Outpatient Liquid Aspirin (OLA),Drug: ASA,https://ClinicalTrials.gov/show/NCT04937088
3116,Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19,Diagnostic Test: Rapid antigen test for SARS CoV2,https://ClinicalTrials.gov/show/NCT04716088
3117,Immune Response to the COVID-19 Vaccine,Biological: SARS-COV2 Pfizer Vaccine,https://ClinicalTrials.gov/show/NCT04936997
3118,Mechanisms of Multi-organ Failure in COVID-19,Other: no intervention-mechanistic study,https://ClinicalTrials.gov/show/NCT04399603
3119,"A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12-17 Years) at Risk for SARS-CoV-2",Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)|Other: Placebo (Initial Vaccination Period)|Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Crossover Vaccination period)|Other: Placebo (Crossover Vaccination period),https://ClinicalTrials.gov/show/NCT04611802
3120,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo,Diagnostic Test: Serological test|Diagnostic Test: Nasopharyngeal Swab|Diagnostic Test: Oropharyngeal Swab,https://ClinicalTrials.gov/show/NCT04408014
3121,Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits,Other: decision science-based design,https://ClinicalTrials.gov/show/NCT04758299
3122,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,Drug: Ivermectin + Doxycycline|Drug: Hydroxychloroquine + Azithromycin,https://ClinicalTrials.gov/show/NCT04434144
3123,Initial CT Findings and CO-RADS Stage in COVID-19,,https://ClinicalTrials.gov/show/NCT04789447
3124,Impact of SARS-CoV-2 Pandemic on Psychological State of Health Care Workers,Other: other,https://ClinicalTrials.gov/show/NCT04779944
3125,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,Other: Rehabilitation by Eccentric exercises|Other: Rehabilitation by Concentric exercises,https://ClinicalTrials.gov/show/NCT04649086
3126,NoRCoRP Assessment Clinic,,https://ClinicalTrials.gov/show/NCT04710836
3127,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,https://ClinicalTrials.gov/show/NCT04371692
3128,Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients,Drug: Ivermectin Injectable Solution|Other: Injectable Placebo|Drug: Zinc|Drug: Placebo empty capsule|Drug: Oral Ivermectin,https://ClinicalTrials.gov/show/NCT04472585
3129,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,Device: vv-ECMO,https://ClinicalTrials.gov/show/NCT04405973
3130,Breathing After COVID-19,Other: No intervention.,https://ClinicalTrials.gov/show/NCT04944342
3131,Methylene Blue Treatment of COVID-19,Drug: Methylene Blue|Drug: Control Test,https://ClinicalTrials.gov/show/NCT04635605
3132,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04561219
3133,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,Other: Blood sample and data record,https://ClinicalTrials.gov/show/NCT04376840
3134,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),Diagnostic Test: diagnostic,https://ClinicalTrials.gov/show/NCT04460534
3135,Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators,Device: UVC Irradiation|Drug: UVC Irradiation|Device: Fit test|Device: Tensile strength,https://ClinicalTrials.gov/show/NCT04749121
3136,Maraviroc in Patients With Moderate and Severe COVID-19,Drug: Maraviroc,https://ClinicalTrials.gov/show/NCT04435522
3137,Methylation Effects of COV-19 Infection and Vaccinations,Biological: SARS-CoV-2 mRNA vaccine,https://ClinicalTrials.gov/show/NCT04939155
3138,Precision Immunology to Determine the Immune Response in Patients With COVID-19,Other: Blood draw,https://ClinicalTrials.gov/show/NCT04360733
3139,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Procedure: Vascular surgery,https://ClinicalTrials.gov/show/NCT04333693
3140,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug: Colchicine|Other: Local standard of care,https://ClinicalTrials.gov/show/NCT04328480
3141,SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients,Diagnostic Test: Tears swab,https://ClinicalTrials.gov/show/NCT04402853
3142,Study of Ameliorating Effect of COVID-19 mRNA Vaccine in Individuals Immunized With Inactivated Vaccine,Biological: SARS-Cov-2 mRNA vaccine immunization|Biological: Inactivated SARS-Cov-2 vaccine immunization,https://ClinicalTrials.gov/show/NCT04944381
3143,Association Between BMI and COVID-19,Other: Patients admitted to Intensive Care Unit with SARS-CoV2,https://ClinicalTrials.gov/show/NCT04391738
3144,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug: Nivolumab,https://ClinicalTrials.gov/show/NCT04356508
3145,Impact of COVID-19 on GU Disease,,https://ClinicalTrials.gov/show/NCT04761107
3146,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",Biological: SCTA01|Other: Placebo,https://ClinicalTrials.gov/show/NCT04483375
3147,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,,https://ClinicalTrials.gov/show/NCT04359693
3148,DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia,Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04836780
3149,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,https://ClinicalTrials.gov/show/NCT04362267
3150,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",Combination Product: JS016 (anti-SARS-CoV-2 monoclonal antibody),https://ClinicalTrials.gov/show/NCT04441918
3151,"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers",Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Serum testing,https://ClinicalTrials.gov/show/NCT04619407
3152,Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19,Drug: Placebo administration|Diagnostic Test: Confirm SARS-CoV-2 infection|Procedure: Physical Examination|Procedure: Vital Signs|Diagnostic Test: Hematology blood test|Diagnostic Test: Biochemistry blood test|Other: NEWS score|Diagnostic Test: PK test|Diagnostic Test: blood test for inflammatory markers|Diagnostic Test: D-dimer test|Other: VAS scale|Diagnostic Test: Urine pregnancy test for women of childbearing potential|Procedure: ECG|Other: COVID-19-Impact on Quality of Life Questionnaire|Drug: CimetrA-1|Drug: CimetrA-2,https://ClinicalTrials.gov/show/NCT04802382
3153,Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination,,https://ClinicalTrials.gov/show/NCT04794829
3154,Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04761913
3155,Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19,Other: Aerobic Exercise Therapy,https://ClinicalTrials.gov/show/NCT04824443
3156,Chinese Medicine for Patients With LCOVID-19 Symptoms,Drug: COVID Rehab Formula granules|Other: Placebo granules,https://ClinicalTrials.gov/show/NCT04924881
3157,Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04460469
3158,Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection,Other: Data collection,https://ClinicalTrials.gov/show/NCT04863547
3159,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,Other: Respiratory and psychological rehabilitation,https://ClinicalTrials.gov/show/NCT04649736
3160,A Phase II/III Study of Sargramostim,Drug: Sargramostim|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04642950
3161,Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,,https://ClinicalTrials.gov/show/NCT04619693
3162,Thromboprophylaxis for Patients in ICU With COVID-19,,https://ClinicalTrials.gov/show/NCT04623177
3163,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,Drug: Sargramostim|Other: Normal Saline 0.9%,https://ClinicalTrials.gov/show/NCT04400929
3164,COVID-19 Longitudinal Biomarkers in Lung Injury,"Other: no interventions performed. Just collecting data, blood samples and post-mortem biopsies.",https://ClinicalTrials.gov/show/NCT04747782
3165,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Behavioral: 1: Prone positioning|Behavioral: 2: No instruction regarding positioning,https://ClinicalTrials.gov/show/NCT04366856
3166,COVID-19 in PID Survey,,https://ClinicalTrials.gov/show/NCT04459689
3167,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,"Other: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.",https://ClinicalTrials.gov/show/NCT04395599
3168,Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,Diagnostic Test: Nasal swab|Diagnostic Test: Serum testing,https://ClinicalTrials.gov/show/NCT04370119
3169,Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 Masks,Behavioral: Surgical Mask,https://ClinicalTrials.gov/show/NCT04823351
3170,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug: Ruxolitinib administration,https://ClinicalTrials.gov/show/NCT04359290
3171,Assessment of Safety and Efficacy of CCP,Biological: COVID Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04542941
3172,INvestigating TELmisartin Study,Drug: Telmisartan Oral Product|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04715763
3173,Using Whatsapp for the Consultation,Other: Sending thorax ct video images via smartphone applications,https://ClinicalTrials.gov/show/NCT04645563
3174,Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital,"Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases",https://ClinicalTrials.gov/show/NCT04780594
3175,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Diagnostic Test: CTUS examination,https://ClinicalTrials.gov/show/NCT04372680
3176,COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity,,https://ClinicalTrials.gov/show/NCT04690114
3177,Lung Ultrasound in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04487769
3178,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),,https://ClinicalTrials.gov/show/NCT04346342
3179,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic,Other: PRO-SERO-COV,https://ClinicalTrials.gov/show/NCT04426006
3180,Donated Antibodies Working Against nCoV,Biological: Convalescent Plasma|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04429854
3181,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:,,https://ClinicalTrials.gov/show/NCT04488510
3182,"Safety, Reactogenicity and Immunogenicity Study of ReCOV",Biological: Recombinant two-component COVID-19 vaccine (CHO cell)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04818801
3183,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",Biological: CSL760,https://ClinicalTrials.gov/show/NCT04638634
3184,Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat,Drug: Niclosamide + Camostat|Other: Placebo,https://ClinicalTrials.gov/show/NCT04750759
3185,Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS,Drug: IFN beta-1a|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04860518
3186,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),Diagnostic Test: ABPM|Diagnostic Test: ECG|Diagnostic Test: FMD|Diagnostic Test: PWV|Diagnostic Test: Rarefaction,https://ClinicalTrials.gov/show/NCT04409847
3187,Honey & Nigella Sativa Trial Against COVID-19,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04347382
3188,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,,https://ClinicalTrials.gov/show/NCT04359706
3189,"Clinical Trial to ""Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)",Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04836299
3190,Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04570982
3191,"Evaluating Auscul-X, a Touch Free Digital Stethoscope",Device: Auscul-X,https://ClinicalTrials.gov/show/NCT04570189
3192,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,Drug: Favipiravir|Drug: Lopinavir/ Ritonavir|Other: Favipiravir Placebo|Other: Lopinavir/ Ritonavir Placebo,https://ClinicalTrials.gov/show/NCT04499677
3193,Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19,Drug: SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04836260
3194,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04398147
3195,Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections,Other: Therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3)|Other: Usual treatments in intensive care unit according to the current state of knowledge,https://ClinicalTrials.gov/show/NCT04751643
3196,CD8+ T-cell PET/CT Imaging in COVID-19 Patients,Diagnostic Test: [89Zr]Df-IAB22M2C PET/CT scan,https://ClinicalTrials.gov/show/NCT04874818
3197,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,Drug: Hydroxychloroquine|Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04458948
3198,Novel Regimens in COVID-19 Treatment,Drug: Nitazoxanide,https://ClinicalTrials.gov/show/NCT04382846
3199,Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health,,https://ClinicalTrials.gov/show/NCT04573062
3200,Ravulizumab and COVID-19,Drug: Ravulizumab,https://ClinicalTrials.gov/show/NCT04570397
3201,COVID-19 Infection and Multiple Myeloma,,https://ClinicalTrials.gov/show/NCT04492371
3202,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,Diagnostic Test: Immunfluorescence,https://ClinicalTrials.gov/show/NCT04429620
3203,Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study,Diagnostic Test: SARS-CoV-2 IgG,https://ClinicalTrials.gov/show/NCT04579471
3204,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",Other: Magnetic Resonance Spectroscopy (MRS).,https://ClinicalTrials.gov/show/NCT04546737
3205,COVID-19 on Placental Gene Expression and Pathology,Diagnostic Test: Positive for SARS-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04585945
3206,COVID-19 in Liver Transplant Recipients,Other: Observational only,https://ClinicalTrials.gov/show/NCT04361591
3207,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,Drug: TriCor® 145mg tablets|Other: Usual Care|Other: Placebo,https://ClinicalTrials.gov/show/NCT04661930
3208,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug: Eicosapentaenoic acid gastro-resistant capsules|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04335032
3209,Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach,Other: COCA is an observational study based on retrospective data issued from patient medial file.,https://ClinicalTrials.gov/show/NCT04910633
3210,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,,https://ClinicalTrials.gov/show/NCT04359927
3211,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),Biological: Vaccinated with polio vaccine (IPV),https://ClinicalTrials.gov/show/NCT04639375
3212,COVID-19 Advanced Respiratory Physiology (CARP) Study,,https://ClinicalTrials.gov/show/NCT04668313
3213,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,Procedure: Study Arm,https://ClinicalTrials.gov/show/NCT04397172
3214,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,Drug: RLS-0071|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04574869
3215,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,Diagnostic Test: Pulmonary function testing,https://ClinicalTrials.gov/show/NCT04519320
3216,Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation,Dietary Supplement: Vitamins|Drug: Telmisartan|Drug: Ciclesonide|Drug: interferon β-1b,https://ClinicalTrials.gov/show/NCT04356495
3217,"Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",Diagnostic Test: Serological Assay or IgG for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04472078
3218,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",Procedure: Covid ICU containment measures,https://ClinicalTrials.gov/show/NCT04430049
3219,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,Drug: low-molecular-weight heparin,https://ClinicalTrials.gov/show/NCT04584580
3220,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),Drug: CORVax|Drug: IL-12 plasmid|Device: Cliniporator,https://ClinicalTrials.gov/show/NCT04627675
3221,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),Drug: Canakinumab Injection 600mg|Drug: Canakinumab Injection 300mg|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04365153
3222,COVID-19 and Cancer Patients,,https://ClinicalTrials.gov/show/NCT04393974
3223,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,Diagnostic Test: Lung ultrasound|Diagnostic Test: Muscle ultrasound,https://ClinicalTrials.gov/show/NCT04373811
3224,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,Diagnostic Test: biological samples day of delivery,https://ClinicalTrials.gov/show/NCT04402918
3225,"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens",Diagnostic Test: Sequence of testing.,https://ClinicalTrials.gov/show/NCT04715607
3226,SARS-COV2 Pandemic Serosurvey and Blood Sampling,,https://ClinicalTrials.gov/show/NCT04334954
3227,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,Biological: Convalescent anti-SARS-CoV-2 MBT plasma|Other: Control Group,https://ClinicalTrials.gov/show/NCT04621123
3228,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),Drug: Methotrexate-LDE phase 1|Drug: Methotrexate-LDE phase 2|Drug: Placebo-LDE phase 2,https://ClinicalTrials.gov/show/NCT04610567
3229,COVID-19 Pandemic and Female Sexual Behavior,Behavioral: fsfi survey,https://ClinicalTrials.gov/show/NCT04374422
3230,Detecting SARS-CoV-2 in Tears,Diagnostic Test: Tear Collection,https://ClinicalTrials.gov/show/NCT04526769
3231,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Other: Survey,https://ClinicalTrials.gov/show/NCT04336787
3232,Imaging Feature of SARS-CoV2 Infection,,https://ClinicalTrials.gov/show/NCT04394026
3233,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients",Device: Extravascular Lung Water Index|Device: Pulmonary Vascular Permeability Index,https://ClinicalTrials.gov/show/NCT04508933
3234,Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2,,https://ClinicalTrials.gov/show/NCT04655521
3235,Monovalent Recombinant COVID19 Vaccine,Biological: COVID19 vaccine|Biological: Saline,https://ClinicalTrials.gov/show/NCT04453852
3236,Influence of COVID-19 on Vascular Endothelial Function,Diagnostic Test: Carotid Artery Reactivity Testing,https://ClinicalTrials.gov/show/NCT04468412
3237,NK Cells Treatment for COVID-19,Biological: NK Cells,https://ClinicalTrials.gov/show/NCT04280224
3238,Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test,"Diagnostic Test: Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test",https://ClinicalTrials.gov/show/NCT04808921
3239,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,Drug: P2Et (Caesalpinia spinosa extract)|Other: Placebo,https://ClinicalTrials.gov/show/NCT04410510
3240,COVID-19 Vaccine Hesitancy Among African Americans,Behavioral: CoVax Facts,https://ClinicalTrials.gov/show/NCT04801030
3241,the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection,,https://ClinicalTrials.gov/show/NCT04893694
3242,Dried Blood Spots for SARS-CoV-2 Serology (COVID-19).,Diagnostic Test: Dried blood spot and venous blood collection,https://ClinicalTrials.gov/show/NCT04880122
3243,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,,https://ClinicalTrials.gov/show/NCT04382469
3244,Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID),Dietary Supplement: Niagen,https://ClinicalTrials.gov/show/NCT04809974
3245,Safety and Tolerability of COVID-19 Vaccine (ABNCoV2),Biological: ABNCoV2 Vaccine,https://ClinicalTrials.gov/show/NCT04839146
3246,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other: PROTECTIVE VENTILATION|Other: ULTRAPROTECTIVE VENTILATION,https://ClinicalTrials.gov/show/NCT04349618
3247,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19,,https://ClinicalTrials.gov/show/NCT04726137
3248,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,Drug: LB1148|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04390217
3249,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,Drug: Bromhexine Hydrochloride,https://ClinicalTrials.gov/show/NCT04405999
3250,Steam Inhalations in COVID-19 Patients,Procedure: Steam inhalations,https://ClinicalTrials.gov/show/NCT04743349
3251,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04344249
3252,COVID-19 Seroprevalence Study in French Guiana,Procedure: Blood sample,https://ClinicalTrials.gov/show/NCT04490850
3253,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,Device: Thermography|Device: Tympanic Temperature,https://ClinicalTrials.gov/show/NCT04397380
3254,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other: Pulmonary Physiotherapy Techniques,https://ClinicalTrials.gov/show/NCT04357340
3255,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",Behavioral: Simha Kriya|Behavioral: Reading a Book,https://ClinicalTrials.gov/show/NCT04498442
3256,Prognosis in Pregnant With COVID-19,"Diagnostic Test: imaging, blood tests",https://ClinicalTrials.gov/show/NCT04409249
3257,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,Radiation: Low dose radiation 35 cGy|Radiation: High dose radiation 100 cGy,https://ClinicalTrials.gov/show/NCT04466683
3258,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,Biological: Serology SARS-CoV2|Behavioral: Data collection,https://ClinicalTrials.gov/show/NCT04442087
3259,Understanding Immunity to the COVID-19 Vaccines,Other: No intervention,https://ClinicalTrials.gov/show/NCT04664309
3260,Post COVID19 Functional and Cognitive Assessments,,https://ClinicalTrials.gov/show/NCT04860206
3261,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,Other: Coronavirus Disease 2019,https://ClinicalTrials.gov/show/NCT04388631
3262,Convalescent Plasma for COVID-19,Biological: Blood plasma,https://ClinicalTrials.gov/show/NCT04365439
3263,Echocardiography in Patients With Covid-19,,https://ClinicalTrials.gov/show/NCT04412460
3264,The Impact of Covid-19 on Skeletal Muscle,Other: No intervetion will be used,https://ClinicalTrials.gov/show/NCT04756674
3265,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,,https://ClinicalTrials.gov/show/NCT04364711
3266,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),Other: blood sample,https://ClinicalTrials.gov/show/NCT04568707
3267,Intermediate IND Severe Illness COVID-19 CP,Drug: SARS-CoV-2 plasma,https://ClinicalTrials.gov/show/NCT04411602
3268,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,,https://ClinicalTrials.gov/show/NCT04459351
3269,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI),Diagnostic Test: Serologic test|Diagnostic Test: Respiratory swabs,https://ClinicalTrials.gov/show/NCT04709003
3270,Impact of COVID19 Outbreak in Cardiac Acute Care,Other: Data collection,https://ClinicalTrials.gov/show/NCT04344912
3271,"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19",Biological: CVnCoV Vaccine,https://ClinicalTrials.gov/show/NCT04860258
3272,Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients,Drug: N-acetylcysteine,https://ClinicalTrials.gov/show/NCT04792021
3273,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,,https://ClinicalTrials.gov/show/NCT04397900
3274,Delirium in Covid-19: Germany-wide Covid-19 Intensive Register,,https://ClinicalTrials.gov/show/NCT04775017
3275,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug: Enoxaparin Prefilled Syringe [Lovenox],https://ClinicalTrials.gov/show/NCT04354155
3276,MS Relapses During COVID-19 Pandemic,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04858763
3277,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),Diagnostic Test: Blood sample,https://ClinicalTrials.gov/show/NCT04425759
3278,SEVERITY SCORE FOR COVID-19 PNEUMONIA,,https://ClinicalTrials.gov/show/NCT04372199
3279,A Study of Immune Responses to the Virus That Causes COVID-19,Other: Sample collection,https://ClinicalTrials.gov/show/NCT04431414
3280,COVID-19 in ART: Perception and Experience,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04456010
3281,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population,Biological: BNT162b2|Other: Placebo,https://ClinicalTrials.gov/show/NCT04649021
3282,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),,https://ClinicalTrials.gov/show/NCT04362930
3283,BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,Biological: BCG-Denmark|Biological: Saline,https://ClinicalTrials.gov/show/NCT04641858
3284,Bacteriotherapy in the Treatment of COVID-19,Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04368351
3285,Prognostic Factors of Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04292964
3286,Home-based Exercise in COVID-19 Survivors,Other: Exercise training,https://ClinicalTrials.gov/show/NCT04615052
3287,Community Health Workers Against COVID19,Other: community health worker support|Other: care as usual,https://ClinicalTrials.gov/show/NCT04426305
3288,Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa,Biological: COVID-19|Biological: HIV|Drug: ART,https://ClinicalTrials.gov/show/NCT04709302
3289,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts,Drug: Nitazoxanide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04788407
3290,Early Short Course Corticosteroids in COVID-19,Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04374071
3291,A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19,Biological: CVnCoV Vaccine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04674189
3292,The Geneva Covid-19 CVD Study,Other: Covid-19 + patients,https://ClinicalTrials.gov/show/NCT04384029
3293,UNITE Study (UMN-GE) for COVID-19,Device: Splenic ultrasound,https://ClinicalTrials.gov/show/NCT04701489
3294,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,Drug: Rayaldee 30Mcg Extended-Release (ER) Capsule|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04551911
3295,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",Biological: SARS-CoV-2 vaccine (inactivated)|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04508075
3296,Covid-19 Vaccine Response in Immunocompromised Haematology Patients,Procedure: Blood test,https://ClinicalTrials.gov/show/NCT04805216
3297,Pediatric Acute and Critical Care COVID-19 Registry of Asia,,https://ClinicalTrials.gov/show/NCT04395781
3298,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,Biological: Biological collection (patients co infected HIV Sras-CoV-2)|Other: Auto-questionnaires (patients co infected HIV Sras-CoV-2)|Other: Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19),https://ClinicalTrials.gov/show/NCT04361604
3299,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Other: Additional biological samples,https://ClinicalTrials.gov/show/NCT04365322
3300,Intensive Care Therapy of Covid-19 Disease in Germany,,https://ClinicalTrials.gov/show/NCT04455451
3301,COVID-19 and ICU-acquired MDR Bacteria,,https://ClinicalTrials.gov/show/NCT04378842
3302,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19,,https://ClinicalTrials.gov/show/NCT04556864
3303,Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection,Drug: Ruconest,https://ClinicalTrials.gov/show/NCT04705831
3304,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,Behavioral: Informational videos and social media campaigns encouraging cancer screening.,https://ClinicalTrials.gov/show/NCT04587258
3305,Myeloproliferative Neoplasms (MPN) and COVID-19,,https://ClinicalTrials.gov/show/NCT04385160
3306,Kidney Involvement in COVID-19 Disease (COVKID),,https://ClinicalTrials.gov/show/NCT04355624
3307,The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease,Other: change in kidney function and proteinuria,https://ClinicalTrials.gov/show/NCT04874753
3308,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,Other: Prospective observation,https://ClinicalTrials.gov/show/NCT04565522
3309,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04408339
3310,High Body Mass Index and Severity of Coronavirus,Other: prospective cohort in high body mass index patient with covid 19,https://ClinicalTrials.gov/show/NCT04876898
3311,Effects of Pilates Exercises on Core Stability After Recovery From COVID -19,Other: Pilates Exercises|Other: Home Exercise program,https://ClinicalTrials.gov/show/NCT04871672
3312,Mortality Due to COVID-19 in the COVID-AGEBRU Study,,https://ClinicalTrials.gov/show/NCT04756479
3313,The COVID-19 Disease and CARdiac Events Study,,https://ClinicalTrials.gov/show/NCT04438993
3314,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,Diagnostic Test: Lung impedance technique,https://ClinicalTrials.gov/show/NCT04406493
3315,Hospital Interns Psychological State During the COVID-19,,https://ClinicalTrials.gov/show/NCT04669054
3316,Characteristics of Neonatal Covid-19 in Turkey,,https://ClinicalTrials.gov/show/NCT04401540
3317,Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy,,https://ClinicalTrials.gov/show/NCT04910958
3318,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,,https://ClinicalTrials.gov/show/NCT04441489
3319,COVID-19 Serology and Immunosenescence,Biological: blood sample,https://ClinicalTrials.gov/show/NCT04563650
3320,T Cells Response to SARS COV 2 Peptides,Diagnostic Test: Savicell's ImmunoBiopsy™,https://ClinicalTrials.gov/show/NCT04573348
3321,An Observational Study of Patients With Coronavirus Disease 2019,,https://ClinicalTrials.gov/show/NCT04331886
3322,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",Diagnostic Test: Blood samples (collection of 5 mL of blood in a dry tube)|Diagnostic Test: Nasopharyngeal swabs,https://ClinicalTrials.gov/show/NCT04369066
3323,The Effect of Aromatherapy on COVID-19-induced Anxiety,Other: Essential Oil Blend|Other: Control Blend,https://ClinicalTrials.gov/show/NCT04495842
3324,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects,Biological: BNT162b1|Other: Placebo,https://ClinicalTrials.gov/show/NCT04523571
3325,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Drug: Inhaled ILOPROST,https://ClinicalTrials.gov/show/NCT04445246
3326,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,Other: Pulmonary Rehabilitation,https://ClinicalTrials.gov/show/NCT04642040
3327,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,Other: Rehabilitation protocol through a digital platform,https://ClinicalTrials.gov/show/NCT04695301
3328,Renin-Angiotensin System Inhibitors and COVID-19,,https://ClinicalTrials.gov/show/NCT04331574
3329,Nasal Photodisinfection COVID Proof of Concept Study,Other: Methylene-Blue Photodisinfection,https://ClinicalTrials.gov/show/NCT04615936
3330,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,Other: COVID 19 impact,https://ClinicalTrials.gov/show/NCT04452682
3331,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,Other: all treatment about COVID-2019,https://ClinicalTrials.gov/show/NCT04346602
3332,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other: Standard interface|Device: Double-Trunk Mask,https://ClinicalTrials.gov/show/NCT04346420
3333,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,Biological: Specific anti-SARS-CoV-2 antibodies,https://ClinicalTrials.gov/show/NCT04424017
3334,Acquiring Convalescent Specimens for COVID-19 Antibodies,Procedure: Blood draw,https://ClinicalTrials.gov/show/NCT04342195
3335,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,Drug: Cholecalciferol|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04733625
3336,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,Other: acute kidney injury,https://ClinicalTrials.gov/show/NCT04407156
3337,COVID-19 Infection in Diabetic Patients,Other: no intervention as it is an observational study,https://ClinicalTrials.gov/show/NCT04765254
3338,Immune Response in Dialysis Patients Vaccinated Against SARS-CoV-2,,https://ClinicalTrials.gov/show/NCT04805632
3339,Lung Ultrasonography in COVID-19 Pneumonia,Device: lung ultrasonography,https://ClinicalTrials.gov/show/NCT04719234
3340,COVID-19 Pandemic and Parents of Disabled Children,Other: Difficulties lived by disabled children's parents in the period of COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04525742
3341,Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples,,https://ClinicalTrials.gov/show/NCT04732767
3342,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Other: Postural Positioning,https://ClinicalTrials.gov/show/NCT04344561
3343,Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR),Device: High-flow nasal cannula treatment|Device: Continuous positive airway pressure (CPAP) treatment|Device: Noninvasive ventilation treatment,https://ClinicalTrials.gov/show/NCT04668196
3344,Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04941144
3345,Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients,Other: Patients with hemopathy,https://ClinicalTrials.gov/show/NCT04852796
3346,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,Device: Bedside lung ultrasound,https://ClinicalTrials.gov/show/NCT04399681
3347,The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19,Drug: Ivermectin|Other: Prophylaxis,https://ClinicalTrials.gov/show/NCT04891250
3348,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" Vaccine",Biological: Sputnik Light,https://ClinicalTrials.gov/show/NCT04713488
3349,Use of UC-MSCs for COVID-19 Patients,Biological: Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Other: Vehicle + Heparin along with best supportive care,https://ClinicalTrials.gov/show/NCT04355728
3350,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",,https://ClinicalTrials.gov/show/NCT04408365
3351,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,,https://ClinicalTrials.gov/show/NCT04360707
3352,Oxygen Saturation: Analytical Comparison for COVID,Other: Measurement of oxygen saturation,https://ClinicalTrials.gov/show/NCT04874805
3353,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug: Sitagliptin,https://ClinicalTrials.gov/show/NCT04365517
3354,Immune Changes in Severe COVID-19 Pulmonary Infections,,https://ClinicalTrials.gov/show/NCT04386395
3355,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Drug: Ivermectin Pill|Drug: Combined ART/hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04435587
3356,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,Biological: CT-P59/Placebo,https://ClinicalTrials.gov/show/NCT04602000
3357,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,Diagnostic Test: Functional MRI,https://ClinicalTrials.gov/show/NCT04476589
3358,Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2,Other: High PEEP with end inspiratory pause|Other: Low PEEP - FiO2 high|Other: High PEEP without end inspiratory pause|Other: Low PEEP - FiO2 low,https://ClinicalTrials.gov/show/NCT04486729
3359,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,Device: 2019-nCoV IgG/IgM Rapid Test Cassette,https://ClinicalTrials.gov/show/NCT04434417
3360,Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region,,https://ClinicalTrials.gov/show/NCT04845984
3361,Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04604119
3362,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug: Autophagy inhibitor (GNS651)|Other: Standard of care|Drug: Avdoralimab|Drug: Monalizumab,https://ClinicalTrials.gov/show/NCT04333914
3363,Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,Device: Extracorporeal membrane oxygenation,https://ClinicalTrials.gov/show/NCT04383678
3364,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,"Diagnostic Test: MRI (heart, brain, lungs, liver)|Diagnostic Test: Bloodwork|Other: Cognitive testing|Other: Olfaction testing|Diagnostic Test: Spirometry|Other: Walk Test",https://ClinicalTrials.gov/show/NCT04525404
3365,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,Behavioral: Tailored recommendations|Behavioral: General recommendation,https://ClinicalTrials.gov/show/NCT04699851
3366,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Other: Physiotherapy,https://ClinicalTrials.gov/show/NCT04402983
3367,Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment,Diagnostic Test: Laboratory Samples,https://ClinicalTrials.gov/show/NCT04779996
3368,A Study of TAK-019 in Healthy Japanese Adults (COVID-19),Biological: TAK-019|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04712110
3369,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314,Drug: CKD-314+SOC|Drug: CKD-314 Placebo+SOC,https://ClinicalTrials.gov/show/NCT04871646
3370,Leveraging Social Networks to Increase COVID-19 Testing Uptake,Behavioral: Chain-referral|Behavioral: Credible Messenger,https://ClinicalTrials.gov/show/NCT04873401
3371,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",Biological: CT-P59,https://ClinicalTrials.gov/show/NCT04593641
3372,Clinical Trial of Sarilumab in Adults With COVID-19,Drug: Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]|Drug: Sarilumab 400 MG/2.28 ML Subcutaneous Solution [KEVZARA]|Drug: Best available treatment,https://ClinicalTrials.gov/show/NCT04357860
3373,A Study of TAK-919 in Healthy Japanese Adults (COVID-19),Biological: TAK-919|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04677660
3374,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients,,https://ClinicalTrials.gov/show/NCT04738760
3375,Oscillation and Lung Expansion Therapy in Patients With COVID-19,Device: MetaNeb® System,https://ClinicalTrials.gov/show/NCT04582214
3376,"Facial Hair, PPE and COVID-19",Behavioral: Questionnaire,https://ClinicalTrials.gov/show/NCT04579627
3377,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Diagnostic Test: CT-scan|Diagnostic Test: EEG|Diagnostic Test: EP|Diagnostic Test: Pulse oximetry|Diagnostic Test: Blood tests,https://ClinicalTrials.gov/show/NCT04405544
3378,A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients,Device: iZephyr hood,https://ClinicalTrials.gov/show/NCT04904484
3379,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,Drug: TNKase,https://ClinicalTrials.gov/show/NCT04558125
3380,Immunoregulatory Therapy for 2019-nCoV,Drug: PD-1 blocking antibody+standard treatment|Drug: Thymosin+standard treatment|Other: standard treatment,https://ClinicalTrials.gov/show/NCT04268537
3381,SARS-CoV-2 Disguise Study,Diagnostic Test: SARS-CoV-2-test|Other: SARS-CoV-2 questionnaire survey,https://ClinicalTrials.gov/show/NCT04395794
3382,COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer,"Procedure: MRM , Toilet Mastectomy , BCS",https://ClinicalTrials.gov/show/NCT04929964
3383,"Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light",Biological: Sputnik Light|Other: Placebo,https://ClinicalTrials.gov/show/NCT04741061
3384,Electrical Stimulation for Critically Ill Covid-19 Patients,Device: Electrical Stimulation|Device: Electrical Stimulation - Sham,https://ClinicalTrials.gov/show/NCT04685213
3385,Personal Protective Equipment Comfort and User Attitude During COVID-19,,https://ClinicalTrials.gov/show/NCT04910880
3386,Mother-infant Bonding During COVID-19,Behavioral: Family Nurture Intervention (FNI),https://ClinicalTrials.gov/show/NCT04531618
3387,Healthcare-associated Infections in Severe COVID-19 During 2020,Other: COVID-19,https://ClinicalTrials.gov/show/NCT04819165
3388,Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines,,https://ClinicalTrials.gov/show/NCT04754633
3389,Risk Factors for COVID-19 Mortality,,https://ClinicalTrials.gov/show/NCT04786808
3390,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,Drug: FX06|Drug: Placebo of FX06,https://ClinicalTrials.gov/show/NCT04618042
3391,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,"Other: Maternal attachment, Edinburgh depression scoring and postpartum anxiety scale scores",https://ClinicalTrials.gov/show/NCT04629638
3392,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,Drug: Cholecalciferol,https://ClinicalTrials.gov/show/NCT04502667
3393,Acute Kidney Injury in Patients Hospitalized With COVID-19,,https://ClinicalTrials.gov/show/NCT04316299
3394,The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children,Drug: Azithromycin,https://ClinicalTrials.gov/show/NCT04699097
3395,Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04892888
3396,CORE Study COVID-19,,https://ClinicalTrials.gov/show/NCT04531202
3397,Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,Other: Prone position,https://ClinicalTrials.gov/show/NCT04641182
3398,Psychological Impact of COVID-19 Outbreak on Caregivers,Other: questionnaire filling,https://ClinicalTrials.gov/show/NCT04511780
3399,Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine,"Biological: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.|Biological: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.",https://ClinicalTrials.gov/show/NCT04801888
3400,MISC COVID-19 Study in Pediatric Population,,https://ClinicalTrials.gov/show/NCT04844242
3401,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,Other: Interview,https://ClinicalTrials.gov/show/NCT04387279
3402,"A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",Biological: CVnCoV 6 μg|Biological: CVnCoV 12 μg|Biological: Hepatitis A vaccine|Biological: Pneumococcal vaccine|Biological: CVnCoV 12μg,https://ClinicalTrials.gov/show/NCT04515147
3403,SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY,Diagnostic Test: SARS-CoV-2 PCR and serology tests,https://ClinicalTrials.gov/show/NCT04784403
3404,Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101),,https://ClinicalTrials.gov/show/NCT04883177
3405,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Behavioral: Online support Group,https://ClinicalTrials.gov/show/NCT04379661
3406,Outcomes of Patients With COVID-19 in the Intensive Care Unit,,https://ClinicalTrials.gov/show/NCT04336345
3407,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,Drug: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04392232
3408,Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients ：a Prospective Observational Study,Other: no intervention,https://ClinicalTrials.gov/show/NCT04941079
3409,"Safety of TY027, a Treatment for COVID-19, in Humans",Biological: TY027|Other: 0.9% Saline,https://ClinicalTrials.gov/show/NCT04429529
3410,ACEI or ARB and COVID-19 Severity and Mortality in US Veterans,Drug: ACEI/ARB|Drug: Non-ACEI/ARB|Drug: ACEI|Drug: ARB,https://ClinicalTrials.gov/show/NCT04467931
3411,Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound,"Diagnostic Test: Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",https://ClinicalTrials.gov/show/NCT04756193
3412,ICU Trial in Critical Ill COVID-19 Patients,"Diagnostic Test: Biomarker (TropT, Myoglobin, CK, CK-MB, LDH, D-dimer, CRP, PCT)",https://ClinicalTrials.gov/show/NCT04349982
3413,Is Precariousness a Risk Factor for COVID-19 Mortality in Intensive Care?,Other: No intervention,https://ClinicalTrials.gov/show/NCT04896944
3414,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),Other: Prolonged Proned Positioning|Other: Traditional Proning Arm,https://ClinicalTrials.gov/show/NCT04581811
3415,"Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine",Biological: QazCoVac-P -COVID-19 Subunit Vaccine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04930003
3416,Prediction of Acute Kidney Injury in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04406688
3417,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,Other: Serial seroconversion measurements in hospital employees during the COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04431310
3418,"Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals",Other: Survey,https://ClinicalTrials.gov/show/NCT04492202
3419,Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.,,https://ClinicalTrials.gov/show/NCT04860687
3420,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,Other: Cross-sectional survey,https://ClinicalTrials.gov/show/NCT04653727
3421,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19","Diagnostic Test: Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19",https://ClinicalTrials.gov/show/NCT04378829
3422,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug: hydroxychloroquine in combination with camostat mesylate|Drug: Hydroxychloroquine in combination of Azithromycin,https://ClinicalTrials.gov/show/NCT04355052
3423,The Impact of COVID-19 on Dialysis Users,,https://ClinicalTrials.gov/show/NCT04422873
3424,Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,"Drug: Cannabidiol, pharmaceutically produced with < 5 ppm THC|Drug: Placebo",https://ClinicalTrials.gov/show/NCT04615949
3425,Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients,Drug: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04922944
3426,A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19,Biological: CVnCoV Vaccine,https://ClinicalTrials.gov/show/NCT04838847
3427,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,Biological: High-Titer COVID-19 Convalescent Plasma (HT-CCP)|Biological: Standard Plasma (FFP),https://ClinicalTrials.gov/show/NCT04361253
3428,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,Other: Questionnary,https://ClinicalTrials.gov/show/NCT04385121
3429,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",Biological: NGM621|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04582318
3430,Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,Device: Closed-loop control of oxygen supplementation by O2matic,https://ClinicalTrials.gov/show/NCT04565106
3431,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostic Test: Saliva collection,https://ClinicalTrials.gov/show/NCT04367545
3432,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,Behavioral: Therapy Intervention,https://ClinicalTrials.gov/show/NCT04385901
3433,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,Drug: Cannabidiol|Other: PLACEBO,https://ClinicalTrials.gov/show/NCT04467918
3434,"Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine",Biological: QazCovid-in®-vaccine against COVID-19|Other: Placebo,https://ClinicalTrials.gov/show/NCT04691908
3435,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,,https://ClinicalTrials.gov/show/NCT04365764
3436,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,,https://ClinicalTrials.gov/show/NCT04393233
3437,Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19,Behavioral: Transcendental Meditation (TM)|Behavioral: Experience Resolution Methodology (ERM)|Behavioral: Transcendental Meditation (TM) and Experience Resolution Methodology (ERM)|Behavioral: Treatment As Usual (TAU),https://ClinicalTrials.gov/show/NCT04922632
3438,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,,https://ClinicalTrials.gov/show/NCT04407923
3439,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,Biological: PLX-PAD,https://ClinicalTrials.gov/show/NCT04614025
3440,A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,Procedure: Tracheostomy,https://ClinicalTrials.gov/show/NCT04572438
3441,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04407507
3442,EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia,Other: EEG based protocol for deep sedation,https://ClinicalTrials.gov/show/NCT04699916
3443,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,Biological: Human umbilical cord mesenchymal stem cells + best supportive care|Other: Placebo control + best supportive care,https://ClinicalTrials.gov/show/NCT04452097
3444,Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients,Biological: mRNA-1273 vaccine|Other: Normal Saline Placebo,https://ClinicalTrials.gov/show/NCT04885907
3445,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,Other: Paraclinical examination|Other: Clinical Examination|Other: Semi-directive interview|Other: quality of life questionnaires,https://ClinicalTrials.gov/show/NCT04556513
3446,"Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine",Biological: QazCovid-in® - COVID-19 inactivated vaccine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04530357
3447,Determination of COVID-19 Related Virus in Central Nervous System,Diagnostic Test: Determination of SARS-CoV2 presence in CNS,https://ClinicalTrials.gov/show/NCT04775784
3448,Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,Procedure: Awake Proning,https://ClinicalTrials.gov/show/NCT04350723
3449,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF),Other: Experts consensus,https://ClinicalTrials.gov/show/NCT04534569
3450,Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU,Other: CAM-ICU 7 score|Other: 4C Mortality Score,https://ClinicalTrials.gov/show/NCT04812041
3451,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,Device: Lucira COVID-19 All-In-One test kit,https://ClinicalTrials.gov/show/NCT04720794
3452,Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure,Other: PRONE POSITION,https://ClinicalTrials.gov/show/NCT04853979
3453,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,Drug: Valproate|Drug: Quetiapine|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04513314
3454,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,Drug: Cannabidiol,https://ClinicalTrials.gov/show/NCT04504877
3455,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,Biological: Convalescent plasma|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04380935
3456,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,Drug: Lidocaine 2%|Drug: Control,https://ClinicalTrials.gov/show/NCT04609865
3457,The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19,Biological: MON002,https://ClinicalTrials.gov/show/NCT04805086
3458,Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms,Device: Inspiratory muscle trainer,https://ClinicalTrials.gov/show/NCT04919031
3459,C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.,"Drug: Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins|Drug: Oral low dose steroid|Drug: Intravenous Antibiotics with Low dose steroid.|Drug: Oral anti-coagulant",https://ClinicalTrials.gov/show/NCT04935515
3460,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,Device: COViage,https://ClinicalTrials.gov/show/NCT04423991
3461,Lessening Organ Dysfunction With VITamin C - COVID-19,Drug: Vitamin C|Drug: Control,https://ClinicalTrials.gov/show/NCT04401150
3462,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",Biological: PLX-PAD|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04389450
3463,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",Biological: INO-4800|Device: CELLECTRA® 2000|Other: Saline-sodium citrate (SSC) buffer,https://ClinicalTrials.gov/show/NCT04447781
3464,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug: BMS-986253,https://ClinicalTrials.gov/show/NCT04347226
3465,Obstructive Sleep Apnea & Covid-19 Outcomes,Diagnostic Test: Home Sleep Apnea Testing or In-hospital Polysomnography,https://ClinicalTrials.gov/show/NCT04363333
3466,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Procedure: alveolar recruitment,https://ClinicalTrials.gov/show/NCT04360837
3467,Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug: recombinant human interferon Alpha-1b|Drug: thymosin alpha 1,https://ClinicalTrials.gov/show/NCT04320238
3468,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,Drug: Dose of Tinzaparin or Dalteparin,https://ClinicalTrials.gov/show/NCT04412304
3469,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug: Itolizumab IV infusion|Drug: Best supportive care (BSC),https://ClinicalTrials.gov/show/NCT04475588
3470,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug: Chloroquine or Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04303507
3471,Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19,Other: Psychological support,https://ClinicalTrials.gov/show/NCT04747249
3472,STRESS From in Charge Relative Facing the Announcement of Decisions Limiting or Stopping Treatments in Emergency Room During the COVID-19 Epidemic,"Other: Post traumatic, Anxiety and depression evaluation",https://ClinicalTrials.gov/show/NCT04785807
3473,COVID-19 Stroke Apical Lung Examination Study,,https://ClinicalTrials.gov/show/NCT04640428
3474,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,Drug: Ivermectin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04635943
3475,Psychological Impact of the Covid-19 Pandemic on Student Nurses,,https://ClinicalTrials.gov/show/NCT04402229
3476,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Drug: Unfractionated Heparin IV|Drug: Enoxaparin 1 mg/kg|Drug: Clopidogrel|Drug: Unfractionated heparin SC|Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution,https://ClinicalTrials.gov/show/NCT04409834
3477,Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,Procedure: Lateral Position (left and right lateral decubitus),https://ClinicalTrials.gov/show/NCT04475068
3478,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Other: Retrospective data collection,https://ClinicalTrials.gov/show/NCT04351854
3479,A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19),Drug: PTC299|Other: SOC|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04439071
3480,Covid-19 Vaccine Responsiveness in MM and Waldenstrom,,https://ClinicalTrials.gov/show/NCT04830046
3481,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,Other: Human milk donors,https://ClinicalTrials.gov/show/NCT04453982
3482,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,Other: COVID-19,https://ClinicalTrials.gov/show/NCT04453969
3483,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,,https://ClinicalTrials.gov/show/NCT04611269
3484,Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04769154
3485,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Diagnostic Test: Schirmer Test I,https://ClinicalTrials.gov/show/NCT04346160
3486,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,Other: Mindfulness based intervention,https://ClinicalTrials.gov/show/NCT04555005
3487,Cardiac Performance in Mechanically Ventilated COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04628195
3488,"Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece",Other: DASS questionnaire|Other: EAT-26 questionnaire,https://ClinicalTrials.gov/show/NCT04700254
3489,"Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers",,https://ClinicalTrials.gov/show/NCT04646642
3490,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,Procedure: Prone position,https://ClinicalTrials.gov/show/NCT04407468
3491,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug: Hidroxicloroquina|Drug: Control group,https://ClinicalTrials.gov/show/NCT04330495
3492,COVID-19 Related Lung Ventilation and Perfusion Injury,Other: V/Q SPECT-CT|Other: St. George's Respiratory Questionnaire (SGRQ)|Other: mMRC (Modified Medical Research Council) Dyspnea Scale|Other: Six-minute walk test (6MWT)|Other: Spirometry|Other: Plethysmography & DLCO|Other: Airwave Oscillometry,https://ClinicalTrials.gov/show/NCT04549636
3493,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure: Prone Positioning|Procedure: Standard of care.,https://ClinicalTrials.gov/show/NCT04347941
3494,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Dietary Supplement: Ascorbic Acid|Dietary Supplement: Zinc Gluconate|Dietary Supplement: Ascorbic Acid and Zinc Gluconate|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04342728
3495,SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study,,https://ClinicalTrials.gov/show/NCT04494776
3496,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,Other: Solution-Focused Support Program,https://ClinicalTrials.gov/show/NCT04609722
3497,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04370015
3498,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Device: Cytokine Adsorption,https://ClinicalTrials.gov/show/NCT04361526
3499,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019,Other: Severe Acute Respiratory Syndrome CoronaVirus 2 detection,https://ClinicalTrials.gov/show/NCT04609774
3500,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,Device: HCFWO|Other: Standard Care Plus Monitoring,https://ClinicalTrials.gov/show/NCT04654481
3501,Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19),Drug: Stabilized hypochlorous acid|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04684550
3502,Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19,Drug: Atorvastatin 80mg|Drug: Atorvastatin-Ezetimibe,https://ClinicalTrials.gov/show/NCT04900155
3503,The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors,Other: Quality-of-Life Assessment|Other: Survey Administration,https://ClinicalTrials.gov/show/NCT04551378
3504,NOsocomial Dissemination Risk of SARS-Cov2,,https://ClinicalTrials.gov/show/NCT04339881
3505,Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting,,https://ClinicalTrials.gov/show/NCT04779346
3506,Gene Polymorphism of IL17 and IL 23,Diagnostic Test: laboratory test,https://ClinicalTrials.gov/show/NCT04948515
3507,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Diagnostic Test: Ultrasound lung imaging as part of FAST+ evaluation,https://ClinicalTrials.gov/show/NCT04340479
3508,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,Other: no intervention,https://ClinicalTrials.gov/show/NCT04403009
3509,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,"Drug: Camostat Mesylate|Drug: Microcrystalline Cellulose, NF",https://ClinicalTrials.gov/show/NCT04435015
3510,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Device: Dexcom G6,https://ClinicalTrials.gov/show/NCT04430608
3511,Safety and Immunogenicity of EXG-5003,Biological: EXG-5003|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04863131
3512,COVID19-hematological Malignancies: the Italian Hematology Alliance,,https://ClinicalTrials.gov/show/NCT04352556
3513,Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,Other: Quality-of-Life Assessment|Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04500600
3514,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,,https://ClinicalTrials.gov/show/NCT04375410
3515,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,Biological: UCMSCs|Other: Placebo,https://ClinicalTrials.gov/show/NCT04490486
3516,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure,Procedure: Medical Ozone procedure,https://ClinicalTrials.gov/show/NCT04388514
3517,Rehabilitation for People With COVID-19 in ICU,Other: Pulmonary and Motor Rehabilitation,https://ClinicalTrials.gov/show/NCT04381338
3518,COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C,Other: SARS-CoV-2 and/or MIS-C Exposure,https://ClinicalTrials.gov/show/NCT04588363
3519,Telmisartan in Respiratory Failure Due to COVID-19,Drug: Telmisartan,https://ClinicalTrials.gov/show/NCT04510662
3520,Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination,Other: Biological samples,https://ClinicalTrials.gov/show/NCT04832022
3521,Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).,,https://ClinicalTrials.gov/show/NCT04898166
3522,Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.,,https://ClinicalTrials.gov/show/NCT04934215
3523,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Drug: Dipyridamole 100 Milligram(mg)|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04391179
3524,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,Diagnostic Test: IgG test,https://ClinicalTrials.gov/show/NCT04407143
3525,Rehabilitation in Intensive Care Unit,,https://ClinicalTrials.gov/show/NCT04713540
3526,"Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.",Other: 0.07% cetylpyridinium chloride (CPC) in mouthwash|Other: Distilled water with the same colorant as the experimental product,https://ClinicalTrials.gov/show/NCT04757818
3527,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug: Anakinra,https://ClinicalTrials.gov/show/NCT04357366
3528,"Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study",Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04652505
3529,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Other: Best Practice|Radiation: Low Dose Radiation Therapy,https://ClinicalTrials.gov/show/NCT04433949
3530,Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients,Other: Blood sampling,https://ClinicalTrials.gov/show/NCT04880720
3531,Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC),Biological: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)|Other: Placebo|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04546581
3532,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,Diagnostic Test: PT-PCR test for SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04434261
3533,Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients,Diagnostic Test: mailer-based finger-prick,https://ClinicalTrials.gov/show/NCT04841785
3534,Tomographic Findings in COVID-19 and Influenza,Diagnostic Test: Thoraxic computed tomography,https://ClinicalTrials.gov/show/NCT04497311
3535,WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19,,https://ClinicalTrials.gov/show/NCT04605965
3536,Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly,,https://ClinicalTrials.gov/show/NCT04414319
3537,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,"Diagnostic Test: Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care",https://ClinicalTrials.gov/show/NCT04320017
3538,Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose,Drug: COMIRNATY,https://ClinicalTrials.gov/show/NCT04860739
3539,COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations,Biological: Moderna COVID-19 Vaccine|Biological: Pfizer-BioNTech COVID-19 Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04761822
3540,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,Biological: pathogen reduced SARS-CoV-2 convalescent plasma|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04362176
3541,Outcomes and Prognostic Factors in COVID-19,,https://ClinicalTrials.gov/show/NCT04321265
3542,Convalescent Plasma Therapy - Zurich Protocol,Drug: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04869072
3543,Risk Factors and Computed Tomography Findings in COVID-19.,Diagnostic Test: Simple chest tomography,https://ClinicalTrials.gov/show/NCT04577105
3544,Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden,Other: Autologous stem cell transplantation,https://ClinicalTrials.gov/show/NCT04760184
3545,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,Diagnostic Test: SARS-CoV-2 IgG Antibody Testing Kit,https://ClinicalTrials.gov/show/NCT04334876
3546,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,Drug: CERC-002|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04412057
3547,The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations,Other: Educational video,https://ClinicalTrials.gov/show/NCT04876885
3548,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug: captopril 25mg,https://ClinicalTrials.gov/show/NCT04355429
3549,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Diagnostic Test: Point-of-Care Ultrasonography (POCUS),https://ClinicalTrials.gov/show/NCT04339998
3550,Host-pathogen Interactions During SARS-CoV-2 Infection,Biological: Blood sample|Biological: Low or upper respiratory tract sample|Biological: Stool collection or fecal swab|Genetic: Blood sample for whole genome sequencing|Other: phone call,https://ClinicalTrials.gov/show/NCT04376476
3551,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",Dietary Supplement: Cretan IAMA,https://ClinicalTrials.gov/show/NCT04705753
3552,COVID-19 and the Brain,Biological: Exposure to COVID-19,https://ClinicalTrials.gov/show/NCT04726176
3553,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",Drug: PLN-74809|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04565249
3554,Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia,Other: SePaRIC-Covid19 cohort,https://ClinicalTrials.gov/show/NCT04806867
3555,The C3I COVID-19 Project,,https://ClinicalTrials.gov/show/NCT04506528
3556,COVID-19 in Pain Perspective,,https://ClinicalTrials.gov/show/NCT04454333
3557,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Diagnostic Test: Ejaculated semen sample,https://ClinicalTrials.gov/show/NCT04391829
3558,Early CPAP in COVID-19 Patients With Respiratory Failure.,Device: CPAP treatment,https://ClinicalTrials.gov/show/NCT04326075
3559,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2,Diagnostic Test: Sampling salivary,https://ClinicalTrials.gov/show/NCT04337424
3560,CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN,Other: Educational Program (CARTOON),https://ClinicalTrials.gov/show/NCT04724616
3561,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Drug: DeltaRex-G,https://ClinicalTrials.gov/show/NCT04378244
3562,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",,https://ClinicalTrials.gov/show/NCT04353609
3563,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Other: NHANES smell and taste tests,https://ClinicalTrials.gov/show/NCT04388618
3564,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Drug: Placebo|Drug: Ivermectin|Drug: Losartan,https://ClinicalTrials.gov/show/NCT04447235
3565,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",Radiation: Low Dose Radiation Therapy (LD-RT)|Other: Sham irradiation,https://ClinicalTrials.gov/show/NCT04598581
3566,"A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois",,https://ClinicalTrials.gov/show/NCT04611230
3567,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Drug: ArtemiC|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04382040
3568,Reliability and Validity of the Turkish Version of SMİLE-C,,https://ClinicalTrials.gov/show/NCT04894279
3569,"Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study",Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04893031
3570,BCG Vaccination to Protect Healthcare Workers Against COVID-19,Drug: BCG Vaccine|Drug: 0.9%NaCl,https://ClinicalTrials.gov/show/NCT04327206
3571,"Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis",,https://ClinicalTrials.gov/show/NCT04930978
3572,Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,Biological: Convalescent plasma|Drug: Camostat Mesilate|Drug: Placebo for Camostat Mesilate|Other: Standard of Care (SoC),https://ClinicalTrials.gov/show/NCT04681430
3573,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group,Other: Questionnaire-based observational study,https://ClinicalTrials.gov/show/NCT04477473
3574,Serological Study of the Exposure of Personnel to Sars-cov-2,Diagnostic Test: Sars-Cov-2 serology,https://ClinicalTrials.gov/show/NCT04422977
3575,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),Drug: EIDD-2801|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04405739
3576,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,"Other: Blood tests sputum, nasal lavage and brushing",https://ClinicalTrials.gov/show/NCT04444609
3577,Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2,Other: Data collection|Other: Querying the INSEE database,https://ClinicalTrials.gov/show/NCT04672343
3578,COG-UK Project Hospital-Onset COVID-19 Infections Study,Other: Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures,https://ClinicalTrials.gov/show/NCT04405934
3579,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,https://ClinicalTrials.gov/show/NCT04334512
3580,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",,https://ClinicalTrials.gov/show/NCT04411784
3581,Rutgers COVID-19 Cohort Study,Other: Non-Interventional,https://ClinicalTrials.gov/show/NCT04336215
3582,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,Other: Physiology,https://ClinicalTrials.gov/show/NCT04524156
3583,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,"Procedure: Sphenopalatine Ganglion Block with Local Anesthetic|Procedure: Sphenopalatine Ganglion Block with Placebo (Isotone NaCl)|Procedure: ""Sham""-block with Placebo (Isotone NaCl)",https://ClinicalTrials.gov/show/NCT04636034
3584,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,,https://ClinicalTrials.gov/show/NCT04362995
3585,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug: Lopinavir-Ritonavir|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04386070
3586,The Containing Coronavirus Disease 19 (COVID-19) Trial,Biological: Peginterferon beta-1a,https://ClinicalTrials.gov/show/NCT04552379
3587,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,Drug: Intravenous Immunoglobulin|Other: Standard care,https://ClinicalTrials.gov/show/NCT04261426
3588,The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19,Device: CPAP helmet|Other: Standard of care non-helmet based CPAP ventilation,https://ClinicalTrials.gov/show/NCT04929691
3589,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04624503
3590,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",Biological: BCG vaccine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04461379
3591,Tolerability and Efficacy of RJX in Patients With COVID-19,Drug: Rejuveinix (RJX) Active Comparator|Drug: Placebo Comparator,https://ClinicalTrials.gov/show/NCT04708340
3592,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,Diagnostic Test: a specifically designed self-administered questionnaire,https://ClinicalTrials.gov/show/NCT04354779
3593,Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04690920
3594,Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion,Dietary Supplement: Vitamin D,https://ClinicalTrials.gov/show/NCT04476680
3595,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04487171
3596,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug: Arbidol|Other: basic treatment,https://ClinicalTrials.gov/show/NCT04260594
3597,Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related,Other: Prone position,https://ClinicalTrials.gov/show/NCT04904731
3598,Oropharyngeal Dysphagia in Patients With COVID-19,Diagnostic Test: Swallowing evaluation with the EAT-10 and the volume-viscosity swallowing test (V-VST),https://ClinicalTrials.gov/show/NCT04346212
3599,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug: Anakinra|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04339712
3600,Impact of COVID-19 Pandemic on Depression and Quality of Life,Other: Online survey,https://ClinicalTrials.gov/show/NCT04394078
3601,Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2,,https://ClinicalTrials.gov/show/NCT04698837
3602,Emotional Freedom Technique (EFT) Effect on Nurses,Behavioral: Emotional Freedom Techniques (EFT),https://ClinicalTrials.gov/show/NCT04910516
3603,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug: Abidol hydrochloride|Drug: Oseltamivir|Drug: Lopinavir/ritonavir,https://ClinicalTrials.gov/show/NCT04255017
3604,MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients,Other: Measurement of sublingual microcirculation|Other: Plasma sampling,https://ClinicalTrials.gov/show/NCT04819802
3605,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,Diagnostic Test: Blood tests,https://ClinicalTrials.gov/show/NCT04409899
3606,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,Diagnostic Test: Multicapillary column coupled ion mobility spectrometry,https://ClinicalTrials.gov/show/NCT04547114
3607,"COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program",Other: Pulmonary rehabilitation,https://ClinicalTrials.gov/show/NCT04881214
3608,Cardiovascular Manifestations of COVID-19,"Diagnostic Test: Electrocardiogram, telemetry, echocardiogram, laboratory values",https://ClinicalTrials.gov/show/NCT04335630
3609,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug: ASC09/ritonavir group|Drug: lopinavir/ritonavir group,https://ClinicalTrials.gov/show/NCT04261907
3610,Long-Term Experience and Health Effects of COVID-19,Other: none - observational,https://ClinicalTrials.gov/show/NCT04477902
3611,Clinical Features of COVID-19 Patients,Diagnostic Test: peripheral lymphocytes subsets,https://ClinicalTrials.gov/show/NCT04815304
3612,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug: Abidol hydrochloride|Drug: Abidol Hydrochloride combined with Interferon atomization,https://ClinicalTrials.gov/show/NCT04254874
3613,SingStrong: Strong Lungs Through Song - Long COVID-19 Study,Other: SingStrong: Strong lungs through Song,https://ClinicalTrials.gov/show/NCT04810065
3614,Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE),,https://ClinicalTrials.gov/show/NCT04551690
3615,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,"Diagnostic Test: Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.",https://ClinicalTrials.gov/show/NCT04689399
3616,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,Drug: Chloroquine|Drug: Hydroxychloroquine|Other: standard care,https://ClinicalTrials.gov/show/NCT04420247
3617,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),Biological: Mesenchymal stromal cells|Other: Placebo,https://ClinicalTrials.gov/show/NCT04466098
3618,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Behavioral: Tele-interventions related to diabetes management and mental well-being,https://ClinicalTrials.gov/show/NCT04344210
3619,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Other: COVID-19 Serology|Behavioral: Health Care Worker Survey,https://ClinicalTrials.gov/show/NCT04367857
3620,Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19,Drug: muscle relaxation,https://ClinicalTrials.gov/show/NCT04922814
3621,The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19,Biological: SARS - COV 2 VACCINE,https://ClinicalTrials.gov/show/NCT04932876
3622,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Behavioral: Intervention program,https://ClinicalTrials.gov/show/NCT04394169
3623,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04408235
3624,Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS,Drug: Aviptadil 67μg|Drug: Placebo 0.9% NaCl solution,https://ClinicalTrials.gov/show/NCT04536350
3625,Radiofrequency Intervention in Post COVID-19 Patients,Device: Radiofrequency therapy|Device: Placebo without radiofrequency.,https://ClinicalTrials.gov/show/NCT04920890
3626,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",Drug: AK119|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04516564
3627,The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers,Biological: COVIGEN 0.8 mg ID or Placebo ID|Biological: COVIGEN 2.0 mg IM or Placebo IM|Biological: COVIGEN 4.0 mg IM or Placebo IM,https://ClinicalTrials.gov/show/NCT04742842
3628,The McMaster Multi-Regional COVID-19 Hospital Case Registry,,https://ClinicalTrials.gov/show/NCT04508959
3629,DNA Damage in Critically Ill COVID-19 Patients,Diagnostic Test: COMET ASSAY,https://ClinicalTrials.gov/show/NCT04772703
3630,Study for Novel Coronavirus Pneumonia (NCP),Combination Product: systemic treatment,https://ClinicalTrials.gov/show/NCT04283396
3631,Netizens' Perception of COVID-19 Information & Information Sources.,Other: Electronic Survey questionnaire,https://ClinicalTrials.gov/show/NCT04497441
3632,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04508439
3633,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Device: CT-V,https://ClinicalTrials.gov/show/NCT04320511
3634,Predictors of Respiratory Failure in SARS-Cov-2 Infection,,https://ClinicalTrials.gov/show/NCT04316949
3635,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,Drug: Vitamin C|Drug: Vitamin E|Drug: Melatonin|Drug: N-acetyl cysteine|Drug: Pentoxifylline,https://ClinicalTrials.gov/show/NCT04570254
3636,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,Biological: convalescent plasma,https://ClinicalTrials.gov/show/NCT04356482
3637,Northeast COVID-19 and Pregnancy Study Group,,https://ClinicalTrials.gov/show/NCT04462367
3638,Hearts of Athletes,,https://ClinicalTrials.gov/show/NCT04736004
3639,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",Behavioral: e-Psychotherapy,https://ClinicalTrials.gov/show/NCT04476667
3640,Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients,Other: No intervention / Compare the difference in respiratory rate between H0 and H12 of the initiation of morphine between the control and interventional groups,https://ClinicalTrials.gov/show/NCT04522037
3641,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,Biological: Convalescent Plasma|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04558476
3642,Menstrual Cycle Characteristics of Healthcare Professionals,,https://ClinicalTrials.gov/show/NCT04413058
3643,Psychologic Impact of COVID-19 Pandemic on the Hospital Staff of the Nouvelle Aquitaine Area,Other: self administered questionnaire,https://ClinicalTrials.gov/show/NCT04945837
3644,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),Other: Meditation (1 x 20-minute guided audio training),https://ClinicalTrials.gov/show/NCT04602312
3645,Acute Encephalopathy in Critically Ill Patients With COVID-19,Other: Follow up,https://ClinicalTrials.gov/show/NCT04320472
3646,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,Other: ePROMs assessment,https://ClinicalTrials.gov/show/NCT04816656
3647,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,Other: Best Practice|Drug: Leflunomide|Drug: Placebo Administration,https://ClinicalTrials.gov/show/NCT04532372
3648,"Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP",,https://ClinicalTrials.gov/show/NCT04735588
3649,Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19,Diagnostic Test: Reviewed clinical records and laboratory results,https://ClinicalTrials.gov/show/NCT04883801
3650,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,Other: SARS-Cov-2 infection,https://ClinicalTrials.gov/show/NCT04343053
3651,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,Biological: Mesenchymal stem cell,https://ClinicalTrials.gov/show/NCT04522986
3652,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,Drug: N-acetylcysteine,https://ClinicalTrials.gov/show/NCT04419025
3653,Antibodies Responses to COVID-19 Infection in Hospitalized Patients,Diagnostic Test: Testing procedure for Binding antibodies|Diagnostic Test: Neutralizing antibodies,https://ClinicalTrials.gov/show/NCT04520880
3654,"A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",Drug: BRII-196 and BRII-198|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04691180
3655,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,https://ClinicalTrials.gov/show/NCT04384042
3656,"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications",Other: No intervention,https://ClinicalTrials.gov/show/NCT04535128
3657,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug: Interferon Beta-1B|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04350281
3658,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Other: Best Practice|Biological: Recombinant Interferon Alfa-2b|Drug: Rintatolimod,https://ClinicalTrials.gov/show/NCT04379518
3659,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,,https://ClinicalTrials.gov/show/NCT04362956
3660,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,https://ClinicalTrials.gov/show/NCT04390165
3661,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,Other: dialysis,https://ClinicalTrials.gov/show/NCT04378686
3662,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug: Sirukumab|Drug: Placebo|Other: Standard of Care (SOC),https://ClinicalTrials.gov/show/NCT04380961
3663,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug: ASC09F+Oseltamivir|Drug: Ritonavir+Oseltamivir|Drug: Oseltamivir,https://ClinicalTrials.gov/show/NCT04261270
3664,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",Drug: BRII-198|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04479644
3665,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",Drug: BRII-196|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04479631
3666,Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y),Biological: mRNA-1273,https://ClinicalTrials.gov/show/NCT04748471
3667,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Other: Nasal swab|Other: Taste and olfactory function evaluation,https://ClinicalTrials.gov/show/NCT04366934
3668,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,Device: CT-imaging,https://ClinicalTrials.gov/show/NCT04357938
3669,Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies,,https://ClinicalTrials.gov/show/NCT04878822
3670,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,Procedure: Therapeutic Plasma exchange|Biological: Convalescent Plasma|Drug: Tocilizumab|Drug: Remdesivir|Biological: Mesenchymal stem cell therapy,https://ClinicalTrials.gov/show/NCT04492501
3671,Statin Therapy and COVID-19 Infection,Drug: observational,https://ClinicalTrials.gov/show/NCT04407273
3672,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Other: questionnaire assesment,https://ClinicalTrials.gov/show/NCT04351399
3673,"National Project on Vaccines, COVID-19 and Frail Patients",Biological: COVID-19 vaccines,https://ClinicalTrials.gov/show/NCT04848493
3674,MSCs in COVID-19 ARDS,Biological: Remestemcel-L|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04371393
3675,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug: favipiravir tablets+chloroquine phosphatetablets tablets|Drug: Favipiravir tablets|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04319900
3676,TOFAcitinib in SARS-CoV2 Pneumonia,Drug: Tofacitinib,https://ClinicalTrials.gov/show/NCT04332042
3677,Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study,,https://ClinicalTrials.gov/show/NCT04602260
3678,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04716556
3679,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),Diagnostic Test: carotid-femoral pulse-wave velocity,https://ClinicalTrials.gov/show/NCT04558450
3680,Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia,Device: LUS Twelve area|Device: LUS Fourteen area,https://ClinicalTrials.gov/show/NCT04805684
3681,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?,Other: Case fatality rate,https://ClinicalTrials.gov/show/NCT04468802
3682,Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy,,https://ClinicalTrials.gov/show/NCT04642703
3683,COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases,Biological: Moderna COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04806113
3684,Burden for STaff Working in the NHS,,https://ClinicalTrials.gov/show/NCT04506632
3685,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Biological: blood sampling,https://ClinicalTrials.gov/show/NCT04337190
3686,Covid-19 Anxiety and Phobia Levels of the Parents,"Other: Coronavirus Anxiety Scale , COVID-19 Phobia Scale",https://ClinicalTrials.gov/show/NCT04631172
3687,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,,https://ClinicalTrials.gov/show/NCT04314271
3688,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,https://ClinicalTrials.gov/show/NCT04321616
3689,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,Drug: Enoxaparin|Drug: Methylprednisolone|Drug: unfractionated heparin,https://ClinicalTrials.gov/show/NCT04528888
3690,Clinical Characteristics of Patients With Leukemia and COVID-19,,https://ClinicalTrials.gov/show/NCT04745416
3691,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug: Valsartan (Diovan)|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04335786
3692,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",,https://ClinicalTrials.gov/show/NCT04335773
3693,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,Other: Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2),https://ClinicalTrials.gov/show/NCT04355611
3694,Clinical Use of Stem Cells for the Treatment of Covid-19,Biological: MSC Treatment|Biological: Saline Control,https://ClinicalTrials.gov/show/NCT04392778
3695,Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19,Drug: Trimetazidine,https://ClinicalTrials.gov/show/NCT04760821
3696,"Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test",Other: Group A (Sample Collection)|Other: Group B (Sample Collection)|Diagnostic Test: On-Site Testing (LumiraDx),https://ClinicalTrials.gov/show/NCT04782336
3697,Immune Response and Risk of Serious Infection to SARS-Cov2,Biological: Blood sample collection,https://ClinicalTrials.gov/show/NCT04410432
3698,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,Biological: Collection of blood samples in order to create a biocollection,https://ClinicalTrials.gov/show/NCT04392401
3699,Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,,https://ClinicalTrials.gov/show/NCT04363632
3700,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),,https://ClinicalTrials.gov/show/NCT04376905
3701,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostic Test: Standard screening strategy|Diagnostic Test: New screening strategy,https://ClinicalTrials.gov/show/NCT04281693
3702,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,"Diagnostic Test: Obtainment of nasopharyngeal, oropharyngeal, buccal, nasal and saliva samples",https://ClinicalTrials.gov/show/NCT04468217
3703,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,Drug: Angiotensin II|Drug: Interleukin-1 receptor antagonist,https://ClinicalTrials.gov/show/NCT04408326
3704,Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,Drug: Aviptadil by intravenous infusion + standard of care|Drug: Normal Saline Infusion + standard of care,https://ClinicalTrials.gov/show/NCT04311697
3705,Hip Fracture and COVID-19,Procedure: Hip fracture surgery,https://ClinicalTrials.gov/show/NCT04944329
3706,International SARS-CoV-2 (COVID-19) Infection Observational Study,Other: Data Collection,https://ClinicalTrials.gov/show/NCT04385251
3707,Telerehabilitation After Coronavirus,Other: Aerobic Exercise Training|Behavioral: Patient Education|Other: Respiratory Exercise Training,https://ClinicalTrials.gov/show/NCT04473898
3708,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04263402
3709,External Validation of the CHOD Risk Scale,,https://ClinicalTrials.gov/show/NCT04889261
3710,Risk Stratification of COVID-19 Using Urine Biomarkers,,https://ClinicalTrials.gov/show/NCT04681040
3711,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,Behavioral: Immediate vs. delayed provision of antibody test results,https://ClinicalTrials.gov/show/NCT04620798
3712,Respiratory Syncytial Virus Infection May be More Dangerous in Neonate,,https://ClinicalTrials.gov/show/NCT04531735
3713,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Device: FFP2|Device: Facial mask|Device: MFS,https://ClinicalTrials.gov/show/NCT04375774
3714,Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.,,https://ClinicalTrials.gov/show/NCT04542512
3715,Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients,Drug: Antibiotic,https://ClinicalTrials.gov/show/NCT04674410
3716,Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population,Other: Screening testing strategy|Other: No screening testing strategy,https://ClinicalTrials.gov/show/NCT04875520
3717,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),Drug: Defibrotide,https://ClinicalTrials.gov/show/NCT04530604
3718,Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis,Drug: Nintedanib 150 MG [Ofev]|Other: Placebo,https://ClinicalTrials.gov/show/NCT04541680
3719,Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection,Other: NBI images and/or videos,https://ClinicalTrials.gov/show/NCT04884061
3720,Bacillus Calmette-guérin Vaccination to Prevent COVID-19,Biological: BCG vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04414267
3721,Cardiovascular Implications of COVID-19,,https://ClinicalTrials.gov/show/NCT04435457
3722,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,Other: EPIC risk score display,https://ClinicalTrials.gov/show/NCT04570488
3723,Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis,Drug: Isavuconazonium Injection [Cresemba]|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04707703
3724,COVID-19 in Immunosuppressed Children,,https://ClinicalTrials.gov/show/NCT04511429
3725,COVID-19 Pandemic Burden in Severe Mental Disease Patients,Other: PSS (Perceived Stress Scale)|Other: GAD-7 (7-item Generalized Anxiety Disorder)|Other: PHQ-9 (9-item Patient Health Questionnaire)|Other: SPEQ (Specific Psychotic Experiences Questionnaire) - Paranoia and Grandiosity Subscales|Other: Zaritt Burden Interview,https://ClinicalTrials.gov/show/NCT04357769
3726,Evolution of Facial Trauma During COVID Containment Measures,Procedure: Facial fractures reduction or osteosynthesis,https://ClinicalTrials.gov/show/NCT04355442
3727,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",Drug: Drug: NA-831|Combination Product: NA-831 and Atazanavir|Combination Product: NA-831and Dexamethasone|Combination Product: Atazanavir and Dexamethasone,https://ClinicalTrials.gov/show/NCT04452565
3728,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,,https://ClinicalTrials.gov/show/NCT04384406
3729,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,Drug: Colchicine plus symptomatic treatment (paracetamol)|Drug: Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations),https://ClinicalTrials.gov/show/NCT04416334
3730,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),Drug: Mavrilimumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04397497
3731,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,Behavioral: Lift,https://ClinicalTrials.gov/show/NCT04581200
3732,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",Biological: BCG|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04369794
3733,Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit,,https://ClinicalTrials.gov/show/NCT04872049
3734,Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection,Drug: Placebo|Drug: Nicotinamide riboside,https://ClinicalTrials.gov/show/NCT04818216
3735,Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients,,https://ClinicalTrials.gov/show/NCT04944433
3736,Improving Thinking in Everyday Life After Covid-19,Behavioral: Speed of Processing Training|Behavioral: Instrumental Activities of Daily Living Shaping|Behavioral: Transfer Package from CI Therapy|Other: Usual Care,https://ClinicalTrials.gov/show/NCT04644172
3737,Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia,Drug: Pirfenidone|Drug: Nintedanib,https://ClinicalTrials.gov/show/NCT04856111
3738,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,Other: questionnaire assesment,https://ClinicalTrials.gov/show/NCT04426279
3739,Biomarkers of Trained Immunity Following MMR Vaccination,Diagnostic Test: Heterologous stimuli|Diagnostic Test: Neutralization assay,https://ClinicalTrials.gov/show/NCT04646239
3740,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,Other: PEEP trial,https://ClinicalTrials.gov/show/NCT04350710
3741,Remote Monitoring of Cancer Patients With Suspected Covid-19,Device: Patient Status Engine,https://ClinicalTrials.gov/show/NCT04397705
3742,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",Behavioral: covid-19 positive pregnant women,https://ClinicalTrials.gov/show/NCT04384887
3743,Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias,Other: ILR implantation,https://ClinicalTrials.gov/show/NCT04726150
3744,Home Management of Adult Egyptian Mild COVID-19 Cases,,https://ClinicalTrials.gov/show/NCT04515199
3745,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Behavioral: Observation,https://ClinicalTrials.gov/show/NCT04373109
3746,The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause,Biological: CYP-001,https://ClinicalTrials.gov/show/NCT04537351
3747,Screening of Cancer Patients to Assess Impact of COVID-19,Diagnostic Test: Nasopharyngeal (NP) swab,https://ClinicalTrials.gov/show/NCT04373005
3748,Adaptive Immune Response Against Corona Virus Vaccination,Other: anti-SARS-CoV-2 antibody testing,https://ClinicalTrials.gov/show/NCT04826770
3749,Cross Sectional CFAR HIV/COVID-19 Study,,https://ClinicalTrials.gov/show/NCT04514016
3750,Cardiac Dysfunction in Critically Ill Patients With COVID-19,Diagnostic Test: Echocardiography,https://ClinicalTrials.gov/show/NCT04524234
3751,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Diagnostic Test: nasopharyngeal swab,https://ClinicalTrials.gov/show/NCT04336761
3752,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Biological: Ravulizumab|Other: Best Supportive Care,https://ClinicalTrials.gov/show/NCT04369469
3753,Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction,Other: RT-PCR SARS-COV2 in urine,https://ClinicalTrials.gov/show/NCT04937712
3754,BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization,Drug: Bromhexine and Spironolactone|Drug: Base therapy,https://ClinicalTrials.gov/show/NCT04424134
3755,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,Device: Therapeutic plasma exchange,https://ClinicalTrials.gov/show/NCT04592705
3756,Assessment of Chilbains Occuring During Covid-19 Infection,,https://ClinicalTrials.gov/show/NCT04344119
3757,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,"Other: Serum zinc, vitamin d vitamin b12 levels .",https://ClinicalTrials.gov/show/NCT04407572
3758,ARDS COVID vs ARDS Influenza,Other: no intervention,https://ClinicalTrials.gov/show/NCT04941092
3759,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,,https://ClinicalTrials.gov/show/NCT04401449
3760,Policy Responses Against the COVID-19 Pandemic in Latin America,Other: Social and public health measures against COVID-19|Other: Control,https://ClinicalTrials.gov/show/NCT04816318
3761,Impact of COVID-19 on Lung Cancer Patients,Other: questionnaire and optional interview,https://ClinicalTrials.gov/show/NCT04538456
3762,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,,https://ClinicalTrials.gov/show/NCT04397588
3763,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Biological: Umbilical cord Wharton's jelly-derived human|Other: NaCl 0.9%,https://ClinicalTrials.gov/show/NCT04333368
3764,The Covid-19 HEalth caRe wOrkErS (HEROES) Study,Other: Exposure to the SARS-CoV-2 and its consequences,https://ClinicalTrials.gov/show/NCT04352634
3765,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),,https://ClinicalTrials.gov/show/NCT04401111
3766,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Drug: Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml,https://ClinicalTrials.gov/show/NCT04400799
3767,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Biological: COVID-19 exposure,https://ClinicalTrials.gov/show/NCT04340921
3768,Long Term Outcomes of Patients With COVID-19,Other: Quality of Life|Other: Impact Event Score|Other: Hospital anxiety and depression scale,https://ClinicalTrials.gov/show/NCT04360538
3769,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04435080
3770,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,Device: N-95 Respirator|Device: Cloth Face Mask|Diagnostic Test: Graded exercise test,https://ClinicalTrials.gov/show/NCT04415879
3771,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug: Naltrexone|Drug: Ketamine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04365985
3772,Incidence of Infection and Mortality by COVID-19 in Specialists,Behavioral: Survey,https://ClinicalTrials.gov/show/NCT04828148
3773,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,Device: Soterix taVNS model 0125-LTE Stimulator - Active-Active Group|Device: Soterix taVNS model 0125-LTE Stimulator - Sham-Active Group,https://ClinicalTrials.gov/show/NCT04638673
3774,Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota,Diagnostic Test: Specimen Collection|Diagnostic Test: Surveys,https://ClinicalTrials.gov/show/NCT04473183
3775,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina",,https://ClinicalTrials.gov/show/NCT04738435
3776,Body Composition Study in Critically Ill Patients-Extended to COVID-19,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04849624
3777,Mental Health Consequences of COVID19 Infection in the French RMD Cohort,,https://ClinicalTrials.gov/show/NCT04510467
3778,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",,https://ClinicalTrials.gov/show/NCT04438954
3779,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,,https://ClinicalTrials.gov/show/NCT04371289
3780,Detection of COVID-19 in Saliva Collection,,https://ClinicalTrials.gov/show/NCT04386551
3781,Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis,"Diagnostic Test: Elecsys Anti-SARS-CoV-2 S (Roche Diagnostics GmbH, Mannheim, Germany), 2) ACCESS SARS-CoV-2 IgG II (Beckman Coulter, Inc. USA)",https://ClinicalTrials.gov/show/NCT04871945
3782,"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT",Drug: [18F]FP-R01-MG-F2,https://ClinicalTrials.gov/show/NCT03183570
3783,"Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers",Drug: XC7 100 mg single|Drug: XC7 200 mg single|Drug: Placebo single|Drug: XC7 200 mg multiple|Drug: Placebo multiple,https://ClinicalTrials.gov/show/NCT04679493
3784,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,Drug: Darunavir/Cobicistat|Drug: Lopinavir/Ritonavir,https://ClinicalTrials.gov/show/NCT04425382
3785,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,,https://ClinicalTrials.gov/show/NCT04445259
3786,Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients,Other: Incentive Spirometer/Respiratory Exerciser,https://ClinicalTrials.gov/show/NCT04826731
3787,Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.,,https://ClinicalTrials.gov/show/NCT04916834
3788,Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19,Behavioral: Early Occupational Therapy,https://ClinicalTrials.gov/show/NCT04904497
3789,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04374656
3790,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,Other: Physiotherapy,https://ClinicalTrials.gov/show/NCT04396197
3791,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,Other: it is a survey,https://ClinicalTrials.gov/show/NCT04357418
3792,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Device: COViage,https://ClinicalTrials.gov/show/NCT04390516
3793,ACCESS A Master Digital Surveillance Protocol for COVID-19,,https://ClinicalTrials.gov/show/NCT04363268
3794,HEALthy Brain and Child Development Study - COVID-19 Supplement,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04713150
3795,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,Combination Product: Respiratory rehabilitation,https://ClinicalTrials.gov/show/NCT04382534
3796,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,Behavioral: Remote pulmonary rehabilitation,https://ClinicalTrials.gov/show/NCT04368793
3797,Pediatrics HOT COVID-19 Database in NY Tristate,,https://ClinicalTrials.gov/show/NCT04445402
3798,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",Drug: ACE inhibitor|Drug: ARB,https://ClinicalTrials.gov/show/NCT04367883
3799,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Diagnostic Test: Rapid detection test|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Stool collection,https://ClinicalTrials.gov/show/NCT04413968
3800,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",,https://ClinicalTrials.gov/show/NCT04342806
3801,Psychological State of Students of Health Sciences During COVID-19,Other: Mental health student,https://ClinicalTrials.gov/show/NCT04769284
3802,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,Diagnostic Test: Blood sample,https://ClinicalTrials.gov/show/NCT04425317
3803,Timing of Tracheotomy in Covid-19 Patients,Procedure: Tracheotomy,https://ClinicalTrials.gov/show/NCT04412356
3804,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,Behavioral: Generalized Anxiety Disorder-7 (GAD-7)|Behavioral: Patient Health Questionnaire-9 (PHQ-9),https://ClinicalTrials.gov/show/NCT04395755
3805,Feasibility Study of Hematology Parameters in COVID-19 Disease,Device: CBC-Diff Monocyte Volume Width Distribution,https://ClinicalTrials.gov/show/NCT04816630
3806,Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19,,https://ClinicalTrials.gov/show/NCT04452604
3807,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,,https://ClinicalTrials.gov/show/NCT04344327
3808,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,Device: AirFLO2,https://ClinicalTrials.gov/show/NCT04649775
3809,The Prevalence of Pulmonary Hypertension in Patients With COVID-19.,,https://ClinicalTrials.gov/show/NCT04459364
3810,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug: Hydroxychloroquine Pre-Exposure Prophylaxis|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04352946
3811,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19,Other: pulmonary rehabilitation,https://ClinicalTrials.gov/show/NCT04649918
3812,Effect of Covid-19 Pandemic in Non Covid-19 Patients at the Emergency Surgical Department,Other: surgery,https://ClinicalTrials.gov/show/NCT04900233
3813,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,Dietary Supplement: Nutritional support system (NSS)|Other: Control,https://ClinicalTrials.gov/show/NCT04507867
3814,Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks,Behavioral: Online Social Network and Collective Intelligence Intervention|Behavioral: Independent Control,https://ClinicalTrials.gov/show/NCT04779827
3815,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,Procedure: Elective Cancer Surgery,https://ClinicalTrials.gov/show/NCT04384926
3816,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",Other: Online Survey,https://ClinicalTrials.gov/show/NCT04453566
3817,COVID-19 Testing Sample Acquisition Throughput and Efficiency,Other: Personal Protective Testing Booth,https://ClinicalTrials.gov/show/NCT04532411
3818,Analysis of Mortality of Critically Ill Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04379258
3819,"Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients",,https://ClinicalTrials.gov/show/NCT04560413
3820,Self-prone Positioning for Awake Non-intubated Patients With COVID-19,Procedure: prone position group,https://ClinicalTrials.gov/show/NCT04760561
3821,Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients,Device: Narrow Band ultraviolet B-Band Light|Device: non Narrow Band ultraviolet B-Band Light,https://ClinicalTrials.gov/show/NCT04818970
3822,Psychosocial Outcomes in Families of COVID-19 ICU Patients,Diagnostic Test: HADS questionnaire,https://ClinicalTrials.gov/show/NCT04498507
3823,Renal Biomarkers in AKI and COVID-19,"Diagnostic Test: urinary NGAL, TIMP-2, IGFBP7, IL-6, viral load and metabolomic",https://ClinicalTrials.gov/show/NCT04517630
3824,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19,,https://ClinicalTrials.gov/show/NCT04716023
3825,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,Behavioral: General Communication Message|Behavioral: Focused/Targeted Message|Behavioral: Best Message Alone|Behavioral: Best Message + Augmented Message or Implementation Strategy,https://ClinicalTrials.gov/show/NCT04565509
3826,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",Drug: Kaletra and beta interferon,https://ClinicalTrials.gov/show/NCT04611243
3827,COVID-19 Immune Repertoire Sequencing,,https://ClinicalTrials.gov/show/NCT04368143
3828,"COVID-Impact ""Psychological IMPACT of Covid-19 on AP-HP Staff""",Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04558437
3829,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,,https://ClinicalTrials.gov/show/NCT04397835
3830,Zofin (Organicell Flow) for Patients With COVID-19,Biological: Zofin|Other: Placebo,https://ClinicalTrials.gov/show/NCT04384445
3831,"Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19",Diagnostic Test: Biomarkers of inflammation,https://ClinicalTrials.gov/show/NCT04706533
3832,Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,Behavioral: Questionnaires,https://ClinicalTrials.gov/show/NCT04583345
3833,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,Biological: CAStem,https://ClinicalTrials.gov/show/NCT04331613
3834,Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation,Other: Data record,https://ClinicalTrials.gov/show/NCT04356378
3835,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Other: Infusion placebo,https://ClinicalTrials.gov/show/NCT04345289
3836,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Behavioral: Personalized health education|Behavioral: General health education,https://ClinicalTrials.gov/show/NCT04321928
3837,Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome,Drug: Instilled T3|Other: Placebo Therapy,https://ClinicalTrials.gov/show/NCT04725110
3838,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Other: Patient management suffering of coronavirus infection,https://ClinicalTrials.gov/show/NCT04346810
3839,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Other: ICU Recovery + Physical Therapy,https://ClinicalTrials.gov/show/NCT04412330
3840,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Other: CT score,https://ClinicalTrials.gov/show/NCT04284046
3841,Lung Ultrasound for COVID-19 Initial Triage and Monitoring,Other: thoracic lung ultrasound,https://ClinicalTrials.gov/show/NCT04474236
3842,Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19,Diagnostic Test: 40-Steps-test,https://ClinicalTrials.gov/show/NCT04618835
3843,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,Other: Electronic questionnaire,https://ClinicalTrials.gov/show/NCT04396353
3844,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,Device: SCD,https://ClinicalTrials.gov/show/NCT04395911
3845,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,Device: Helmet Continuous Positive Airway Pressure (CPAP)|Device: High Flow Nasal Oxygen (HFNO),https://ClinicalTrials.gov/show/NCT04381923
3846,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04363827
3847,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,Behavioral: Assessment of work-related stress|Biological: Saliva sample collection|Device: Cardiac and electrodermal recordings|Behavioral: Assessment of behavioral response to emotional stimulation,https://ClinicalTrials.gov/show/NCT04517136
3848,Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT,,https://ClinicalTrials.gov/show/NCT04519255
3849,Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19,,https://ClinicalTrials.gov/show/NCT04513561
3850,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,"Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care|Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine",https://ClinicalTrials.gov/show/NCT04366089
3851,The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs,Diagnostic Test: Physical examination,https://ClinicalTrials.gov/show/NCT04646525
3852,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other: Psychoeducational intervention,https://ClinicalTrials.gov/show/NCT04351789
3853,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,,https://ClinicalTrials.gov/show/NCT04378881
3854,Kidney in Coronavirus Disease 2019 Registry,Other: Retrospective data collection,https://ClinicalTrials.gov/show/NCT04797091
3855,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Other: global survey,https://ClinicalTrials.gov/show/NCT04344197
3856,Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials,Other: Quality-of-Life Assessment|Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04650178
3857,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,,https://ClinicalTrials.gov/show/NCT04352699
3858,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,Diagnostic Test: Questionnaire forms,https://ClinicalTrials.gov/show/NCT04362319
3859,Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19,Drug: Cyproheptadine Hydrochloride 4 MG,https://ClinicalTrials.gov/show/NCT04876573
3860,Mindfulness During COVID-19,Behavioral: Mindfulness session(s),https://ClinicalTrials.gov/show/NCT04319445
3861,LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),Drug: LSALT peptide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04402957
3862,COPE - COVID-19 in Pregnancy and Early Childhood,"Other: biological samples, questionnaires and interviews",https://ClinicalTrials.gov/show/NCT04433364
3863,Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study,Other: therapy group,https://ClinicalTrials.gov/show/NCT04747405
3864,SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer,Biological: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes,https://ClinicalTrials.gov/show/NCT04742595
3865,HIV/COV in Ukraine-NL,,https://ClinicalTrials.gov/show/NCT04711954
3866,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,Other: Feeling Good Digital App,https://ClinicalTrials.gov/show/NCT04449627
3867,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug: Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04363450
3868,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,Drug: Collagen-Polyvinylpyrrolidone,https://ClinicalTrials.gov/show/NCT04517162
3869,Effects of Face Masks on Cardiopulmonary Capacity in Healthy Individuals,"Other: without masks|Other: Surgical face mask (Vheal Med Co., Ltd., Istanbul, Turkey)|Other: FFP2\N95 protective face mask (Musk protective technology, Gaziantep, Turkey)",https://ClinicalTrials.gov/show/NCT04785781
3870,Nebulised Rt-PA for ARDS Due to COVID-19,Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1|Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 IMV|Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 NIV,https://ClinicalTrials.gov/show/NCT04356833
3871,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Other: Clinical data,https://ClinicalTrials.gov/show/NCT04374110
3872,"Characteristics of Patients and Healthcare Workers With COVID-19 in Meta State, Colombia",,https://ClinicalTrials.gov/show/NCT04456426
3873,Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients,Diagnostic Test: Venous blood was collected for biochemistry testing.,https://ClinicalTrials.gov/show/NCT04659200
3874,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,Drug: Colchicine|Drug: Ruxolitinib 5 MG|Drug: Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX]|Other: standard therapy,https://ClinicalTrials.gov/show/NCT04403243
3875,Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease,Other: Inspiratory muscle training group|Other: Inspiratory muscle training placebo group|Other: Inspiratory + expiratory muscle training group|Other: Inspiratory + expiratory muscle training placebo group,https://ClinicalTrials.gov/show/NCT04734561
3876,Anosmia and / or Ageusia and Early Corticosteroid Use,Drug: Early-Dexamethasone|Drug: Late dexamethazone,https://ClinicalTrials.gov/show/NCT04528329
3877,Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies,,https://ClinicalTrials.gov/show/NCT04694573
3878,Seroprevalence of SARS-Cov-2 Antibodies in Children,Diagnostic Test: Covid-19 Antibody testing (IgG and IgM),https://ClinicalTrials.gov/show/NCT04347408
3879,Advanced Endoscopy During COVID-19,Other: Endoscopic management according to standard of care,https://ClinicalTrials.gov/show/NCT04385147
3880,Serology to Covid for Recording Exposures and Evaluating Needs,Diagnostic Test: SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04566965
3881,The COGCOV Study in ICU Patients,Behavioral: Neurocognitive assessment,https://ClinicalTrials.gov/show/NCT04593069
3882,"Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas",Other: MRI,https://ClinicalTrials.gov/show/NCT04448054
3883,Surgery and Lung Ultrasound in COVID-19 Infection,Diagnostic Test: Lung ultrasound,https://ClinicalTrials.gov/show/NCT04661631
3884,The Effectiveness of Phytotherapy in SARS-COV2(COVID-19),Drug: Quercetin,https://ClinicalTrials.gov/show/NCT04851821
3885,A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients,Other: Lung Ultrasound (LUS),https://ClinicalTrials.gov/show/NCT04692779
3886,National Survey on the Lockdown of Children With Disabilities,,https://ClinicalTrials.gov/show/NCT04395833
3887,Randomized Open Investigation Determining Steroid Dose,Drug: Weight-based dexamethasone dose,https://ClinicalTrials.gov/show/NCT04834375
3888,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",Drug: Fostamatinib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04629703
3889,Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery,Other: pre-operative screening|Other: telephone consult,https://ClinicalTrials.gov/show/NCT04449783
3890,COVID-19 Convalescent Plasma,Biological: anti-SARS-CoV-2 convalescent plasma,https://ClinicalTrials.gov/show/NCT04340050
3891,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug: Hyperbaric oxygen,https://ClinicalTrials.gov/show/NCT04327505
3892,Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications,,https://ClinicalTrials.gov/show/NCT04432350
3893,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,,https://ClinicalTrials.gov/show/NCT04655612
3894,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug: BAT + Calcifediol|Drug: BAT,https://ClinicalTrials.gov/show/NCT04366908
3895,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period,Diagnostic Test: Hospital Anxiety Depression Scale,https://ClinicalTrials.gov/show/NCT04698044
3896,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,Behavioral: Behaviour Change Technique Intervention to Improve Quality of Life,https://ClinicalTrials.gov/show/NCT04522128
3897,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Diagnostic Test: Diagnostic examination for venous thromboembolism,https://ClinicalTrials.gov/show/NCT04400877
3898,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,Diagnostic Test: CLIA of IgG and IgM against SARS-Cov-2,https://ClinicalTrials.gov/show/NCT04410471
3899,"Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada",Other: No intervention,https://ClinicalTrials.gov/show/NCT04913948
3900,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,Other: venous ultrasound|Other: blood sample,https://ClinicalTrials.gov/show/NCT04366752
3901,COVID-19 Infection and Fetal-neonatal Outcomes,Diagnostic Test: Covid-19 positive,https://ClinicalTrials.gov/show/NCT04699578
3902,Smell in Covid-19 and Efficacy of Nasal Theophylline,Drug: Theophylline Powder,https://ClinicalTrials.gov/show/NCT04789499
3903,PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis,,https://ClinicalTrials.gov/show/NCT04513847
3904,Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection,Drug: Nitazoxanide and Ciclésonide|Drug: Telmisartan 20Mg Oral Tablet|Drug: Paracetamol,https://ClinicalTrials.gov/show/NCT04920838
3905,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Other: prone position,https://ClinicalTrials.gov/show/NCT04363463
3906,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,Other: web based survey,https://ClinicalTrials.gov/show/NCT04448418
3907,Obesity and Mortality of Critically Ill Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04425213
3908,Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04500652
3909,CCP Cancer UK Companion Study,,https://ClinicalTrials.gov/show/NCT04603105
3910,Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19,Drug: ADM03820|Other: Placebo,https://ClinicalTrials.gov/show/NCT04592549
3911,French Single Centre Experience of Critically Ill Patients With Covid 19,,https://ClinicalTrials.gov/show/NCT04354558
3912,Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit,Other: Pain and neuropsychological questionnaires|Diagnostic Test: Quantitative Sensory testing,https://ClinicalTrials.gov/show/NCT04940208
3913,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.,Diagnostic Test: Thoracic CT Scan,https://ClinicalTrials.gov/show/NCT04339686
3914,Assessment of the Psycho-social Impact of COVID-19 Outbreak,Behavioral: COM-COVID anonimous survey,https://ClinicalTrials.gov/show/NCT04378452
3915,"Phase 1 Study to Assess Safety, Reactogenicity and Immunogenicity of the HDT-301 Vaccine Against COVID-19",Biological: Cohort 1 HDT 301 vaccine|Biological: Cohort 2 HDT 301 vaccine|Biological: Cohort 3 HDT 301 vaccine,https://ClinicalTrials.gov/show/NCT04844268
3916,Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19,Other: 6-min-walk surgical mask|Other: 6-min-walk Fpp2|Other: 6-min-walk without mask,https://ClinicalTrials.gov/show/NCT04789603
3917,Pathological Findings of Fatal COVID-19,Other: 2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,https://ClinicalTrials.gov/show/NCT04675281
3918,Mental Health Outcomes in Healthcare Workers During COVID-19,,https://ClinicalTrials.gov/show/NCT04397848
3919,Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus,Diagnostic Test: RT-PCR for SARS-Cov-2,https://ClinicalTrials.gov/show/NCT04925908
3920,"Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study",Diagnostic Test: Antibodies testing,https://ClinicalTrials.gov/show/NCT04839913
3921,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,Drug: AVM0703|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04366115
3922,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Other: Simulation of Repurposed Drugs for COVID-19,https://ClinicalTrials.gov/show/NCT04339634
3923,Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2),Drug: Dornase Alfa Inhalation Solution,https://ClinicalTrials.gov/show/NCT04402970
3924,"COVID-19, bLOod Coagulation and Thrombosis",Diagnostic Test: Echo-Doppler,https://ClinicalTrials.gov/show/NCT04388657
3925,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Other: There is no intervention in this study,https://ClinicalTrials.gov/show/NCT04359836
3926,MYocardial DOmmages Related to COVID-19,Biological: Biological data|Other: Clinical data,https://ClinicalTrials.gov/show/NCT04498065
3927,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),Other: EIT-Group|Other: ARDSNet,https://ClinicalTrials.gov/show/NCT04497454
3928,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;,Other: quesionnair,https://ClinicalTrials.gov/show/NCT04351568
3929,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Procedure: Prone Positioning (PP),https://ClinicalTrials.gov/show/NCT04402879
3930,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,Drug: Immunoglobulin of cured patients|Drug: γ-Globulin,https://ClinicalTrials.gov/show/NCT04264858
3931,COVID-19 Vaccine and Impact on Fertility Study,,https://ClinicalTrials.gov/show/NCT04665258
3932,Effect of COVID-19 Pandemic on Vaccination Compliance,Other: vaccine,https://ClinicalTrials.gov/show/NCT04618796
3933,Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19,Device: Robotic assisted early mobilization,https://ClinicalTrials.gov/show/NCT04750265
3934,Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial,Drug: Cyproheptadine Hydrochloride 4 MG,https://ClinicalTrials.gov/show/NCT04820751
3935,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),Drug: L-ascorbic acid|Other: Placebo,https://ClinicalTrials.gov/show/NCT04344184
3936,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,Drug: glenzocimab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04659109
3937,Remdesivir Efficacy in Coronavirus Disease,Drug: Remdesivir|Other: Standard of care treatment,https://ClinicalTrials.gov/show/NCT04345419
3938,Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study,Drug: methylprednisolone,https://ClinicalTrials.gov/show/NCT04847687
3939,The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome,Procedure: A survey form was applied to individuals included in the study face-to-face.,https://ClinicalTrials.gov/show/NCT04912934
3940,"Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic COVID-19 Patients. Prospective Cohort Study.",Device: Oxygen Hood,https://ClinicalTrials.gov/show/NCT04407260
3941,Covid-19 Pandemic and Cerebral Palsy,,https://ClinicalTrials.gov/show/NCT04686565
3942,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Other: Invasive mechanical ventilation,https://ClinicalTrials.gov/show/NCT04411459
3943,Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients,Drug: Imatinib Mesylate intravenous solution|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04794088
3944,COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry,Other: Transthoracic echocardiogram (TTE)|Other: Cardiovascular Magnetic Resonance (CMR) Imaging,https://ClinicalTrials.gov/show/NCT04661657
3945,COVID-19 (SARS-CoV-2) in Urine and Semen,Diagnostic Test: SARS-CoV 2 RNA PCR Urine|Diagnostic Test: SARS-CoV 2 RNA PCR Semen|Diagnostic Test: Semen Qualitative Analysis|Diagnostic Test: IIEF-5 questionnaire|Diagnostic Test: Male Sexual Health Questionnaire (MSHQ)|Diagnostic Test: IPSS questionnaire|Diagnostic Test: SECRET questionnaire|Diagnostic Test: Interleukin assessment in semen,https://ClinicalTrials.gov/show/NCT04446169
3946,Anti-Androgen Treatment for COVID-19,Drug: Proxalutamide|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04446429
3947,Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP),Behavioral: Antimicrobial stewardship prospective audit and feedback,https://ClinicalTrials.gov/show/NCT04896866
3948,"Covid-19, Acute Myocardial Infarctions and Strokes in France",,https://ClinicalTrials.gov/show/NCT04542083
3949,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,Dietary Supplement: Viusid and Asbrip,https://ClinicalTrials.gov/show/NCT04407182
3950,Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations,Other: Dissemination and Implementation Research,https://ClinicalTrials.gov/show/NCT04870307
3951,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,Dietary Supplement: Lactoferrin (Apolactoferrin)|Drug: Placebo of excipient(s) will be administered,https://ClinicalTrials.gov/show/NCT04412395
3952,User Experience of the OSR M-1,,https://ClinicalTrials.gov/show/NCT04733677
3953,"A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine",Biological: UB-612|Other: Placebo,https://ClinicalTrials.gov/show/NCT04683224
3954,Modulation of Gut Microbiota to Enhance Health and Immunity,Dietary Supplement: Microbiome immunity formula|Dietary Supplement: Active placebo,https://ClinicalTrials.gov/show/NCT04884776
3955,Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year,,https://ClinicalTrials.gov/show/NCT04910971
3956,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,,https://ClinicalTrials.gov/show/NCT04415359
3957,Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System,Biological: BNT162b2|Biological: Other vaccine against SARS-Cov-2,https://ClinicalTrials.gov/show/NCT04743388
3958,Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell,Behavioral: Smell Training,https://ClinicalTrials.gov/show/NCT04710394
3959,Evaluation of Allied Healthcare in Patients Recovering From COVID-19,Other: Patients recovering from COVID19 receive usual care by allied health professionals,https://ClinicalTrials.gov/show/NCT04735744
3960,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug: Aspirin 81 mg|Dietary Supplement: Vitamin D,https://ClinicalTrials.gov/show/NCT04363840
3961,Electrolyte State in Patients With COVID-19,Other: electrolytes,https://ClinicalTrials.gov/show/NCT04539834
3962,Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment,Drug: Dapsone 100 MG,https://ClinicalTrials.gov/show/NCT04918914
3963,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,Other: Non-interventional,https://ClinicalTrials.gov/show/NCT04405232
3964,Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups,Other: Shorter duration higher frequency PT|Other: Standard PT,https://ClinicalTrials.gov/show/NCT04844307
3965,Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,Drug: Immunosuppressive Agents,https://ClinicalTrials.gov/show/NCT04568421
3966,Pediatric Intensive Care and COVID-19,,https://ClinicalTrials.gov/show/NCT04544878
3967,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug: Hydroxychloroquine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04332991
3968,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,"Diagnostic Test: COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support|Other: Telemedicine",https://ClinicalTrials.gov/show/NCT04348864
3969,"COVID-19, Aging, and Cardiometabolic Risk Factors Study",,https://ClinicalTrials.gov/show/NCT04802044
3970,Tomographic Findings in COVID-19 and Influenza H1N1,Diagnostic Test: Lung CT,https://ClinicalTrials.gov/show/NCT04499378
3971,A Retrospective Study of COVID-19 Treatments,Other: No Intervention Used,https://ClinicalTrials.gov/show/NCT04949230
3972,Glycaemia and Cardiac Function in Patients With COVID-19,Other: Glycaemic levels,https://ClinicalTrials.gov/show/NCT04410718
3973,Safety and Tolerability Study of IV ST266 in COVID-19 Subjects,Biological: ST266,https://ClinicalTrials.gov/show/NCT04720378
3974,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,,https://ClinicalTrials.gov/show/NCT04431869
3975,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",,https://ClinicalTrials.gov/show/NCT04366219
3976,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,Drug: Nebulised heparin,https://ClinicalTrials.gov/show/NCT04511923
3977,Evaluation of Sedation in COVID-19 ARDS,Other: Treatment group,https://ClinicalTrials.gov/show/NCT04667936
3978,AKI Biomarkers in Coronavirus(COVID)-19,,https://ClinicalTrials.gov/show/NCT04408248
3979,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug: Angiotensin 1-7|Drug: Placebos,https://ClinicalTrials.gov/show/NCT04332666
3980,Influence Physical Activity Psychological Responses COVID-19 Pandemic,Other: Online Survey,https://ClinicalTrials.gov/show/NCT04352517
3981,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,Drug: Zotatifin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04632381
3982,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,Other: risk factors,https://ClinicalTrials.gov/show/NCT04378582
3983,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),Drug: Hydroxychloroquine Only Product in Oral Dose Form,https://ClinicalTrials.gov/show/NCT04400019
3984,Endothelial Damage and Angiogenesis Biomarkers During COVID-19,Diagnostic Test: Endothelial damage and angiogenic biomarkers,https://ClinicalTrials.gov/show/NCT04609332
3985,The New Silicone N99 Half-Piece Respirator,Device: Fit test|Device: Filtration Test,https://ClinicalTrials.gov/show/NCT04454606
3986,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,Drug: agenT-797,https://ClinicalTrials.gov/show/NCT04582201
3987,Survival Rates and Longterm Outcomes After COVID-19,Other: ICU treatment,https://ClinicalTrials.gov/show/NCT04601090
3988,Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic,,https://ClinicalTrials.gov/show/NCT04852757
3989,Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic,Other: No Intervention,https://ClinicalTrials.gov/show/NCT04720118
3990,Home-based Care and Hand Hygiene Interventions in Honduras,Other: Phone-based monitoring|Other: In-person monitoring|Other: Oxygen saturation monitoring|Other: Alcohol-based hand sanitizer,https://ClinicalTrials.gov/show/NCT04886414
3991,Convalescent Plasma for Patients With COVID-19: A Pilot Study,Drug: Plasma,https://ClinicalTrials.gov/show/NCT04332380
3992,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Other: observational,https://ClinicalTrials.gov/show/NCT04323787
3993,Anakinra in the Management of COVID-19 Infection,Drug: Anakinra|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04643678
3994,"COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring",Biological: Vaccine anti-Covid19,https://ClinicalTrials.gov/show/NCT04844632
3995,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",Drug: Single high dose vitamin D|Drug: Placebo|Drug: Treatment as usual vitamin D,https://ClinicalTrials.gov/show/NCT04525820
3996,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,Device: Doctor Spot,https://ClinicalTrials.gov/show/NCT04452695
3997,The COVID-ICU Healthcare Professional Study,Behavioral: Views and experiences of health care professionals working in intensive care units during the COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04372056
3998,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Device: Nitric Oxide delivered via LungFit™ system,https://ClinicalTrials.gov/show/NCT04397692
3999,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),Other: rapid serological test,https://ClinicalTrials.gov/show/NCT04492410
4000,A Study on the Prospective Cohort Library of COVID-19 in Southeran,,https://ClinicalTrials.gov/show/NCT04342702
4001,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Other: ICU treatment,https://ClinicalTrials.gov/show/NCT04357275
4002,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Diagnostic Test: CAG length <22|Diagnostic Test: CAG length >=22,https://ClinicalTrials.gov/show/NCT04368897
4003,Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic,Other: Physical exercise|Other: Physical exercise and computerized cognitive training,https://ClinicalTrials.gov/show/NCT04842734
4004,Evaluation of the Psychosocial Impact on Health Professionals Exposed During COVID 19 Coronavirus Pandemic,,https://ClinicalTrials.gov/show/NCT04752839
4005,COVID-19 Associated Coagulopathy in Egypt,,https://ClinicalTrials.gov/show/NCT04507230
4006,Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),,https://ClinicalTrials.gov/show/NCT04610515
4007,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),Drug: Oral-B Mouth Sore mouthwash|Drug: Crest Pro-Health Multi-Protection mouthwash|Drug: CloSYS Ultra Sensitive Rinse mouthwash|Drug: Distilled water|Drug: Listerine Zero Mouthwash Product,https://ClinicalTrials.gov/show/NCT04409873
4008,Neurocognitive Impairment in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04359914
4009,Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration,Diagnostic Test: IgM and IgG antibodies assay,https://ClinicalTrials.gov/show/NCT04627623
4010,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,Biological: Umbilical Cord Lining Stem Cells (ULSC)|Other: Placebo (carrier control),https://ClinicalTrials.gov/show/NCT04494386
4011,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Behavioral: Daily Coping Toolkit,https://ClinicalTrials.gov/show/NCT04398277
4012,COVID-19 and Psycological Well-being in Healthcare Workers,Behavioral: well-being assessment,https://ClinicalTrials.gov/show/NCT04890600
4013,Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients,Drug: Recombinant human interferon α1β,https://ClinicalTrials.gov/show/NCT04293887
4014,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04396210
4015,International Study of Inflammation in COVID-19,"Diagnostic Test: SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase",https://ClinicalTrials.gov/show/NCT04818866
4016,Glycine Supplement for Severe COVID-19,Dietary Supplement: Glycine,https://ClinicalTrials.gov/show/NCT04443673
4017,"Feasibility, of Tele-rehabilitation Following COVID-19",Other: Tele-Pulmonary rehabilitation,https://ClinicalTrials.gov/show/NCT04511962
4018,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil],https://ClinicalTrials.gov/show/NCT04384380
4019,Convalescent Plasma Therapy for COVID-19 Patients,Biological: convalescent plasma,https://ClinicalTrials.gov/show/NCT04565197
4020,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Device: Cordio App,https://ClinicalTrials.gov/show/NCT04325048
4021,A Study of a Candidate COVID-19 Vaccine (COV001),Biological: ChAdOx1 nCoV-19|Biological: MenACWY|Biological: ChAdOx1 nCoV-19 full boost|Biological: ChAdOx1 nCoV-19 half boost|Biological: MenACWY boost|Drug: Paracetamol|Biological: ChAdOx1 nCoV-19 0.5mL boost|Biological: ChAdOx1 nCoV-19 0.5mL (3.5-6.5x10^10vp) late vaccine (LV)|Biological: ChAdOx1 nCoV-19 0.5mL (3.5-6.5x10^10vp) late vaccine two (LVT),https://ClinicalTrials.gov/show/NCT04324606
4022,The Impact of Camostat Mesilate on COVID-19 Infection,Drug: Camostat Mesilate|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04321096
4023,Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors,Other: Face-to-face rehabilitation|Other: Telerehabilitation,https://ClinicalTrials.gov/show/NCT04767477
4024,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04334148
4025,The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia,,https://ClinicalTrials.gov/show/NCT04686578
4026,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),https://ClinicalTrials.gov/show/NCT04324528
4027,Psychological Impact of COVID-19 Pandemic in Healthcare Workers,Diagnostic Test: Psychological stress and adaptation at work score (PSAS),https://ClinicalTrials.gov/show/NCT04506515
4028,Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt,Biological: Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04816942
4029,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug: Chloroquine Diphosphate|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04342650
4030,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,Drug: High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma,https://ClinicalTrials.gov/show/NCT04374565
4031,Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19,Drug: azoximer bromide|Other: Placebo,https://ClinicalTrials.gov/show/NCT04381377
4032,Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04605692
4033,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Drug: Tocilizumab|Other: Standard of care|Procedure: Continuous renal replacement therapy,https://ClinicalTrials.gov/show/NCT04306705
4034,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug: DAS181|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04298060
4035,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,,https://ClinicalTrials.gov/show/NCT04397237
4036,The Effect of Laughter Therapy on Students in the COVID-19 Pandemic,Other: Laughter Theraphy,https://ClinicalTrials.gov/show/NCT04786483
4037,The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,Device: The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19,https://ClinicalTrials.gov/show/NCT04632719
4038,Risk Perception Associated With Covid-19 Among Anesthetists,Behavioral: Survey,https://ClinicalTrials.gov/show/NCT04861272
4039,Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19,Drug: USB002|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04778059
4040,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",Drug: Plasma|Drug: Standard Therapy,https://ClinicalTrials.gov/show/NCT04332835
4041,Mental Health of Professionals Working in Pediatric Intensive Care Units During the COVID-19 Pandemic,Other: Web-based survey,https://ClinicalTrials.gov/show/NCT04846907
4042,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),Biological: NasoVAX|Other: Placebo,https://ClinicalTrials.gov/show/NCT04442230
4043,Sevoflurane in COVID-19 ARDS (SevCov),Drug: Sevoflurane|Drug: Intravenous drug,https://ClinicalTrials.gov/show/NCT04355962
4044,KIDney Injury in Times of COVID-19 (KIDCOV),Other: Urine Collection,https://ClinicalTrials.gov/show/NCT04705766
4045,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Other: Thrombin generation test assay|Other: Fibrin generation markers assays,https://ClinicalTrials.gov/show/NCT04356950
4046,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Device: AirGo Respiratory Monitor,https://ClinicalTrials.gov/show/NCT04356443
4047,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19","Drug: Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets|Other: Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets|Other: Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.",https://ClinicalTrials.gov/show/NCT04425863
4048,Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19),Drug: Silmitasertib,https://ClinicalTrials.gov/show/NCT04668209
4049,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug: Selinexor|Other: Placebo,https://ClinicalTrials.gov/show/NCT04349098
4050,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Diagnostic Test: NG test|Diagnostic Test: Blood test|Behavioral: Self-questionnary,https://ClinicalTrials.gov/show/NCT04416308
4051,Tocilizumab in COVID-19 Lahore General Hospital,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04560205
4052,Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19,,https://ClinicalTrials.gov/show/NCT04791085
4053,"Post-traumatic Stress, Signs of Depression and Burnout Syndrome Among Nursing Home Staff in Occitanie During the COVID-19 Pandemic",Other: Cognitive tests,https://ClinicalTrials.gov/show/NCT04916275
4054,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",Drug: Hydroxychloroquine Sulfate Tablets|Drug: Lopinavir/ Ritonavir Oral Tablet|Drug: Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04403100
4055,FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context,Diagnostic Test: FilmArray PCR on respiratory samples,https://ClinicalTrials.gov/show/NCT04453540
4056,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,Biological: blood tests|Biological: Nasopharyngeal swabs|Biological: Stools,https://ClinicalTrials.gov/show/NCT04584541
4057,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),,https://ClinicalTrials.gov/show/NCT04354818
4058,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug: Budesonide Nasal|Other: Physiological serum,https://ClinicalTrials.gov/show/NCT04361474
4059,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,Behavioral: RECHARGE|Behavioral: Self Study,https://ClinicalTrials.gov/show/NCT04531774
4060,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir,https://ClinicalTrials.gov/show/NCT04376814
4061,Assessment of Immune Response After Vaccination Against COVID-19 in Dialyzed Patients,Diagnostic Test: Venous blood collection,https://ClinicalTrials.gov/show/NCT04905862
4062,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04169542
4063,The Impact of COVID-19 Pandemic on Cancer Care,Other: survey,https://ClinicalTrials.gov/show/NCT04382495
4064,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug: Emtricitabine/tenofovir disoproxil|Drug: Hydroxychloroquine|Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo|Drug: Placebo: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04334928
4065,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,Biological: BCG-Denmark|Biological: Saline,https://ClinicalTrials.gov/show/NCT04373291
4066,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",Diagnostic Test: Antibody testing for SARS-CoV-2 IgG|Diagnostic Test: Testing for SARS-CoV-2 RNA|Diagnostic Test: Testing for SARS-CoV-2 IgM/IgG,https://ClinicalTrials.gov/show/NCT04718220
4067,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,Other: observation of covid 19 pneumonia,https://ClinicalTrials.gov/show/NCT04408378
4068,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Other: telehealth applications,https://ClinicalTrials.gov/show/NCT04337788
4069,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)|Behavioral: SHG,https://ClinicalTrials.gov/show/NCT04431856
4070,Observational Maternal COVID-19 Vaccination Study,Other: Observational,https://ClinicalTrials.gov/show/NCT04826640
4071,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19),,https://ClinicalTrials.gov/show/NCT04458337
4072,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia,Other: The study does not required,https://ClinicalTrials.gov/show/NCT04584424
4073,"Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation",Diagnostic Test: Physiological testing,https://ClinicalTrials.gov/show/NCT04859894
4074,A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC,Biological: COVIVAC|Biological: Phosphate-buffered saline,https://ClinicalTrials.gov/show/NCT04830800
4075,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04652648
4076,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug: Nintedanib 150 MG|Other: Placebo,https://ClinicalTrials.gov/show/NCT04338802
4077,"COVID-19, Obesity and Lifestyle in Children",Other: Exposure to the Dutch measures due to the Covid-19 pandemic.,https://ClinicalTrials.gov/show/NCT04411511
4078,Impact of the COVID-19 Pandemic in Gynecological Oncology,Other: modification of the planned therapeutic management,https://ClinicalTrials.gov/show/NCT04351139
4079,Coronavirus: Ventilator Outcomes Using Artificial Intelligence Chest Radiographs & Other Evidence-based Co-variates,,https://ClinicalTrials.gov/show/NCT04855539
4080,MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC,Procedure: laparoscopic or open appendicectomy,https://ClinicalTrials.gov/show/NCT04615728
4081,"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers",Device: nasal spray,https://ClinicalTrials.gov/show/NCT04681001
4082,TARGet Kids! COVID-19 Study of Children and Families,,https://ClinicalTrials.gov/show/NCT04449978
4083,Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine,Diagnostic Test: Immunoglobulin G detection,https://ClinicalTrials.gov/show/NCT04843917
4084,Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France,Other: Teleconsultation|Other: Outpatient clinic,https://ClinicalTrials.gov/show/NCT04934202
4085,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",Drug: Remimazolam,https://ClinicalTrials.gov/show/NCT04611425
4086,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,,https://ClinicalTrials.gov/show/NCT04343664
4087,A Trial Among HealthCare Workers (HCW) Vaccinated With Janssen Vaccine: the SWITCH Trial,Biological: Vaccination once with Janssen vaccine (only priming)|Biological: Vaccination with Janssen vaccine followed with Janssen vaccine (homologous boosting).|Biological: Vaccination with Janssen vaccine followed with Moderna vaccine (heterologous boosting).|Biological: Vaccination with Janssen vaccine followed with Pfizer vaccine (heterologous boosting).,https://ClinicalTrials.gov/show/NCT04927936
4088,Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris,"Other: Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)",https://ClinicalTrials.gov/show/NCT04918160
4089,Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs,Drug: Xylocaine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04901065
4090,"REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)","Behavioral: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)|Other: Comparator",https://ClinicalTrials.gov/show/NCT04664101
4091,Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products,Drug: Colgate Total Clean Mint|Drug: Tom's Botanically Bright Peppermint,https://ClinicalTrials.gov/show/NCT04864925
4092,The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus,Diagnostic Test: 6-minute walk test|Diagnostic Test: Incremental shuttle walk test,https://ClinicalTrials.gov/show/NCT04864132
4093,Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning,,https://ClinicalTrials.gov/show/NCT04855162
4094,Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs,Diagnostic Test: Nasopharyngeal swab for COVID-19 testing,https://ClinicalTrials.gov/show/NCT04840082
4095,CORONA in the Saarland,Diagnostic Test: Cytokine measurements,https://ClinicalTrials.gov/show/NCT04837755
4096,Adhesive Tape Placement on Patients' Masks in the ED Increases Compliance of Proper Face Mask Use,Device: Tape Face Mask,https://ClinicalTrials.gov/show/NCT04812184
4097,Implementation of SARS-CoV Testing Strategies in Community Health Centers,Other: RADx CHCs testing intervention strategy|Other: Usual care control,https://ClinicalTrials.gov/show/NCT04802187
4098,The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load,Drug: Distilled Water|Drug: 1% Povidone Iodine (PVP-I)|Drug: 1.5% Hydrogen Peroxide (H2O2)|Drug: 0.075% Cetylpyridinium Chloride (CPC)|Drug: 0.1% Sodium Hypochlorite,https://ClinicalTrials.gov/show/NCT04721457
4099,ABC Science Collaborative Registry Study,,https://ClinicalTrials.gov/show/NCT04781218
4100,Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children,Device: Ultrasound using the telerobotic Melody system,https://ClinicalTrials.gov/show/NCT04776174
4101,Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt,Drug: Sofosbuvir 400 MG/ Daclatasvir 60mg,https://ClinicalTrials.gov/show/NCT04773756
4102,Evaluating Bubble-PAPR for Healthcare Workers,Other: Staff will wear and evaluate Bubble-PAPR (non-CE marked PAPR),https://ClinicalTrials.gov/show/NCT04681365
4103,"Occupational Balance, Fear and Agoraphobia",Other: this study is not an intervention study,https://ClinicalTrials.gov/show/NCT04681261
4104,Evaluation of Aerosol in a Dental Clinic,Device: High volume evacuation (HVE)|Device: Extraoral vacuum aspirator (EVA)|Device: External evacuation device (EED)|Drug: Hydrogen Peroxide,https://ClinicalTrials.gov/show/NCT04659928
4105,The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign,Behavioral: Facebook Ads on the importance of staying safe during the Thanksgiving / Christmas holiday,https://ClinicalTrials.gov/show/NCT04644328
4106,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),Device: sample of blood and saliva,https://ClinicalTrials.gov/show/NCT04597216
4107,A Clinical Study to Evaluate MW33 Injection,Combination Product: MW33 injection|Combination Product: MW33 injection placebo,https://ClinicalTrials.gov/show/NCT04533048
4108,Nutritional Assessment of Hospitalized Patients With COVID-19,Other: Nutritional assessment,https://ClinicalTrials.gov/show/NCT04503525
4109,Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),,https://ClinicalTrials.gov/show/NCT04595175
4110,Impact of Spectacles on Compliance to Mask-wearing Directives,Behavioral: Questionnaire completion,https://ClinicalTrials.gov/show/NCT04501172
4111,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,Drug: inhaled hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04497519
4112,Intranasal Heparin Tolerability Study,Drug: Intranasal heparin sodium (porcine),https://ClinicalTrials.gov/show/NCT04490239
4113,"Phase I Double-blind, Placebo-controlled Study of AZD7442",Biological: AZD7442 300 mg IM(male)|Biological: AZD7442 600 mg IM (male)|Biological: AZD7442 300 mg IV (male and female)|Biological: AZD7442 1000 mg IV (male),https://ClinicalTrials.gov/show/NCT04896541
4114,"The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers",Drug: TLC19|Drug: TLC19 Vehicle,https://ClinicalTrials.gov/show/NCT04697654
4115,A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers,Biological: Nanocovax|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04683484
4116,Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection,,https://ClinicalTrials.gov/show/NCT04709120
4117,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,Drug: HLX70|Other: Placebo,https://ClinicalTrials.gov/show/NCT04561076
4118,Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study,,https://ClinicalTrials.gov/show/NCT04520191
4119,Study on Kidney Disease and EnviromenTal Chemical,,https://ClinicalTrials.gov/show/NCT04679168
4120,Repeated Employee Testing for Understanding Our Recovery to Normal,Diagnostic Test: SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04472793
4121,Trial of Combination Therapy to Treat COVID-19 Infection,Drug: Ivermectin|Drug: Doxycycline Hcl|Dietary Supplement: Zinc|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin C,https://ClinicalTrials.gov/show/NCT04482686
4122,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",Other: Resistance Exercise,https://ClinicalTrials.gov/show/NCT04706299
4123,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Drug: Drug: Isotretinoin plus Tamoxifen|Drug: Aerosolized Isotretinoin plus Tamoxifen,https://ClinicalTrials.gov/show/NCT04389580
4124,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04357106
4125,Renin Angiotensin System - CoronaVirus,Other: blood draw,https://ClinicalTrials.gov/show/NCT04337008
4126,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Diagnostic Test: New QIAstat-Dx fully automatic multiple PCR detection platform,https://ClinicalTrials.gov/show/NCT04311398
4127,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Drug: Lopinavir / ritonavir tablets combined with Xiyanping injection|Drug: Lopinavir/ritonavir treatment,https://ClinicalTrials.gov/show/NCT04295551
4128,"First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.",Drug: PF-07304814|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04535167
4129,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,Behavioral: Generic Best Practices|Behavioral: Tailored Best Practices,https://ClinicalTrials.gov/show/NCT04726371
4130,Activity Level and Quality of Life of Individuals With Physical Disabilities,Other: Survey,https://ClinicalTrials.gov/show/NCT04900402
4131,Spanish Registry of Pregnant Women With COVID-19,,https://ClinicalTrials.gov/show/NCT04558996
4132,Early Intervention in COVID-19: Favipiravir Verses Standard Care,Drug: Favipiravir|Other: Standard of care management,https://ClinicalTrials.gov/show/NCT04373733
4133,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,Drug: TL-895,https://ClinicalTrials.gov/show/NCT04419623
4134,National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE),Biological: COMIRNATY - BioNTech Manufacturing GmbH|Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH|Biological: COVID-19 Vaccine AstraZeneca suspension for injection,https://ClinicalTrials.gov/show/NCT04760132
4135,Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor,Biological: Vaccine inoculation against SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04894682
4136,Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era,Diagnostic Test: COVID-19 testing,https://ClinicalTrials.gov/show/NCT04636021
4137,Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine,Dietary Supplement: ABBC1 Immunoessential|Dietary Supplement: Placebo,https://ClinicalTrials.gov/show/NCT04798677
4138,Mapping COVID-19 Spread in a Tertiary Hospital,Other: no intervention,https://ClinicalTrials.gov/show/NCT04581096
4139,Follow-up of Critical COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04474249
4140,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,Biological: Intravenous Infusions of Stem Cells,https://ClinicalTrials.gov/show/NCT04437823
4141,A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,Drug: APL-9|Other: Vehicle Control,https://ClinicalTrials.gov/show/NCT04402060
4142,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Other: No intervention,https://ClinicalTrials.gov/show/NCT04357639
4143,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,"Diagnostic Test: Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)",https://ClinicalTrials.gov/show/NCT04410263
4144,Effectiveness of Colchicine Among Patients With COVID-19 Infection,Drug: Colchicine 0.5 MG|Drug: usual care treatment,https://ClinicalTrials.gov/show/NCT04867226
4145,Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19),Biological: COVID-19 vaccine|Biological: Concentrate beetroot Juice|Biological: Nitrate-deplete beetroot juice,https://ClinicalTrials.gov/show/NCT04889274
4146,Short Term Corticosteroids in SARS-CoV2 Patients,Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04445506
4147,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,Genetic: Complete thrombophilic profile testing by multiplex PCR,https://ClinicalTrials.gov/show/NCT04519398
4148,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Other: Cross-sectional observational study,https://ClinicalTrials.gov/show/NCT04365881
4149,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Dietary Supplement: Lactobaciltus rhamnosus GG|Dietary Supplement: Lactobaciltus rhamnosus GG Placebo,https://ClinicalTrials.gov/show/NCT04399252
4150,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,"Other: ""Calm"" is a mindfulness meditation mobile app",https://ClinicalTrials.gov/show/NCT04329533
4151,COVID-19 Antibody Responses In Cystic Fibrosis,,https://ClinicalTrials.gov/show/NCT04904445
4152,Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting,Dietary Supplement: Zinc Sulfate 220 MG|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04621461
4153,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit,,https://ClinicalTrials.gov/show/NCT04645433
4154,Cereset Research In Healthcare Workers During COVID-19,Device: Cereset Research,https://ClinicalTrials.gov/show/NCT04682197
4155,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,Other: RECOP unit patient,https://ClinicalTrials.gov/show/NCT04371328
4156,Mechanisms for Organ Dysfunction in Covid-19,,https://ClinicalTrials.gov/show/NCT04316884
4157,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,Drug: Pioglitazone 30 mg|Other: standard of care,https://ClinicalTrials.gov/show/NCT04535700
4158,"Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff",,https://ClinicalTrials.gov/show/NCT04799808
4159,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,Procedure: Awake Prone Positioning|Procedure: Standard care,https://ClinicalTrials.gov/show/NCT04395144
4160,Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04695379
4161,Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19,Drug: ZYESAMI™ (aviptadil acetate)|Drug: Placebo|Device: Nebulized administration of ZYESAMI™ or Placebo,https://ClinicalTrials.gov/show/NCT04360096
4162,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,https://ClinicalTrials.gov/show/NCT04335084
4163,Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases,,https://ClinicalTrials.gov/show/NCT04690816
4164,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,Other: No intervention,https://ClinicalTrials.gov/show/NCT04389996
4165,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,Other: Awake proning,https://ClinicalTrials.gov/show/NCT04408222
4166,Randomised Evaluation of COVID-19 Therapy,Drug: Lopinavir-Ritonavir|Drug: Corticosteroid|Drug: Hydroxychloroquine|Drug: Azithromycin|Biological: Convalescent plasma|Drug: Tocilizumab|Biological: Immunoglobulin|Drug: Synthetic neutralising antibodies|Drug: Aspirin|Drug: Colchicine|Drug: Baricitinib|Drug: Anakinra|Drug: Dimethyl fumarate|Drug: Infliximab|Drug: High Dose Corticosteroid,https://ClinicalTrials.gov/show/NCT04381936
4167,Cyclosporine For The Treatment Of COVID-19(+),Drug: Cyclosporine|Other: Standard of Care Treatment,https://ClinicalTrials.gov/show/NCT04492891
4168,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Diagnostic Test: Duplex ultrasound and Computed Tomography Angiography,https://ClinicalTrials.gov/show/NCT04374617
4169,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,"Other: Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail",https://ClinicalTrials.gov/show/NCT04375501
4170,OPV as Potential Protection Against COVID-19,Biological: oral polio vaccine + information|Behavioral: Information,https://ClinicalTrials.gov/show/NCT04445428
4171,Staff Physical and Mental Health Assessment in the Aftermath of the First Peak of the Covid-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04849546
4172,Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection,Other: Supervised rehabilitation program.,https://ClinicalTrials.gov/show/NCT04935437
4173,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug: Losartan|Other: Placebo,https://ClinicalTrials.gov/show/NCT04312009
4174,Trial of Treatments for COVID-19 in Hospitalized Adults,Drug: Remdesivir|Drug: Lopinavir/ritonavir|Drug: Interferon Beta-1A|Drug: Hydroxychloroquine|Other: Standard of care|Drug: AZD7442|Other: Placebo,https://ClinicalTrials.gov/show/NCT04315948
4175,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug: Losartan|Other: Placebo,https://ClinicalTrials.gov/show/NCT04311177
4176,Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects,Biological: ARCT-021 Dose 1|Biological: ARCT-021 Dose 2|Biological: ARCT-021 Dose 3|Biological: ARCT-021 Dose 4|Biological: ARCT-021 Dose Regimen 1|Biological: ARCT-021 Dose Regimen 2|Other: Placebo,https://ClinicalTrials.gov/show/NCT04480957
4177,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,Procedure: Colorectal resections,https://ClinicalTrials.gov/show/NCT04588909
4178,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,Other: non-interventional,https://ClinicalTrials.gov/show/NCT04492384
4179,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Other: No intervention,https://ClinicalTrials.gov/show/NCT04325919
4180,COVID-19 in Polish Ice Swimmers.,Other: Ice Swimming,https://ClinicalTrials.gov/show/NCT04817280
4181,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,"Drug: Cannabis, Medical",https://ClinicalTrials.gov/show/NCT03944447
4182,Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2,,https://ClinicalTrials.gov/show/NCT04665960
4183,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),Drug: vadadustat|Drug: placebo,https://ClinicalTrials.gov/show/NCT04478071
4184,COVID-19 Brain Injury,,https://ClinicalTrials.gov/show/NCT04496076
4185,Somerset and South Essex Coronavirus Antigen Testing,Diagnostic Test: PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test),https://ClinicalTrials.gov/show/NCT04403906
4186,Social Media and COVID-19,Behavioral: Social media & news consumption,https://ClinicalTrials.gov/show/NCT04367363
4187,COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave,Other: COVID-19 infection,https://ClinicalTrials.gov/show/NCT04782427
4188,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,Other: Prone position,https://ClinicalTrials.gov/show/NCT04391140
4189,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study),Diagnostic Test: Fibreoptic Endoscopic Evaluation of Swallowing (FEES)|Diagnostic Test: Videofluoroscopy|Other: Dysphagia Handicap Index (DHI)|Other: Voice Symptom Scale (VoiSS),https://ClinicalTrials.gov/show/NCT04584658
4190,National Survey of the Impact of COVID-19 Pandemics,Other: Customized questionnaire,https://ClinicalTrials.gov/show/NCT04491201
4191,PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT),"Drug: RESP301, a Nitric Oxide generating solution",https://ClinicalTrials.gov/show/NCT04842331
4192,Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection,,https://ClinicalTrials.gov/show/NCT04466982
4193,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Other: Yoga,https://ClinicalTrials.gov/show/NCT04414371
4194,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,Dietary Supplement: Viusid|Dietary Supplement: Asbrip|Drug: Standard Care,https://ClinicalTrials.gov/show/NCT04701502
4195,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Diagnostic Test: Scanning Chest X-rays and performing AI algorithms on images,https://ClinicalTrials.gov/show/NCT04313946
4196,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,Device: Remote Ischemic Conditioning,https://ClinicalTrials.gov/show/NCT04659460
4197,In-depth Immunological Investigation of COVID-19.,Other: Patient sampling,https://ClinicalTrials.gov/show/NCT04327570
4198,"National Study ""AEC COVID-19""",,https://ClinicalTrials.gov/show/NCT04573868
4199,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Other: No intervention,https://ClinicalTrials.gov/show/NCT04340466
4200,Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness,,https://ClinicalTrials.gov/show/NCT04769349
4201,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04632615
4202,Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication,Other: Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus,https://ClinicalTrials.gov/show/NCT04796584
4203,Birth Experience During COVID-19 Confinement,Other: Self-administered questionnaires,https://ClinicalTrials.gov/show/NCT04348929
4204,Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East,Other: Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience from the Middle East,https://ClinicalTrials.gov/show/NCT04542954
4205,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Drug: Enoxaparin,https://ClinicalTrials.gov/show/NCT04373707
4206,Psychiatric Disturbances and COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04459403
4207,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,,https://ClinicalTrials.gov/show/NCT04427735
4208,Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS),,https://ClinicalTrials.gov/show/NCT04503057
4209,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,Other: CHEST CT SCAN,https://ClinicalTrials.gov/show/NCT04483752
4210,Methylprednisolone in COVID-19 Patients (Methyl19LGH),Drug: Methylprednisolone Injectable Product,https://ClinicalTrials.gov/show/NCT04559113
4211,Liver Function Test Abnormalities in COVID-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04763395
4212,Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution,Other: surgery,https://ClinicalTrials.gov/show/NCT04750018
4213,Immunity and Infections in the Psychiatric Population,Diagnostic Test: COVID19 immunization testing,https://ClinicalTrials.gov/show/NCT04381845
4214,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",,https://ClinicalTrials.gov/show/NCT04377581
4215,Covid-19 Vaccine Cohort in Specific Populations,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04824651
4216,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,Biological: Convalescent Plasma of patients with COVID-19|Other: placebo (hartmann plus albumine),https://ClinicalTrials.gov/show/NCT04405310
4217,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,Drug: Tocilizumab|Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04519385
4218,Cardiac COVID-19 Health Care Workers,Other: Passed infection of SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04413071
4219,Extracellular Water in Covid 19 Pneumonia,Device: NİCaS,https://ClinicalTrials.gov/show/NCT04416009
4220,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,Behavioral: Occupational health workers,https://ClinicalTrials.gov/show/NCT04619576
4221,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Behavioral: Brief educational video,https://ClinicalTrials.gov/show/NCT04373135
4222,COVID-19 Biological Samples Collection,Other: biological samples collection,https://ClinicalTrials.gov/show/NCT04332016
4223,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis",,https://ClinicalTrials.gov/show/NCT04698382
4224,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,Biological: CYNK-001,https://ClinicalTrials.gov/show/NCT04365101
4225,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,,https://ClinicalTrials.gov/show/NCT04358640
4226,BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment,Biological: BNT162b2 mRNA Covid-19 Vaccine,https://ClinicalTrials.gov/show/NCT04932863
4227,Covid-19 Pandemic and Pancreatic Surgery in Italy,Procedure: Evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer,https://ClinicalTrials.gov/show/NCT04380766
4228,Venous Thrombosis Virtual Surveillance in COVID,Other: Observational,https://ClinicalTrials.gov/show/NCT04865913
4229,Responses to COVID-19 Vaccination in Patients With Cancer,Diagnostic Test: IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus,https://ClinicalTrials.gov/show/NCT04745377
4230,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,Drug: Colchicine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04367168
4231,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,Drug: Therapeutic anticoagulation,https://ClinicalTrials.gov/show/NCT04444700
4232,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery),,https://ClinicalTrials.gov/show/NCT04541472
4233,COVID-19 Vaccination in Patients With Rheumatic Diseases,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04845997
4234,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,Biological: BCG-Denmark|Biological: Saline,https://ClinicalTrials.gov/show/NCT04542330
4235,Renal Involvement in Hospitalized Children With COVID-19,Other: To determine the prevalence of renal dysfunction in hospitalized children with COVID19 in Qatar.,https://ClinicalTrials.gov/show/NCT04788394
4236,The Status of Parathyroid Hormone Secretion in Covid-19 Patients,Diagnostic Test: Venous blood was collected for biochemistry testing,https://ClinicalTrials.gov/show/NCT04662437
4237,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),Other: NaCl Solution,https://ClinicalTrials.gov/show/NCT04382131
4238,Impact of COVID-19 on Mental Health of Health Care Workers,Other: Online survey,https://ClinicalTrials.gov/show/NCT04382196
4239,SARS Cov_2 Incidence of Healthy Health Workers,Diagnostic Test: Spike protein (S) or the nucleocapsid (N) of SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04845880
4240,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug: Colchicine,https://ClinicalTrials.gov/show/NCT04322565
4241,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),Drug: Ibrutinib|Other: Quality-of-Life Assessment,https://ClinicalTrials.gov/show/NCT04665115
4242,GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19),Drug: GLS-1027|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04590547
4243,High Flow Nasal Cannula HFNC In Covid-19 Patients,Device: High flow nasal cannula HFNC,https://ClinicalTrials.gov/show/NCT04560257
4244,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",Drug: DWRX2003,https://ClinicalTrials.gov/show/NCT04592835
4245,COPD in the Time of COVID-19,,https://ClinicalTrials.gov/show/NCT04407598
4246,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug: Hydroxychloroquine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04328467
4247,COVID-19 Detection Test in Oncology,,https://ClinicalTrials.gov/show/NCT04367870
4248,Oral and Olfactory Complications of Recovered COVID-19 Patients,Diagnostic Test: Gustatory and olfactory function test|Diagnostic Test: Molecular assessment of saliva,https://ClinicalTrials.gov/show/NCT04791436
4249,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,Device: Audio-Visual Triage System (AVT),https://ClinicalTrials.gov/show/NCT04621214
4250,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,Dietary Supplement: Ozonized oil (HOO,https://ClinicalTrials.gov/show/NCT04651387
4251,Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme,Behavioral: Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): An Educational Intervention Programme,https://ClinicalTrials.gov/show/NCT04930185
4252,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04336748
4253,"Behavior, Environment And Treatments for Covid-19","Other: Observation of patients with known, suspected, or at risk for COVID-19 infection",https://ClinicalTrials.gov/show/NCT04321811
4254,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,Other: WHOQOL-BREF survey,https://ClinicalTrials.gov/show/NCT04409535
4255,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,Drug: Ophtamesone,https://ClinicalTrials.gov/show/NCT04569825
4256,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,Other: RECOP unit patient,https://ClinicalTrials.gov/show/NCT04422587
4257,Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug: Bevacizumab Injection,https://ClinicalTrials.gov/show/NCT04275414
4258,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,Other: PHQ-9 (Patient Health Questionnaire) Depression Scale|Other: GAD-7 (General Anxiety Disorder) scale|Other: 38 questions questionnaire|Other: EPDS (Edinburgh Postnatal Depression Scale),https://ClinicalTrials.gov/show/NCT04437342
4259,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),Biological: MultiStem|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04367077
4260,Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis,Diagnostic Test: microcirculation recording,https://ClinicalTrials.gov/show/NCT04644302
4261,Persistence of Symptoms After Improvement of Acute COVID-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04764773
4262,COVID-19 in Osteoarthritis Patients,,https://ClinicalTrials.gov/show/NCT04791462
4263,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,Drug: virgin coconut oil (VCO)|Other: placebo,https://ClinicalTrials.gov/show/NCT04594330
4264,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Other: Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery,https://ClinicalTrials.gov/show/NCT04368208
4265,"Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection",Other: Body position change,https://ClinicalTrials.gov/show/NCT04694638
4266,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Other: This is an online survey with no intervention.,https://ClinicalTrials.gov/show/NCT04385238
4267,Investigating a Vaccine Against COVID-19,Biological: ChAdOx1 nCoV-19 (Abs 260)|Biological: MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost|Biological: Two dose MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (qPCR)|Biological: ChAdOx1 nCoV-19 0.5mL prime plus boost|Biological: Two dose MenACWY vaccine min. 4 weeks apart|Biological: Two dose ChAdOx1 nCoV-19/Covishield 0.5mL|Biological: Two dose ChAdOx1 nCoV-19/Covishield 0.25mL & 0.5mL,https://ClinicalTrials.gov/show/NCT04400838
4268,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,Other: Questionnaire by phone call,https://ClinicalTrials.gov/show/NCT04345159
4269,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,,https://ClinicalTrials.gov/show/NCT04371835
4270,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,,https://ClinicalTrials.gov/show/NCT04426266
4271,Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN),Drug: Hesperidin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04715932
4272,Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients,Other: Patients received standard of care treatment during hospitalization,https://ClinicalTrials.gov/show/NCT04465552
4273,Appendicitis During the National Lockdown During the COVID-19 Pandemic,Behavioral: Lock-down and social distancing,https://ClinicalTrials.gov/show/NCT04407117
4274,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",Diagnostic Test: test,https://ClinicalTrials.gov/show/NCT04631497
4275,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,Other: During COVID-19 Pandemic|Other: After COVID-19 Pandemic,https://ClinicalTrials.gov/show/NCT04378595
4276,PR-VR At-home Program During and After COVID-19,Other: Off the Shelf VR|Other: Custom VR,https://ClinicalTrials.gov/show/NCT04912817
4277,COVID19 and Physical and Emotional Wellbeing of HCP,"Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index|Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.|Other: Informed consent",https://ClinicalTrials.gov/show/NCT04433260
4278,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Radiation: Low-dose radiotherapy|Drug: Hydroxychloroquine Sulfate|Drug: Ritonavir/lopinavir|Drug: Tocilizumab Injection [Actemra]|Drug: Azithromycin|Drug: Corticosteroid|Drug: Low molecular weight heparin|Device: Oxygen supply,https://ClinicalTrials.gov/show/NCT04380818
4279,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Behavioral: Chat-based support|Behavioral: AWARD plus COVID-specific advice|Behavioral: AWARD advice|Behavioral: COVID-19 related health warning leaflet|Behavioral: Health warning leaflet|Behavioral: SMS-based support|Behavioral: Referral card|Behavioral: COSH Self-help smoking cessation booklet,https://ClinicalTrials.gov/show/NCT04399967
4280,Obstetric Anaesthesia And Analgesia Month Attributes - in COVID-19,Procedure: Obstetric anesthesia and analgesia,https://ClinicalTrials.gov/show/NCT04912791
4281,Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency,Other: Telegeriatric intervention,https://ClinicalTrials.gov/show/NCT04747132
4282,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,Behavioral: Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell|Behavioral: Internet Cognitive Behavioral Therapy plus CHAMindWell|Behavioral: CHAMindWell,https://ClinicalTrials.gov/show/NCT04595084
4283,COVID-19 Pandemic and General Surgery Emergencies,Other: Emergency general surgical admissions,https://ClinicalTrials.gov/show/NCT04686708
4284,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,Drug: Levamisole and isoprinosine|Drug: Azithromycin and hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04383717
4285,Study to Assess the Efficacy and Safety of Favipiravir-HU,Drug: Favipiravir HU 200 mg hard capsules|Drug: Placebo HU,https://ClinicalTrials.gov/show/NCT04940871
4286,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Device: VibroLUNG,https://ClinicalTrials.gov/show/NCT04435353
4287,BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19,Drug: BNO 1030|Other: Standard care,https://ClinicalTrials.gov/show/NCT04797936
4288,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,,https://ClinicalTrials.gov/show/NCT04357847
4289,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,,https://ClinicalTrials.gov/show/NCT04423315
4290,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,Other: Transplant patient,https://ClinicalTrials.gov/show/NCT04376775
4291,COVIDAR - Arrhythmias in COVID-19,,https://ClinicalTrials.gov/show/NCT04437901
4292,Physical Activity Level in Patients With OSAS During Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04451993
4293,Covid-19 Epidemic on Acute Stroke Management,,https://ClinicalTrials.gov/show/NCT04370197
4294,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Diagnostic Test: laboratory biomarkers|Diagnostic Test: muscle ultrasound,https://ClinicalTrials.gov/show/NCT04367350
4295,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),,https://ClinicalTrials.gov/show/NCT04456556
4296,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure,,https://ClinicalTrials.gov/show/NCT04733105
4297,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Other: COVID-19 Pandemic,https://ClinicalTrials.gov/show/NCT04338672
4298,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Diagnostic Test: Nasopharyngeal swab,https://ClinicalTrials.gov/show/NCT04324866
4299,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),,https://ClinicalTrials.gov/show/NCT04427280
4300,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",Other: Description of groups caracteristics,https://ClinicalTrials.gov/show/NCT04417374
4301,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,,https://ClinicalTrials.gov/show/NCT04368637
4302,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,,https://ClinicalTrials.gov/show/NCT04547218
4303,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,Other: Community popular opinion leader (POL) based intervention,https://ClinicalTrials.gov/show/NCT04646616
4304,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,Other: Telephone survey,https://ClinicalTrials.gov/show/NCT04360863
4305,Brain Health in the Time of COVID-19,,https://ClinicalTrials.gov/show/NCT04438967
4306,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,Other: COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04379063
4307,Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales,Other: Not applicable as observational study,https://ClinicalTrials.gov/show/NCT04838106
4308,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug: Ruxolitinib plus simvastatin|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04348695
4309,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,Procedure: Questionnaire|Other: Data collection up to 1 year,https://ClinicalTrials.gov/show/NCT04395859
4310,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,Other: Exercise|Behavioral: Psychological and Behaviour Change Support|Other: Nutrition,https://ClinicalTrials.gov/show/NCT04425616
4311,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19),Diagnostic Test: Machine Learning Classification of parenchymal lung change cause|Diagnostic Test: Machine Learning Classification of recurrence and non-recurrence,https://ClinicalTrials.gov/show/NCT04721444
4312,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Behavioral: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic,https://ClinicalTrials.gov/show/NCT04341922
4313,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,Drug: Adenosine,https://ClinicalTrials.gov/show/NCT04588441
4314,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Drug: Alteplase 50 MG [Activase],https://ClinicalTrials.gov/show/NCT04357730
4315,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,,https://ClinicalTrials.gov/show/NCT04643548
4316,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",Biological: SAB-185|Other: Normal saline,https://ClinicalTrials.gov/show/NCT04468958
4317,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Diagnostic Test: Collection of breath sample,https://ClinicalTrials.gov/show/NCT04341012
4318,Household Transmission Investigation Study for COVID-19 in Tropical Regions,Procedure: Human biological samples,https://ClinicalTrials.gov/show/NCT04328129
4319,University of Utah COVID-19 Hydrochloroquine Trial,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04342169
4320,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Device: VivaDiag™ COVID-19 lgM/IgG Rapid Test,https://ClinicalTrials.gov/show/NCT04316728
4321,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes,Other: no intervention,https://ClinicalTrials.gov/show/NCT04485351
4322,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Other: Telerehabilitation,https://ClinicalTrials.gov/show/NCT04334434
4323,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,Procedure: Surgical procedures performed under general anesthesia,https://ClinicalTrials.gov/show/NCT04430062
4324,Sero-epidemiological Survey of England in 2019/2020 - COVID-19,Procedure: Venepuncture|Procedure: Oral fluid swab,https://ClinicalTrials.gov/show/NCT04061382
4325,Remdesivir in COVID-19 Lahore General Hospital,Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04560231
4326,Cardiovascular Complications and COVID-19 (CovCardioVasc-Study),,https://ClinicalTrials.gov/show/NCT04335162
4327,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies,https://ClinicalTrials.gov/show/NCT04382391
4328,"Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years",Biological: BNT162b2,https://ClinicalTrials.gov/show/NCT04895982
4329,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,Behavioral: Eating habits,https://ClinicalTrials.gov/show/NCT04621084
4330,Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19),Drug: Maraviroc experimental group|Other: Standard treatment,https://ClinicalTrials.gov/show/NCT04710199
4331,Evaluation of Immune Response in COVID-19 Patients,Drug: COVID-19 treatment,https://ClinicalTrials.gov/show/NCT04438629
4332,Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression,,https://ClinicalTrials.gov/show/NCT04516668
4333,Analysis of Vital Signs in Patients With COVID-19,Other: Observation of breathing pattern,https://ClinicalTrials.gov/show/NCT04927078
4334,Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19,Other: Adjunctive therapies,https://ClinicalTrials.gov/show/NCT04719182
4335,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Diagnostic Test: identify SARS-CoV-2 infection by serology|Biological: collection of biological samples,https://ClinicalTrials.gov/show/NCT04355234
4336,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed|Drug: Group 2: control group with enoxaparin 40mg/d,https://ClinicalTrials.gov/show/NCT04394377
4337,"The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO",Other: VV-ECMO,https://ClinicalTrials.gov/show/NCT04708457
4338,CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic,,https://ClinicalTrials.gov/show/NCT04775966
4339,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",Drug: Ibudilast|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04429555
4340,Convalescent Plasma Therapy in Patients With COVID-19,Biological: Convalescent plasma,https://ClinicalTrials.gov/show/NCT04407208
4341,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Behavioral: psychological assessment,https://ClinicalTrials.gov/show/NCT04366817
4342,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,Biological: Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients,https://ClinicalTrials.gov/show/NCT04346589
4343,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Drug: Chemotherapy,https://ClinicalTrials.gov/show/NCT04341480
4344,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Procedure: Robot Assisted Percutaneous Cardiovascular Intervention,https://ClinicalTrials.gov/show/NCT04379453
4345,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug: pirfenidone,https://ClinicalTrials.gov/show/NCT04282902
4346,COVAXIN in a Pediatric Cohort,Biological: COVAXIN,https://ClinicalTrials.gov/show/NCT04918797
4347,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other: Tele-medicine platform,https://ClinicalTrials.gov/show/NCT04325867
4348,COVID-19 Testing Pilot Study,Diagnostic Test: COVID Detect,https://ClinicalTrials.gov/show/NCT04843878
4349,A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty™ or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects,Biological: BNT162b2s01|Biological: BNT162b2,https://ClinicalTrials.gov/show/NCT04949490
4350,Health Care Use During the Covid19 Crisis,Other: Online questionnaire,https://ClinicalTrials.gov/show/NCT04372030
4351,Drug Abuse During the COVID-19 Pandemic.,,https://ClinicalTrials.gov/show/NCT04811352
4352,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),Biological: Human umbilical cord derived CD362 enriched MSCs|Biological: Placebo (Plasma-Lyte 148),https://ClinicalTrials.gov/show/NCT03042143
4353,Electrocardiogram Analysis in COVID-19 Patients,Diagnostic Test: ECG,https://ClinicalTrials.gov/show/NCT04367129
4354,Thromboembolic Events in Severe COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04405869
4355,Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.,Drug: Reparixin|Other: Placebo,https://ClinicalTrials.gov/show/NCT04878055
4356,Epigenetic Tools as Prognostic Predictors in Covid19,Other: Taking biological samples,https://ClinicalTrials.gov/show/NCT04411563
4357,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Other: Follow up,https://ClinicalTrials.gov/show/NCT04339322
4358,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,Other: hospital bedroom booking,https://ClinicalTrials.gov/show/NCT04665778
4359,Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases,Biological: AntiSARS-CoV-2 Serum|Other: Placebo,https://ClinicalTrials.gov/show/NCT04834089
4360,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",,https://ClinicalTrials.gov/show/NCT04637295
4361,Digital Acoustic Surveillance for Early Detection of Respiratory Disease Outbreaks,Device: Hyfe cough tracker,https://ClinicalTrials.gov/show/NCT04762693
4362,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Other: Best Practice|Drug: Ibrutinib,https://ClinicalTrials.gov/show/NCT04439006
4363,Italian Web-based Cross-sectional Survey on COVID-19,Behavioral: Environmental exposure and clinical features,https://ClinicalTrials.gov/show/NCT04471701
4364,"Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)",Other: Clinical follow-up for 24 months,https://ClinicalTrials.gov/show/NCT04944823
4365,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Other: mobile internet survey on self-test,https://ClinicalTrials.gov/show/NCT04256395
4366,COVID-19 Risk Stratification,,https://ClinicalTrials.gov/show/NCT04339387
4367,Evaluation of Newborns Presenting With Suspected COVID 19,,https://ClinicalTrials.gov/show/NCT04519307
4368,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,Diagnostic Test: Laboratory tests,https://ClinicalTrials.gov/show/NCT04490772
4369,Important Data on COVID-19 Profile in Africa,,https://ClinicalTrials.gov/show/NCT04847817
4370,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug: Darunavir and Cobicistat,https://ClinicalTrials.gov/show/NCT04252274
4371,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug: Lopinavir/ritonavir|Drug: Ribavirin|Drug: Interferon Beta-1B,https://ClinicalTrials.gov/show/NCT04276688
4372,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Device: Aerosol Box|Device: Intubation Box,https://ClinicalTrials.gov/show/NCT04385576
4373,Survey on COVID-19 Airway Management,Other: Survey,https://ClinicalTrials.gov/show/NCT04487977
4374,Experience of Orthopaedic and Spine Center Pakistan During COVID-19,Procedure: Orthopaedic Surgical Procedures,https://ClinicalTrials.gov/show/NCT04516824
4375,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,,https://ClinicalTrials.gov/show/NCT04412551
4376,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,Drug: Nitric Oxide-Sessions|Drug: Nitric Oxide-Continuous and Sessions,https://ClinicalTrials.gov/show/NCT04476992
4377,Immunogenetics Predictors With COVID-19,,https://ClinicalTrials.gov/show/NCT04390269
4378,Post COVID-19 Biorepository,,https://ClinicalTrials.gov/show/NCT04885504
4379,The Use of Lung Ultrasonography in COVID-19 Patients,Behavioral: mechanical ventilator settings and position,https://ClinicalTrials.gov/show/NCT04432051
4380,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,,https://ClinicalTrials.gov/show/NCT04393142
4381,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,Drug: Inactivated convalescent plasma|Drug: Support treatment,https://ClinicalTrials.gov/show/NCT04385186
4382,A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults,"Biological: ARCT-021 single dose priming|Biological: ARCT-021 two lower dose priming|Biological: ARCT-021 two higher dose priming|Biological: Placebo (two doses), priming|Biological: Randomized booster|Biological: Placebo booster",https://ClinicalTrials.gov/show/NCT04668339
4383,Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19,,https://ClinicalTrials.gov/show/NCT04772586
4384,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug: Nitric Oxide,https://ClinicalTrials.gov/show/NCT04305457
4385,Awareness of COVID-19 in Turkey,,https://ClinicalTrials.gov/show/NCT04357886
4386,Registry of Patients With Hematologic Disease and COVID-19 in Russia,Other: Non-interventional study,https://ClinicalTrials.gov/show/NCT04422470
4387,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device,Device: Hemopurifier,https://ClinicalTrials.gov/show/NCT04595903
4388,Immune Cells Phenotypes During COVID-19,Biological: Peripheral blood samples,https://ClinicalTrials.gov/show/NCT04816760
4389,HFNC and NIV for COVID-19 Complicated by Respiratory Failure,Device: HFNC,https://ClinicalTrials.gov/show/NCT04452708
4390,"Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19",Drug: DEXAMETHASONE|Drug: PREDNISOLONE,https://ClinicalTrials.gov/show/NCT04765371
4391,Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study,,https://ClinicalTrials.gov/show/NCT04815850
4392,Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients,,https://ClinicalTrials.gov/show/NCT04924673
4393,The Professional Values and Ethical Sensitivities During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04872673
4394,Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients,Other: PT Pal|Other: Exercise Manual,https://ClinicalTrials.gov/show/NCT04821531
4395,Complementary And Alternative Medicine During The COVID-19 Pandemic,Other: Complementary And Alternative Medicine,https://ClinicalTrials.gov/show/NCT04884321
4396,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug: Baricitinib,https://ClinicalTrials.gov/show/NCT04320277
4397,COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management,Other: glucose control and sensor usage,https://ClinicalTrials.gov/show/NCT04669912
4398,Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19),,https://ClinicalTrials.gov/show/NCT04595123
4399,Understanding Reactions to Emotional Material in the Media During COVID-19,Behavioral: Simple cognitive task intervention|Behavioral: Attention Placebo,https://ClinicalTrials.gov/show/NCT04608097
4400,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Other: Survey to assess Post traumatic stress and anxiety at inclusion and 6 months later,https://ClinicalTrials.gov/show/NCT04401046
4401,Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,Diagnostic Test: Generalized Anxiety Disorder-7 (GAD 7)|Diagnostic Test: Background questionnaire|Diagnostic Test: Impact of COVID-19 questionnaire|Diagnostic Test: Confinement and Communication During the COVID-19 Pandemic|Diagnostic Test: Mental Health questionnaire|Diagnostic Test: Patient Health Questionnaire (PHQ-9)|Diagnostic Test: Post Traumatic Stress Disorder questionnaire (PTSD-8)|Diagnostic Test: Experiences in Close Relationship Scale questionnaire (ECR-S),https://ClinicalTrials.gov/show/NCT04491071
4402,Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU,,https://ClinicalTrials.gov/show/NCT04476914
4403,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,Other: Eye Movement Desensitisation and Reprocessing Recent traumatic Event Protocol,https://ClinicalTrials.gov/show/NCT04455360
4404,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,Other: Training load,https://ClinicalTrials.gov/show/NCT04602637
4405,Self-Help for Stress Related to COVID-19,Device: Online self-help intervention,https://ClinicalTrials.gov/show/NCT04762173
4406,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Radiation: Ultra-Low-dose radiotherapy|Device: ventilatory support with oxygen therapy|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Piperacillin/tazobactam|Drug: Low molecular weight heparin|Drug: Corticosteroid injection|Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04394182
4407,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Behavioral: Remote Cognitive Behavioral Therapy for Insomnia,https://ClinicalTrials.gov/show/NCT04409743
4408,Convalescent Antibodies Infusion in COVID 19 Patients,Biological: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients,https://ClinicalTrials.gov/show/NCT04418531
4409,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,,https://ClinicalTrials.gov/show/NCT04391816
4410,Profiling Recovery of Those Discharged Into the Community With COVID-19,,https://ClinicalTrials.gov/show/NCT04649957
4411,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,Other: No intervention,https://ClinicalTrials.gov/show/NCT04389463
4412,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms,Other: Nil intervention,https://ClinicalTrials.gov/show/NCT04510441
4413,Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes,Other: antidiabetic treatment,https://ClinicalTrials.gov/show/NCT04501991
4414,Management of Acute Appendicitis at District General Hospital,Procedure: Appendicectomy,https://ClinicalTrials.gov/show/NCT04707339
4415,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Behavioral: HADS|Behavioral: a survey,https://ClinicalTrials.gov/show/NCT04406181
4416,Characteristics of COVID-19 Infection Among PREGnant Women,Other: COVID-19 positive via testing,https://ClinicalTrials.gov/show/NCT04398264
4417,EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19,Drug: BEVA+SOC|Drug: SOC,https://ClinicalTrials.gov/show/NCT04822818
4418,"Knowledge, Attitude and Practice of Dental Students About COVID-19","Behavioral: Knowledge, Attitude, Practice, Awareness, Preference",https://ClinicalTrials.gov/show/NCT04449081
4419,COVID-19 and Lactating Mothers,,https://ClinicalTrials.gov/show/NCT04558320
4420,COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes,Device: Hospital telemedicine management system|Other: Usual care,https://ClinicalTrials.gov/show/NCT04723550
4421,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,Diagnostic Test: Global Longitudinal Strain,https://ClinicalTrials.gov/show/NCT04358952
4422,The Effectiveness of Culturally Adapted Cognitive Behavioral Intervention Among COVID-19 Survivors,Behavioral: Culturally Adapted Cognitive Behavioral Intervention (CA-CBI),https://ClinicalTrials.gov/show/NCT04949061
4423,Short and Long-term Psychological Impact of Covid-19 on The Egyptians,Diagnostic Test: A questionnaire or scales,https://ClinicalTrials.gov/show/NCT04344834
4424,Modafinil for Wakefulness in the Critical Care Units,Drug: Modafinil,https://ClinicalTrials.gov/show/NCT04751227
4425,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Diagnostic Test: COPAN swabbing and blood sample collection,https://ClinicalTrials.gov/show/NCT04318314
4426,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,Behavioral: Ultra Brief Online Mindfulness-based Intervention|Behavioral: Control,https://ClinicalTrials.gov/show/NCT04536441
4427,TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic,Device: Transcranial Direct Current Stimulation|Device: Placebo-simulation of transcranial direct current stimulation|Drug: Fluoxetine Tablets,https://ClinicalTrials.gov/show/NCT04780152
4428,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Device: ARFC mask,https://ClinicalTrials.gov/show/NCT04427176
4429,Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,,https://ClinicalTrials.gov/show/NCT04343404
4430,"Effect of Social Isolation on Physical Activity Level, and Kinesophobia in Heart Rhythm Disorders During Pandemic",,https://ClinicalTrials.gov/show/NCT04818697
4431,Effects of NMES in Critically Ill Patients,Device: neuromuscular electrical stimulation,https://ClinicalTrials.gov/show/NCT04382378
4432,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",Behavioral: Questionnaire|Behavioral: Interview,https://ClinicalTrials.gov/show/NCT04463628
4433,Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics,Biological: Blood sample,https://ClinicalTrials.gov/show/NCT04870411
4434,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,Biological: VPM1002|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04387409
4435,Supervised Versus Home Based Exercises Neck and Low Back Pain Among Students Due to Quarantine During COVID-19,Other: Supervised stretching and strengthening exercise|Other: Home-based stretching and strengthening exercise,https://ClinicalTrials.gov/show/NCT04880135
4436,Mental Health and Academic Performance in COVID-19,Other: Survey,https://ClinicalTrials.gov/show/NCT04420416
4437,Taste and Smell Impairment in Critically Ill COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04532632
4438,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),,https://ClinicalTrials.gov/show/NCT04361877
4439,Covid-19 and Diabetes in West of Algeria,Drug: MANAGEMENT OF COVID-19,https://ClinicalTrials.gov/show/NCT04412746
4440,Plasma Adsorption in Patients With Confirmed COVID-19,Device: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol),https://ClinicalTrials.gov/show/NCT04358003
4441,Plant Stanol Esters and COVID-19 Vaccination Response,Dietary Supplement: Plant stanol mini drinks|Dietary Supplement: Placebo mini drinks|Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04844346
4442,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,Biological: BCG GROUP|Other: PLACEBO GROUP,https://ClinicalTrials.gov/show/NCT04384549
4443,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Device: Intravenous access|Device: Intraosseous access,https://ClinicalTrials.gov/show/NCT04366297
4444,Yoga Pranayama Adjuvant to Treat Burden COVID-19,Behavioral: morning Yoga-based breathing support|Behavioral: pre_lunch Yoga-based breathing support|Behavioral: pre_dinner Yoga-based breathing support,https://ClinicalTrials.gov/show/NCT04413747
4445,Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients,Diagnostic Test: Chest CT scan + baseline spirometry,https://ClinicalTrials.gov/show/NCT04686721
4446,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Other: Collection of samples,https://ClinicalTrials.gov/show/NCT04361396
4447,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",Behavioral: Telephonic interview during the Italian lockdown.,https://ClinicalTrials.gov/show/NCT04453579
4448,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,Drug: XAV-19|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04453384
4449,CBD Oil for Reducing Emotional Impact of COVID-19,Dietary Supplement: CBD Isolate|Dietary Supplement: Full Spectrum CBD Oil|Dietary Supplement: Broad-Spectrum CBD Oil|Dietary Supplement: Placebo Oil,https://ClinicalTrials.gov/show/NCT04603781
4450,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,,https://ClinicalTrials.gov/show/NCT04339790
4451,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",Drug: REGN10933+REGN10987|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04519437
4452,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug: Hydroxychloroquine + azithromycin|Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04321278
4453,Sparing in Neuromuscular Blockade in COVID 19 ICU,Device: TOF protocol,https://ClinicalTrials.gov/show/NCT04459533
4454,Tele-health Enabled Clinical Trial for COVID-19,Drug: Vitamin D3 or Placebo|Device: Doctella telehealth monitoring,https://ClinicalTrials.gov/show/NCT04489628
4455,Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile,,https://ClinicalTrials.gov/show/NCT04497636
4456,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Drug: Methylprednisolone|Other: standard care,https://ClinicalTrials.gov/show/NCT04323592
4457,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Diagnostic Test: pulmonary anomalies 4 months after documented COVID-19 pneumonia,https://ClinicalTrials.gov/show/NCT04422613
4458,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",Biological: Gam-COVID-Vac,https://ClinicalTrials.gov/show/NCT04587219
4459,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),Biological: COVID-19 Specific T Cell derived exosomes (CSTC-Exo),https://ClinicalTrials.gov/show/NCT04389385
4460,Pharmacokinetics of Voriconazole in Adult ECMO Patients,Other: 5 blood samples|Genetic: Determination of CYP2C19 genotype,https://ClinicalTrials.gov/show/NCT04868188
4461,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Behavioral: Peer Resilience Champion|Behavioral: Enriched Survey Feedback,https://ClinicalTrials.gov/show/NCT04373382
4462,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,Drug: Canakinumab|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04510493
4463,The Effect of Nurses' Having COVID-19 on Their Professional Lives,,https://ClinicalTrials.gov/show/NCT04900389
4464,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,Device: Continuous blind glucose measurement device (Free style Pro),https://ClinicalTrials.gov/show/NCT04726163
4465,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostic Test: COVID 19 diagnostic test by PCR,https://ClinicalTrials.gov/show/NCT04360811
4466,Health Behavior Change During COVID-19 Pandemic,Other: No intervention,https://ClinicalTrials.gov/show/NCT04367337
4467,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,Drug: Nintedanib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04619680
4468,"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy",Biological: mRNA-1273,https://ClinicalTrials.gov/show/NCT04847050
4469,Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions,Other: questionnaire,https://ClinicalTrials.gov/show/NCT04898192
4470,The Provider Insurance Revenue Study in Healthcare Providers in the United States of America,Other: Online questionnaire and interviews,https://ClinicalTrials.gov/show/NCT04587245
4471,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure,Radiation: thoracic CT-scan,https://ClinicalTrials.gov/show/NCT04534400
4472,Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,,https://ClinicalTrials.gov/show/NCT04452422
4473,Ventilatory Efficiency in Critically Ill COVID-19 Patients,Other: data collecting,https://ClinicalTrials.gov/show/NCT04694742
4474,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),Behavioral: Mindfulness-Based Stress Reduction|Other: Self-help mindfulness/compassion exercises|Other: Support as usual,https://ClinicalTrials.gov/show/NCT04720404
4475,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04383470
4476,COVID-19 and Pregnancy Outcomes,Diagnostic Test: RT PCR SARS-CoV-2,https://ClinicalTrials.gov/show/NCT04416373
4477,"Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake",Behavioral: Full VEPMP Intervention|Behavioral: Partial VEPMP Intervention|Behavioral: Delayed VEPMP Intervention,https://ClinicalTrials.gov/show/NCT04761692
4478,Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19,,https://ClinicalTrials.gov/show/NCT04613245
4479,BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers,Biological: two doses of BNT162b2 vaccine|Biological: one dose of BNT162b2 vaccine,https://ClinicalTrials.gov/show/NCT04824638
4480,Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19),Other: Longan nasal spray|Other: Placebo,https://ClinicalTrials.gov/show/NCT04887233
4481,COVID-19 Quarantine on Musculoskeletal Status in Hemophilia,Other: Observational,https://ClinicalTrials.gov/show/NCT04491318
4482,Covid-19 and Vitamin D in Nursing-home,,https://ClinicalTrials.gov/show/NCT04435119
4483,The Global PCHF-COVICAV Registry,,https://ClinicalTrials.gov/show/NCT04390555
4484,Telemedicine for SNAS Patients in COVID-19 Pandemic,Other: Dietary intervention|Other: Video call,https://ClinicalTrials.gov/show/NCT04894331
4485,Covid-19 Triage Using Camera-based AI,Device: RIA-device (Remote Investigation and Assessment),https://ClinicalTrials.gov/show/NCT04383457
4486,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Behavioral: Phone-call screening and management by a medical student/general practitioner tandem,https://ClinicalTrials.gov/show/NCT04359875
4487,Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination,Behavioral: Text Messaging Only|Behavioral: INFORMED,https://ClinicalTrials.gov/show/NCT04893265
4488,Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,Biological: Otilimab|Biological: Placebo 1|Biological: Placebo 2|Drug: Standard of care,https://ClinicalTrials.gov/show/NCT04376684
4489,Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?,Procedure: Gastric cancer surgery,https://ClinicalTrials.gov/show/NCT04797624
4490,Evaluation of Novel Diagnostic Tests for COVID-19,Diagnostic Test: SAMBA II (Diagnostic for the Real World)|Diagnostic Test: Public Health England Gold Standard|Diagnostic Test: Cambridge Validated Viral Detection Method|Diagnostic Test: Radiological Detection,https://ClinicalTrials.gov/show/NCT04326387
4491,"COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education",,https://ClinicalTrials.gov/show/NCT04934085
4492,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19,,https://ClinicalTrials.gov/show/NCT04486417
4493,"Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",Genetic: COVID-19 Diagnostic and Assessment Tests,https://ClinicalTrials.gov/show/NCT04583566
4494,"SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)",Procedure: blood sample for seroepidemiological investigation,https://ClinicalTrials.gov/show/NCT04487197
4495,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,Diagnostic Test: Respiratory mechanics measurement|Diagnostic Test: Gas exchange measurement,https://ClinicalTrials.gov/show/NCT04445961
4496,Serological Diagnostics of COVID-19 in Health Care Workers,Diagnostic Test: SARS-CoV2 nasal swab,https://ClinicalTrials.gov/show/NCT04635592
4497,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Other: Interview by psychologists,https://ClinicalTrials.gov/show/NCT04416360
4498,Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center,Biological: serology and ELISPOT test|Biological: serology,https://ClinicalTrials.gov/show/NCT04935528
4499,Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic,Procedure: Mout-to-mouth ventilation|Procedure: Mout-to-mouth ventilation with quantitative analysis,https://ClinicalTrials.gov/show/NCT04867265
4500,Sarilumab COVID-19,Drug: Sarilumab SAR153191|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04327388
4501,An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic,Behavioral: 5-week prevention program|Behavioral: Control,https://ClinicalTrials.gov/show/NCT04870385
4502,Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,Diagnostic Test: Performing routine care (clinical and paraclinical tests)|Diagnostic Test: Examinations for the research:,https://ClinicalTrials.gov/show/NCT04375748
4503,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,Other: Maternal stress,https://ClinicalTrials.gov/show/NCT04540029
4504,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,Diagnostic Test: Questionnaire,https://ClinicalTrials.gov/show/NCT04371302
4505,Analysis of the Immune Response to COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations,,https://ClinicalTrials.gov/show/NCT04852276
4506,COVID-19 Vaccine and Ovarian Reserve,Biological: SARS-CoV-2 virus vaccines|Diagnostic Test: AMH sampling,https://ClinicalTrials.gov/show/NCT04748172
4507,mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels,Other: None (not interventional),https://ClinicalTrials.gov/show/NCT04923386
4508,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,Behavioral: eHealth +counselling contacts|Behavioral: eHealth|Behavioral: Usual care,https://ClinicalTrials.gov/show/NCT04587414
4509,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Diagnostic Test: Lung ultrasound,https://ClinicalTrials.gov/show/NCT04322487
4510,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,Other: Data record,https://ClinicalTrials.gov/show/NCT04406571
4511,Vaccination Against COVID-19 in Cancer,Biological: mRNA-1273 SARS-CoV-2 vaccine from Moderna,https://ClinicalTrials.gov/show/NCT04715438
4512,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",Behavioral: Medical Music|Behavioral: Narrative Writing|Behavioral: Prolonged Exposure Therapy|Behavioral: Interpersonal Psychotherapy,https://ClinicalTrials.gov/show/NCT04626050
4513,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,Drug: hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04597775
4514,Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents,Other: no intervention,https://ClinicalTrials.gov/show/NCT04732702
4515,Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People,Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19,https://ClinicalTrials.gov/show/NCT04844489
4516,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",Other: Practice details,https://ClinicalTrials.gov/show/NCT04377776
4517,Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic,Other: Telestroke,https://ClinicalTrials.gov/show/NCT04761874
4518,Home Based Exercises With and Without Posture and Ergonomics Among Students During COVID-19,Other: Home based exercises with postural and ergonomic training|Other: Home based exercises,https://ClinicalTrials.gov/show/NCT04935502
4519,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Drug: Povidone-Iodine|Drug: Normal saline,https://ClinicalTrials.gov/show/NCT04393792
4520,Health cAre woRkers exposeD to COVID-19,Behavioral: EMDR,https://ClinicalTrials.gov/show/NCT04570202
4521,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,Drug: CM4620-IE (Injectable Emulsion)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04661540
4522,COVID-19: Post-covid Olfactory Disorders Assessment,,https://ClinicalTrials.gov/show/NCT04799977
4523,A Study of Auxora in Patients With Severe COVID-19 Pneumonia,Drug: Auxora|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04345614
4524,"Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic",,https://ClinicalTrials.gov/show/NCT04823988
4525,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,Device: VESTA respirator|Device: Conventional N95 respirator,https://ClinicalTrials.gov/show/NCT04490200
4526,GERAS Frailty Rehabilitation at Home During COVID-19,Behavioral: Socialization|Behavioral: Virtual Group Exercise|Combination Product: Nutrition Consult and Protein Supplementation|Behavioral: Medication Review,https://ClinicalTrials.gov/show/NCT04500366
4527,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,Other: specific exercise rehabilitation treatment,https://ClinicalTrials.gov/show/NCT04569266
4528,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,"Diagnostic Test: COVID-19 IgG / IgM rapid test (whole blood, serum, plasma)",https://ClinicalTrials.gov/show/NCT04511949
4529,COVID-19 Health Messaging to Underserved Communities,Behavioral: Messaging,https://ClinicalTrials.gov/show/NCT04371419
4530,COVID-19 Burnout Study,Behavioral: Mindfulness Based Intervention,https://ClinicalTrials.gov/show/NCT04594278
4531,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",Diagnostic Test: Covid-19 presto test,https://ClinicalTrials.gov/show/NCT04387968
4532,A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,Other: Ofatumumab|Other: Covid-19 vaccine,https://ClinicalTrials.gov/show/NCT04847596
4533,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Procedure: Direct laryngoscopy|Procedure: Vie Scope laryngoscopy,https://ClinicalTrials.gov/show/NCT04365608
4534,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,,https://ClinicalTrials.gov/show/NCT04366921
4535,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",Biological: CVnCoV Vaccine|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04449276
4536,Perceived Stress Among ICU Medical Staff During COVID-19 Crisis,,https://ClinicalTrials.gov/show/NCT04604769
4537,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers,,https://ClinicalTrials.gov/show/NCT04594395
4538,COVID-19 in People With Primary Ciliary Dyskinesia,,https://ClinicalTrials.gov/show/NCT04602481
4539,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,Biological: Plasma|Other: Best Available Therapy,https://ClinicalTrials.gov/show/NCT04358783
4540,Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04501432
4541,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,Behavioral: Emotion Regulation Training via Telehealth,https://ClinicalTrials.gov/show/NCT04615416
4542,Can COVID-19 Persist in Intraocular Fluid?,,https://ClinicalTrials.gov/show/NCT04945850
4543,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,Other: Observation only,https://ClinicalTrials.gov/show/NCT04379544
4544,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,Device: MejoraCare,https://ClinicalTrials.gov/show/NCT04659746
4545,COVID-19 and the Healthy Minds Program for Educators,Behavioral: Healthy Minds Program Foundations Training,https://ClinicalTrials.gov/show/NCT04426318
4546,W-SUDs for COVID-19,Other: Woebot Substance Use Disorder,https://ClinicalTrials.gov/show/NCT04460027
4547,"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia",Drug: Fixed-duration Hydrocortisone|Drug: Shock-dependent hydrocortisone|Drug: Ceftriaxone|Drug: Moxifloxacin or Levofloxacin|Drug: Piperacillin-tazobactam|Drug: Ceftaroline|Drug: Amoxicillin-clavulanate|Drug: Macrolide administered for 3-5 days|Drug: Macrolide administered for up to 14 days|Drug: Five-days oseltamivir|Drug: Ten-days oseltamivir|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + lopinavir/ritonavir|Drug: Interferon-β1a|Drug: Anakinra|Drug: Fixed-duration higher dose Hydrocortisone|Drug: Tocilizumab|Drug: Sarilumab|Drug: Vitamin C|Drug: Therapeutic anticoagulation|Drug: Simvastatin|Biological: Convalescent plasma|Other: Protocolised mechanical ventilation strategy|Drug: Eritoran|Drug: Apremilast|Drug: Aspirin|Drug: Clopidogrel|Drug: Prasugrel|Drug: Ticagrelor,https://ClinicalTrials.gov/show/NCT02735707
4548,COVID-19 Related Lockdown Effects On Chronic Diseases,Other: life questionnaires|Other: questionnaire,https://ClinicalTrials.gov/show/NCT04390126
4549,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,,https://ClinicalTrials.gov/show/NCT04388605
4550,Insomnia After the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04443361
4551,Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort,,https://ClinicalTrials.gov/show/NCT04758039
4552,National Survey of Mental Health After COVID-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04896983
4553,Telerehabilitation During Pandemic Containment Measures of COVID19,Other: upper limb training,https://ClinicalTrials.gov/show/NCT04945356
4554,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Other: Assembled mask,https://ClinicalTrials.gov/show/NCT04416919
4555,Expectations About the COVID-19 Vaccines,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04928911
4556,Assocation Between In-person Instruction and COVID-19 Risk,Behavioral: Online instruction|Behavioral: In-person instruction,https://ClinicalTrials.gov/show/NCT04529421
4557,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),Drug: Intravenous sedation|Drug: Inhaled sedation,https://ClinicalTrials.gov/show/NCT04383730
4558,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,Other: Telephone interview,https://ClinicalTrials.gov/show/NCT04385797
4559,Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC),Procedure: Surgical procedure for cancer,https://ClinicalTrials.gov/show/NCT04712292
4560,"The Psychological, Social, and Economic Impacts of COVID-19",,https://ClinicalTrials.gov/show/NCT04369690
4561,Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach,Genetic: Multi-OMICS,https://ClinicalTrials.gov/show/NCT04873128
4562,COVID-19 RELATED KIDNEY DAMAGE,Other: ACUTE KIDNEY INJURY,https://ClinicalTrials.gov/show/NCT04706325
4563,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,Biological: MMR vaccine,https://ClinicalTrials.gov/show/NCT04475081
4564,Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).,Diagnostic Test: saliva sample combined to an anterior nare self-swabbing (Self-samples)|Diagnostic Test: saliva sample (Self-sample)|Other: Survey of SARS-COV-19 knowledge|Other: Survey of acceptability of the different self-samples.,https://ClinicalTrials.gov/show/NCT04859023
4565,Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards,,https://ClinicalTrials.gov/show/NCT04544072
4566,COVID-19 Neurological Disease: A Prospective Study,Other: Primary exposure is hypoxia (no intervention),https://ClinicalTrials.gov/show/NCT04672590
4567,Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine,Biological: Pfizer|Biological: Moderna,https://ClinicalTrials.gov/show/NCT04900467
4568,COVID-19-Related Health and Practices Among Dental Hygienists,Other: No intervention,https://ClinicalTrials.gov/show/NCT04542915
4569,First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects,Drug: Orally Suspension of CoV2-OGEN1,https://ClinicalTrials.gov/show/NCT04893512
4570,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug: Colchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban,https://ClinicalTrials.gov/show/NCT04324463
4571,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug: Lopinavir/ritonavir,https://ClinicalTrials.gov/show/NCT04321174
4572,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Behavioral: Questionnaires,https://ClinicalTrials.gov/show/NCT04370210
4573,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04374097
4574,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),,https://ClinicalTrials.gov/show/NCT04435327
4575,Covid-19 Infection in Pregnancy,Diagnostic Test: COVID-19 test,https://ClinicalTrials.gov/show/NCT04869202
4576,A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,Drug: Ofatumumab|Biological: mRNA COVID-19 vaccine|Drug: interferon or glatiramer acetate,https://ClinicalTrials.gov/show/NCT04878211
4577,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study,,https://ClinicalTrials.gov/show/NCT04371848
4578,Exploring Interventions for Glue Ear During Covid-19,Device: Bone conduction headphones,https://ClinicalTrials.gov/show/NCT04427631
4579,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,,https://ClinicalTrials.gov/show/NCT04377074
4580,Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers and Patients Consequent to the COVID-19 Pandemic,Behavioral: Virtual Reality Exposure Therapy,https://ClinicalTrials.gov/show/NCT04887116
4581,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,Behavioral: Choices and judgements,https://ClinicalTrials.gov/show/NCT04542122
4582,Serology COVID-19 From the Cornwall Hospital Union,Biological: Serological test|Biological: Serum test,https://ClinicalTrials.gov/show/NCT04363593
4583,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04433286
4584,Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital,,https://ClinicalTrials.gov/show/NCT04736680
4585,COVID-19 in Nursing Homes 2020 and 2021,,https://ClinicalTrials.gov/show/NCT04945863
4586,Physical Activity in University Students Around COVID-19 Confinement,Other: On-Line Survey,https://ClinicalTrials.gov/show/NCT04361019
4587,Neuro-COVID-19: Neurological Complications of COVID-19,Other: further processing of health data,https://ClinicalTrials.gov/show/NCT04418609
4588,The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic,Behavioral: Culturally Adapted Cognitive Behavioral Intervention (CA-CBI),https://ClinicalTrials.gov/show/NCT04858789
4589,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Other: Exercise Group,https://ClinicalTrials.gov/show/NCT04381000
4590,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,Behavioral: Virtual Peer Support Platform|Behavioral: Control Period,https://ClinicalTrials.gov/show/NCT04474080
4591,ARDS Caused by COVID-19,,https://ClinicalTrials.gov/show/NCT04368975
4592,Active Pregnancy Against COVID-19,Other: Exercise program|Other: Healthy lifestyle advise,https://ClinicalTrials.gov/show/NCT04563065
4593,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Other: Survey administration,https://ClinicalTrials.gov/show/NCT04340219
4594,FOODLIT-PRO: Improving Food Literacy and Food Sustainability Amidst the COVID-19 Pandemic,Behavioral: Experimental Group|Behavioral: Comparison Group,https://ClinicalTrials.gov/show/NCT04806074
4595,App-based Symptom Tracking After Corona Vaccination (CoCoV),Biological: COVID-19 vaccines,https://ClinicalTrials.gov/show/NCT04686409
4596,Antimalarial and Covid 19 in Rheumatoid Arthritis,Drug: Hydroxychloroquine,https://ClinicalTrials.gov/show/NCT04389320
4597,"Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection",Diagnostic Test: EasyCov POC,https://ClinicalTrials.gov/show/NCT04583319
4598,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),Behavioral: Stress First Aid,https://ClinicalTrials.gov/show/NCT04723576
4599,The COVID-19 and Healthcare Workers: An Active Intervention,Other: Video-Based intervention,https://ClinicalTrials.gov/show/NCT04497415
4600,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,,https://ClinicalTrials.gov/show/NCT04397575
4601,COVID-19 and Its Effects on Chronic Pain Patients,Other: No intervention (only interview),https://ClinicalTrials.gov/show/NCT04715815
4602,Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx,Drug: 0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient|Drug: 0.6% PVP-I Oral and nasal spray to asymptomatic to mild COVID-19 patient having multiple comorbidity|Drug: 0.6% PVP-I Oral and nasal spray to healthy volunteer|Other: Oral and nasal spray by distilled water to control group,https://ClinicalTrials.gov/show/NCT04872686
4603,Addressing COVID-19 Mental Health Problems Among US Veterans,Other: A short video intervention|Other: A vignette intervention,https://ClinicalTrials.gov/show/NCT04484207
4604,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Other: Pandemic control measures,https://ClinicalTrials.gov/show/NCT04377412
4605,Pharmacy Education During Covid-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04409951
4606,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),Procedure: Tracheal intubation and cardiopulmonary resuscitation,https://ClinicalTrials.gov/show/NCT04479332
4607,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Other: COVID-19 infection,https://ClinicalTrials.gov/show/NCT04335747
4608,Effect of COVID19-related COntainment in ChildreN,Other: cries 13 questionnaire,https://ClinicalTrials.gov/show/NCT04615195
4609,COVID-19 Vaccination in Rheumatic Disease Patients,Biological: mRNA COVD19 vaccine,https://ClinicalTrials.gov/show/NCT04839315
4610,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures,,https://ClinicalTrials.gov/show/NCT04482205
4611,The COVID-19 Pandemic and Exercise Study,Behavioral: Yoga group|Behavioral: High Intensity Interval Training group|Behavioral: Combination,https://ClinicalTrials.gov/show/NCT04400279
4612,Determinants of COVID-19 Pneumonia (MC-19),Diagnostic Test: Serology for Covid-19,https://ClinicalTrials.gov/show/NCT04387799
4613,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients,Diagnostic Test: Testing of SARS-CoV-2 antibodies,https://ClinicalTrials.gov/show/NCT04498286
4614,Immune Response Following COVID-19 Vaccination,Other: Rapid antibody test,https://ClinicalTrials.gov/show/NCT04736524
4615,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy,Other: data collection,https://ClinicalTrials.gov/show/NCT04733846
4616,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Behavioral: Virtual-Care Cognitive Behavioural Therapy,https://ClinicalTrials.gov/show/NCT04408027
4617,Understanding COVID-19 Infection in Pregnant Women and Their Babies,,https://ClinicalTrials.gov/show/NCT04703270
4618,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),Behavioral: Simulation Intervention|Behavioral: Control,https://ClinicalTrials.gov/show/NCT04614844
4619,SMS Maama Project COVID-19,Behavioral: mHealth Platform,https://ClinicalTrials.gov/show/NCT04739462
4620,Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine,Biological: Evaluation of the immunogenicity of the vaccine in haemodialysis patients,https://ClinicalTrials.gov/show/NCT04881396
4621,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",,https://ClinicalTrials.gov/show/NCT04402905
4622,Knowledge About Covid-19 Infection in Pregnant Women,Other: labs,https://ClinicalTrials.gov/show/NCT04423692
4623,Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic,Behavioral: Online Lifestyle Intervention|Other: Control Group,https://ClinicalTrials.gov/show/NCT04772859
4624,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,Other: No interverntion,https://ClinicalTrials.gov/show/NCT04430374
4625,Covid-19 Lockdown and Deviant Sexual Fantasies,Behavioral: Questionnaire for evaluation of confinement on deviant sexual fantasies,https://ClinicalTrials.gov/show/NCT04448405
4626,Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19,Other: Follow up calls,https://ClinicalTrials.gov/show/NCT04619368
4627,Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe,Other: None - Descriptive study,https://ClinicalTrials.gov/show/NCT04782739
4628,Spironolactone in Covid-19 Induced ARDS,Drug: Spironolactone 100mg|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04345887
4629,Non-contact Endoscopy at Covid-19 Outbreak,Device: Non-contact MCE system,https://ClinicalTrials.gov/show/NCT04320953
4630,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,,https://ClinicalTrials.gov/show/NCT04409574
4631,Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients,Drug: Dexamethasone|Drug: Methylprednisolone,https://ClinicalTrials.gov/show/NCT04780581
4632,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor",,https://ClinicalTrials.gov/show/NCT04568551
4633,Exercise Influence on COVID-19,Diagnostic Test: COVID-19 survey,https://ClinicalTrials.gov/show/NCT04624048
4634,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic,Other: Sudarshan Kriya Yoga (SKY)|Other: Health Enhancement Program,https://ClinicalTrials.gov/show/NCT04368676
4635,Characteristics in Post Covid-19 Patients,Other: Exercise,https://ClinicalTrials.gov/show/NCT04514705
4636,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Behavioral: HOPE intervention,https://ClinicalTrials.gov/show/NCT04376515
4637,Comparing the Antibody Response to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab or Natalizumab,Device: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test|Device: T-Detect COVID T-cell blood test,https://ClinicalTrials.gov/show/NCT04837651
4638,Psychological Impairment Due to Covid-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04368312
4639,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug: Conestat alfa,https://ClinicalTrials.gov/show/NCT04414631
4640,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Dietary Supplement: Chinese Herbal Medicine,https://ClinicalTrials.gov/show/NCT04380870
4641,Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study,Drug: DAS181|Drug: Placebo|Drug: DAS181 COVID-19|Drug: DAS181 OL,https://ClinicalTrials.gov/show/NCT03808922
4642,LIBERATE Trial in COVID-19,Drug: Ibuprofen,https://ClinicalTrials.gov/show/NCT04334629
4643,COVID-19 Contact Study by Antigen Detection Test,Diagnostic Test: Antigen detection test,https://ClinicalTrials.gov/show/NCT04745533
4644,"Covid-19, Hospitalized, PatIents, Nasafytol",Drug: NASAFYTOL®|Drug: FULTIUM® -D3 800,https://ClinicalTrials.gov/show/NCT04844658
4645,COVID-19 Health Professional Impact Study,Other: Survey|Diagnostic Test: SARS-CoV-2 antibody test,https://ClinicalTrials.gov/show/NCT04527432
4646,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,Other: service of questionnaire,https://ClinicalTrials.gov/show/NCT04604080
4647,Dexamethasone and COVID-19 Inpatient Mortality,Drug: Dexamethasone Oral,https://ClinicalTrials.gov/show/NCT04926571
4648,Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies,,https://ClinicalTrials.gov/show/NCT04748185
4649,Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222,Other: None (Observational study),https://ClinicalTrials.gov/show/NCT04877743
4650,The Seniors COvid-19 Pandemic and Exercise Study,Behavioral: Virtual Group Intervention|Behavioral: Personal Exercise Intervention,https://ClinicalTrials.gov/show/NCT04412343
4651,Acute kIDnEy Injury in coviD-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04583293
4652,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Other: Cross-sectional study investigating the association of NPIs with mental health,https://ClinicalTrials.gov/show/NCT04356365
4653,COVID-19 and Psychotic Symptoms in France,,https://ClinicalTrials.gov/show/NCT04356885
4654,Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns,Other: healthcare workers with the coronavac vaccine,https://ClinicalTrials.gov/show/NCT04854408
4655,Impact of the Covid-19 on RSV Epidemic,Other: Medical records analysis|Other: Comparison of cohorts,https://ClinicalTrials.gov/show/NCT04944160
4656,CoViD-19 Patient in Reims University Hospital in March to April 2020,Biological: serology,https://ClinicalTrials.gov/show/NCT04553575
4657,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug: Tirofiban Injection|Drug: Clopidogrel|Drug: Acetylsalicylic acid|Drug: Fondaparinux,https://ClinicalTrials.gov/show/NCT04368377
4658,COVID-19 Vaccine Confidence Among Pregnant Women and Mothers,Other: This is an online survey with no intervention.,https://ClinicalTrials.gov/show/NCT04694664
4659,Percutaneous Tracheostomy With COVID-19,Procedure: Tracheostomy with aerosol box in COVID-19 positive patients,https://ClinicalTrials.gov/show/NCT04447638
4660,3D Telemedicine During COVID-19: Cohort Study,Other: 3D Telemedicine,https://ClinicalTrials.gov/show/NCT04444323
4661,Analysis Before and After COVID 19,Other: Cost,https://ClinicalTrials.gov/show/NCT04748614
4662,Surgical Consent During the COVID-19 Pandemic,Behavioral: Educational meetings and visual prompts,https://ClinicalTrials.gov/show/NCT04556604
4663,Consequences of COVID 19 Pandemic on Childhood Asthma,,https://ClinicalTrials.gov/show/NCT04821908
4664,Sexual Function During COVID 19 Pandemic,Other: Electronic questionnaire,https://ClinicalTrials.gov/show/NCT04395885
4665,Self-sampling for the Study of COVID-19,Diagnostic Test: iAMP test,https://ClinicalTrials.gov/show/NCT04447495
4666,Cerebral Compliance Impairment in COVID-19,Device: Cerebral compliance and hemodynamics monitoring,https://ClinicalTrials.gov/show/NCT04429477
4667,HFNC Treatment in COVID-19 Pneumonia,Device: high flow nasal cannula device,https://ClinicalTrials.gov/show/NCT04424836
4668,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,Dietary Supplement: Probiotics|Other: Placebo,https://ClinicalTrials.gov/show/NCT04517422
4669,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other: SPIN-CHAT Program,https://ClinicalTrials.gov/show/NCT04335279
4670,COVID-19 Psychological Wellbeing for Healthcare Students,Other: COVID-19 e-package: Psychological wellbeing for healthcare workers,https://ClinicalTrials.gov/show/NCT04429828
4671,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",Other: Rehabilitation exercise protocol,https://ClinicalTrials.gov/show/NCT04471831
4672,Parental Stress After the Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04442308
4673,Immunogenicity of COVID-19 Vaccination in PLWH,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04894448
4674,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,Other: Questionnaires,https://ClinicalTrials.gov/show/NCT04431284
4675,SARS-CoV-2 (COVID-19) and Surgery,Other: No intervention (survey study for medical doctors).,https://ClinicalTrials.gov/show/NCT04368026
4676,Social Acceptability of COVID-19 Vaccines in Pakistan,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04727372
4677,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,,https://ClinicalTrials.gov/show/NCT04386460
4678,Etiology of Lymphopenia in Covid19 Infection,"Diagnostic Test: Complete blood picture, bone marrow aspiration cytology",https://ClinicalTrials.gov/show/NCT04404608
4679,Influence of the COvid-19 Epidemic on STRESS,,https://ClinicalTrials.gov/show/NCT04308187
4680,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Behavioral: Enhanced hygiene measures,https://ClinicalTrials.gov/show/NCT04348227
4681,The Get Outside Study,Behavioral: Hiking challenge|Other: Activity list,https://ClinicalTrials.gov/show/NCT04685681
4682,STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During COVID-19,Behavioral: Supportive Trauma Exposure Preparation Program,https://ClinicalTrials.gov/show/NCT04682561
4683,Renal Outcome in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04353583
4684,Virtual Reality Study - COVID-19 Protocol,Behavioral: Physical and Cognitive Activity,https://ClinicalTrials.gov/show/NCT04678778
4685,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Diagnostic Test: Low-dose Chest CT,https://ClinicalTrials.gov/show/NCT04379531
4686,3D Telemedicine During COVID-19: Non-clinical Validation,Other: 3D Telemedicine|Other: 2D Telemedicine,https://ClinicalTrials.gov/show/NCT04444297
4687,Southampton Women's Survey COVID-19 Study,Other: Experience of pandemic,https://ClinicalTrials.gov/show/NCT04666285
4688,Escin in Patients With Covid-19 Infection,Drug: Escin|Drug: standard therapy,https://ClinicalTrials.gov/show/NCT04322344
4689,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India,,https://ClinicalTrials.gov/show/NCT04469660
4690,COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic,,https://ClinicalTrials.gov/show/NCT04451902
4691,COVID-19 Risk Reduction Among African American Parishioners,"Behavioral: Change in knowledge, motivation, skills, resources",https://ClinicalTrials.gov/show/NCT04542343
4692,The Impact of the COVID-19 Pandemic on Diabetes Management,Other: No intervention,https://ClinicalTrials.gov/show/NCT04821921
4693,Fibromyalgia During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04422522
4694,CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,Radiation: cardiac magnetic resonance,https://ClinicalTrials.gov/show/NCT04628104
4695,ASCO Survey on COVID-19 in Oncology (ASCO) Registry,,https://ClinicalTrials.gov/show/NCT04659135
4696,Distress in Crisis Situations During COVID-19,Other: questionnaire assesment,https://ClinicalTrials.gov/show/NCT04337047
4697,COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2,Other: Additional biological samples,https://ClinicalTrials.gov/show/NCT04836793
4698,Clinical and Radiomic Model of COVID-19,Diagnostic Test: Machine learning model,https://ClinicalTrials.gov/show/NCT04337502
4699,Acute Kidney Injury Risk in COVID-19,Other: non,https://ClinicalTrials.gov/show/NCT04874779
4700,Treating COVID-19 With a Bidirectional Oxygenation Valve,Device: bidirectional oxygenation mouthpiece,https://ClinicalTrials.gov/show/NCT04326452
4701,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,,https://ClinicalTrials.gov/show/NCT04327180
4702,Functional Exhaustion of T Cells in COVID19 Patients,Diagnostic Test: Flow cytometry,https://ClinicalTrials.gov/show/NCT04470323
4703,Non-Invasive Intracranial Pressure in COVID-19 Individuals,Device: The ICP monitoring will be performed in a non-invasive method developed by Brain4Care,https://ClinicalTrials.gov/show/NCT04861402
4704,Inhaled Ibuprofen to Treat COVID-19,Drug: Inhaled Hypertonic ibuprofen,https://ClinicalTrials.gov/show/NCT04382768
4705,Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk,Other: Data collection,https://ClinicalTrials.gov/show/NCT04891276
4706,Virtual Pain Care Management (COVID-19),Other: VCPM,https://ClinicalTrials.gov/show/NCT04539821
4707,Surfactant Protein Genetic Variants in COVID-19 Infection,Other: Identification of genetic variants,https://ClinicalTrials.gov/show/NCT04650191
4708,Collection of RNA Extracted From Nasopharyngeal and Saliva Samples From Same Patients With Suspicion of Covid-19,Other: saliva sampling,https://ClinicalTrials.gov/show/NCT04949074
4709,NO Prevention of COVID-19 for Healthcare Providers,Drug: Inhaled nitric oxide gas,https://ClinicalTrials.gov/show/NCT04312243
4710,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,Other: gastroscopy in transnasal techique,https://ClinicalTrials.gov/show/NCT04734912
4711,Emails Promoting COVID-19 Vaccination Among Healthcare Workers,Behavioral: Social Proof|Behavioral: Reframing|Behavioral: Scarcity Message,https://ClinicalTrials.gov/show/NCT04728594
4712,Sequencing and Tracking of Phylogeny in COVID-19 Study,,https://ClinicalTrials.gov/show/NCT04359849
4713,Evaluation of a Synbiotic Formula in Patient With COVID-19,Other: Health supplements,https://ClinicalTrials.gov/show/NCT04730284
4714,UVA Light Device to Treat COVID-19,Device: UV Light Treatment,https://ClinicalTrials.gov/show/NCT04572399
4715,Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services,,https://ClinicalTrials.gov/show/NCT04668937
4716,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,Other: maslach burnout inventory questionnair,https://ClinicalTrials.gov/show/NCT04363229
4717,Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy,Drug: Atorvastatin|Other: Standard Care,https://ClinicalTrials.gov/show/NCT04904536
4718,COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos),Behavioral: Promotores de Salud|Behavioral: Services as usual,https://ClinicalTrials.gov/show/NCT04793464
4719,Dental Anxiety Among Children Pre and Post COVID 19 Pandemic,Other: routine dental restorative procedures,https://ClinicalTrials.gov/show/NCT04815759
4720,Prognostic Factors Keeping Track for COVID-19 Pneumonia,,https://ClinicalTrials.gov/show/NCT04324684
4721,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Biological: Blood sample,https://ClinicalTrials.gov/show/NCT04408131
4722,Behavior Change in Context to Contain the Spread of COVID-19,Behavioral: Motivation|Behavioral: Habit|Behavioral: Social,https://ClinicalTrials.gov/show/NCT04830761
4723,Capturing MultiORgan Effects of COVID-19,Diagnostic Test: Magnetic Resonance Imaging,https://ClinicalTrials.gov/show/NCT04510025
4724,Supporting the Wellness of Ontario Physicians During COVID-19,"Other: Remote SMS (short message service, also known as ""text message"") delivery",https://ClinicalTrials.gov/show/NCT04803812
4725,Can the Prediction Market Improve Predictions of COVID-19?,Other: Prediction Market,https://ClinicalTrials.gov/show/NCT04410692
4726,The Impact of Sinopharm COVID-19 Vaccination on Male Fertility,Diagnostic Test: Semen analysis,https://ClinicalTrials.gov/show/NCT04946565
4727,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers,,https://ClinicalTrials.gov/show/NCT04510519
4728,At Home Monitoring for Patients With Covid19,Device: Covidfree@home,https://ClinicalTrials.gov/show/NCT04453774
4729,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",,https://ClinicalTrials.gov/show/NCT04357041
4730,COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study,Biological: SARS-CoV-2 virus,https://ClinicalTrials.gov/show/NCT04864548
4731,Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death,Biological: AZD1222,https://ClinicalTrials.gov/show/NCT04914832
4732,Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD),Diagnostic Test: Study questionnaire,https://ClinicalTrials.gov/show/NCT04876443
4733,Effects of the COVID-19 Pandemic on Fibromyalgia Patients,"Other: Perceived stress scale|Other: Fibromyalgia impact questionnaire|Other: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status",https://ClinicalTrials.gov/show/NCT04730934
4734,COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector,Other: Health Questionnaire,https://ClinicalTrials.gov/show/NCT04481529
4735,Predictors of Mental Well-being During the COVID-19 Pandemic,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,https://ClinicalTrials.gov/show/NCT04443699
4736,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,"Other: Data research, database analysis",https://ClinicalTrials.gov/show/NCT04379245
4737,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,Diagnostic Test: ELISPOT,https://ClinicalTrials.gov/show/NCT04707820
4738,Blood Donor Recruitment During Epidemic of COVID-19,Other: Questionnaire with precaution information|Other: Experimental: Questionnaire without precaution information,https://ClinicalTrials.gov/show/NCT04306055
4739,Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment,Other: Online questionnaire,https://ClinicalTrials.gov/show/NCT04496869
4740,Role of Mega Dose of Vitamin C in Critical COVID-19 Patients,Drug: Vitamin C,https://ClinicalTrials.gov/show/NCT04682574
4741,Handling Oxygenation Targets in COVID-19,Drug: Oxygen,https://ClinicalTrials.gov/show/NCT04425031
4742,A Comparison of 3D and 2D Telemedicine During Covid 19,Other: 3D Telemedicine|Other: 2D Telemedicine,https://ClinicalTrials.gov/show/NCT04359225
4743,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience,Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04728880
4744,Impact of COVID-19 on Mental Health of Patients With Skin Picking,Behavioral: Internet-based Cognitive Behavioral Therapy|Other: Quality of life promotion,https://ClinicalTrials.gov/show/NCT04522492
4745,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,Biological: Mesenchymal stromal cells,https://ClinicalTrials.gov/show/NCT04445454
4746,Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era,Other: Remote Automated Monitoring System,https://ClinicalTrials.gov/show/NCT04661423
4747,tDCS in Post-Acute COVID-19 Patients With SARDs,Device: Transcranial direct current stimulation,https://ClinicalTrials.gov/show/NCT04890483
4748,Ozone Therapy in the Prevention of COVID-19 Infection,,https://ClinicalTrials.gov/show/NCT04400006
4749,Disease Containment Measures Among Older Adults During the Covid-19 Pandemia,,https://ClinicalTrials.gov/show/NCT04792086
4750,"Repercussion of the COVID-19 Pandemic on Physical Activity, Psychological State and Sleep",,https://ClinicalTrials.gov/show/NCT04772404
4751,The Psychological Impact of the COVID-19 on Students.,,https://ClinicalTrials.gov/show/NCT04365361
4752,BIO 300 Oral Suspension in Discharged COVID-19 Patients,Drug: BIO 300 Oral Suspension|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04482595
4753,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,https://ClinicalTrials.gov/show/NCT04442386
4754,COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,Drug: REGN10933 + REGN10987|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04452318
4755,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug: Experimental drug,https://ClinicalTrials.gov/show/NCT04357613
4756,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,Other: Beck Depression Inventory (BDI),https://ClinicalTrials.gov/show/NCT04444557
4757,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),"Drug: cholecalciferol 200,000 IU|Drug: cholecalciferol 50,000 IU",https://ClinicalTrials.gov/show/NCT04344041
4758,The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,Other: The Effects of Covid 19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,https://ClinicalTrials.gov/show/NCT04811885
4759,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,Procedure: Observation for study group,https://ClinicalTrials.gov/show/NCT04623346
4760,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Behavioral: blood donation SMS,https://ClinicalTrials.gov/show/NCT04370886
4761,Risk Factors for Community- and Workplace Transmission of COVID-19,Behavioral: Observation of behavior and COVID-19 infection will be conducted.,https://ClinicalTrials.gov/show/NCT04320732
4762,Obstetric and Perinatal Outcomes of Women With COVID-19,Behavioral: Examine the impact of COVID-19 during pregnancy,https://ClinicalTrials.gov/show/NCT04369859
4763,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Behavioral: Anxiety Reduction Training|Behavioral: Kundalini Yoga and Anxiety Reduction Training|Behavioral: Meditation and Anxiety Reduction Training,https://ClinicalTrials.gov/show/NCT04386291
4764,Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak,Other: A questionnaire and scales.,https://ClinicalTrials.gov/show/NCT04836039
4765,Immune Responses to COVID-19 Vaccination in Lymphoma Patients,,https://ClinicalTrials.gov/show/NCT04858568
4766,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,Drug: Colchicine 0.5 MG|Combination Product: CONTROL GROUP,https://ClinicalTrials.gov/show/NCT04539873
4767,An Approach to Screening for COVID-19 at Vancouver Airport,Diagnostic Test: Rapid Antigen Test,https://ClinicalTrials.gov/show/NCT04665193
4768,Improving Activity Engagement Among Persons With SCI During COVID-19,Other: WebEx Physical Activity Program,https://ClinicalTrials.gov/show/NCT04408287
4769,Evaluation of Dental Emergency Treatments During COVID19 Crisis,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04354272
4770,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,,https://ClinicalTrials.gov/show/NCT04440098
4771,SARS-CoV 2 in Personal Protective Equipment,,https://ClinicalTrials.gov/show/NCT04398043
4772,Correlation Between Oxidative Stress Status and COVID-19 Severity,Diagnostic Test: Oxidative Stress ELISA Kit,https://ClinicalTrials.gov/show/NCT04375137
4773,Migrant Workers' Responses to the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04718519
4774,Living With Sickle Cell Disease in the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04417673
4775,Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis,Device: cytokine hemadsorption,https://ClinicalTrials.gov/show/NCT04920851
4776,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults,Biological: BNT162a1|Biological: BNT162b1|Biological: BNT162b2|Biological: BNT162c2,https://ClinicalTrials.gov/show/NCT04380701
4777,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug: Apo-Hydroxychloroquine|Drug: Matched Placebo,https://ClinicalTrials.gov/show/NCT04371523
4778,Access to Chiropractic Care During the COVID-19 Pandemic,Other: Chiropractic care,https://ClinicalTrials.gov/show/NCT04666779
4779,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,,https://ClinicalTrials.gov/show/NCT04548505
4780,COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies,Other: Data collection,https://ClinicalTrials.gov/show/NCT04776005
4781,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Other: There is no intervention,https://ClinicalTrials.gov/show/NCT04373148
4782,Mask Usage and Exercise During the COVİD-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04498546
4783,Acupressure for COVID-19 Related Quality of Life and Stress,Behavioral: Self-acupressure,https://ClinicalTrials.gov/show/NCT04472559
4784,Psychological Symptoms and Families of COVID-19 Patients,Behavioral: Written Summary of Rounds,https://ClinicalTrials.gov/show/NCT04501445
4785,Carotid Stenosis Management During COVID-19 Era - Pilot Study,,https://ClinicalTrials.gov/show/NCT04947046
4786,Cerebral Bleeding in COVID-19 ARDS Patients on Veno-venous ECMO,Other: Incidence of bleeding complications in ARDS patients on veno-venous ECMO,https://ClinicalTrials.gov/show/NCT04853953
4787,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),Drug: Opaganib|Drug: Standard of Care,https://ClinicalTrials.gov/show/NCT04435106
4788,"COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency",,https://ClinicalTrials.gov/show/NCT04724642
4789,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,,https://ClinicalTrials.gov/show/NCT04444661
4790,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,Biological: Biological data|Other: Clinical data,https://ClinicalTrials.gov/show/NCT04498091
4791,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug: Inhaled budesonide,https://ClinicalTrials.gov/show/NCT04355637
4792,Iron and COVID-19 Vaccine Response,Dietary Supplement: Ferinject,https://ClinicalTrials.gov/show/NCT04915820
4793,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,Diagnostic Test: Serological test,https://ClinicalTrials.gov/show/NCT04530461
4794,VRQOL in Cataract Patients During the COVID-19 Pandemic,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04468308
4795,ACE2 Gender Differences in Stroke With COVID-19,Device: Robotic assisted intervention|Genetic: epigenetic analyses|Diagnostic Test: biochemical analyses,https://ClinicalTrials.gov/show/NCT04766645
4796,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Other: Mindfulness Rounds,https://ClinicalTrials.gov/show/NCT04431297
4797,Mental Health in Communities Affected by COVID-19 in Uganda,Behavioral: Psycho-education|Behavioral: Comparator,https://ClinicalTrials.gov/show/NCT04616989
4798,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,Other: HIT-exercise|Other: Sham intervention,https://ClinicalTrials.gov/show/NCT04420806
4799,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,Diagnostic Test: Serological test for COVID-19.,https://ClinicalTrials.gov/show/NCT04429815
4800,Creating a Virtual Village for People Aging With HIV During COVID-19,Other: Virtual Village,https://ClinicalTrials.gov/show/NCT04747756
4801,Evaluation of Covid-19 Vaccination in Elderly Subjects in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-de-France,,https://ClinicalTrials.gov/show/NCT04900376
4802,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Dietary Supplement: Ayurveda|Other: Usual Care,https://ClinicalTrials.gov/show/NCT04351542
4803,"Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage",Other: Pre-pandemic stroke related metrics|Other: Stroke related metrics during the pandemic,https://ClinicalTrials.gov/show/NCT04934020
4804,Heart Patch for Myocardial Infarction COVID-19,Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells,https://ClinicalTrials.gov/show/NCT04728906
4805,Reflective Tasks With Healthcare Workers During COVID-19,Behavioral: Gratitude,https://ClinicalTrials.gov/show/NCT04728958
4806,Annexin A5 in Patients With Severe COVID-19 Disease,Drug: recombinant human annexin A5|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04748757
4807,External Dead Space in Ventilated COVID-19 Patients,Other: Removal of dead space filter,https://ClinicalTrials.gov/show/NCT04424082
4808,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Device: SensiumVitals wearable sensor,https://ClinicalTrials.gov/show/NCT04337489
4809,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,Other: Colonoscopy,https://ClinicalTrials.gov/show/NCT04637893
4810,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,Procedure: Thyroidectomy,https://ClinicalTrials.gov/show/NCT04635813
4811,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,Other: COVID positive via testing,https://ClinicalTrials.gov/show/NCT04385914
4812,Medical Masks vs N95 Respirators for COVID-19,Device: Medical Mask|Device: N95 respirator,https://ClinicalTrials.gov/show/NCT04296643
4813,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Other: No intervention,https://ClinicalTrials.gov/show/NCT04343898
4814,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,Behavioral: VR for psychoeducation and relaxation|Behavioral: Text material for psychoeducation and audio for relaxation techniques,https://ClinicalTrials.gov/show/NCT04611399
4815,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Other: pregnant women with laboratory-confirmed 2019-n-CoV,https://ClinicalTrials.gov/show/NCT04319016
4816,MRI Changes of Acute Kidney Injury in COVID-19,Procedure: MRI scans,https://ClinicalTrials.gov/show/NCT04594291
4817,Accurate Classification System for Patients With COVID-19 Pneumonitis,,https://ClinicalTrials.gov/show/NCT04302688
4818,Prospective Electroencephalography Evaluation of Sedation in COVID-19,Other: Encephalography measurement,https://ClinicalTrials.gov/show/NCT04815109
4819,Impact of Isolation in Patients With IBD During the COVID-19 Crisis,,https://ClinicalTrials.gov/show/NCT04488471
4820,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,Drug: Hydroxychloroquine|Drug: Ivermectin,https://ClinicalTrials.gov/show/NCT04384458
4821,Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients,Drug: Nitroglycerin,https://ClinicalTrials.gov/show/NCT04686760
4822,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04448704
4823,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,https://ClinicalTrials.gov/show/NCT04442360
4824,C-reactive Protein Levels Among Individuals With COVID-19,Diagnostic Test: C-reactive protein,https://ClinicalTrials.gov/show/NCT04373798
4825,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Drug: Nitazoxanide 500Mg Oral Tablet,https://ClinicalTrials.gov/show/NCT04406246
4826,Antibody Response to COVID-19 Vaccines in Liver Disease Patients,Biological: BNT162b2|Biological: CoronaVac|Biological: AZD1222,https://ClinicalTrials.gov/show/NCT04775069
4827,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Other: Prospective study across two time-points examining the impact of viral mitigation protocols on mental health,https://ClinicalTrials.gov/show/NCT04442204
4828,Surfactant Levels in the Lungs of COVID-19 Patients,Diagnostic Test: Surfactant assessment,https://ClinicalTrials.gov/show/NCT04609488
4829,Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics,Diagnostic Test: Senior Fitness Test,https://ClinicalTrials.gov/show/NCT04819282
4830,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,Other: Online questionnaire,https://ClinicalTrials.gov/show/NCT04475484
4831,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,,https://ClinicalTrials.gov/show/NCT04357314
4832,Hesperidin and Diosmin for Treatment of COVID-19,Drug: Hesperidin and Diosmin mixture,https://ClinicalTrials.gov/show/NCT04452799
4833,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,Other: measurement of circulating sFlt1 concentration,https://ClinicalTrials.gov/show/NCT04394195
4834,Copeptin and Psychological Stress of Medic During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04757285
4835,Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.,"Device: Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA",https://ClinicalTrials.gov/show/NCT04479280
4836,Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic,Device: Digital dance for PD,https://ClinicalTrials.gov/show/NCT04942392
4837,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,Behavioral: Transcendental Meditation,https://ClinicalTrials.gov/show/NCT04632368
4838,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,"Other: Dietary counselling on Food Groups according to IYC Feeding practices, WHO",https://ClinicalTrials.gov/show/NCT04447209
4839,A Study to Evaluate Vaccines Against COVID-19 in the Real World,,https://ClinicalTrials.gov/show/NCT04775056
4840,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,,https://ClinicalTrials.gov/show/NCT04333849
4841,GlobalSurg-CovidSurg Week,,https://ClinicalTrials.gov/show/NCT04509986
4842,Vaccination Against COVID-19 in Chronic Kidney Disease,Other: No intervention; observational study,https://ClinicalTrials.gov/show/NCT04743947
4843,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,,https://ClinicalTrials.gov/show/NCT04319172
4844,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Device: NIO® (Intraosseous access)|Device: Standard of Care (Intravenous access),https://ClinicalTrials.gov/show/NCT04366947
4845,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,Other: exposure,https://ClinicalTrials.gov/show/NCT04535297
4846,Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown,Behavioral: Evaluation,https://ClinicalTrials.gov/show/NCT04738721
4847,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,Behavioral: Emotional Support Plan|Behavioral: Daily Monitoring,https://ClinicalTrials.gov/show/NCT04460677
4848,The Investigation of the Neonates With or With Risk of COVID-19,,https://ClinicalTrials.gov/show/NCT04279899
4849,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Behavioral: Computer task questionnaires,https://ClinicalTrials.gov/show/NCT04377100
4850,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,Other: Non interventional study,https://ClinicalTrials.gov/show/NCT04459975
4851,Effect of Covid-19 Pandemic on Emergency Surgery Practice,Other: Observational study,https://ClinicalTrials.gov/show/NCT04815135
4852,Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19,Drug: Interleukin 6 (IL6) Antagonist|Drug: Interleukin 6 (IL6) Antagonist and corticosteroids|Drug: corticosteroid alone,https://ClinicalTrials.gov/show/NCT04486521
4853,Effects on the Qt Interval of COVID-19 Coronavirus Infection,,https://ClinicalTrials.gov/show/NCT04422535
4854,Sisonke (Together): OPEN LABEL TRIAL COVID-19,Biological: To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04838795
4855,Muscle-targeted Nutritional Therapy for the Recovery From COVID-19,Other: Muscle-target oral nutritional supplementation,https://ClinicalTrials.gov/show/NCT04756856
4856,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,,https://ClinicalTrials.gov/show/NCT04365348
4857,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Device: MAGEC Spine Rod|Diagnostic Test: Titanium blood test,https://ClinicalTrials.gov/show/NCT04337151
4858,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",Behavioral: Contain COVID Anxiety SSI|Behavioral: Remain COVID Free SSI,https://ClinicalTrials.gov/show/NCT04459455
4859,Burnout Determinants Among Pediatric Psychiatry Workers During COVID-19 Crisis,,https://ClinicalTrials.gov/show/NCT04902118
4860,Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient,Other: Asynchronous telerehabilitation programme|Other: Rehabilitation programme,https://ClinicalTrials.gov/show/NCT04794036
4861,Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic,Other: Group 1,https://ClinicalTrials.gov/show/NCT04576299
4862,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,Other: Bacterial species isolated,https://ClinicalTrials.gov/show/NCT04344509
4863,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,Diagnostic Test: conjunctival RT PCR,https://ClinicalTrials.gov/show/NCT04397666
4864,Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),Other: Survey,https://ClinicalTrials.gov/show/NCT04488549
4865,A Survey to Assess Effects of Covid-19 on Cardiovascular Patients,"Other: Symptomatology, Treatment. daily Activities and Anxiety for Cardiovascular patients Survey (STRATA)",https://ClinicalTrials.gov/show/NCT04508920
4866,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04524754
4867,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Other: Learning running subcuticular sutures on the Gamified Educational Network,https://ClinicalTrials.gov/show/NCT04425499
4868,Clinical Characteristics of Critically Ill Patients With COVID-19,Other: File Scanning,https://ClinicalTrials.gov/show/NCT04413435
4869,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04315480
4870,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,Drug: Tocilizumab|Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04476979
4871,Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04497467
4872,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostic Test: Serological tests will be applied on patients blood sampling,https://ClinicalTrials.gov/show/NCT04341142
4873,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,Drug: topical steroids and cyclosporin-A,https://ClinicalTrials.gov/show/NCT04451239
4874,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Device: Freestyle Libre 14 day CGM system|Device: Accuchek Inform II platform,https://ClinicalTrials.gov/show/NCT04417270
4875,Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:,Other: blood collection,https://ClinicalTrials.gov/show/NCT04916847
4876,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,Behavioral: Reward Re-Training|Behavioral: Supportive Therapy,https://ClinicalTrials.gov/show/NCT04661410
4877,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Other: retrospective analysis,https://ClinicalTrials.gov/show/NCT04328454
4878,Prioritising Prevention of COVID-19 in Persons With Cancer in the French West Indies,Biological: Serology,https://ClinicalTrials.gov/show/NCT04768153
4879,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,Behavioral: Trauma-informed yoga video recording,https://ClinicalTrials.gov/show/NCT04453514
4880,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,Drug: Vitamin D|Drug: PLACEBO,https://ClinicalTrials.gov/show/NCT04621058
4881,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Device: COVSurf Drug Delivery System|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04362059
4882,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Drug: ACE inhibitor,https://ClinicalTrials.gov/show/NCT04322786
4883,Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19,Drug: Spironolactone + Dexamethasone|Drug: Standard-of-care SARS-CoV-2 treatment,https://ClinicalTrials.gov/show/NCT04826822
4884,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital,Device: CT of the chest,https://ClinicalTrials.gov/show/NCT04481360
4885,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,Device: Percutaneous Coronary Revascularization for STEMI,https://ClinicalTrials.gov/show/NCT04412655
4886,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,Diagnostic Test: Novel laser inferometry test for CORONA virus,https://ClinicalTrials.gov/show/NCT04401644
4887,Yoga in NHS Health Care Workers With COVID-19 Related Stress,Other: Yoga,https://ClinicalTrials.gov/show/NCT04481516
4888,Maternal Telemental Health Interventions in Response to Covid-19*,Other: Low-Intensity Psychosocial Interventions through Telemental health,https://ClinicalTrials.gov/show/NCT04594525
4889,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era",Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04479345
4890,The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19,Other: Wingate exercise test and on-ice testing while wearing a face mask|Other: Wingate exercise test and on-ice testing while wearing a sham face mask,https://ClinicalTrials.gov/show/NCT04874766
4891,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04433312
4892,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,,https://ClinicalTrials.gov/show/NCT04342208
4893,The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19,,https://ClinicalTrials.gov/show/NCT04746092
4894,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Other: Home-based exercise,https://ClinicalTrials.gov/show/NCT04425005
4895,Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases,,https://ClinicalTrials.gov/show/NCT04693975
4896,Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic,Device: Intermittent Theta Burst Stimulation (form of repetitive transcranial magnetic stimulation) given in an accelerated form,https://ClinicalTrials.gov/show/NCT04935489
4897,Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication,,https://ClinicalTrials.gov/show/NCT04798625
4898,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,Other: data record,https://ClinicalTrials.gov/show/NCT04445870
4899,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure: Prone positioning,https://ClinicalTrials.gov/show/NCT04344106
4900,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Drug: Baricitinib,https://ClinicalTrials.gov/show/NCT04399798
4901,Implementation of a CDSS in Oncology Patients During COVID-19,Other: Application of CDSS to provide nutritional care in breast cancer patients from home|Other: General lifestyle advice to breast cancer patients by phone,https://ClinicalTrials.gov/show/NCT04876560
4902,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Other: Farmalarm,https://ClinicalTrials.gov/show/NCT04423289
4903,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Behavioral: online survey,https://ClinicalTrials.gov/show/NCT04360850
4904,Evaluation of Lymphedema Patients Status During Covid-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04568005
4905,Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19,Drug: Polyoxidonium,https://ClinicalTrials.gov/show/NCT04542226
4906,Tele-rehabilitation in Children With Cerebral Palsy in the Covid-19 Pandemic,"Other: Telerehabilitation İntervention, Motor learning",https://ClinicalTrials.gov/show/NCT04896840
4907,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Drug: Colchicine|Drug: Usual Care,https://ClinicalTrials.gov/show/NCT04363437
4908,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,Other: Chiropractic care (one visit)|Other: Chiropractic care (more than one visit),https://ClinicalTrials.gov/show/NCT04573361
4909,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Other: Questionnaires|Biological: blood test|Other: Maximal effort test|Device: actigraphy|Device: Neuromuscular evaluation|Other: stool analysis|Other: food diary,https://ClinicalTrials.gov/show/NCT04363606
4910,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Diagnostic Test: Odd/Even birth year intervention groups,https://ClinicalTrials.gov/show/NCT04327804
4911,"MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey",Behavioral: Questionnaire,https://ClinicalTrials.gov/show/NCT04727294
4912,Status of Management of Surgery in Beijing During COVID-19,Other: no intervention,https://ClinicalTrials.gov/show/NCT04401124
4913,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Other: no intervention,https://ClinicalTrials.gov/show/NCT04345640
4914,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Diagnostic Test: Assessment of ventilator-associated pneumonia criteria,https://ClinicalTrials.gov/show/NCT04372576
4915,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04372043
4916,Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics,Procedure: Surgical repair|Procedure: Percutaneous treatment|Procedure: Mitral valve surgery,https://ClinicalTrials.gov/show/NCT04813692
4917,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Device: high flow nasal cannula (HFNC)|Procedure: Prone positioning (PP),https://ClinicalTrials.gov/show/NCT04325906
4918,Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis,,https://ClinicalTrials.gov/show/NCT04780113
4919,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,Device: Personal protective equipment (PPE)|Device: No Personal protective equipment (PPE),https://ClinicalTrials.gov/show/NCT04548934
4920,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Other: None - NA,https://ClinicalTrials.gov/show/NCT04344964
4921,Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece,,https://ClinicalTrials.gov/show/NCT04756817
4922,Quality of Life and Long-term Outcomes After Hospitalization for COVID-19,Other: COVID-19,https://ClinicalTrials.gov/show/NCT04376658
4923,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines,Other: Survey research,https://ClinicalTrials.gov/show/NCT04731870
4924,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Other: Individualised Ayurveda,https://ClinicalTrials.gov/show/NCT04345549
4925,Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic,Other: No intervention,https://ClinicalTrials.gov/show/NCT04948216
4926,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Biological: Anti-SARS-CoV-2 IgT seropositivity,https://ClinicalTrials.gov/show/NCT04448769
4927,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,Dietary Supplement: PreserVision AREDS formulation soft gels or tablets|Dietary Supplement: Multivitamin with 11mg of zinc,https://ClinicalTrials.gov/show/NCT04551339
4928,Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04753632
4929,Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care,,https://ClinicalTrials.gov/show/NCT04887220
4930,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19,Device: CoronaCheck Device,https://ClinicalTrials.gov/show/NCT04742712
4931,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,Device: Limbix Spark|Other: Psychoeducation,https://ClinicalTrials.gov/show/NCT04524598
4932,CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19),Other: n/a - samples collected along routine care samples only,https://ClinicalTrials.gov/show/NCT04659252
4933,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain,Other: Online questionnaire,https://ClinicalTrials.gov/show/NCT04667962
4934,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic,Other: Digital Storytelling Intervention,https://ClinicalTrials.gov/show/NCT04738032
4935,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,Other: Non invasive visual acuity testing,https://ClinicalTrials.gov/show/NCT04391166
4936,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04443764
4937,One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19,,https://ClinicalTrials.gov/show/NCT04457505
4938,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",Device: Virtual Reality,https://ClinicalTrials.gov/show/NCT04505761
4939,"Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic",Drug: Sublingual Micro-Dose Ketamine,https://ClinicalTrials.gov/show/NCT04769297
4940,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil",https://ClinicalTrials.gov/show/NCT04384965
4941,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,Procedure: Plasma exchange and convalescent plasma,https://ClinicalTrials.gov/show/NCT04634422
4942,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,Other: Staff Wellbeing Centres,https://ClinicalTrials.gov/show/NCT04410016
4943,Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints,Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04871854
4944,Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19,Behavioral: ACT,https://ClinicalTrials.gov/show/NCT04821037
4945,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,"Other: Cognitive behavior therapy (CBT), specifically using the Facing Your Fears (FYF) curriculum",https://ClinicalTrials.gov/show/NCT04666493
4946,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,Drug: Ivermectin|Other: Standard treatment for COVID-19,https://ClinicalTrials.gov/show/NCT04431466
4947,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",Behavioral: Dialectical Behavioral Therapy (DBT) Skills,https://ClinicalTrials.gov/show/NCT04558411
4948,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,Biological: Screening test for covid ( RT PCR and CT Chest),https://ClinicalTrials.gov/show/NCT04379232
4949,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,Drug: SIR1-365|Drug: Matching Placebo,https://ClinicalTrials.gov/show/NCT04622332
4950,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,Other: EXTRA-CVD Virtual Care,https://ClinicalTrials.gov/show/NCT04661813
4951,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,Other: Caring Contacts,https://ClinicalTrials.gov/show/NCT04456062
4952,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE),Other: Tele-rheumatology,https://ClinicalTrials.gov/show/NCT04704544
4953,"Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic",Other: Breathing Exercises|Other: Information on COVID-19,https://ClinicalTrials.gov/show/NCT04910932
4954,Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome,,https://ClinicalTrials.gov/show/NCT04818164
4955,Hemodynamic Characteristics of Patients With SARS-CoV-2,Device: Transpulmonary thermodilution|Device: Echocardiography,https://ClinicalTrials.gov/show/NCT04337983
4956,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,Other: Tele-yoga therapy|Other: Primary care,https://ClinicalTrials.gov/show/NCT04466605
4957,Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD),Biological: Pfizer Comirnaty vaccine,https://ClinicalTrials.gov/show/NCT04769258
4958,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19,Diagnostic Test: Saliva collection,https://ClinicalTrials.gov/show/NCT04550390
4959,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Diagnostic Test: Pleth variability index,https://ClinicalTrials.gov/show/NCT04373213
4960,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil",https://ClinicalTrials.gov/show/NCT04427137
4961,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,Behavioral: Training session adressing information and health literacy,https://ClinicalTrials.gov/show/NCT04453475
4962,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Other: Satisfaction evaluation,https://ClinicalTrials.gov/show/NCT04341714
4963,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Drug: Plaquenil 200Mg Tablet,https://ClinicalTrials.gov/show/NCT04326725
4964,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Diagnostic Test: Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,https://ClinicalTrials.gov/show/NCT04321369
4965,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Other: blood sample,https://ClinicalTrials.gov/show/NCT04369456
4966,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,Biological: Plasma exchange|Drug: Standar medical treatmen,https://ClinicalTrials.gov/show/NCT04374539
4967,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",Other: COVID visitation restrictions,https://ClinicalTrials.gov/show/NCT04538469
4968,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,Behavioral: Online Intervention Mental Health COVID-19,https://ClinicalTrials.gov/show/NCT04468893
4969,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,"Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules|Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)",https://ClinicalTrials.gov/show/NCT04251871
4970,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,Other: Exercise training group,https://ClinicalTrials.gov/show/NCT04458246
4971,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,,https://ClinicalTrials.gov/show/NCT04442243
4972,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,,https://ClinicalTrials.gov/show/NCT04292340
4973,The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period,Behavioral: Wellness Education,https://ClinicalTrials.gov/show/NCT04815057
4974,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Behavioral: Internet-based self-help|Behavioral: Internet-based self-help after 3 weeks,https://ClinicalTrials.gov/show/NCT04380909
4975,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Device: Inspiratory training device|Device: Expiratory training device,https://ClinicalTrials.gov/show/NCT04326114
4976,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Behavioral: online mindfulness group,https://ClinicalTrials.gov/show/NCT04346082
4977,"Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination",Other: Low tailored message|Other: No message|Other: Low tailored message plus COVID-19 vaccine message,https://ClinicalTrials.gov/show/NCT04904744
4978,Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19,Behavioral: Educational Vocal Health Modules,https://ClinicalTrials.gov/show/NCT04858542
4979,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Behavioral: Meditation app usage,https://ClinicalTrials.gov/show/NCT04369378
4980,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,Other: Psycho-Social Questionnaire,https://ClinicalTrials.gov/show/NCT04389684
4981,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,Other: Pulmonary Rehabilitation,https://ClinicalTrials.gov/show/NCT04388579
4982,Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic,Behavioral: Digital problem solving tool,https://ClinicalTrials.gov/show/NCT04677270
4983,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,Biological: Convalescent plasma|Drug: Hydroxychloroquin with Azithromycin,https://ClinicalTrials.gov/show/NCT04441424
4984,Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness,Drug: Proxalutamide (GT0918)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04870606
4985,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Device: non-contact magnetically-controlled capsule endoscopy,https://ClinicalTrials.gov/show/NCT04389333
4986,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,Behavioral: Usual Care|Behavioral: online KKH Sports Singapore Program with Usual Care,https://ClinicalTrials.gov/show/NCT04395430
4987,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",,https://ClinicalTrials.gov/show/NCT04371315
4988,Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04406844
4989,Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19,,https://ClinicalTrials.gov/show/NCT04746066
4990,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,Other: physiological effects of awake prone position in COVID 19 patients,https://ClinicalTrials.gov/show/NCT04632602
4991,Manual Acupuncture Using Acupuncture Needle vs Press Needle for COVID-19 Healthcare Anxiety,Procedure: Manual Acupuncture,https://ClinicalTrials.gov/show/NCT04860271
4992,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Diagnostic Test: Assessment of cardiovascular diseases and cardiovascular risk factors,https://ClinicalTrials.gov/show/NCT04327479
4993,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Behavioral: Behavioral: OCAT-sham|Behavioral: Behavioral: OCAT|Other: psycho-education video,https://ClinicalTrials.gov/show/NCT04367636
4994,COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs,Biological: Biological samples,https://ClinicalTrials.gov/show/NCT04530682
4995,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,Behavioral: Self-focused acts|Behavioral: Prosocial acts,https://ClinicalTrials.gov/show/NCT04517006
4996,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,Behavioral: Mindfulness intervention|Behavioral: Non-Mindfulness intervention,https://ClinicalTrials.gov/show/NCT04394013
4997,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,Other: Semi-structured telephone questionnaire,https://ClinicalTrials.gov/show/NCT04581577
4998,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,Diagnostic Test: Asynchronies detection,https://ClinicalTrials.gov/show/NCT04448782
4999,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,Drug: Symptomatic drugs|Drug: Bridge therapy|Behavioral: Mindfulness program,https://ClinicalTrials.gov/show/NCT04410536
5000,Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19,Biological: BBV154 Vaccine|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04751682
5001,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug: Hydroxychloroquine Oral Product|Drug: Hydroxychloroquine + azithromycin,https://ClinicalTrials.gov/show/NCT04322123
5002,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,Drug: Dexmedetomidine Injectable Product,https://ClinicalTrials.gov/show/NCT04358627
5003,Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia,Other: low-intensity aerobic training,https://ClinicalTrials.gov/show/NCT04796064
5004,Improving Wellbeing and Health for Care Home Residents During COVID-19,Other: COVID WHELD,https://ClinicalTrials.gov/show/NCT04590469
5005,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04442282
5006,Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic,Other: Standard Care,https://ClinicalTrials.gov/show/NCT04633941
5007,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,Other: Video Dance classes|Other: Unsupervised physical activities,https://ClinicalTrials.gov/show/NCT04422353
5008,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,https://ClinicalTrials.gov/show/NCT04442217
5009,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Diagnostic Test: SARS-CoV-2 PCR,https://ClinicalTrials.gov/show/NCT04381819
5010,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Behavioral: Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms,https://ClinicalTrials.gov/show/NCT04444336
5011,Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic,Other: no intervention,https://ClinicalTrials.gov/show/NCT04876872
5012,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,Device: patients receiving nasal high flow,https://ClinicalTrials.gov/show/NCT04385823
5013,Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,Other: survey,https://ClinicalTrials.gov/show/NCT04460196
5014,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Behavioral: Video based exercise,https://ClinicalTrials.gov/show/NCT04346953
5015,Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood,,https://ClinicalTrials.gov/show/NCT04556630
5016,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,,https://ClinicalTrials.gov/show/NCT04324047
5017,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,"Behavioral: Intervention, TBN",https://ClinicalTrials.gov/show/NCT04604743
5018,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",,https://ClinicalTrials.gov/show/NCT04419870
5019,The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic,Behavioral: Experimental,https://ClinicalTrials.gov/show/NCT04847362
5020,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination,Diagnostic Test: serological testing,https://ClinicalTrials.gov/show/NCT04880174
5021,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),Drug: Eltrombopag|Drug: rhTPO,https://ClinicalTrials.gov/show/NCT04516837
5022,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,"Diagnostic Test: SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics",https://ClinicalTrials.gov/show/NCT04487639
5023,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Device: Robotic therapy,https://ClinicalTrials.gov/show/NCT04392453
5024,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Other: pregnant women with laboratory-confirmed 2019-n-CoV,https://ClinicalTrials.gov/show/NCT04315870
5025,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",,https://ClinicalTrials.gov/show/NCT04384419
5026,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,Drug: Nitric Oxide-Releasing Drug,https://ClinicalTrials.gov/show/NCT04443868
5027,Performance Study of SONA Saliva C-19 Rapid Test,Diagnostic Test: Sona Saliva C-19 Rapid Test,https://ClinicalTrials.gov/show/NCT04877002
5028,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,Procedure: Bone Marrow Harvest,https://ClinicalTrials.gov/show/NCT04397471
5029,Breastfeeding Education in the Time of COVID-19,Behavioral: Telesimulation,https://ClinicalTrials.gov/show/NCT04519216
5030,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,"Behavioral: Transitional Online Peer Support Group (n=20)|Other: Control Group (pharmacotherapy and/or psychotherapy, n=10)",https://ClinicalTrials.gov/show/NCT04445324
5031,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,Diagnostic Test: Online Survey,https://ClinicalTrials.gov/show/NCT04410835
5032,Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic,Other: Experimental: Active care group|Other: Active Comparator: Self-care group,https://ClinicalTrials.gov/show/NCT04690400
5033,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,Device: WARD CSS,https://ClinicalTrials.gov/show/NCT04724681
5034,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,Other: Best Practice|Biological: Mesenchymal Stem Cell,https://ClinicalTrials.gov/show/NCT04565665
5035,Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19,Diagnostic Test: Sit to stand test,https://ClinicalTrials.gov/show/NCT04730661
5036,A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,Drug: SAR443122|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04469621
5037,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Behavioral: Assessment of work-related stress|Biological: Saliva sample collection|Other: Cardiac and electrodermal recordings|Behavioral: Assessment of behavioral response to emotional stimulation,https://ClinicalTrials.gov/show/NCT04365335
5038,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,Behavioral: Assigned Strategies: Opt-in|Behavioral: Assigned Strategies: Active Choice|Behavioral: Assigned Strategies: Enhanced Active Choice|Behavioral: Choice of Assignment: Opt-in|Behavioral: Choice of Assignment: Active Choice|Behavioral: Choice of Assignment: Enhanced Active Choice,https://ClinicalTrials.gov/show/NCT04488796
5039,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,Diagnostic Test: Serological testing for COVID-19 infection,https://ClinicalTrials.gov/show/NCT04707833
5040,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,"Behavioral: Training for Awareness, Resilience, and Action (TARA)",https://ClinicalTrials.gov/show/NCT04548544
5041,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals,Other: Survey,https://ClinicalTrials.gov/show/NCT04548492
5042,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug: Ruconest,https://ClinicalTrials.gov/show/NCT04530136
5043,"Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences",,https://ClinicalTrials.gov/show/NCT04741412
5044,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Device: ECCO2R,https://ClinicalTrials.gov/show/NCT04351906
5045,An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies,Other: Quality of life assessment,https://ClinicalTrials.gov/show/NCT04581187
5046,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug: NORS (Nitric Oxide Releasing Solution),https://ClinicalTrials.gov/show/NCT04337918
5047,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,Behavioral: COMPASS|Behavioral: Standard charity resources,https://ClinicalTrials.gov/show/NCT04535778
5048,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)|Device: Centricyte 1000|Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution|Drug: Liberase Enzyme (Roche)|Drug: Sterile Normal Saline for Intravenous Use,https://ClinicalTrials.gov/show/NCT04326036
5049,ChulaCov19 mRNA Vaccine in Healthy Adults,Biological: ChulaCov19 mRNA vaccine,https://ClinicalTrials.gov/show/NCT04566276
5050,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,Biological: COVIV+IIV4; COVIV+PPV23|Biological: COVIV only (1st and 2nd dose)|Biological: IIV4 for the 1st dose and PPV23 for the 2nd dose,https://ClinicalTrials.gov/show/NCT04790851
5051,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic,Diagnostic Test: Serology test for COVID-19,https://ClinicalTrials.gov/show/NCT04465656
5052,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,Behavioral: Data registry,https://ClinicalTrials.gov/show/NCT04391946
5053,Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic,Behavioral: EMPOWER,https://ClinicalTrials.gov/show/NCT04931888
5054,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,Behavioral: Online Intervention Grief COVID-19,https://ClinicalTrials.gov/show/NCT04638842
5055,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,Behavioral: Simple cognitive task intervention|Behavioral: Attention Placebo,https://ClinicalTrials.gov/show/NCT04460014
5056,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,Other: Prone positioning,https://ClinicalTrials.gov/show/NCT04359407
5057,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,"Biological: SHINGRIX (Zoster Vaccine REcombinant, Adjuvanted)|Drug: Normal Saline",https://ClinicalTrials.gov/show/NCT04523246
5058,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,Other: Survey and Questionnaire,https://ClinicalTrials.gov/show/NCT04371250
5059,Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis,Other: overnight intensive recovery / extended post anaesthetic care in PACU,https://ClinicalTrials.gov/show/NCT04717089
5060,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,,https://ClinicalTrials.gov/show/NCT04422418
5061,"Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis",Biological: Covishield,https://ClinicalTrials.gov/show/NCT04794946
5062,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",,https://ClinicalTrials.gov/show/NCT04409197
5063,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,Drug: Mefloquine|Drug: Hydroxychloroquine|Combination Product: Mefloquine + azithromycin + / - tocilizumab|Combination Product: Hydroxychloroquine + azithromycin + / - tocilizumab,https://ClinicalTrials.gov/show/NCT04347031
5064,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation.|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin inhalation|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection combined with Dalargin inhalation,https://ClinicalTrials.gov/show/NCT04346693
5065,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,Behavioral: Intervention App,https://ClinicalTrials.gov/show/NCT04393818
5066,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic,Other: Patient Quality of life assessment|Other: Control group Quality of life assessment,https://ClinicalTrials.gov/show/NCT04696679
5067,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,Diagnostic Test: Susceptibility to infection,https://ClinicalTrials.gov/show/NCT04402827
5068,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Behavioral: Digital Health Online Platform,https://ClinicalTrials.gov/show/NCT04400305
5069,"Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic",Other: exercise capacity,https://ClinicalTrials.gov/show/NCT04673331
5070,"Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19",Drug: bovhyaluronidase azoxymer,https://ClinicalTrials.gov/show/NCT04645368
5071,COVID-19 Prevalence in HIV-infected Patients,Other: Blood Sample,https://ClinicalTrials.gov/show/NCT04515225
5072,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism,Other: questionnaires,https://ClinicalTrials.gov/show/NCT04723407
5073,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,Behavioral: insurance navigation,https://ClinicalTrials.gov/show/NCT04613739
5074,BCG Vaccine for Health Care Workers as Defense Against COVID 19,Biological: BCG Vaccine|Biological: Placebo Vaccine,https://ClinicalTrials.gov/show/NCT04348370
5075,Psychological and Ethical Support for Hospital Professionals During the COVID-19 Pandemic: Suitability and Post-crisis Implications for the Experience of All Professionals,Other: online questionnaire|Other: questionnaire survey,https://ClinicalTrials.gov/show/NCT04944394
5076,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Behavioral: PTSD|Behavioral: Burnout,https://ClinicalTrials.gov/show/NCT04341519
5077,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Device: Electrical Impedance tomography,https://ClinicalTrials.gov/show/NCT04603755
5078,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Other: Nutrition support,https://ClinicalTrials.gov/show/NCT04274322
5079,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Behavioral: Patient-centred advice on Telephone Consultation in TB Patients:,https://ClinicalTrials.gov/show/NCT04412239
5080,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Behavioral: Therapist Guided E-Therapy|Behavioral: Self-Help Therapy,https://ClinicalTrials.gov/show/NCT04378257
5081,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug: Sarilumab,https://ClinicalTrials.gov/show/NCT04324073
5082,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,Other: research specific blood sample,https://ClinicalTrials.gov/show/NCT04384705
5083,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,Diagnostic Test: Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus,https://ClinicalTrials.gov/show/NCT04387253
5084,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Behavioral: Online cognitive behavioral therapy (CBT)|Behavioral: Online bibliotherapy programme,https://ClinicalTrials.gov/show/NCT04362358
5085,THE ROLE OF MANUAL ACUPUNCTURE USING PRESS NEEDLES COMPARED WITH FILIFORM NEEDLES IN IMPROVING SYMPTOMS OF INSOMNIA AND MELATONIN HORMONE FOR HEALTHCARE WORKERS TREATING COVID-19 PATIENTS.,Procedure: Press needles|Procedure: Filiform Needles,https://ClinicalTrials.gov/show/NCT04872712
5086,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,"Drug: Wharton's jelly derived Mesenchymal stem cells.|Drug: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",https://ClinicalTrials.gov/show/NCT04390152
5087,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,Drug: Amlodipine,https://ClinicalTrials.gov/show/NCT04559074
5088,"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers",Drug: Aerolized Hydroxychloroquine Sulfate|Other: Placebo,https://ClinicalTrials.gov/show/NCT04461353
5089,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Other: Doppler Echo,https://ClinicalTrials.gov/show/NCT04363528
5090,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,,https://ClinicalTrials.gov/show/NCT04386720
5091,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,Other: Questionnaires|Other: psychological and sociological interviews,https://ClinicalTrials.gov/show/NCT04441476
5092,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,Drug: Camostat Mesilate|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04470544
5093,"Online Multi-component Psychological Intervention for Anxiety, Depression, and Burnout on Healthcare Workers During the COVID-19 Pandemic",Behavioral: Online psychological intervention for healtchare workers,https://ClinicalTrials.gov/show/NCT04890665
5094,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,,https://ClinicalTrials.gov/show/NCT04279795
5095,A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,Drug: Alteplase|Procedure: Standard of care,https://ClinicalTrials.gov/show/NCT04640194
5096,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Other: Comprehensive treatment,https://ClinicalTrials.gov/show/NCT04279782
5097,The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection,Other: no intervention,https://ClinicalTrials.gov/show/NCT04874363
5098,Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.,Diagnostic Test: swabbing of conjunctiva,https://ClinicalTrials.gov/show/NCT04799704
5099,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,Drug: L-Citrulline|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04570384
5100,EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial,Drug: Baricitinib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04891133
5101,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",Other: Telemedicine to remote outpatient visit in bariatric patient,https://ClinicalTrials.gov/show/NCT04407663
5102,SARS-CoV-2 Donor-Recipient Immunity Transfer,Procedure: Biospecimen Collection|Other: Diagnostic Laboratory Biomarker Analysis|Other: Electronic Health Record Review|Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04666025
5103,Turkish of the SARS-CoV-2 Anxiety Scale,Other: survey work,https://ClinicalTrials.gov/show/NCT04490473
5104,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Device: Low flow ECMO driving by CVVH machine,https://ClinicalTrials.gov/show/NCT04340414
5105,Clinical Characteristics and Outcomes of Pediatric COVID-19,Other: Exposure (not intervention) - SARS-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04330261
5106,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,Biological: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,https://ClinicalTrials.gov/show/NCT04445194
5107,Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma,Biological: Determination of COVID-19 vacciantion efficacy,https://ClinicalTrials.gov/show/NCT04918940
5108,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug: Methylprednisolone Sodium Succinate|Drug: Placebo solution,https://ClinicalTrials.gov/show/NCT04343729
5109,Finding Wellness in the Pandemic,Behavioral: Trauma Informed Yoga|Behavioral: Trauma Informed Psychotherapy,https://ClinicalTrials.gov/show/NCT04615741
5110,Apparatus and Method for Moving Patients,Device: assist,https://ClinicalTrials.gov/show/NCT04882865
5111,Pandemia And Exercise in Turkey in University Students of Turkey,Other: survey,https://ClinicalTrials.gov/show/NCT04757207
5112,Mask Adhesive Institutional Study,Device: Mask with Mask Adhesive/Arm 1|Device: Mask without Mask Adhesive / Arm 2,https://ClinicalTrials.gov/show/NCT04644276
5113,A Research Platform to Screen Healthcare Workers,Diagnostic Test: Nasopharyngeal swab|Other: Questionnaire collection|Other: Optional blood completion|Other: Optional questionnaire completion,https://ClinicalTrials.gov/show/NCT04574765
5114,Study of Descartes-30 in Acute Respiratory Distress Syndrome,Biological: Descartes 30,https://ClinicalTrials.gov/show/NCT04524962
5115,imPROving prenaTal carE During ConfinemenT,Other: Remote consultation,https://ClinicalTrials.gov/show/NCT04368832
5116,Impact Nerium Oleander on Immune Function,Other: Proprietary extract of Nerium oleander,https://ClinicalTrials.gov/show/NCT04486144
5117,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,Drug: Acalabrutinib Treatment A|Drug: Acalabrutinib Treatment B|Drug: Acalabrutinib Treatment C|Drug: Acalabrutinib Treatment D,https://ClinicalTrials.gov/show/NCT04564040
5118,Containment Measures and Eating Disorders,,https://ClinicalTrials.gov/show/NCT04492189
5119,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population,Other: Slef questionnaires fulfilment,https://ClinicalTrials.gov/show/NCT04374643
5120,Inflammatory Bowel Disease (IBD) and Covid-19 Infection,,https://ClinicalTrials.gov/show/NCT04492267
5121,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,Biological: Flucelvax|Biological: Fluvirin|Biological: Fluzone High Dose,https://ClinicalTrials.gov/show/NCT04025580
5122,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Other: Standard administration of oxygen flow|Device: Automated oxygen administration - FreeO2,https://ClinicalTrials.gov/show/NCT04320056
5123,"Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVID",Procedure: Systematic offer of nurse-driven SARS-CoV-2 screening combined with usual practice|Other: Usual emergency department practice with physician-directed diagnostic testing,https://ClinicalTrials.gov/show/NCT04756609
5124,Prevention of Complications (SARS-CoV-2): Clinical Study,Drug: Control group (standard hospital treatment)|Drug: Group Hydroxychloroquine|Drug: Group Hydroxychloroquine and apixaban|Drug: Group Apixaban,https://ClinicalTrials.gov/show/NCT04788355
5125,"""COVID-19 and Diabetes Outcomes""",Other: no interventional study,https://ClinicalTrials.gov/show/NCT04324736
5126,Early Prone Position on Coronavirus Disease 2019 Pneumonia,Behavioral: prone position,https://ClinicalTrials.gov/show/NCT04427969
5127,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug: Anakinra,https://ClinicalTrials.gov/show/NCT04341584
5128,Neurological Features During COVID19,Other: Observation,https://ClinicalTrials.gov/show/NCT04460599
5129,Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab,Drug: Ofatumumab,https://ClinicalTrials.gov/show/NCT04869358
5130,Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS),Device: ReferID,https://ClinicalTrials.gov/show/NCT04941001
5131,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,,https://ClinicalTrials.gov/show/NCT04292327
5132,Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study,,https://ClinicalTrials.gov/show/NCT04844697
5133,Association Between Body Mass Index and HFNC Therapy Success,,https://ClinicalTrials.gov/show/NCT04799132
5134,Asymptomatic COVID-19 Infection Among Healthcare Workers,Diagnostic Test: Serum SARs COV 2 IGg screening in health care workers,https://ClinicalTrials.gov/show/NCT04354792
5135,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,,https://ClinicalTrials.gov/show/NCT04410484
5136,Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia,Other: epidemiological and demographic characteristics,https://ClinicalTrials.gov/show/NCT04430023
5137,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug: Hydroxychloroquine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04308668
5138,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,Biological: Convalescent Plasma 1 Unit|Biological: Convalescent Plasma 2 Units|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04376034
5139,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,Biological: UC-MSCs,https://ClinicalTrials.gov/show/NCT04269525
5140,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,Biological: 2019-nCoV PCR,https://ClinicalTrials.gov/show/NCT04259892
5141,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Other: nosocomial infection/hospital acquired infection,https://ClinicalTrials.gov/show/NCT04290780
5142,Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic,Biological: blood sample,https://ClinicalTrials.gov/show/NCT04517097
5143,COVID-19 Pandemic Response Network,,https://ClinicalTrials.gov/show/NCT04320862
5144,Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy,Device: multiECCO2R blood-gas exchanger,https://ClinicalTrials.gov/show/NCT04871893
5145,Regional COVID Epidemiology in England (RECEDE),Other: No intervention,https://ClinicalTrials.gov/show/NCT04579562
5146,Biomarkers for Identification of COVID-19 Infection,Diagnostic Test: Biomarkers expression,https://ClinicalTrials.gov/show/NCT04322513
5147,Oral Manifestation in Patients With SARS-CoV2 Infection.,,https://ClinicalTrials.gov/show/NCT04821986
5148,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),"Other: Collection of blood, salivary and nasopharyngeal samples.",https://ClinicalTrials.gov/show/NCT04637867
5149,IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA),Diagnostic Test: anti-spike SARS-CoV-2 IgG,https://ClinicalTrials.gov/show/NCT04832841
5150,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,Drug: Veru-111,https://ClinicalTrials.gov/show/NCT04388826
5151,Use of Angiotensin-(1-7) in COVID-19,Drug: Angiotensin-(1-7)|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04633772
5152,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Other: Observational Study,https://ClinicalTrials.gov/show/NCT04318366
5153,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,Device: Breath Biopsy face masks with removable filters and fitted PVA strip,https://ClinicalTrials.gov/show/NCT04467112
5154,Triggers for Post-Viral Parosmia After Covid and Non-Covid Infections,,https://ClinicalTrials.gov/show/NCT04868435
5155,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,Biological: anti-SARS-CoV-2 human convalescent plasma,https://ClinicalTrials.gov/show/NCT04462848
5156,ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE),,https://ClinicalTrials.gov/show/NCT04702295
5157,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,Drug: Losartan,https://ClinicalTrials.gov/show/NCT04340557
5158,"SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)",,https://ClinicalTrials.gov/show/NCT04750356
5159,Intensive Care Anxiety in SARS-CoV-2 Patients,Behavioral: Hospital Anxiety Depression Measure,https://ClinicalTrials.gov/show/NCT04715477
5160,A First-in-Human Study of AV-001 in Healthy Subjects,Drug: AV-001|Other: Placebo,https://ClinicalTrials.gov/show/NCT04737486
5161,Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19),Drug: SARS-CoV-2 vaccine,https://ClinicalTrials.gov/show/NCT04747522
5162,The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology,Other: Psychometric scale administration,https://ClinicalTrials.gov/show/NCT04694482
5163,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,Biological: ChAdOx1 nCoV-19|Biological: Normal saline 0.9%,https://ClinicalTrials.gov/show/NCT04444674
5164,Acute Respiratory Failure and COVID-19 in Real Life,Other: standard operating procedures,https://ClinicalTrials.gov/show/NCT04307459
5165,Safety and Immunogenicity of Inactivated Vaccine Against COVID-19 Infection,Biological: SARS-Cov-2 neutralizing antibody titer,https://ClinicalTrials.gov/show/NCT04756271
5166,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,Diagnostic Test: Serology|Genetic: Sequencing,https://ClinicalTrials.gov/show/NCT04322279
5167,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,,https://ClinicalTrials.gov/show/NCT04407546
5168,Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021,Biological: ARCT-021,https://ClinicalTrials.gov/show/NCT04728347
5169,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),Other: blood sampling,https://ClinicalTrials.gov/show/NCT04429594
5170,Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,Procedure: Biospecimen Collection|Other: Electronic Health Record Review,https://ClinicalTrials.gov/show/NCT04852822
5171,Outcomes in Hospitalized Older Patients With COVID-19,,https://ClinicalTrials.gov/show/NCT04385212
5172,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,Behavioral: Telehealth coaching sessions,https://ClinicalTrials.gov/show/NCT04492527
5173,Annexin A1 Levels in SARS-CoV-2 Infection,Other: Blood serum samples,https://ClinicalTrials.gov/show/NCT04948229
5174,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,Behavioral: Intervention for TECC Model,https://ClinicalTrials.gov/show/NCT04607915
5175,To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment,Biological: COVID-19 Vaccine,https://ClinicalTrials.gov/show/NCT04821570
5176,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),,https://ClinicalTrials.gov/show/NCT04365166
5177,Using PRP and Cord Blood in Treatment of Covid -19,Combination Product: stem cells,https://ClinicalTrials.gov/show/NCT04393415
5178,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,Diagnostic Test: Cytokines measurement|Diagnostic Test: Cellular response|Diagnostic Test: TLRs activation measurement|Diagnostic Test: KIR phenotype evaluation,https://ClinicalTrials.gov/show/NCT04403061
5179,Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR,Diagnostic Test: SARS-CoV-2 testing on the Eppendorf Thermal Cycler PCR system using self-collected saliva as the specimen,https://ClinicalTrials.gov/show/NCT04604145
5180,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis,https://ClinicalTrials.gov/show/NCT04299152
5181,Antiviral Drugs on the Treatment of SARS-CoV-2,Drug: Favipiravir|Drug: Remdesivir,https://ClinicalTrials.gov/show/NCT04727775
5182,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,Behavioral: Remote Problem Management Plus,https://ClinicalTrials.gov/show/NCT04617262
5183,Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients,Other: Study of the synthesis of antibodies directed against SARS,https://ClinicalTrials.gov/show/NCT04757883
5184,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,,https://ClinicalTrials.gov/show/NCT04453527
5185,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,Other: evaluation of skin microvascular flow and reactivity,https://ClinicalTrials.gov/show/NCT04406545
5186,Impact of Aerosol Box Use on Healthcare Provider Contamination,Device: Aerosol Box (Splashguard),https://ClinicalTrials.gov/show/NCT04880668
5187,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug: Nitric Oxide Gas,https://ClinicalTrials.gov/show/NCT04306393
5188,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,Other: Ultrasonography,https://ClinicalTrials.gov/show/NCT04567927
5189,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,Other: biochemical analysis,https://ClinicalTrials.gov/show/NCT04433754
5190,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,Other: COVID-19 Pneumonia,https://ClinicalTrials.gov/show/NCT04416464
5191,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection",Other: congenital malformation,https://ClinicalTrials.gov/show/NCT04492449
5192,SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY,,https://ClinicalTrials.gov/show/NCT04740125
5193,COVID-19 Antibody Levels After Vaccines,Biological: COVID-19 Vaccination,https://ClinicalTrials.gov/show/NCT04944134
5194,Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography,,https://ClinicalTrials.gov/show/NCT04473300
5195,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug: INO-4800|Device: CELLECTRA® 2000,https://ClinicalTrials.gov/show/NCT04336410
5196,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,Behavioral: Increasing Willingness and Uptake of COVID-19 Testing and Vaccination,https://ClinicalTrials.gov/show/NCT04542395
5197,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Biological: Blood sample|Biological: Serum tube collection,https://ClinicalTrials.gov/show/NCT04420338
5198,The PREPARE for COVID Trial,Behavioral: The PREPARE program,https://ClinicalTrials.gov/show/NCT04392115
5199,"The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19",Diagnostic Test: lung ultrasound,https://ClinicalTrials.gov/show/NCT04871685
5200,Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Behavioral: Lifestyle program,https://ClinicalTrials.gov/show/NCT04784624
5201,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,Behavioral: exercise group|Other: control group,https://ClinicalTrials.gov/show/NCT04639349
5202,Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?,,https://ClinicalTrials.gov/show/NCT04757272
5203,Incidence of Postoperative Delirium After Cardiac Surgery in Adults.,Procedure: cardiac surgery,https://ClinicalTrials.gov/show/NCT04828902
5204,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",Drug: HFB30132A|Other: Placebo,https://ClinicalTrials.gov/show/NCT04590430
5205,Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic,Other: Ointment and dressing for external use,https://ClinicalTrials.gov/show/NCT04913740
5206,COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS,Biological: CoronaVac,https://ClinicalTrials.gov/show/NCT04754698
5207,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,Drug: Opaganib|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04414618
5208,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,Other: HOME-CoV rule implementation,https://ClinicalTrials.gov/show/NCT04338841
5209,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Biological: VPM1002|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04435379
5210,"Stress, Personality, Attachment and Coping During the Covid Crisis.",Other: PTSD Check List (PCL) scale|Other: Brief COPE scale|Other: GAD-7 (Generalized Anxiety Disorder) scale (during containment)|Other: Analog scale|Other: GAD-7 (Generalized Anxiety Disorder) scale (post containment)|Other: Big Five Inventory (BFI) scale|Other: Relationship Scales Questionnaire (RSQ),https://ClinicalTrials.gov/show/NCT04760795
5211,The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients,Drug: Cholecalciferol|Drug: Placebo,https://ClinicalTrials.gov/show/NCT03188796
5212,Heterologous Vaccination With an Vaxzevria (ChAdOx1-S) Prime and a Comirnaty (BNT162b2) Boost Compared With Homolog Vaccination With Vaxzervria (Prime/Boost) or Comirnaty (Prime/Boost),Biological: Vaxzevria|Biological: Comirnaty,https://ClinicalTrials.gov/show/NCT04907331
5213,Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC),Biological: COVID-19 Vaccination,https://ClinicalTrials.gov/show/NCT04930055
5214,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04349163
5215,"To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects",Drug: CT-P59|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04525079
5216,Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2,Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)|Biological: BNT162b2|Other: Saline,https://ClinicalTrials.gov/show/NCT04887948
5217,A Clinical Trial of COVAC-2 in Healthy Adults,Biological: COVAC-2|Biological: Saline Placebo,https://ClinicalTrials.gov/show/NCT04702178
5218,Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON),Other: Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings,https://ClinicalTrials.gov/show/NCT04768998
5219,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2,Drug: Chloroquine diphosphate,https://ClinicalTrials.gov/show/NCT04323527
5220,Tocilizumab in Coronavirus-19 Positive Patients,Biological: Tocilizumab,https://ClinicalTrials.gov/show/NCT04423042
5221,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,Biological: MSCs-derived exosomes,https://ClinicalTrials.gov/show/NCT04276987
5222,Olfactory Disfunction and Co-ultraPEALut,Combination Product: co-ultraPEALut|Dietary Supplement: PEALut|Procedure: Olfactory Rehab,https://ClinicalTrials.gov/show/NCT04853836
5223,Convalescent Plasma to Stem Coronavirus (CSSC-001),Biological: Anti- SARS-CoV-2 Plasma|Biological: SARS-CoV-2 non-immune Plasma,https://ClinicalTrials.gov/show/NCT04323800
5224,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Diagnostic Test: Recombinase aided amplification (RAA) assay,https://ClinicalTrials.gov/show/NCT04245631
5225,Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19),Biological: Respiratory infections,https://ClinicalTrials.gov/show/NCT04664075
5226,Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC),Drug: BAF312|Drug: Baseline disease modifying therapies (DMTs),https://ClinicalTrials.gov/show/NCT04792567
5227,Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2,"Other: Inhalation of N-acetylcysteine|Other: Inhalation of 5% sodium chloride|Other: Inhalation of 8,4% sodium bicarbonate",https://ClinicalTrials.gov/show/NCT04755972
5228,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",,https://ClinicalTrials.gov/show/NCT04385004
5229,HUNgarian COronaVirus Disease-19 Epidemiological Research,,https://ClinicalTrials.gov/show/NCT04370067
5230,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,"Drug: Xiyanping injection|Drug: Lopinavir / ritonavir, alpha-interferon nebulization,Abidor Hydrochloride",https://ClinicalTrials.gov/show/NCT04275388
5231,Covid Radiographic Images Data-set for A.I,Diagnostic Test: Neural network diagnosis algorithm,https://ClinicalTrials.gov/show/NCT04419545
5232,imPulse™ Una Infrasound-to-ultrasound E-stethoscope,Device: imPulse™ Una infrasound-to-ultrasound e-stethoscope|Diagnostic Test: (PPA >95%) FDA EUA RT-PCR|Radiation: HR-CT-scan,https://ClinicalTrials.gov/show/NCT04941209
5233,Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study),Biological: AdCOVID|Other: Placebo,https://ClinicalTrials.gov/show/NCT04679909
5234,Sequelae of Sars-CoV-2 Infections,,https://ClinicalTrials.gov/show/NCT04442789
5235,Norwegian Coronavirus Disease 2019 Study,Drug: Hydroxychloroquine Sulfate,https://ClinicalTrials.gov/show/NCT04316377
5236,"Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes",,https://ClinicalTrials.gov/show/NCT04559542
5237,Social Media Use During COVID-19,Behavioral: Use of social media during COVID-19,https://ClinicalTrials.gov/show/NCT04305574
5238,2019-nCoV Outbreak and Cardiovascular Diseases,,https://ClinicalTrials.gov/show/NCT04255940
5239,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug: Colchicine|Drug: Placebo oral tablet,https://ClinicalTrials.gov/show/NCT04322682
5240,"The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt",Behavioral: Emotion Regulation training based on DBT,https://ClinicalTrials.gov/show/NCT04932369
5241,Skeletal Muscle Wasting in SARS-CoV-2,Procedure: Muscle Biopsy,https://ClinicalTrials.gov/show/NCT04698798
5242,Stay Well at Home: a Text-messaging Study Social Distancing,Behavioral: Uniform random message delivery|Behavioral: Reinforcement learning message delivery,https://ClinicalTrials.gov/show/NCT04473599
5243,Quercetin In The Treatment Of SARS-COV 2,Drug: Quercetin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04853199
5244,The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh,Behavioral: Low Intensity Nudges|Behavioral: High Intensity Activities|Behavioral: BRAC's business-as-usual,https://ClinicalTrials.gov/show/NCT04765540
5245,Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations,Behavioral: Motivational social support from nurse|Behavioral: Motivational social support from nurse with additional support from significant other|Behavioral: Attention control,https://ClinicalTrials.gov/show/NCT03907891
5246,COV2Base-A Rare Disease by COVID Study,,https://ClinicalTrials.gov/show/NCT04564274
5247,COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics,Biological: Recently Vaccination,https://ClinicalTrials.gov/show/NCT04871932
5248,Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus,Biological: SRAS-CoV-2 vaccination immunological response,https://ClinicalTrials.gov/show/NCT04894253
5249,Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients,Diagnostic Test: COVID-19 serology IgG,https://ClinicalTrials.gov/show/NCT04723706
5250,Effect of a COVID-specific Advance Care Planning Intervention,Behavioral: Advance Care Planning Video|Behavioral: Advance Care Planning Video and Conversation,https://ClinicalTrials.gov/show/NCT04852055
5251,Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection,Other: Probiotics,https://ClinicalTrials.gov/show/NCT04854941
5252,Emotional Freedom Technique (EFT) Effect on Nurses,Behavioral: Emotional Freedom Technique,https://ClinicalTrials.gov/show/NCT04393077
5253,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling,Diagnostic Test: MCC IMS,https://ClinicalTrials.gov/show/NCT04282135
5254,Sexual Health and Problems During the Covid -19 Infection,Behavioral: questionaire to husband and wife,https://ClinicalTrials.gov/show/NCT04427813
5255,LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION,,https://ClinicalTrials.gov/show/NCT04409275
5256,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Drug: Any drug used to treat Covid-19,https://ClinicalTrials.gov/show/NCT04314817
5257,REstoring Mental Health After SARS-CoV-2 Through commUnity-based Psychological Services in New York City,Behavioral: Problem Management Plus|Behavioral: Services as Usual,https://ClinicalTrials.gov/show/NCT04913766
5258,Creating a Sustainable Infrastructure for SARS-CoV-2 Testing at Syringe Exchange Programs,Behavioral: Connect2Test Intervention,https://ClinicalTrials.gov/show/NCT04852848
5259,Protective Measures Against SARS-CoV-2 Contamination of Young Healthy Volunteers During a Concert of Actual Music,Other: Assisting to the event,https://ClinicalTrials.gov/show/NCT04868942
5260,Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID),,https://ClinicalTrials.gov/show/NCT03738774
5261,"RinasciMENTE, An Internet-Based Self-Help Intervention for People With Psychological Distress Due to COVID-19",Other: internet-based intervention,https://ClinicalTrials.gov/show/NCT04907903
5262,A Study of a Candidate COVID-19 Vaccine (COV003),Biological: ChAdOx1 nCoV-19 single dose + paracetamol|Biological: MenACWY single dose + paracetamol|Biological: ChAdOx1 nCoV-19 two dose + paracetamol|Biological: MenACWY prime & saline placebo boost + paracetamol,https://ClinicalTrials.gov/show/NCT04536051
5263,Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand,Biological: Normal Saline|Biological: NDV-HXP-S vaccine,https://ClinicalTrials.gov/show/NCT04764422
5264,COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2,Drug: RESP301,https://ClinicalTrials.gov/show/NCT04858451
5265,Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients: The Rovid Study,,https://ClinicalTrials.gov/show/NCT04811781
5266,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug: Lopinavir and Ritonavir Tablets|Drug: Arbidol,https://ClinicalTrials.gov/show/NCT04252885
5267,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Other: Exposed to the novel coronavirus disease 2019,https://ClinicalTrials.gov/show/NCT04299711
5268,Haemoglobin Concentration on COVID-19,Other: File scanning,https://ClinicalTrials.gov/show/NCT04377607
5269,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,,https://ClinicalTrials.gov/show/NCT04260308
5270,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,Behavioral: Mindfulness-Based Cognitive Therapy|Behavioral: Muscle Relaxation Therapy,https://ClinicalTrials.gov/show/NCT04540939
5271,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Drug: alpha one antitrypsin inhalation,https://ClinicalTrials.gov/show/NCT04385836
5272,Evaluation of the Effects of Treatment With Bioarginin C in Adult Subjects Belonging to the Post-Covid Day Hospital,Dietary Supplement: Bioarginina C,https://ClinicalTrials.gov/show/NCT04947488
5273,VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study,Drug: VERU-111,https://ClinicalTrials.gov/show/NCT04842747
5274,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,Other: Blood sampling|Other: Skin biopsy,https://ClinicalTrials.gov/show/NCT04590209
5275,Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation,Procedure: Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection|Procedure: Neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection,https://ClinicalTrials.gov/show/NCT04666233
5276,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP),Other: attendance by ambulance crew,https://ClinicalTrials.gov/show/NCT04474444
5277,A Study of Ad26.COV2.S in Adults (COVID-19),Biological: Ad26.COV2.S|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04436276
5278,New Reusable Mask Design With Superior Filtration and Fit,Device: N95 mask|Device: Nordell single E-100 layer mask|Device: Nordell double E-100 layer mask,https://ClinicalTrials.gov/show/NCT04826809
5279,Gestational Immunity for Transfer,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04802278
5280,New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations,Behavioral: Healthcare Worker Focused Outreach|Behavioral: Community Organization Led Outreach,https://ClinicalTrials.gov/show/NCT04766333
5281,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,Drug: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205,https://ClinicalTrials.gov/show/NCT04447833
5282,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,Diagnostic Test: RBA-2,https://ClinicalTrials.gov/show/NCT04357977
5283,Information and Communication Technologies (ICTS) in Dentistry for SUS,Other: Telemonitoring and teleorientation|Other: Control Group - Waiting list,https://ClinicalTrials.gov/show/NCT04798599
5284,Obesity Surgery During 2020 Italian Pandemic,Procedure: Bariatric procedures,https://ClinicalTrials.gov/show/NCT04480034
5285,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT),Behavioral: decisions of limitations and stop processing,https://ClinicalTrials.gov/show/NCT04452487
5286,"The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic",Other: Telerehabilitation-based|Other: Follow-up based,https://ClinicalTrials.gov/show/NCT04742049
5287,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,Behavioral: Home exercise program,https://ClinicalTrials.gov/show/NCT04480606
5288,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,Dietary Supplement: Vitamin D supplementation,https://ClinicalTrials.gov/show/NCT04596657
5289,Supporting Parent and Child Engagement,Behavioral: SPACE Parenting Program,https://ClinicalTrials.gov/show/NCT04925258
5290,Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE,Diagnostic Test: glycomic analysis|Other: Phone interview,https://ClinicalTrials.gov/show/NCT04788433
5291,Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas,Device: Mask,https://ClinicalTrials.gov/show/NCT04715854
5292,Strados System at Center of Excellence,Device: RESP,https://ClinicalTrials.gov/show/NCT04485741
5293,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,Diagnostic Test: Rapid Pathogen Detection,https://ClinicalTrials.gov/show/NCT04233268
5294,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,Behavioral: Video about safety and effectiveness of adult seasonal flu vaccination,https://ClinicalTrials.gov/show/NCT04160975
5295,A Patient-Centered PaTH to Addressing Diabetes,Other: Weight Counseling|Other: Telemedicine,https://ClinicalTrials.gov/show/NCT02788903
5296,MR-Evaluation of Renal Function In Septic Patients,Other: Plasma expansion with Ringer's Acetate,https://ClinicalTrials.gov/show/NCT02765191
5297,Less Frequency Hemodialysis and COVID-19,Other: less-frequency hemodialysis,https://ClinicalTrials.gov/show/NCT04374058
5298,"CoV-ICU Score, Intensive Care Unit, SARS-CoV-2",Other: COVICU,https://ClinicalTrials.gov/show/NCT04383483
5299,"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2",Combination Product: PurWet|Combination Product: FurFat|Combination Product: PurApo|Combination Product: PurPhl|Combination Product: PurClo|Combination Product: PurInf|Combination Product: Smoliv,https://ClinicalTrials.gov/show/NCT04846010
5300,Coronavirus Associated Pneumomediastinum and Pneumothorax,,https://ClinicalTrials.gov/show/NCT04897152
5301,Stress Levels and Mental Well-Being Among Slovak Students During e-Learning,Diagnostic Test: Stress Levels and Mental Well-Being assessment,https://ClinicalTrials.gov/show/NCT04924634
5302,The Effect of Acupressure on the Anxiety Level,Other: Acupressure,https://ClinicalTrials.gov/show/NCT04849793
5303,Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old),Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) placebo group,https://ClinicalTrials.gov/show/NCT04550351
5304,Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19),Other: Respiratory Mechanics|Other: Standard Ventilation Strategy,https://ClinicalTrials.gov/show/NCT03963622
5305,Effect Psychological Triaging Intervention on Students' Psychological Distress and Resilience Capacity,Behavioral: Psychological Triaging Intervention|Behavioral: Routine psychological support,https://ClinicalTrials.gov/show/NCT04822285
5306,Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children,Other: Diagnostic test,https://ClinicalTrials.gov/show/NCT04581889
5307,Nurse Leadership for Hospital Infection Control,Behavioral: Intervention for COVID-19 preventive protocols,https://ClinicalTrials.gov/show/NCT04603079
5308,Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products,,https://ClinicalTrials.gov/show/NCT00571389
5309,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,Radiation: Angiography scanner,https://ClinicalTrials.gov/show/NCT04479540
5310,"imPulse™ Una Full-spectrum, Over Clothing E-stethoscope",Device: imPulse™ Una e-stethoscope|Device: Philips Lumify Ultrasound System,https://ClinicalTrials.gov/show/NCT04556149
5311,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,Drug: Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation,https://ClinicalTrials.gov/show/NCT03331445
5312,Supporting Parents & Kids Through Lockdown Experiences (SPARKLE).,Behavioral: Parent Positive,https://ClinicalTrials.gov/show/NCT04786080
5313,The COVID-19 ICU PRAYER Study,Behavioral: prayer,https://ClinicalTrials.gov/show/NCT04361838
5314,French COVID Cohort,,https://ClinicalTrials.gov/show/NCT04262921
5315,MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology,,https://ClinicalTrials.gov/show/NCT04872309
5316,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,Other: BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM,https://ClinicalTrials.gov/show/NCT04353245
5317,Needle Stick Injuries in Emergency Medical Service Practice,Procedure: double gloves,https://ClinicalTrials.gov/show/NCT04363788
5318,International Lung UltraSound Analysis (ILUSA) Study,Diagnostic Test: standardized Lung Ultrasound (LUS) examination,https://ClinicalTrials.gov/show/NCT04353141
5319,COVID-19 Sero-prevalence Health Care Workers Kinshasa,Diagnostic Test: COVID-antibody test,https://ClinicalTrials.gov/show/NCT04699058
5320,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,Behavioral: Stress and emotion management,https://ClinicalTrials.gov/show/NCT04526145
5321,COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients,Other: No intervention,https://ClinicalTrials.gov/show/NCT04852809
5322,Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction),"Behavioral: Couple HOPES Guided, Internet-Delivered, Self-Help Intervention",https://ClinicalTrials.gov/show/NCT04763681
5323,Effect of Positive Attitudes on Behavior and Wellness,Behavioral: Positive feedback,https://ClinicalTrials.gov/show/NCT04441632
5324,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor),Other: Review of medical patient file|Other: Phone call interview,https://ClinicalTrials.gov/show/NCT04664296
5325,Behavior During and After COVID-19 Crisis,Behavioral: Covid19,https://ClinicalTrials.gov/show/NCT04502108
5326,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,,https://ClinicalTrials.gov/show/NCT04426071
5327,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2),Other: Review of medical file|Other: Phone call interview,https://ClinicalTrials.gov/show/NCT04924842
5328,First Responder Resiliency Program During COVID-19,Behavioral: Resilience Program,https://ClinicalTrials.gov/show/NCT04536376
5329,A Study of Ad26.COV2.S in Adults (COVID-19),Biological: Ad26.COV2.S|Biological: Placebo,https://ClinicalTrials.gov/show/NCT04509947
5330,"COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",Drug: EIDD-2801|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04392219
5331,A Study of Ad26.COV2.S in Healthy Adults (COVID-19),Biological: Ad26.COV2.S,https://ClinicalTrials.gov/show/NCT04894305
5332,The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff,Behavioral: Phase 3 Cardiac rehabilitation,https://ClinicalTrials.gov/show/NCT04740489
5333,A Check-list Including Lung Ultrasound for ED Patients With ARF,Other: check-list including lung ultrasound,https://ClinicalTrials.gov/show/NCT04791241
5334,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),,https://ClinicalTrials.gov/show/NCT04413877
5335,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),Drug: CUROSURF® (poractant alfa),https://ClinicalTrials.gov/show/NCT04502433
5336,"COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers",Drug: REGN10933+REGN10987|Biological: Moderna mRNA-1273 vaccine,https://ClinicalTrials.gov/show/NCT04852978
5337,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Behavioral: Change in preference to surgery under COVID-19 pandemic.,https://ClinicalTrials.gov/show/NCT04370678
5338,Variation in Acute Appendicitis During COVID-19 Pandemic in Italy,Procedure: Appendectomy,https://ClinicalTrials.gov/show/NCT04649996
5339,A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19),Biological: Ad26.COV2.S,https://ClinicalTrials.gov/show/NCT04765384
5340,Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D),Diagnostic Test: blood test,https://ClinicalTrials.gov/show/NCT04905823
5341,Post-Pandemic Perception of Public Space in Singapore,Other: Public space exposure,https://ClinicalTrials.gov/show/NCT04394039
5342,Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza),,https://ClinicalTrials.gov/show/NCT04786301
5343,Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis,Diagnostic Test: Accuracy of CAD4TB and Afinion CRP assay for pulmonary TB|Diagnostic Test: CAD4COVID+WBC and COVID-19 RDT for SARS-CoV-2 infection,https://ClinicalTrials.gov/show/NCT04666311
5344,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,Behavioral: Internet-based guided self-help based on CBT principles,https://ClinicalTrials.gov/show/NCT04394403
5345,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',Behavioral: Brief Skills for Safer Living,https://ClinicalTrials.gov/show/NCT04495543
5346,Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents,Other: Questionnaire,https://ClinicalTrials.gov/show/NCT04406558
5347,Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19,Other: Community Mask|Other: Surgical Mask|Other: FFP2 respirator|Other: FFP3 respirator,https://ClinicalTrials.gov/show/NCT04771585
5348,Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program,Behavioral: Overcoming Anxiety in Pregnancy and Postpartum Online Self-Directed Program,https://ClinicalTrials.gov/show/NCT04844138
5349,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,,https://ClinicalTrials.gov/show/NCT04445441
5350,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,Other: Deep Breathing training|Other: Compassion focused intervention,https://ClinicalTrials.gov/show/NCT04382560
5351,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,,https://ClinicalTrials.gov/show/NCT04408196
5352,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",Behavioral: Supportive Therapy SSI|Behavioral: Behavioral Activation SSI|Behavioral: Growth Mindset SSI,https://ClinicalTrials.gov/show/NCT04634903
5353,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,Behavioral: SSE educational intervention|Other: Home sample collection of concerning mole with physician supervision|Behavioral: Active control:Healthy Living,https://ClinicalTrials.gov/show/NCT04420273
5354,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,,https://ClinicalTrials.gov/show/NCT04388644
5355,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",Drug: DWRX2003|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04524052
5356,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,Other: PT-X and IMT,https://ClinicalTrials.gov/show/NCT04600713
5357,A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults,Biological: 1 µg CoV2 SAM (LNP),https://ClinicalTrials.gov/show/NCT04758962
5358,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,Biological: T memory cells and NK cells,https://ClinicalTrials.gov/show/NCT04578210
5359,CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19,Diagnostic Test: Quantitative and qualitative assessments of mental health,https://ClinicalTrials.gov/show/NCT04498416
5360,Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations,"Other: Educational, culturally appropriate COVID-19 messages",https://ClinicalTrials.gov/show/NCT04765839
5361,European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol,Drug: ART Therapy,https://ClinicalTrials.gov/show/NCT04677842
5362,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,Other: Museum virtual guided tours,https://ClinicalTrials.gov/show/NCT04593433
5363,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),Other: Meditation (1 x 20-minute guided audio training),https://ClinicalTrials.gov/show/NCT04602286
5364,CoV-PICS: A Virtual Post-ICU Clinic,Other: Medical Record Review - Inpatient Treatment|Other: Online Questionnaires,https://ClinicalTrials.gov/show/NCT04490278
5365,Expressive Writing for the Management of Stress in Cancer Survivors,Behavioral: Behavioral Intervention|Other: Quality-of-Life Assessment|Other: Questionnaire Administration,https://ClinicalTrials.gov/show/NCT04776941
5366,Brief Video Interventions for Depression,Behavioral: Entrée: Cognitive skills|Behavioral: Entrée: Behavioral skills|Behavioral: Entrée: Interpersonal skills|Behavioral: Sampler skills,https://ClinicalTrials.gov/show/NCT04643964
5367,ePLH Pilot Study: Online Support Parent Groups - ParentChat,Behavioral: ParentChat for parents of children ages 2-17,https://ClinicalTrials.gov/show/NCT04809272
5368,Mindfulness Training for Seniors,Behavioral: Mindfulness training (MT) Connect,https://ClinicalTrials.gov/show/NCT04378803
5369,Use of the Mask and Current Pandemic,,https://ClinicalTrials.gov/show/NCT04727762
5370,Teleprehabilitation for Surgical Cancer Patients,Behavioral: Multimodal Teleprehabilitation,https://ClinicalTrials.gov/show/NCT04799561
5371,Sleep Quality Among HCWs,Other: PSQI,https://ClinicalTrials.gov/show/NCT04549350
5372,"Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain",Behavioral: painTRAINER®|Device: PICO G2 4k,https://ClinicalTrials.gov/show/NCT04933474
5373,A Clinical Study of Online Active Play Program With Adolescents,,https://ClinicalTrials.gov/show/NCT04618341
5374,Needs of Persons With Spinal Cord Injury (SCI),,https://ClinicalTrials.gov/show/NCT04422769
5375,BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition,Behavioral: Handwashing stations at the public places and no soap|Behavioral: No activities of the HBCC project and also no soap (Pure Control)|Behavioral: Soap distributed but no activities of the HBCC project|Behavioral: HBCC project and Soap,https://ClinicalTrials.gov/show/NCT04753645
5376,Caregiving During Crisis,Behavioral: Psychoeducational Intervention,https://ClinicalTrials.gov/show/NCT04939714
5377,Impact of Pandemic of Presentation to Emergency Department and Admissions,Other: COVID-19 pandemic,https://ClinicalTrials.gov/show/NCT04893122
5378,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,Other: DIG Axial|Other: DIG Tilted|Other: CIG Axial|Other: CIG Tilted,https://ClinicalTrials.gov/show/NCT04475913
5379,Music Therapy in Frontline Healthcare Workers,Behavioral: Music Therapy,https://ClinicalTrials.gov/show/NCT04551274
5380,Biofeedback for CHAMPS,Behavioral: Heart rate variability biofeedback,https://ClinicalTrials.gov/show/NCT04921228
5381,Hospitalizations During Pandemia in the Italian Coronary Care Unit Network,Other: Epidemiology of admissions,https://ClinicalTrials.gov/show/NCT04744415
5382,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),Device: TAPE-Software,https://ClinicalTrials.gov/show/NCT04518514
5383,Effects of Mindfulness Practice on Healthcare Workers,Behavioral: Mindfulness Practice|Behavioral: Cognitive training,https://ClinicalTrials.gov/show/NCT04936893
5384,Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study,Other: Virtual Individual Cognitive Simulation Therapy,https://ClinicalTrials.gov/show/NCT04828434
5385,The Effect of Work Requirements in SNAP in Virginia,Other: Work requirement exemption months,https://ClinicalTrials.gov/show/NCT04888832
5386,Correlation of Carotid Flow Time and Cardiac Output.,Procedure: Carotid Artery Ultrasound Measure,https://ClinicalTrials.gov/show/NCT04614701
5387,Group CST Using Zoom: A Proof of Concept Study,Other: Online Cognitive Stimulation Therapy,https://ClinicalTrials.gov/show/NCT04695743
5388,RSV Burden in Outpatient Settings,Diagnostic Test: nasopharyngeal samples,https://ClinicalTrials.gov/show/NCT04743609
5389,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,Other: Pulmonary tele-rehabilitation,https://ClinicalTrials.gov/show/NCT04658979
5390,Comparative Effectiveness of Telemedicine in Primary Care,"Other: Exposure to telemedicine, after the onset of the pandemic",https://ClinicalTrials.gov/show/NCT04684836
5391,Effects of a Face Mask on Oxygenation During Exercise,Other: Progressive cycling exercise test to exhaustion,https://ClinicalTrials.gov/show/NCT04557605
5392,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Other: Virtual Care and Remote Automated Monitoring,https://ClinicalTrials.gov/show/NCT04344665
5393,Antibody Detection of Vaccine-Induced Secretory Effects,Behavioral: SARS-CoV-2 vaccine,https://ClinicalTrials.gov/show/NCT04895475
5394,Effects of Wearing a Face Mask During CrossFit Exercise,Other: High intensity interval training|Other: Continuous exercise training,https://ClinicalTrials.gov/show/NCT04688502
5395,The Effectiveness of Calistenic Exercise Training in Adolescents,Other: calisthenic exercises,https://ClinicalTrials.gov/show/NCT04942990
5396,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,Drug: Icosapent ethyl,https://ClinicalTrials.gov/show/NCT04505098
5397,Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty,Procedure: hip arthropalsty,https://ClinicalTrials.gov/show/NCT04688840
5398,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,Other: Telerehabilitation-based relaxation exercise group (EG),https://ClinicalTrials.gov/show/NCT04826367
5399,Video-Based Exercises and Well-Being During Social Isolation,Other: Video based aerobic exercise,https://ClinicalTrials.gov/show/NCT04335851
5400,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Other: after-each-case room disinfection|Other: daily room disinfection,https://ClinicalTrials.gov/show/NCT04399005
5401,Effectiveness of Convalescent Immune Plasma Therapy,Other: Convalescent Immune Plasma,https://ClinicalTrials.gov/show/NCT04442958
5402,The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness,Other: Acupressure|Other: Plasebo acupressure,https://ClinicalTrials.gov/show/NCT04800939
5403,New Predictors in Determining the Need for Invasive Treatment in Non-STEMI,Diagnostic Test: Coronary Angiography,https://ClinicalTrials.gov/show/NCT04763213
5404,Tele-Yoga Therapy for Chronic Pain,Other: Tele-Yoga Therapy,https://ClinicalTrials.gov/show/NCT04457388
5405,Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic,Behavioral: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE),https://ClinicalTrials.gov/show/NCT04760418
5406,The Impact of Lifestyle Changes on Non-COVID Deaths,,https://ClinicalTrials.gov/show/NCT04550312
5407,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,Behavioral: Video Chat +Personalized Feedback|Behavioral: Video Chat + Basic Feedback|Behavioral: Discussion Board for Social Support +Basic Feedback|Behavioral: Discussion Board for Social Support+Personalized Feedback,https://ClinicalTrials.gov/show/NCT04514900
5408,Telemedicine in HIV Care in Buenos Aires,,https://ClinicalTrials.gov/show/NCT04513496
5409,Telerehabilitation for Patients Diagnosed With Coronavirus,Other: Telerehabilitation|Other: exercise brochure,https://ClinicalTrials.gov/show/NCT04346927
5410,Chat-based Support for Preventing Smoking Relapse,Behavioral: Chat-based instant messaging support|Behavioral: SMS message support|Behavioral: Self-help booklet,https://ClinicalTrials.gov/show/NCT04409496
5411,Increasing Vaccine Uptake in Underresourced Public Housing Areas,Behavioral: Increasing Willingness and Uptake of COVID-19 Vaccination,https://ClinicalTrials.gov/show/NCT04779138
5412,Palliative Care Educator,"Behavioral: ACP Educator led, video assisted discussion",https://ClinicalTrials.gov/show/NCT04857060
5413,Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial,Behavioral: Chair-yoga program,https://ClinicalTrials.gov/show/NCT04884529
5414,Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain,Other: Stepped-Care Model,https://ClinicalTrials.gov/show/NCT04885192
5415,Feasibility and Quality of TeleConsultation in Pediatric Anesthesia,Other: teleconsultation,https://ClinicalTrials.gov/show/NCT04583865
5416,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Other: Telemedicine|Other: Standard care,https://ClinicalTrials.gov/show/NCT04368299
5417,Specimen Collection Study Protocol,,https://ClinicalTrials.gov/show/NCT04468386
5418,Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE),Procedure: Non-cardiac surgery,https://ClinicalTrials.gov/show/NCT04787536
5419,Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CT,Diagnostic Test: Cardiac Magnetic Resonance|Diagnostic Test: Additional CT acquisition|Diagnostic Test: Blood tests,https://ClinicalTrials.gov/show/NCT04880317
5420,Digital Cardiac Counseling Trial: DCC Trial,Other: Digital cardiac Counseling,https://ClinicalTrials.gov/show/NCT04393636
5421,"Bidirectional, Upbeat Communication and Differentiated, Distanced Care for Young People",Behavioral: Mobile phone support|Behavioral: Remote service delivery model,https://ClinicalTrials.gov/show/NCT04781400
5422,Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations,Other: Fluorescein|Other: Particle measurement,https://ClinicalTrials.gov/show/NCT04687488
5423,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",Behavioral: Mindfulness,https://ClinicalTrials.gov/show/NCT04389372
5424,The Effect of Acupressure on the Sleep Quality and Fatigue,Other: Acupressure|Other: Sham acupressure group,https://ClinicalTrials.gov/show/NCT04923061
5425,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,Drug: Niclosamide|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04644705
5426,"Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid",,https://ClinicalTrials.gov/show/NCT04848831
5427,Virtual Parental Presence on Induction,Other: Use of Facetime with child and parents during induction,https://ClinicalTrials.gov/show/NCT04574219
5428,Computer Assisted Lessening of Intrusive Memories in the Emergency Department,Behavioral: Simple cognitive task,https://ClinicalTrials.gov/show/NCT04769999
5429,Determining the Physical Activity Level of Healthy Adults During Pandemic,Other: surveys and questionnaires,https://ClinicalTrials.gov/show/NCT04555954
5430,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,Drug: Dexamethasone,https://ClinicalTrials.gov/show/NCT04545242
5431,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,Behavioral: Mindfulness,https://ClinicalTrials.gov/show/NCT04604977
5432,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress","Other: Determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.",https://ClinicalTrials.gov/show/NCT04319211
5433,Auricular Stimulation for Relief of Stress and Anxiety,Other: Auricular stimulation,https://ClinicalTrials.gov/show/NCT04703907
5434,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Device: Mechanical ventilation with the automated BVM compressor,https://ClinicalTrials.gov/show/NCT04369274
5435,Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles,Drug: LH Suppression,https://ClinicalTrials.gov/show/NCT04052607
5436,Online Culture for Mental Health in People Aged 16-24,Other: WofB|Other: Ashmolean Website,https://ClinicalTrials.gov/show/NCT04663594
5437,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,Behavioral: brief mindfulness based intervention|Behavioral: Progressive muscle relaxation,https://ClinicalTrials.gov/show/NCT04656626
5438,"The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction",Other: Motivational messages,https://ClinicalTrials.gov/show/NCT04751474
5439,Project Resurgence Communication Trial,Other: Communication type,https://ClinicalTrials.gov/show/NCT04418947
5440,TRACERx Renal CAPTURE Sub-study,,https://ClinicalTrials.gov/show/NCT03226886
5441,DigiVis: Self-testing Vision App for Telephone Consultations,Device: DigiVis visual acuity app,https://ClinicalTrials.gov/show/NCT04482387
5442,Bronchopulmonary PK of AT-527 (R07496998),Drug: AT-527,https://ClinicalTrials.gov/show/NCT04877769
5443,Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis,Diagnostic Test: ECG from handheld device,https://ClinicalTrials.gov/show/NCT04601415
5444,Self-compassion for Chronic Pain Virtual Group Treatment Program,Behavioral: Self-Compassion for Chronic Pain Virtual Group Treatment Program,https://ClinicalTrials.gov/show/NCT04413006
5445,Physical Training and Diet for Childhood Obesity,Other: High-intensity aerobic training with high protein diet,https://ClinicalTrials.gov/show/NCT04789525
5446,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug: Tocilizumab,https://ClinicalTrials.gov/show/NCT04331808
5447,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,Behavioral: Lifestyle change promotion program|Behavioral: Mindfullness based cognitive program|Behavioral: Written Information,https://ClinicalTrials.gov/show/NCT04428099
5448,Prednisolone in Early Diffuse Systemic Sclerosis,Drug: Prednisolone 5 mg|Drug: Placebo oral capsule; From August 2020 'no additional treatment',https://ClinicalTrials.gov/show/NCT03708718
5449,Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management,Device: EMA + Automated Text Message Intervention|Behavioral: EMA Alone,https://ClinicalTrials.gov/show/NCT04907942
5450,Exploratory Study About the Implementation of Technology in the Rehabilitation,Other: Focus group discussions,https://ClinicalTrials.gov/show/NCT04833088
5451,"Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors",Other: Kinesiotherapy protocol|Other: Usual orientations,https://ClinicalTrials.gov/show/NCT04779450
5452,The Effect of Clear Masks in Improving Patient Relationships,Behavioral: Transparent mask|Behavioral: Typical surgical covered mask,https://ClinicalTrials.gov/show/NCT04595695
5453,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,Combination Product: Insulin film|Device: Fast dissolving film,https://ClinicalTrials.gov/show/NCT04657809
5454,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,Behavioral: Basic Body Awareness Therapy|Behavioral: Psychological treatment,https://ClinicalTrials.gov/show/NCT04396314
5455,Remote Glucose Monitoring in Hospital Settings,Device: Real-Time CGM|Device: Capillary blood glucose testing with masked CGM,https://ClinicalTrials.gov/show/NCT04797208
5456,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,Drug: Ketotifen 1 MG,https://ClinicalTrials.gov/show/NCT04435028
5457,Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers,Drug: IRL201104|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04748536
5458,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,,https://ClinicalTrials.gov/show/NCT04444713
5459,Effects of Face Masks During Exercise,Other: Cardiopulmonary Exercise Test|Other: Cognitive Performance Test,https://ClinicalTrials.gov/show/NCT04833010
5460,Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia,Behavioral: Structured Telephone Support (STS)|Behavioral: Low-intensity Remote Patient Monitoring (RPM-Low)|Behavioral: High-intensity Remote Patient Monitoring (RPM-High)|Behavioral: Standard Response Team|Behavioral: Enhanced Response Team,https://ClinicalTrials.gov/show/NCT04829188
5461,A Smartphone Intervention for Relational and Mental Well Being,Behavioral: Intervention,https://ClinicalTrials.gov/show/NCT04629755
5462,SSIPP vs. PST vs. WLC,Behavioral: Student-Senior Isolation Prevention Partnership (SSIPP)|Behavioral: Problem Solving Therapy (PST).,https://ClinicalTrials.gov/show/NCT04887350
5463,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana",Behavioral: DESMOND|Other: usual care,https://ClinicalTrials.gov/show/NCT04780425
5464,A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy,Drug: Anakinra,https://ClinicalTrials.gov/show/NCT04148430
5465,Corona Virus Infection Among Liver Transplant Recipients,,https://ClinicalTrials.gov/show/NCT04565782
5466,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,Device: MakAir,https://ClinicalTrials.gov/show/NCT04475185
5467,Brain Imaging in Babies Study,,https://ClinicalTrials.gov/show/NCT04443179
5468,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,Diagnostic Test: Chest MRI,https://ClinicalTrials.gov/show/NCT04424355
5469,Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study,Procedure: Extracorporeal left hemicolectomy anastomosis|Procedure: Intracorporeal left hemicolectomy anastomosis,https://ClinicalTrials.gov/show/NCT04456933
5470,Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement.,Other: Phone call,https://ClinicalTrials.gov/show/NCT04470869
5471,Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department,Other: telemedicine|Other: traditional communication tools,https://ClinicalTrials.gov/show/NCT04591873
5472,Immunocompromised Swiss Cohorts Based Trial Platform,"Biological: Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)|Biological: Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)",https://ClinicalTrials.gov/show/NCT04805125
5473,Study Testing Convalescent Plasma vs Best Supportive Care,Biological: high-titer anti-Sars-CoV-2 plasma|Other: oxygen therapy,https://ClinicalTrials.gov/show/NCT04333251
5474,Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids,Other: Storage of operating waste,https://ClinicalTrials.gov/show/NCT04640610
5475,Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis,Other: Teleconsultation either by phone or by computer consultation. Quantitative and qualitative approaches to analysis|Other: Care modalities. Quantitative and qualitative approaches to analysis,https://ClinicalTrials.gov/show/NCT04768413
5476,Clinical Study of Recombinant Novel Coronavirus Vaccine,Biological: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,https://ClinicalTrials.gov/show/NCT04466085
5477,Serum Prevalence of Sars-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE),Diagnostic Test: Anti-COVID test,https://ClinicalTrials.gov/show/NCT04712448
5478,Analysis of Long Term Risk of Coronavirus Disease-19 Emergency,,https://ClinicalTrials.gov/show/NCT04422262
5479,Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era,Dietary Supplement: proper diet,https://ClinicalTrials.gov/show/NCT04434014
5480,To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn,Device: McGrath videolaryngoscope|Device: Direct laryngoscope,https://ClinicalTrials.gov/show/NCT04424953
5481,Universal Anti-Viral Vaccine for Healthy Elderly Adults,Drug: AlloStim,https://ClinicalTrials.gov/show/NCT04441047
5482,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,Drug: Sodium bicarbonate|Other: Standard of Care,https://ClinicalTrials.gov/show/NCT04530448
5483,Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections,Diagnostic Test: Thrombin Generation Assay (TGA)|Diagnostic Test: Thrombomodulin Modified Thrombin Generation Assay (TGA-TM),https://ClinicalTrials.gov/show/NCT04356144
5484,Diode Laser 940 nm in Management of Loss of Taste Sensation,Device: a 940-nm diode laser,https://ClinicalTrials.gov/show/NCT04821999
5485,First Level Socio-geriatric Evaluation: ESOGER Databank,Other: ESOGER,https://ClinicalTrials.gov/show/NCT04393649
5486,Telerehabilitation in Lung Surgery Patients,"Other: Breathing exercise, intensive spirometry use, supported cough, progressive mobilisation and ambulation|Other: Exercise booklet",https://ClinicalTrials.gov/show/NCT04568564
5487,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,Device: faecal sample collector,https://ClinicalTrials.gov/show/NCT04443075
5488,Conversational Agent Vaccine Promotion RCT,Behavioral: ECA-ACE Vaccination Promotion Intervention,https://ClinicalTrials.gov/show/NCT04884750
5489,Mobile Mental Health Apps for Suicide Prevention,Behavioral: Mobile Mental Health App - 1|Behavioral: Mobile Mental Health App - 2|Behavioral: Mobile Mental Health App - 3|Behavioral: Mobile Mental Health App - 4,https://ClinicalTrials.gov/show/NCT04536935
5490,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,Device: TAVR or SAVR,https://ClinicalTrials.gov/show/NCT04333875
5491,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,Drug: Botulinum Neurotoxin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT04439825
5492,Collection of the Thrombo-VaxCov Cohort,Other: Retrospective data and biological samples,https://ClinicalTrials.gov/show/NCT04889326
5493,Heal-Me Personalized Online Nutrition and Exercise Routines,Other: Exercise & Nutrition,https://ClinicalTrials.gov/show/NCT04666558
5494,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,,https://ClinicalTrials.gov/show/NCT04663776
5495,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,Drug: Propranolol Hydrochloride,https://ClinicalTrials.gov/show/NCT04467086
5496,Virtual White Boards for Patient Satisfaction,Device: e-ink screen|Behavioral: Treatment as usual,https://ClinicalTrials.gov/show/NCT04497922
5497,Global Mental Health of Urban Mothers,Behavioral: Web-based psychosocial peer-to-peer support,https://ClinicalTrials.gov/show/NCT04363177
5498,Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.,Drug: PF-07321332/ritonavir,https://ClinicalTrials.gov/show/NCT04909853
5499,High Resolution Micro OCT Imaging,,https://ClinicalTrials.gov/show/NCT03256773
5500,Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia,Drug: Methylprednisolone|Other: Usual Care,https://ClinicalTrials.gov/show/NCT03852537
5501,The Effectiveness of Telerehabilitation-Based Exercises in Elderly People,Other: Telerehabilitation|Other: Exercise brochure,https://ClinicalTrials.gov/show/NCT04346940
5502,Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw,Other: Vacciantion status in health care workers,https://ClinicalTrials.gov/show/NCT04569019
5503,Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.,Biological: CoronoVAC,https://ClinicalTrials.gov/show/NCT04765215
5504,Inhaled NO for the Treatment of Viral Pneumonia in Adults,Device: LungFit™,https://ClinicalTrials.gov/show/NCT04606407
5505,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",Drug: Drug: NA-831 - 0.10 mg/kg|Drug: Placebo- 0.10 mg/kg|Drug: Drug: NA-831 - 0.20 mg/kg|Drug: Placebo- 0.20 mg/kg|Drug: Drug: GS-5734 - 1.00 mg/kg|Drug: Placebo- 1.00 mg/kg|Drug: Drug: GS-5734 - 2.00 mg/kg|Drug: Placebo- 2.00 mg/kg|Combination Product: Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg)|Combination Product: Placebo 0.10 mg + 1.00 mg/kg|Combination Product: Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg)|Combination Product: Placebo 0.20 mg + 2.00 mg/kg,https://ClinicalTrials.gov/show/NCT04480333
5506,Advance Care Planning: Communicating With Outpatients for Vital Informed Decision,Other: VitalTalk communication skills training|Other: ACP Decisions Video Program|Other: Intervention training:|Other: Medical Record Review,https://ClinicalTrials.gov/show/NCT04660422
5507,coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis,Procedure: Early Definitive Treatment,https://ClinicalTrials.gov/show/NCT04747990
5508,Lessening Organ Dysfunction With VITamin C,Drug: Vitamin C|Other: Control,https://ClinicalTrials.gov/show/NCT03680274
5509,PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock,"Other: Assessment of coagulopathy, Platelets activation and Platelets-Neutrophils interplay",https://ClinicalTrials.gov/show/NCT04107402
5510,"Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL",Diagnostic Test: COVID-19 serology,https://ClinicalTrials.gov/show/NCT04862806
5511,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,"Other: Primary care professionals reports of potential patient safety incidents, non-COVID-19 related",https://ClinicalTrials.gov/show/NCT04348552
5512,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,"Other: GPs reports of potential patient safety incidents, non-COVID-19 related",https://ClinicalTrials.gov/show/NCT04346121
5513,"Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers",Drug: ZYIL1 capsule,https://ClinicalTrials.gov/show/NCT04731324
5514,Further Development and Initial Testing of RESTORE in Frontline Workers,Behavioral: RESTORE: Recovering from Extreme Stressors Through Online Resources and E-health,https://ClinicalTrials.gov/show/NCT04873622
5515,A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers,Behavioral: LIFT Mindfulness,https://ClinicalTrials.gov/show/NCT04816708
5516,Integrated Platform for Multimodal Patient Monitoring and Therapy Support in ICU Patients,Device: ICU Cockpit software testing,https://ClinicalTrials.gov/show/NCT04748289
5517,The Effectiveness of Video-Based Exercises in Young Adults,Other: Study Group,https://ClinicalTrials.gov/show/NCT04346966
5518,Audio Data Collection for Identification and Classification of Coughing,,https://ClinicalTrials.gov/show/NCT04326309
5519,Characteristics of TraceTogether Users,Behavioral: Use of mobile application,https://ClinicalTrials.gov/show/NCT04468581
5520,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device,Device: Sensbiosys,https://ClinicalTrials.gov/show/NCT04379986
5521,Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA),Drug: SARS-COV-2 mRNA Vaccine,https://ClinicalTrials.gov/show/NCT04843774
5522,"GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study",Drug: Pioglitazone,https://ClinicalTrials.gov/show/NCT04473274
5523,SELF-BREATHE RCT for Chronic Breathlessness,Other: SELF-BREATHE,https://ClinicalTrials.gov/show/NCT04574050
5524,Vaccine Observation to Include All Communities for Equitable Science,Biological: COVID-19 vaccine,https://ClinicalTrials.gov/show/NCT04770649
5525,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:",https://ClinicalTrials.gov/show/NCT04278404
5526,Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina,Other: anonymous survey,https://ClinicalTrials.gov/show/NCT04703400
5527,Acceptance and Commitment Therapy Delivered by Automated Software Messaging,Behavioral: Software Messaging,https://ClinicalTrials.gov/show/NCT04329897
5528,Digital Interventions to Treat Hazardous Drinking,Behavioral: 4-week intervention,https://ClinicalTrials.gov/show/NCT04890652
5529,Effectiveness of a Mindfulness Training Program in Health Care Proffesional,Behavioral: Mindfulness Training Program,https://ClinicalTrials.gov/show/NCT04870775
5530,Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study,Other: revised HOME-CoV score,https://ClinicalTrials.gov/show/NCT04657471
5531,Stress Levels and Mental Well-Being Among Students During e-Learning,Diagnostic Test: Stress Levels and Mental Well-Being assessment,https://ClinicalTrials.gov/show/NCT04926441
5532,Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID),,https://ClinicalTrials.gov/show/NCT04387708
5533,Clinical Evaluation of an Aerosol Protective Intubation Device on Videolaryngoscopic Intubation Difficulty,Device: VACCIN box,https://ClinicalTrials.gov/show/NCT04865081
5534,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,Behavioral: Mindfulness Alone (MO) Intervention|Behavioral: Mindfulness + Compassion Intervention (MC),https://ClinicalTrials.gov/show/NCT04414826
5535,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,Other: Clinical Trial Matching,https://ClinicalTrials.gov/show/NCT03452774
5536,Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions,Drug: FAVIR 200 MG FT|Drug: AVIGAN 200 mg FT,https://ClinicalTrials.gov/show/NCT04444986
5537,Topical Lidocaine Anesthesia for Nasopharyngeal Sampling,Drug: Lidocaine|Other: Placebo,https://ClinicalTrials.gov/show/NCT04885777
5538,Comparison of VieScope vs. Macintosh Laryngoscope for Intubation in Level Cpersonal Protective Equipment Conditions,Device: The standard Macintosh laryngoscope|Device: The Vie Scope laryngoscope,https://ClinicalTrials.gov/show/NCT04363775
5539,Longitudinal Innate Immunity and Aging Study,,https://ClinicalTrials.gov/show/NCT03944603
5540,Reopening Schools Safely and Educating Youth (ROSEY) Research Study,Diagnostic Test: SARS-CoV-2 testing,https://ClinicalTrials.gov/show/NCT04859699
5541,Healthy Lifestyle or Pro-health Obsession During the Pandemic,,https://ClinicalTrials.gov/show/NCT04432038
5542,ICBT for Mental Health Problems Related to the Coronavirus Pandemic,Behavioral: Intervention group CoronaCope,https://ClinicalTrials.gov/show/NCT04424212
5543,#Stayhealthy - Monitoring and Maintenance of Mental Health Under Conditions of Social Isolation During the Corona Crisis,Behavioral: Acceptance and commitment therapy (ACT) exercises|Behavioral: Positive psychology (PP) exercises,https://ClinicalTrials.gov/show/NCT04871386
5544,Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients,Device: Conventional (low flow) oxygen delivery via nasal cannula|Device: Revoxa Oxygen Rebrearther,https://ClinicalTrials.gov/show/NCT04699942
5545,Telehealth Intervention Program for Older Adults,Behavioral: Telehealth phone calls|Other: Volunteer of TIP-OA Program|Other: Stakeholder of TIP-OA Program,https://ClinicalTrials.gov/show/NCT04523610
5546,Telerehabilitation-based Yoga and Mindfulness Home Program in Postmenopausal Women Having Social Isolation,Other: Telerehabilitation-Based|Other: Video-Based,https://ClinicalTrials.gov/show/NCT04346979
5547,Diagnostic Accuracy Comparison Between Telemedicine and Face-to-face Consultations in Respiratory Infection Patients.,Other: Telemedicine Consultation|Other: Face-to-face Consultation,https://ClinicalTrials.gov/show/NCT04806477
5548,Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden.,Behavioral: Motivational telephone intervention,https://ClinicalTrials.gov/show/NCT04646421
5549,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions",Drug: AVICOD 200 MG Film Tablet|Drug: AVIGAN 200 MG Film Tablets,https://ClinicalTrials.gov/show/NCT04651959
5550,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions",Drug: FAVICOVIR 200 mg Film Tablet|Drug: AVIGAN 200 mg Film Tablets,https://ClinicalTrials.gov/show/NCT04406194
5551,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions",Drug: FAVIRA 200 MG Film Tablet|Drug: AVIGAN 200 MG Film Tablets,https://ClinicalTrials.gov/show/NCT04400682
5552,Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.,Diagnostic Test: SARS-CoV-2/Influenza/RSV RT-PCR,https://ClinicalTrials.gov/show/NCT04748445
5553,Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds,Drug: fosmanogepix,https://ClinicalTrials.gov/show/NCT04240886
5554,"Novelty, Conformity and Trust in Vaccines",Other: RNA vaccine|Other: 20% adoption rate|Other: 40% adoption rate|Other: 60% adoption rate|Other: 80% adoption rate|Other: Conventional vaccine|Other: 0% adoption rate,https://ClinicalTrials.gov/show/NCT04693689
5555,Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Crossover Trial,Other: Gown personal protective equipment (PPE-G) suit|Other: Coverall personal protective equipment (PPE-C) suit,https://ClinicalTrials.gov/show/NCT04763304
5556,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes,Behavioral: Mindfulness Based Intervention,https://ClinicalTrials.gov/show/NCT04417153
5557,Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot,Diagnostic Test: CYP phenotyping,https://ClinicalTrials.gov/show/NCT03262051
5558,Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation,Other: Semi-structured interviews-Patients|Other: Semi-structured interviews-Health system,https://ClinicalTrials.gov/show/NCT04683744
5559,The Cognitive and spOrt Virtual EPIC Training Study for Cardiovascular Diseases,Behavioral: Physical exercise training|Behavioral: Cognitive training,https://ClinicalTrials.gov/show/NCT04661189
5560,Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients,Procedure: Fiberoptic Bronchoscopy (FOB)|Procedure: Bronchoalveolar Lavage (BAL)|Diagnostic Test: Electrical Impedance Tomography (EIT)|Diagnostic Test: Arterial Blood Gas test (ABG),https://ClinicalTrials.gov/show/NCT04502368
5561,Virtual Simulation for Woven EndoBridge Device Sizing,Device: WEB embolization,https://ClinicalTrials.gov/show/NCT04621552
5562,Eating Habits of Adults During the Quarantine,Other: Assessment of Dietary Changes in Adults in the Quarantine,https://ClinicalTrials.gov/show/NCT04339842
5563,"The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions",Drug: ATAFENOVIR 200 MG KAPSUL|Drug: ARBIDOL 100 MG KAPSUL,https://ClinicalTrials.gov/show/NCT04476719
5564,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions",Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug: Reference: Favipiravir 200 mg (Avigan),https://ClinicalTrials.gov/show/NCT04407000
5565,Feasibility of Remote Home Support Coaches (SOCIAL Study),Behavioral: Telephone-based coaching,https://ClinicalTrials.gov/show/NCT04772820
5566,Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome),Device: NOA-001,https://ClinicalTrials.gov/show/NCT04804943
5567,Treadmill Stress Test With and Without Mask,Diagnostic Test: Treadmill test (Bruce protocol),https://ClinicalTrials.gov/show/NCT04891120
5568,Pandemic-adapted Caries Care Multicentre Case Series,Procedure: Modified CariesCare International management,https://ClinicalTrials.gov/show/NCT04666597
5569,The TELEAP1 CPAP-telemonitoring Study,Other: SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm.,https://ClinicalTrials.gov/show/NCT04897646
5570,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,Biological: PrimePro™/ PrimeMSK™,https://ClinicalTrials.gov/show/NCT04684602
5571,The VISION-Acute Study,Device: Lifelight® Data Collect Blood Pressure Group|Device: Lifelight® Data Collect Oxygen Saturation Group,https://ClinicalTrials.gov/show/NCT04589923
5572,Azithromycin-Prevention in Labor Use Study (A-PLUS),Drug: Azithromycin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT03871491
5573,Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults,Drug: Pitavastatin|Drug: Placebo,https://ClinicalTrials.gov/show/NCT02344290
5574,"Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions",Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Tablet|Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Coated Tablet,https://ClinicalTrials.gov/show/NCT04386876
5575,Mindfulness-SOS: Stress Reduction for Refugees,Behavioral: Mindfulness-SOS for Refugees,https://ClinicalTrials.gov/show/NCT04761510
5576,Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021,Other: questionnaire,https://ClinicalTrials.gov/show/NCT04939350
5577,"Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults",Biological: cAd3-Marburg|Biological: cAd3-EBO-S,https://ClinicalTrials.gov/show/NCT04723602